Term,NES,FDR q-val,Perturbation
G2_M_DNA_DAMAGE_CHECKPOINT,-2.045146161,0.194702608,neratinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.813838045,0.41454165,neratinib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-1.946000123,0.246042102,neratinib
G2_M_CHECKPOINTS,-1.940395836,0.175006325,neratinib
EUKARYOTIC_TRANSLATION_ELONGATION,1.730453864,0.317771675,neratinib
CELLULAR_RESPONSE_TO_STARVATION,1.704856349,0.244104442,neratinib
EUKARYOTIC_TRANSLATION_INITIATION,1.696814318,0.190924546,neratinib
METABOLISM_OF_LIPIDS,1.672109836,0.174709036,neratinib
CHROMOSOME_MAINTENANCE,-1.896339138,0.202694133,neratinib
PHOSPHOLIPID_METABOLISM,1.643904147,0.169347457,neratinib
CELL_CYCLE,-4.214802206,0,AZD-9291
METABOLISM_OF_STEROIDS,2.609027132,0,AZD-9291
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.68640945,0,AZD-9291
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,-2.686521191,0,AZD-9291
AURKA_ACTIVATION_BY_TPX2,-2.690449863,0,AZD-9291
DNA_REPAIR,-2.714856592,0,AZD-9291
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.746530954,0,AZD-9291
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.779144627,0,AZD-9291
SYNTHESIS_OF_DNA,-2.912551497,0,AZD-9291
DNA_REPLICATION_PRE_INITIATION,-2.997591639,0,AZD-9291
SENSORY_PERCEPTION,1.994121672,0.291076011,BRD-K68202742
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.589925197,1,BRD-K68202742
TRNA_PROCESSING,-1.577236119,1,BRD-K68202742
METABOLISM_OF_NUCLEOTIDES,-1.378466294,1,BRD-K68202742
NEURONAL_SYSTEM,1.562440611,1,BRD-K68202742
PROTEIN_LOCALIZATION,1.553513255,1,BRD-K68202742
INFLUENZA_INFECTION,-1.222292527,1,BRD-K68202742
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-1.193429247,1,BRD-K68202742
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.512999194,1,BRD-K68202742
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.493249473,1,BRD-K68202742
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.625646771,0.00221372,chloroquine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.090606746,0.160494671,chloroquine
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.903309096,0.336485379,chloroquine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.84537132,0.344786827,chloroquine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.893102615,0.430774659,chloroquine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.834408556,0.291325499,chloroquine
ECM_PROTEOGLYCANS,-1.723559034,0.457871003,chloroquine
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.743729835,0.811874401,chloroquine
SEPARATION_OF_SISTER_CHROMATIDS,-1.570841974,0.734006169,chloroquine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.48754327,0.866671222,chloroquine
METABOLISM_OF_LIPIDS,2.528188307,0,vorinostat
SUMOYLATION,-2.410049564,0.012454005,vorinostat
CELL_CYCLE_CHECKPOINTS,-2.357203148,0.008491367,vorinostat
METABOLISM_OF_RNA,-2.345968148,0.0064157,vorinostat
DNA_REPAIR,-2.33208201,0.005660911,vorinostat
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.310342512,0.005660911,vorinostat
DNA_REPLICATION,-2.253508364,0.007925276,vorinostat
RRNA_PROCESSING,-2.143962026,0.013909668,vorinostat
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.120784657,0.014293801,vorinostat
SYNTHESIS_OF_DNA,-2.118698775,0.012705601,vorinostat
TRANSLATION,3.510891048,0,rosiglitazone
G2_M_CHECKPOINTS,3.493119754,0,rosiglitazone
CELL_CYCLE_CHECKPOINTS,3.478340087,0,rosiglitazone
UB_SPECIFIC_PROCESSING_PROTEASES,3.260604886,0,rosiglitazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.894837306,0,rosiglitazone
S_PHASE,2.838455498,0,rosiglitazone
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.79424287,0,rosiglitazone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.594026613,0,rosiglitazone
METABOLISM_OF_RNA,2.55270723,0,rosiglitazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.314289649,0,rosiglitazone
RESPIRATORY_ELECTRON_TRANSPORT,2.929624404,0,BRD-K76188144
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.597683058,0.003478749,BRD-K76188144
TRANSLATION,2.296643584,0.013141941,BRD-K76188144
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.238751481,0.017393746,BRD-K76188144
RRNA_PROCESSING,2.199882645,0.017161829,BRD-K76188144
INTERLEUKIN_1_FAMILY_SIGNALING,2.110854035,0.025897355,BRD-K76188144
INTERLEUKIN_1_SIGNALING,2.035588969,0.030811778,BRD-K76188144
CELL_CYCLE_CHECKPOINTS,2.022413919,0.029279472,BRD-K76188144
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1.959507172,0.04277573,BRD-K76188144
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.95086315,0.040817323,BRD-K76188144
MITOTIC_METAPHASE_AND_ANAPHASE,-2.27351602,0.029501394,carbamazepine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.258518953,0.021774838,carbamazepine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.21122963,0.020604148,carbamazepine
SEPARATION_OF_SISTER_CHROMATIDS,-2.148880585,0.034067086,carbamazepine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.985573838,0.130224373,carbamazepine
RAC2_GTPASE_CYCLE,-1.999156793,0.094123495,carbamazepine
M_PHASE,-1.998369659,0.078670384,carbamazepine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.987516885,0.074656589,carbamazepine
CELLULAR_RESPONSE_TO_HEAT_STRESS,-1.96833712,0.076211935,carbamazepine
ISG15_ANTIVIRAL_MECHANISM,-1.967585035,0.068680494,carbamazepine
CELL_CYCLE,-4.445030543,0,mitoxantrone
DNA_REPLICATION_PRE_INITIATION,-3.001828846,0,mitoxantrone
CHROMOSOME_MAINTENANCE,-2.977421424,0,mitoxantrone
DISEASES_OF_DNA_REPAIR,-2.950049184,0,mitoxantrone
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.938748872,0,mitoxantrone
MITOTIC_G2_G2_M_PHASES,-2.937412911,0,mitoxantrone
DNA_STRAND_ELONGATION,-2.921544866,0,mitoxantrone
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.903810884,0,mitoxantrone
G2_M_DNA_DAMAGE_CHECKPOINT,-3.034624044,0,mitoxantrone
PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,-2.897231112,0,mitoxantrone
SELENOAMINO_ACID_METABOLISM,-2.627542182,0,aspirin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.493630041,0.004970737,aspirin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.467357802,0.003313825,aspirin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.387555541,0.006213421,aspirin
INFLUENZA_INFECTION,-2.300924996,0.006959032,aspirin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.174140892,0.013669526,aspirin
EUKARYOTIC_TRANSLATION_INITIATION,-2.100677532,0.019882947,aspirin
CELLULAR_RESPONSE_TO_STARVATION,-2.075233847,0.017397579,aspirin
RRNA_PROCESSING,-2.07991534,0.019261605,aspirin
NONSENSE_MEDIATED_DECAY_NMD,-2.038700598,0.020131484,aspirin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.529434445,0,sorafenib
GPCR_LIGAND_BINDING,-2.476129904,0,sorafenib
G_ALPHA_I_SIGNALLING_EVENTS,-2.136944769,0.001552963,sorafenib
SIGNALING_BY_GPCR,-2.107809326,0.002329445,sorafenib
EUKARYOTIC_TRANSLATION_INITIATION,2.22298715,0.074784881,sorafenib
CELLULAR_RESPONSE_TO_STARVATION,2.209637579,0.039262062,sorafenib
RRNA_PROCESSING,2.134686874,0.036146026,sorafenib
MEMBRANE_TRAFFICKING,2.125075412,0.027109519,sorafenib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.075967952,0.027670406,sorafenib
NEURONAL_SYSTEM,-2.030714814,0.005856889,sorafenib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.846658854,0,gemcitabine
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.669798105,0.002189122,gemcitabine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.292032731,0.01386444,gemcitabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.291148114,0.01039833,gemcitabine
HCMV_EARLY_EVENTS,-2.237271681,0.011821259,gemcitabine
MITOTIC_SPINDLE_CHECKPOINT,-2.084248816,0.026999172,gemcitabine
PROTEIN_FOLDING,-2.027880097,0.033149563,gemcitabine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.985296452,0.039677838,gemcitabine
HCMV_INFECTION,-1.867890593,0.077348981,gemcitabine
METABOLISM_OF_RNA,-1.853831256,0.074430151,gemcitabine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.971403211,0.234520636,NU-1025
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.007962285,0.284706597,NU-1025
NEUTROPHIL_DEGRANULATION,-1.708085509,0.646234641,NU-1025
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.591050362,0.802147434,NU-1025
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.790788981,0.946532753,NU-1025
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.512300034,0.901927279,NU-1025
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.508138746,0.741606366,NU-1025
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.498440703,0.646017492,NU-1025
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,-1.460818512,0.671361852,NU-1025
SIGNALING_BY_NTRKS,-1.44267446,0.636137225,NU-1025
SYNTHESIS_OF_DNA,-2.932509291,0,veliparib
DNA_REPLICATION,-2.816306816,0,veliparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.654421354,0,veliparib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.743666055,0.001717759,veliparib
G1_S_DNA_DAMAGE_CHECKPOINTS,-2.469806328,0.002576638,veliparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.329983038,0.000358956,veliparib
GPCR_LIGAND_BINDING,2.359207831,0.000538434,veliparib
S_PHASE,-2.455620356,0.003091966,veliparib
DNA_REPLICATION_PRE_INITIATION,-2.455160053,0.002576638,veliparib
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,-2.427139291,0.00294473,veliparib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.888651172,0,PJ-34
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.732147508,0,PJ-34
METABOLISM_OF_RNA,2.693092693,0,PJ-34
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.684179905,0,PJ-34
M_PHASE,2.506929005,0,PJ-34
CELL_CYCLE,2.501408766,0,PJ-34
GPCR_LIGAND_BINDING,-2.5965392,0.000196017,PJ-34
CELL_CYCLE_MITOTIC,2.409949635,0.002757359,PJ-34
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.405345644,0.000514545,PJ-34
MRNA_SPLICING,2.348807641,0.00328257,PJ-34
GPCR_LIGAND_BINDING,-2.34552067,0,olaparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.335582958,0,olaparib
SIGNALING_BY_ALK_IN_CANCER,2.490498739,0.005399436,olaparib
MITOTIC_PROPHASE,2.367500605,0.005399436,olaparib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.311636163,0.007199247,olaparib
SARS_COV_2_HOST_INTERACTIONS,2.207454575,0.010798871,olaparib
SIGNALING_BY_GPCR,-2.10277517,0.001704135,olaparib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.076434791,0.001661532,olaparib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.172144705,0.015118419,olaparib
MEMBRANE_TRAFFICKING,2.110149425,0.021597742,olaparib
RESPIRATORY_ELECTRON_TRANSPORT,2.67628529,0,7-nitroindazole
EUKARYOTIC_TRANSLATION_INITIATION,2.621541546,0.000606559,7-nitroindazole
RRNA_PROCESSING,2.546145233,0.000404373,7-nitroindazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.52043116,0.000303279,7-nitroindazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.648154459,0.006298674,7-nitroindazole
TRANSLATION,2.435095086,0.001940989,7-nitroindazole
SELENOAMINO_ACID_METABOLISM,2.324871997,0.004650285,7-nitroindazole
DNA_REPLICATION,2.014622899,0.037433351,7-nitroindazole
METABOLISM_OF_RNA,1.976851152,0.03942633,7-nitroindazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.944511126,0.042459125,7-nitroindazole
METABOLISM_OF_RNA,4.042996934,0,LY-294002
MITOTIC_SPINDLE_CHECKPOINT,2.983367774,0,LY-294002
RESOLUTION_OF_SISTER_CHROMATID_COHESION,3.212640819,0,LY-294002
RHO_GTPASES_ACTIVATE_FORMINS,3.255272978,0,LY-294002
MRNA_SPLICING,3.433624337,0,LY-294002
CELL_CYCLE_CHECKPOINTS,3.434833154,0,LY-294002
MITOTIC_PROMETAPHASE,3.521120957,0,LY-294002
S_PHASE,3.143395648,0,LY-294002
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.700233545,0,LY-294002
MITOTIC_METAPHASE_AND_ANAPHASE,3.757514248,0,LY-294002
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.709071031,0.018483895,menadione
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.593570923,0.025205311,menadione
DEVELOPMENTAL_CELL_LINEAGES,-2.458771386,0.037527907,menadione
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.138520446,0.215505408,menadione
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.906945168,0.536032944,menadione
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.811443406,0.556477252,menadione
ECM_PROTEOGLYCANS,-1.721339554,0.561478306,menadione
SENSORY_PERCEPTION,1.793838679,1,menadione
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.658900907,0.557247414,menadione
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.547826312,0.621170883,menadione
GPCR_LIGAND_BINDING,2.37268212,0.009161295,estradiol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.314459025,0.009772048,estradiol
RHO_GTPASE_CYCLE,-2.137402216,0.163309508,estradiol
MYD88_INDEPENDENT_TLR4_CASCADE,-2.031392222,0.185834958,estradiol
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,-1.964253013,0.199444083,estradiol
INTERLEUKIN_17_SIGNALING,-1.949983621,0.165421269,estradiol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.915388434,0.168377734,estradiol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.90860973,0.128665301,estradiol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.912570851,0.1421919,estradiol
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.899513983,0.130124694,estradiol
EUKARYOTIC_TRANSLATION_ELONGATION,2.264211712,0.027596475,isoniazid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.243436286,0.017740591,isoniazid
G_ALPHA_Q_SIGNALLING_EVENTS,-2.147823857,0.104548185,isoniazid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.094870557,0.044022948,isoniazid
NONSENSE_MEDIATED_DECAY_NMD,2.069046735,0.03991633,isoniazid
MUSCLE_CONTRACTION,-2.044475922,0.105583315,isoniazid
SELENOAMINO_ACID_METABOLISM,2.047435853,0.039620653,isoniazid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.034889926,0.037780888,isoniazid
NEURONAL_SYSTEM,-1.943361632,0.129046274,isoniazid
EUKARYOTIC_TRANSLATION_INITIATION,1.983732758,0.053080975,isoniazid
DEVELOPMENTAL_CELL_LINEAGES,-2.592488279,0.011310143,methylene-blue
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.458858818,0.014394728,methylene-blue
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.45117836,0.010281948,methylene-blue
SIGNALING_BY_MET,-2.361856894,0.015165874,methylene-blue
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.247689676,0.028172539,methylene-blue
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.193429969,0.032902235,methylene-blue
MUSCLE_CONTRACTION,-2.152174331,0.035839934,methylene-blue
HEMOSTASIS,-2.147666715,0.031745516,methylene-blue
CELL_JUNCTION_ORGANIZATION,-2.113240543,0.036101063,methylene-blue
METABOLISM_OF_RNA,1.971599724,0.364645591,methylene-blue
DEVELOPMENTAL_CELL_LINEAGES,-2.637854394,0,mepacrine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.637466048,0,mepacrine
SIGNALING_BY_MET,-2.526218706,0.001376012,mepacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.421830878,0.004128036,mepacrine
COLLAGEN_FORMATION,-2.343758885,0.007980869,mepacrine
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.322205798,0.008256071,mepacrine
SELENOAMINO_ACID_METABOLISM,-2.321677786,0.007076632,mepacrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.318914191,0.006364055,mepacrine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.215518757,0.013913009,mepacrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.179776451,0.01623694,mepacrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.167078157,0.118848008,sildenafil
SENSORY_PERCEPTION,2.039218694,0.143519842,sildenafil
SARS_COV_1_INFECTION,-2.000633126,0.229442683,sildenafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.006898855,0.090386964,sildenafil
DEVELOPMENTAL_CELL_LINEAGES,-1.974636889,0.187625791,sildenafil
SELENOAMINO_ACID_METABOLISM,-1.972828664,0.14237001,sildenafil
G_ALPHA_I_SIGNALLING_EVENTS,1.879234794,0.164284415,sildenafil
GPCR_LIGAND_BINDING,1.874333573,0.127183009,sildenafil
SARS_COV_2_HOST_INTERACTIONS,-1.660879736,0.790339255,sildenafil
SARS_COV_1_HOST_INTERACTIONS,-1.66074906,0.659166268,sildenafil
DEVELOPMENTAL_CELL_LINEAGES,-2.621311237,0.001097032,perhexiline
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.47806392,0.00274258,perhexiline
SIGNALING_BY_MET,-2.402847207,0.004388128,perhexiline
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.366172033,0.00548516,perhexiline
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.320528734,0.008556849,perhexiline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.095254823,0.040224506,perhexiline
HEMOSTASIS,-2.01814473,0.059083008,perhexiline
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.934267861,0.09023088,perhexiline
PTEN_REGULATION,1.881391445,0.681342081,perhexiline
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.861597659,0.125061645,perhexiline
RESPIRATORY_ELECTRON_TRANSPORT,3.831504257,0,lenalidomide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.721478215,0,lenalidomide
TRANSLATION,3.4324928,0,lenalidomide
MITOCHONDRIAL_TRANSLATION,2.665562811,0.000386719,lenalidomide
EUKARYOTIC_TRANSLATION_INITIATION,2.462766129,0.004331249,lenalidomide
RRNA_PROCESSING,2.34343168,0.009281248,lenalidomide
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.274790704,0.010607141,lenalidomide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.924327441,0.087591778,lenalidomide
FATTY_ACID_METABOLISM,1.885610619,0.094531229,lenalidomide
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.835141793,0.107507789,lenalidomide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,3.045699708,0,BRD-K31342827
METABOLISM_OF_RNA,2.851899721,0,BRD-K31342827
MITOTIC_METAPHASE_AND_ANAPHASE,2.716982828,0,BRD-K31342827
M_PHASE,2.645765638,0,BRD-K31342827
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.601809127,0,BRD-K31342827
MRNA_SPLICING,2.521414606,0,BRD-K31342827
CELL_CYCLE_MITOTIC,2.44530636,0,BRD-K31342827
CELL_CYCLE_CHECKPOINTS,2.43324371,0,BRD-K31342827
TRANSLATION,2.432777095,0,BRD-K31342827
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.419911524,0,BRD-K31342827
CELL_CYCLE_MITOTIC,-2.890350672,0,TG-101348
CELL_CYCLE,-2.772554857,0,TG-101348
CELL_CYCLE_CHECKPOINTS,-2.530427249,0,TG-101348
S_PHASE,-2.383059357,0.001767602,TG-101348
MITOTIC_G2_G2_M_PHASES,-2.378006215,0.001649762,TG-101348
G2_M_CHECKPOINTS,-2.372628197,0.001374802,TG-101348
SYNTHESIS_OF_DNA,-2.372298233,0.001178402,TG-101348
CELLULAR_RESPONSE_TO_STARVATION,2.401459613,0.005341013,TG-101348
DNA_REPLICATION,-2.340096201,0.001178402,TG-101348
M_PHASE,-2.308093213,0.001702136,TG-101348
SARS_COV_1_INFECTION,-2.415258487,0.012071923,enalapril
GPCR_LIGAND_BINDING,2.176200146,0.013881063,enalapril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.135077219,0.012839983,enalapril
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.037578828,0.147277464,enalapril
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.009462559,0.027993476,enalapril
SIGNALING_BY_GPCR,1.947650485,0.036090763,enalapril
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.734129108,0.560137239,enalapril
ESR_MEDIATED_SIGNALING,-1.712361107,0.478651757,enalapril
G_ALPHA_S_SIGNALLING_EVENTS,1.822384814,0.098694355,enalapril
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.685964048,0.439900883,enalapril
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.96109853,0.258985192,DR-2313
DNA_REPLICATION,-1.589725738,1,DR-2313
CELL_JUNCTION_ORGANIZATION,-1.539237732,1,DR-2313
SENSORY_PERCEPTION,1.792057375,0.595462016,DR-2313
DNA_REPLICATION_PRE_INITIATION,-1.527605149,1,DR-2313
FATTY_ACID_METABOLISM,-1.511624957,1,DR-2313
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.496698538,1,DR-2313
SYNTHESIS_OF_DNA,-1.456140897,1,DR-2313
CELL_CELL_COMMUNICATION,-1.435360062,1,DR-2313
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.393814517,1,DR-2313
CELL_CYCLE,-4.226824056,0,doxorubicin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-2.963057083,0,doxorubicin
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.991658868,0,doxorubicin
RHO_GTPASES_ACTIVATE_FORMINS,-3.068157898,0,doxorubicin
G2_M_DNA_DAMAGE_CHECKPOINT,-3.098284338,0,doxorubicin
G2_M_CHECKPOINTS,-3.427503552,0,doxorubicin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-3.585756122,0,doxorubicin
MITOTIC_SPINDLE_CHECKPOINT,-3.535292242,0,doxorubicin
MITOTIC_PROMETAPHASE,-3.662858645,0,doxorubicin
MITOTIC_METAPHASE_AND_ANAPHASE,-3.668105023,0,doxorubicin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.296298048,0.005049594,valdecoxib
SELENOAMINO_ACID_METABOLISM,2.296494627,0.010099188,valdecoxib
HEMOSTASIS,-2.548387908,0.029242555,valdecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,2.254545294,0.005290051,valdecoxib
CELLULAR_RESPONSE_TO_STARVATION,2.229114536,0.00418395,valdecoxib
RRNA_PROCESSING,2.23608738,0.005229937,valdecoxib
RESPIRATORY_ELECTRON_TRANSPORT,2.203429563,0.003812959,valdecoxib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.210185197,0.004087767,valdecoxib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.193629573,0.003787196,valdecoxib
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.384740367,0.043863832,valdecoxib
RESPIRATORY_ELECTRON_TRANSPORT,3.375357345,0,promethazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.040887605,0,promethazine
TRANSLATION,2.57820291,0.001803974,promethazine
RRNA_PROCESSING,2.512596249,0.002367715,promethazine
METABOLISM_OF_NUCLEOTIDES,1.866522168,0.088214312,promethazine
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.724159705,0.163259616,promethazine
CELL_CYCLE_CHECKPOINTS,1.627833369,0.226334267,promethazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.236824452,1,promethazine
BIOLOGICAL_OXIDATIONS,1.556410794,0.285817077,promethazine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.513412395,0.31825102,promethazine
METABOLISM_OF_RNA,-2.3084268,0.010978064,AZD-7545
MITOTIC_G2_G2_M_PHASES,-2.29810071,0.00686129,AZD-7545
M_PHASE,-2.290865396,0.005031613,AZD-7545
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.242388452,0.006518226,AZD-7545
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.363133385,0.00717762,AZD-7545
CELL_CYCLE_MITOTIC,-2.174704466,0.012624774,AZD-7545
CELL_CYCLE,-2.16416648,0.011892903,AZD-7545
MRNA_SPLICING,-2.150862605,0.01313447,AZD-7545
SEPARATION_OF_SISTER_CHROMATIDS,-2.134640874,0.01372258,AZD-7545
MITOTIC_METAPHASE_AND_ANAPHASE,-2.130610344,0.012807742,AZD-7545
MITF_M_DEPENDENT_GENE_EXPRESSION,2.117928386,0.115419297,afatinib
CELLULAR_RESPONSE_TO_STARVATION,2.091068668,0.063480613,afatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.059729318,0.046409896,afatinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.78908052,0.225708847,afatinib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.895414006,0.142972421,afatinib
GPCR_LIGAND_BINDING,-1.893893286,0.096562525,afatinib
MRNA_SPLICING_MINOR_PATHWAY,1.657182164,0.379921852,afatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.61293413,0.377805831,afatinib
KEAP1_NFE2L2_PATHWAY,1.612646321,0.314838193,afatinib
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.517986323,0.421555241,afatinib
GPCR_LIGAND_BINDING,-2.433261619,0,trametinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.350110202,0,trametinib
MEMBRANE_TRAFFICKING,2.511709332,0.005491991,trametinib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.510860245,0.002745995,trametinib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.470770781,0.001830664,trametinib
VESICLE_MEDIATED_TRANSPORT,2.436423433,0.002059497,trametinib
METABOLISM_OF_STEROIDS,2.333006937,0.002196796,trametinib
SIGNALING_BY_GPCR,-2.148115746,0.002926775,trametinib
SARS_COV_INFECTIONS,2.081081212,0.014187643,trametinib
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,2.080575638,0.012553122,trametinib
GPCR_LIGAND_BINDING,-2.616890788,0,swainsonine
CELLULAR_RESPONSE_TO_STARVATION,2.677327276,0.000895576,swainsonine
RESPIRATORY_ELECTRON_TRANSPORT,2.546772208,0.000447788,swainsonine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.459417127,0.000895576,swainsonine
SIGNALING_BY_GPCR,-2.529956607,0.004215894,swainsonine
SELENOAMINO_ACID_METABOLISM,2.317611432,0.002015046,swainsonine
EUKARYOTIC_TRANSLATION_ELONGATION,2.285074282,0.002865843,swainsonine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.269044953,0.002985253,swainsonine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.256189509,0.003070546,swainsonine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.457921894,0.011593707,swainsonine
KEAP1_NFE2L2_PATHWAY,2.665204859,0,talazoparib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.566137459,0,talazoparib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.314326292,0,talazoparib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.153719707,0.012162324,talazoparib
NEDDYLATION,2.040997593,0.01680612,talazoparib
HIV_INFECTION,1.899480145,0.033169974,talazoparib
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.776919669,0.057494621,talazoparib
INTERLEUKIN_1_FAMILY_SIGNALING,1.733443599,0.06689278,talazoparib
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1.630622734,0.103686881,talazoparib
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.567388156,0.132237628,talazoparib
PHASE_II_CONJUGATION_OF_COMPOUNDS,2.311734952,0.017318483,paracetamol
BIOLOGICAL_OXIDATIONS,2.288517598,0.010308621,paracetamol
DEVELOPMENTAL_CELL_LINEAGES,-2.223696787,0.080918077,paracetamol
DISEASES_OF_METABOLISM,2.09610239,0.033812277,paracetamol
RESPIRATORY_ELECTRON_TRANSPORT,2.096058883,0.025359208,paracetamol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.038247976,0.035296718,paracetamol
ECM_PROTEOGLYCANS,-2.040639709,0.155972525,paracetamol
PROTEIN_LOCALIZATION,1.879596743,0.095251658,paracetamol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.870830449,0.086356791,paracetamol
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.904362771,0.290835986,paracetamol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.462146348,0.02579509,lestaurtinib
SARS_COV_2_HOST_INTERACTIONS,2.375787222,0.017196726,lestaurtinib
MRNA_SPLICING,2.19810398,0.031527332,lestaurtinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.191862384,0.02794468,lestaurtinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.122839617,0.027514762,lestaurtinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.038911645,0.035826513,lestaurtinib
SIGNALING_BY_ALK_IN_CANCER,2.006403099,0.03562179,lestaurtinib
VESICLE_MEDIATED_TRANSPORT,1.985531677,0.037617839,lestaurtinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.058691814,0.021541568,lestaurtinib
S_PHASE,1.96540895,0.037259574,lestaurtinib
G2_M_CHECKPOINTS,2.768145238,0,mevastatin
ISG15_ANTIVIRAL_MECHANISM,2.694880232,0,mevastatin
CELL_CYCLE_CHECKPOINTS,2.629537981,0,mevastatin
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.546112516,0,mevastatin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.528412769,0,mevastatin
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.330222265,0.001390526,mevastatin
MITOTIC_METAPHASE_AND_ANAPHASE,2.302473831,0.00119188,mevastatin
METABOLISM_OF_RNA,2.28130258,0.001042895,mevastatin
S_PHASE,2.254008923,0.002781053,mevastatin
MRNA_SPLICING,2.230389502,0.004171579,mevastatin
G2_M_CHECKPOINTS,-2.142945189,0.087194294,ampicillin
HOMOLOGY_DIRECTED_REPAIR,-2.055987912,0.078015947,ampicillin
MEIOSIS,-1.997794194,0.071387141,ampicillin
SELENOAMINO_ACID_METABOLISM,-1.828167604,0.171329139,ampicillin
RRNA_PROCESSING,-1.780106563,0.189379888,ampicillin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.754843639,0.181527302,ampicillin
SYNTHESIS_OF_DNA,-1.753108113,0.157124555,ampicillin
GPCR_LIGAND_BINDING,1.880211193,0.621981198,ampicillin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.712444386,0.174197373,ampicillin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.695939909,0.17115917,ampicillin
METABOLISM_OF_RNA,3.725585566,0,caffeine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.036933653,0,caffeine
STRIATED_MUSCLE_CONTRACTION,2.428955796,0.00144545,caffeine
NEURONAL_SYSTEM,-2.292978434,0.003748444,caffeine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.126226191,0.014093137,caffeine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.154266466,0.00599751,caffeine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.130518425,0.004748029,caffeine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.127578959,0.003561022,caffeine
POTASSIUM_CHANNELS,-2.107084161,0.00404832,caffeine
RHOG_GTPASE_CYCLE,1.94145022,0.045965309,caffeine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.202955422,0.005816049,erlotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.057762724,0.024718207,erlotinib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.786557188,0.612630532,erlotinib
MYD88_INDEPENDENT_TLR4_CASCADE,1.725642293,0.424664346,erlotinib
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.721826972,0.287750704,erlotinib
GPCR_LIGAND_BINDING,-1.936859132,0.053556116,erlotinib
TRNA_PROCESSING,1.655846833,0.319078402,erlotinib
METABOLISM_OF_NUCLEOTIDES,1.625623763,0.307243494,erlotinib
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.590338135,0.310182883,erlotinib
MITOCHONDRIAL_TRANSLATION,1.555453608,0.322227747,erlotinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.172957592,0.00875134,fasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.028973378,0.119991927,fasudil
GPCR_LIGAND_BINDING,-1.992078079,0.036596511,fasudil
INTERLEUKIN_1_FAMILY_SIGNALING,1.849078702,0.206882632,fasudil
CELL_CYCLE_CHECKPOINTS,1.826041621,0.159989235,fasudil
TRANSLATION,1.785719131,0.156196387,fasudil
MITOTIC_METAPHASE_AND_ANAPHASE,1.729409755,0.154748209,fasudil
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.877585182,0.079292441,fasudil
VISUAL_PHOTOTRANSDUCTION,-1.866833639,0.067027306,fasudil
SIGNALING_BY_GPCR,-1.824932751,0.082421708,fasudil
CELL_CYCLE_CHECKPOINTS,3.31314272,0,pentoxifylline
CELL_CYCLE,3.140714953,0,pentoxifylline
M_PHASE,3.034440367,0,pentoxifylline
MITOTIC_METAPHASE_AND_ANAPHASE,2.929417806,0,pentoxifylline
CELL_CYCLE_MITOTIC,2.894163474,0,pentoxifylline
G2_M_CHECKPOINTS,2.894031624,0,pentoxifylline
SEPARATION_OF_SISTER_CHROMATIDS,2.723464484,0,pentoxifylline
SIGNALING_BY_ROBO_RECEPTORS,2.707840485,0,pentoxifylline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.64783091,0.000490264,pentoxifylline
SYNTHESIS_OF_DNA,2.599836736,0.000441238,pentoxifylline
UB_SPECIFIC_PROCESSING_PROTEASES,2.426819779,0.012024176,curcumin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,2.367102841,0.013026191,curcumin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.327656002,0.014028206,curcumin
KEAP1_NFE2L2_PATHWAY,2.295196934,0.014028206,curcumin
NEURONAL_SYSTEM,-2.166372899,0.023338163,curcumin
REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,2.238703227,0.021643517,curcumin
ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,2.218968224,0.022044323,curcumin
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.179833255,0.025479802,curcumin
DOWNSTREAM_TCR_SIGNALING,2.176430864,0.022294827,curcumin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.135491252,0.026720392,curcumin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.883703715,0,BRD-K45330754
VIRAL_INFECTION_PATHWAYS,-2.532810076,0,BRD-K45330754
METABOLISM_OF_RNA,-2.573083729,0,BRD-K45330754
SARS_COV_2_INFECTION,-2.693099671,0,BRD-K45330754
NERVOUS_SYSTEM_DEVELOPMENT,-2.902372835,0,BRD-K45330754
SARS_COV_2_HOST_INTERACTIONS,-2.99075819,0,BRD-K45330754
TRANSLATION,-3.265786268,0,BRD-K45330754
SARS_COV_1_INFECTION,-3.398165252,0,BRD-K45330754
RRNA_PROCESSING,-3.442548042,0,BRD-K45330754
SARS_COV_1_HOST_INTERACTIONS,-3.530398993,0,BRD-K45330754
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,3.15745414,0,ruxolitinib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,2.979556384,0,ruxolitinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.811710066,0,ruxolitinib
INFLUENZA_INFECTION,2.75358946,0,ruxolitinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.742969607,0,ruxolitinib
CHROMATIN_ORGANIZATION,2.619651696,0,ruxolitinib
CELL_CYCLE,2.578049806,0,ruxolitinib
CELL_CYCLE_MITOTIC,2.492228951,0.000950003,ruxolitinib
GOLGI_TO_ER_RETROGRADE_TRANSPORT,2.516418083,0.001068753,ruxolitinib
KEAP1_NFE2L2_PATHWAY,2.436963842,0.001282504,ruxolitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.379731119,0.004295045,BRD-A04553218
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.324501427,0.037663755,BRD-A04553218
GPCR_LIGAND_BINDING,2.23787144,0.00894801,BRD-A04553218
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.21082562,0.006919794,BRD-A04553218
SIGNALING_BY_GPCR,2.105347504,0.014674736,BRD-A04553218
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-2.016559378,0.136008006,BRD-A04553218
CILIUM_ASSEMBLY,-1.674904447,0.694687045,BRD-A04553218
MYD88_INDEPENDENT_TLR4_CASCADE,-1.665466585,0.544555131,BRD-A04553218
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,-1.654721685,0.461590247,BRD-A04553218
G2_M_CHECKPOINTS,-1.639873146,0.414998787,BRD-A04553218
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.244898006,0.001563005,losartan
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.983276141,0.140535694,losartan
HIV_INFECTION,1.974494791,0.070267847,losartan
TRANSLATION,1.899633589,0.083753596,losartan
SIGNALING_BY_GPCR,-2.020397121,0.033995356,losartan
GPCR_LIGAND_BINDING,-1.906356862,0.071637724,losartan
G_ALPHA_S_SIGNALLING_EVENTS,-1.863458221,0.082253132,losartan
ESR_MEDIATED_SIGNALING,1.50788872,0.490810266,losartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.842389827,0.079713249,losartan
NEURONAL_SYSTEM,-1.828157707,0.074372982,losartan
DEVELOPMENTAL_CELL_LINEAGES,1.784702291,0.411376717,fluorouracil
SIGNALING_BY_MET,1.764147962,0.235180439,fluorouracil
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.740396463,0.173927656,fluorouracil
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.49850304,0.467714154,fluorouracil
REGULATION_OF_PTEN_GENE_TRANSCRIPTION,-1.749773962,1,fluorouracil
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.471570408,0.42529093,fluorouracil
FOXO_MEDIATED_TRANSCRIPTION,1.451863418,0.390707054,fluorouracil
RAB_REGULATION_OF_TRAFFICKING,-1.715585266,0.942585564,fluorouracil
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.411944434,0.406191296,fluorouracil
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.388179735,0.395496366,fluorouracil
MUSCLE_CONTRACTION,-3.284930321,0,BRD-K76674262
METABOLISM_OF_RNA,3.070494079,0,BRD-K76674262
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.993828851,0,BRD-K76674262
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.69172601,0,BRD-K76674262
STRIATED_MUSCLE_CONTRACTION,-2.691549303,0.000217279,BRD-K76674262
GLYCOSAMINOGLYCAN_METABOLISM,-2.637790496,0.00016296,BRD-K76674262
NEURONAL_SYSTEM,-2.620065837,0.000130368,BRD-K76674262
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.476864503,0.000434559,BRD-K76674262
MRNA_SPLICING,2.400071602,0.004702592,BRD-K76674262
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.330972359,0.001210556,BRD-K76674262
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.679599605,0.259942119,tosedostat
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,-1.848410584,1,tosedostat
TRNA_PROCESSING,1.530900316,0.29385751,tosedostat
ESR_MEDIATED_SIGNALING,-1.75237449,1,tosedostat
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.727235014,1,tosedostat
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.715444283,0.821927695,tosedostat
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.285766946,0.660401695,tosedostat
SIGNALING_BY_FGFR,-1.655282153,1,tosedostat
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.6503467,0.898775675,tosedostat
G_ALPHA_I_SIGNALLING_EVENTS,1.239972889,0.608314636,tosedostat
CELL_CYCLE_CHECKPOINTS,-3.061309915,0,iniparib
POTASSIUM_CHANNELS,2.397566613,0.001064916,iniparib
TRANSLATION,-2.353225998,0.014821524,iniparib
G2_M_CHECKPOINTS,-2.348031258,0.009881016,iniparib
DNA_REPLICATION,-2.329218466,0.009881016,iniparib
CELL_CYCLE,-2.301032579,0.011857219,iniparib
GPCR_LIGAND_BINDING,2.19738279,0.003194748,iniparib
SIGNALING_BY_NOTCH4,-2.272205051,0.010704434,iniparib
METABOLISM_OF_RNA,-2.234174199,0.01340995,iniparib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.203306639,0.014203961,iniparib
MUSCLE_CONTRACTION,-2.370590526,0.025512117,bisphenol-a
G2_M_CHECKPOINTS,-2.221095,0.038268175,bisphenol-a
GPCR_LIGAND_BINDING,2.160993214,0.044412064,bisphenol-a
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.133023393,0.028828884,bisphenol-a
CELLULAR_RESPONSE_TO_STARVATION,-1.988493525,0.108590035,bisphenol-a
TRANSLATION,-1.944309578,0.106464025,bisphenol-a
SELENOAMINO_ACID_METABOLISM,-1.939945573,0.086348702,bisphenol-a
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.938332408,0.07228433,bisphenol-a
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.885376474,0.085227291,bisphenol-a
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.875837149,0.07653635,bisphenol-a
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.363919892,0.003544259,kynurenic-acid
GPCR_LIGAND_BINDING,2.343480565,0.003101227,kynurenic-acid
MRNA_SPLICING,-2.216219305,0.049320424,kynurenic-acid
MITOTIC_PROMETAPHASE,-2.064588412,0.059184508,kynurenic-acid
SIGNALING_BY_NTRKS,-2.027594321,0.05307817,kynurenic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.973908661,0.05601391,kynurenic-acid
G2_M_CHECKPOINTS,-1.945036213,0.054957044,kynurenic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.00924597,0.066454855,kynurenic-acid
SIGNALING_BY_GPCR,1.993096562,0.056929659,kynurenic-acid
CELL_CYCLE_CHECKPOINTS,-1.872632976,0.075154931,kynurenic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.717283851,0.000865091,ASN-05257430
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.625825391,0.000432545,ASN-05257430
CILIUM_ASSEMBLY,-2.416815328,0.02611968,ASN-05257430
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.147252819,0.214703771,ASN-05257430
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.830508501,0.177343575,ASN-05257430
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-2.043997291,0.310998325,ASN-05257430
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-2.024802809,0.260152014,ASN-05257430
GPCR_LIGAND_BINDING,1.728281147,0.242657916,ASN-05257430
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.702137336,0.223193378,ASN-05257430
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,-1.923870641,0.388869798,ASN-05257430
MEMBRANE_TRAFFICKING,2.7989229,0,selumetinib
GPCR_LIGAND_BINDING,-2.331821863,0,selumetinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.282861278,0.000318107,selumetinib
VESICLE_MEDIATED_TRANSPORT,2.400133631,0.005187988,selumetinib
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,2.320611458,0.008646647,selumetinib
SIGNALING_BY_MET,2.313119239,0.007781982,selumetinib
RHO_GTPASE_CYCLE,2.214630926,0.01348877,selumetinib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.142016448,0.01642863,selumetinib
G_ALPHA_S_SIGNALLING_EVENTS,-2.069969382,0.005301777,selumetinib
EPH_EPHRIN_SIGNALING,2.090370411,0.020751953,selumetinib
INFLUENZA_INFECTION,-3.035420696,0,glutamine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.015434702,0,glutamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.9774865,0,glutamine
SELENOAMINO_ACID_METABOLISM,-2.976094644,0,glutamine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.958836132,0,glutamine
SARS_COV_1_HOST_INTERACTIONS,-2.764488386,0,glutamine
NEUTROPHIL_DEGRANULATION,-2.564786276,0.00040569,glutamine
EUKARYOTIC_TRANSLATION_INITIATION,-2.551714379,0.000354979,glutamine
TRANSLATION,-2.550418004,0.000315537,glutamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.496342926,0.000473306,glutamine
RESPIRATORY_ELECTRON_TRANSPORT,3.011834677,0,batimastat
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.412175858,0.005011377,batimastat
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.307270496,0.019262603,batimastat
TRANSLATION,2.151716171,0.031462252,batimastat
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.215938975,0.030485879,batimastat
C_TYPE_LECTIN_RECEPTORS_CLRS,1.932852317,0.099202408,batimastat
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.890986553,0.102091798,batimastat
CELL_CYCLE_CHECKPOINTS,1.855026202,0.109475796,batimastat
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.049171499,0.106074153,batimastat
BIOLOGICAL_OXIDATIONS,1.84525391,0.101541438,batimastat
RESPIRATORY_ELECTRON_TRANSPORT,3.345181969,0,AR-C133057XX
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.822537505,0.000705648,AR-C133057XX
TRANSLATION,2.367752349,0.008467775,AR-C133057XX
RRNA_PROCESSING,1.863819918,0.095615297,AR-C133057XX
COLLAGEN_FORMATION,-2.168225774,0.347681291,AR-C133057XX
DEVELOPMENTAL_LINEAGE_OF_PANCREATIC_DUCTAL_CELLS,-2.109608755,0.284383114,AR-C133057XX
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.099763388,0.207630252,AR-C133057XX
C_TYPE_LECTIN_RECEPTORS_CLRS,1.727486496,0.174436173,AR-C133057XX
GPCR_LIGAND_BINDING,-2.075879993,0.190123872,AR-C133057XX
SIGNALING_BY_MET,-2.047769836,0.188793693,AR-C133057XX
METABOLISM_OF_RNA,4.05034588,0,thioridazine
M_PHASE,3.061365607,0,thioridazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.999603066,0,thioridazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.383082396,0,thioridazine
MRNA_SPLICING,2.845684035,0.001776988,thioridazine
MITOTIC_METAPHASE_AND_ANAPHASE,2.620289052,0.00142159,thioridazine
CELL_CYCLE_CHECKPOINTS,2.608076544,0.001184659,thioridazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.259185566,0.000323726,thioridazine
GPCR_LIGAND_BINDING,-2.206833393,0.000215817,thioridazine
CELL_CYCLE,2.475003218,0.002030843,thioridazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.452170066,0,BRD-K97118047
NONSENSE_MEDIATED_DECAY_NMD,-2.272642497,0.001826855,BRD-K97118047
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.265660336,0.001217903,BRD-K97118047
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.264032268,0.000913427,BRD-K97118047
RRNA_PROCESSING,-2.256822581,0.000730742,BRD-K97118047
SELENOAMINO_ACID_METABOLISM,-2.245015975,0.001065665,BRD-K97118047
SIGNALING_BY_ROBO_RECEPTORS,-2.225750099,0.001304896,BRD-K97118047
EUKARYOTIC_TRANSLATION_INITIATION,-2.193875339,0.001484319,BRD-K97118047
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.186741267,0.001420887,BRD-K97118047
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.165843762,0.001735512,BRD-K97118047
EUKARYOTIC_TRANSLATION_INITIATION,5.657245495,0,flutamide
DNA_REPLICATION,3.148502757,0,flutamide
M_PHASE,3.138392819,0,flutamide
MRNA_SPLICING,2.990505761,0,flutamide
HOST_INTERACTIONS_OF_HIV_FACTORS,2.93799681,0,flutamide
DNA_REPLICATION_PRE_INITIATION,2.90846156,0,flutamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.90592058,0,flutamide
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.90132726,0,flutamide
CELL_CYCLE_MITOTIC,2.89199413,0,flutamide
ORC1_REMOVAL_FROM_CHROMATIN,2.862597991,0,flutamide
G_ALPHA_S_SIGNALLING_EVENTS,-2.375288518,0,trifluoperazine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.847196725,0.006211604,trifluoperazine
ISG15_ANTIVIRAL_MECHANISM,2.745697132,0.003105802,trifluoperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.362079862,0.000306562,trifluoperazine
GPCR_LIGAND_BINDING,-2.252833619,0.000408749,trifluoperazine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.272017735,0.022775882,trifluoperazine
VIRAL_MESSENGER_RNA_SYNTHESIS,2.21060821,0.026399317,trifluoperazine
SIGNALING_BY_GPCR,-2.115032362,0.002452496,trifluoperazine
HCMV_LATE_EVENTS,2.119697898,0.0298157,trifluoperazine
TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,2.115929264,0.024846416,trifluoperazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.477229108,0.017169501,zileuton
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.455714655,0.009245116,zileuton
HEMOSTASIS,-2.380375956,0.011006091,zileuton
NEUTROPHIL_DEGRANULATION,-2.34753387,0.012216761,zileuton
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.278497,0.022980717,zileuton
INNATE_IMMUNE_SYSTEM,-2.11860303,0.060533499,zileuton
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.041282812,0.087734266,zileuton
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.038460681,0.078088213,zileuton
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.96975975,0.105218227,zileuton
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.883541664,0.670322956,zileuton
GPCR_LIGAND_BINDING,-2.736320066,0,gefitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.585849191,0.000289505,gefitinib
MEMBRANE_TRAFFICKING,2.312697396,0.050122907,gefitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.224870903,0.006369106,gefitinib
VESICLE_MEDIATED_TRANSPORT,2.118350159,0.09838941,gefitinib
SARS_COV_2_HOST_INTERACTIONS,2.106935061,0.074256158,gefitinib
SIGNALING_BY_ALK_IN_CANCER,2.082468326,0.063581835,gefitinib
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.028293251,0.077968966,gefitinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.023958659,0.066211741,gefitinib
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.957690058,0.077732044,gefitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.094746457,0.079442951,lonidamine
PROTEIN_LOCALIZATION,2.029115483,0.168097605,lonidamine
EXTRACELLULAR_MATRIX_ORGANIZATION,2.02757101,0.084952553,lonidamine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.702531165,0.343425215,lonidamine
NONSENSE_MEDIATED_DECAY_NMD,-1.897696399,0.307270726,lonidamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.888224174,0.228284343,lonidamine
MUSCLE_CONTRACTION,1.646475085,0.344328965,lonidamine
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.63763629,0.288838681,lonidamine
SELENOAMINO_ACID_METABOLISM,-1.876827974,0.190160858,lonidamine
DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,-1.875901561,0.153407079,lonidamine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-3.013911029,0,tretinoin
SIGNALING_BY_MET,-2.273545145,0.028626302,tretinoin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.268912553,0.02011578,tretinoin
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.252485878,0.017794728,tretinoin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.230928617,0.017949465,tretinoin
DEVELOPMENTAL_CELL_LINEAGES,-2.202707857,0.019084201,tretinoin
SIGNALING_BY_NTRKS,-1.972176703,0.069631544,tretinoin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.961134771,0.065569704,tretinoin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.864376415,0.102642054,tretinoin
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.838192721,0.103518896,tretinoin
DNA_REPLICATION_PRE_INITIATION,-2.312972096,0.010542647,brequinar
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.195603095,0.017251605,brequinar
SIGNALING_BY_ALK_IN_CANCER,2.108124854,0.088624914,brequinar
FOXO_MEDIATED_TRANSCRIPTION,2.008069559,0.088034082,brequinar
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.897514714,0.114227668,brequinar
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.874135012,0.098669071,brequinar
DNA_REPLICATION,-1.950902677,0.144721797,brequinar
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.716195322,0.192611481,brequinar
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-1.871619591,0.216843089,brequinar
METABOLISM_OF_RNA,-1.858180438,0.194368082,brequinar
EUKARYOTIC_TRANSLATION_ELONGATION,-3.131985263,0,tamoxifen
SARS_COV_1_INFECTION,-2.460836555,0,tamoxifen
RRNA_PROCESSING,-2.58412548,0,tamoxifen
SIGNALING_BY_ROBO_RECEPTORS,-2.644314811,0,tamoxifen
TRANSLATION,-2.657404514,0,tamoxifen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.685525855,0,tamoxifen
SARS_COV_1_HOST_INTERACTIONS,-2.730799921,0,tamoxifen
INFLUENZA_INFECTION,-2.797637462,0,tamoxifen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.420489231,0,tamoxifen
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.909526136,0,tamoxifen
TRANSLATION,-2.661161217,0.00203232,phenylephrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.635989798,0.00101616,phenylephrine
INTEGRIN_CELL_SURFACE_INTERACTIONS,2.085245806,0.135182272,phenylephrine
RRNA_PROCESSING,-2.039762592,0.054195212,phenylephrine
GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,-1.963290865,0.069098895,phenylephrine
G2_M_CHECKPOINTS,-1.960965479,0.05568558,phenylephrine
SARS_COV_2_INFECTION,1.92223862,0.296208213,phenylephrine
CELL_CYCLE_CHECKPOINTS,-1.80309988,0.119737547,phenylephrine
G2_M_DNA_DAMAGE_CHECKPOINT,-1.703728182,0.180295857,phenylephrine
CELLULAR_RESPONSE_TO_STARVATION,-1.680968132,0.17846314,phenylephrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.642098018,0,saccharin
GPCR_LIGAND_BINDING,2.597607265,0,saccharin
SIGNALING_BY_GPCR,2.361033999,0.001749946,saccharin
SELENOAMINO_ACID_METABOLISM,-2.090996973,0.185851379,saccharin
NUCLEOTIDE_EXCISION_REPAIR,-2.089432494,0.093603979,saccharin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.101831254,0.027124158,saccharin
G_ALPHA_S_SIGNALLING_EVENTS,2.033838691,0.039898762,saccharin
G_ALPHA_Q_SIGNALLING_EVENTS,1.985072894,0.050456767,saccharin
MUSCLE_CONTRACTION,-1.893141639,0.185399186,saccharin
CILIUM_ASSEMBLY,-1.891008819,0.140066824,saccharin
NEUTROPHIL_DEGRANULATION,2.10628415,0.120003901,acetohexamide
INTERFERON_ALPHA_BETA_SIGNALING,1.985295599,0.173903958,acetohexamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.982571923,0.119664907,acetohexamide
MUSCLE_CONTRACTION,-1.933895246,0.35975534,acetohexamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.962307939,0.105003413,acetohexamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.907254707,0.133021273,acetohexamide
FOXO_MEDIATED_TRANSCRIPTION,1.854141781,0.168480053,acetohexamide
GPCR_LIGAND_BINDING,1.847638674,0.152692615,acetohexamide
LATE_SARS_COV_2_INFECTION_EVENTS,1.825925287,0.156361015,acetohexamide
INNATE_IMMUNE_SYSTEM,1.800719675,0.162265161,acetohexamide
RESPIRATORY_ELECTRON_TRANSPORT,2.539262687,0.003553575,sparfosic-acid
RRNA_PROCESSING,2.533274423,0.001776787,sparfosic-acid
TRANSLATION,2.288310948,0.011845249,sparfosic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.207378256,0.015991086,sparfosic-acid
CELL_CYCLE_CHECKPOINTS,2.199052879,0.013858941,sparfosic-acid
MITOTIC_G2_G2_M_PHASES,2.174399236,0.011845249,sparfosic-acid
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.067749082,0.019037007,sparfosic-acid
G2_M_CHECKPOINTS,2.030194708,0.020210956,sparfosic-acid
SYNTHESIS_OF_DNA,2.023092774,0.018952398,sparfosic-acid
DNA_REPLICATION,1.920502022,0.034114317,sparfosic-acid
G2_M_CHECKPOINTS,-2.166906664,0.07024228,emodin
GPCR_LIGAND_BINDING,2.046860507,0.162569104,emodin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.795545832,0.351958659,emodin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.937698031,0.215884779,emodin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.77553481,0.262536749,emodin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.888533742,0.222294313,emodin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.661246669,0.395673269,emodin
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.653142175,0.328494748,emodin
INTERFERON_GAMMA_SIGNALING,1.841450595,0.244509177,emodin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-1.62203123,0.330537254,emodin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.131063987,0.07285519,tryptophan
G2_M_CHECKPOINTS,-2.125273393,0.159383338,tryptophan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.105364558,0.048151418,tryptophan
GPCR_LIGAND_BINDING,2.090429713,0.038241996,tryptophan
INTERFERON_ALPHA_BETA_SIGNALING,1.994668244,0.075786146,tryptophan
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.937355881,0.097307736,tryptophan
HOMOLOGY_DIRECTED_REPAIR,-1.809624725,0.559976282,tryptophan
MUSCLE_CONTRACTION,-1.808296877,0.377112363,tryptophan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.696962114,0.52582271,tryptophan
SIGNALING_BY_GPCR,1.787975706,0.260575937,tryptophan
MRNA_SPLICING,-2.639661504,0,capsaicin
METABOLISM_OF_RNA,-2.333562814,0.015427357,capsaicin
NEUTROPHIL_DEGRANULATION,-2.321708154,0.012243934,capsaicin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.306455712,0.009917587,capsaicin
SEPARATION_OF_SISTER_CHROMATIDS,-2.251707993,0.014105012,capsaicin
INNATE_IMMUNE_SYSTEM,-2.232143192,0.012733691,capsaicin
RHO_GTPASE_EFFECTORS,-2.154621782,0.019100537,capsaicin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.135877828,0.018916878,capsaicin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.119101318,0.020406557,capsaicin
SARS_COV_INFECTIONS,-2.117702102,0.018806683,capsaicin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.047404406,0.152385208,doxylamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.047804217,0.093674121,doxylamine
GPCR_LIGAND_BINDING,2.044459674,0.049592182,doxylamine
HIV_INFECTION,-1.91608372,0.157002942,doxylamine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.850619033,0.186248588,doxylamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.95748526,0.074519469,doxylamine
MRNA_SPLICING,-1.781201642,0.199139761,doxylamine
METABOLISM_OF_RNA,-1.776595622,0.165314862,doxylamine
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.775803637,0.138147196,doxylamine
RRNA_PROCESSING,-1.744059922,0.145458608,doxylamine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.962239516,0,BRD-K59058747
INFLUENZA_INFECTION,-2.928138043,0,BRD-K59058747
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.790791684,0,BRD-K59058747
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.768327659,0,BRD-K59058747
NEUTROPHIL_DEGRANULATION,-2.721603478,0,BRD-K59058747
SELENOAMINO_ACID_METABOLISM,-2.541401788,0.001350469,BRD-K59058747
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.472712013,0.001157545,BRD-K59058747
EUKARYOTIC_TRANSLATION_INITIATION,-2.443851164,0.001350469,BRD-K59058747
GPCR_LIGAND_BINDING,2.256649292,0.01568969,BRD-K59058747
SARS_COV_1_INFECTION,-2.247881928,0.007202503,BRD-K59058747
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.843935513,0,alvocidib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.501608174,0.005762596,alvocidib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.433724629,0.003841731,alvocidib
DEVELOPMENTAL_CELL_LINEAGES,2.301698116,0.012245517,alvocidib
NEUTROPHIL_DEGRANULATION,2.293099826,0.010948933,alvocidib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2.128038141,0.023050385,alvocidib
CHROMATIN_ORGANIZATION,-2.033060477,0.044934041,alvocidib
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.036199217,0.029636209,alvocidib
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,2.016290916,0.028452819,alvocidib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.962796659,0.047180743,alvocidib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.273174419,0.009018743,PX-12
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.13343271,0.103311453,PX-12
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,1.756788689,0.526525914,PX-12
GABA_RECEPTOR_ACTIVATION,-1.891306036,0.295568816,PX-12
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.690131495,0.499640769,PX-12
ADIPOGENESIS,1.639934435,0.488010679,PX-12
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.612289933,0.449495444,PX-12
POTASSIUM_CHANNELS,-1.791510533,0.439458767,PX-12
RRNA_PROCESSING,1.56559599,0.477286829,PX-12
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.509675177,0.545556971,PX-12
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.53087205,0.000936093,chlorpropamide
GPCR_LIGAND_BINDING,2.373276142,0.001404139,chlorpropamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.354496724,0.000936093,chlorpropamide
DNA_REPLICATION,-2.015468052,0.181210617,chlorpropamide
CELL_CYCLE_CHECKPOINTS,-1.945871084,0.123496276,chlorpropamide
TRANSLATION,-1.923538073,0.095569983,chlorpropamide
SIGNALING_BY_GPCR,1.99933991,0.062250164,chlorpropamide
EUKARYOTIC_TRANSLATION_INITIATION,-1.895927178,0.085950926,chlorpropamide
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.723880748,0.175253007,chlorpropamide
HOMOLOGY_DIRECTED_REPAIR,-1.695655989,0.169833238,chlorpropamide
GPCR_LIGAND_BINDING,2.509685273,0.000961262,prednisone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.443655918,0.001441893,prednisone
SIGNALING_BY_GPCR,2.23540066,0.010253459,prednisone
G2_M_CHECKPOINTS,-2.058493117,0.167776298,prednisone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.027667794,0.049504983,prednisone
G_ALPHA_I_SIGNALLING_EVENTS,1.952128196,0.075362925,prednisone
G_ALPHA_Q_SIGNALLING_EVENTS,1.926948526,0.077701996,prednisone
INTERFERON_SIGNALING,1.846839929,0.133478068,prednisone
INTERFERON_GAMMA_SIGNALING,1.837321826,0.124723719,prednisone
SENSORY_PERCEPTION,1.759418533,0.200583296,prednisone
GAP_JUNCTION_TRAFFICKING_AND_REGULATION,2.038238958,0.130826803,serotonin
GPCR_LIGAND_BINDING,2.001414466,0.103647995,serotonin
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.793188696,0.609427753,serotonin
SIGNALING_BY_GPCR,1.900098432,0.18825547,serotonin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.741741262,0.422624898,serotonin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.867610348,0.186796721,serotonin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.674499805,0.423508127,serotonin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-1.655293929,0.354064276,serotonin
AURKA_ACTIVATION_BY_TPX2,-1.646187919,0.298619599,serotonin
SENSORY_PERCEPTION,1.819214907,0.230328879,serotonin
METABOLISM_OF_RNA,2.833160556,0,gossypol
MRNA_SPLICING,2.257281098,0.006053269,gossypol
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.230303031,0.006725854,gossypol
TRANSLATION,2.187872809,0.005044391,gossypol
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.097858376,0.00968523,gossypol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.95727308,0.021522733,gossypol
SYNTHESIS_OF_DNA,1.839559445,0.040355125,gossypol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.952851906,0.088374061,gossypol
SENSORY_PERCEPTION,-1.91902759,0.065446828,gossypol
INTERLEUKIN_1_FAMILY_SIGNALING,1.700376561,0.085754641,gossypol
G2_M_CHECKPOINTS,-2.735141974,0,phenacetin
DNA_REPLICATION,-2.530276489,0,phenacetin
SYNTHESIS_OF_DNA,-2.52011541,0,phenacetin
DNA_REPLICATION_PRE_INITIATION,-2.424626696,0.003405362,phenacetin
GPCR_LIGAND_BINDING,2.277969013,0.007019162,phenacetin
TRANSLATION,-2.321941964,0.009535013,phenacetin
HOMOLOGY_DIRECTED_REPAIR,-2.260011035,0.014189008,phenacetin
PROTEASOME_ASSEMBLY,-2.177592033,0.021891612,phenacetin
SIGNALING_BY_GPCR,2.150929025,0.016271693,phenacetin
SELENOAMINO_ACID_METABOLISM,-2.073487497,0.029371246,phenacetin
MITOTIC_G2_G2_M_PHASES,-2.373829339,0.018645021,dacarbazine
M_PHASE,-2.359595081,0.010039627,dacarbazine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.324924231,0.008605394,dacarbazine
METABOLISM_OF_RNA,-2.230394265,0.015776556,dacarbazine
SEPARATION_OF_SISTER_CHROMATIDS,-2.166276986,0.024668797,dacarbazine
CELL_CYCLE_MITOTIC,-2.154875452,0.022469641,dacarbazine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.135720395,0.054803325,dacarbazine
SIGNALING_BY_HEDGEHOG,-2.128982859,0.024791732,dacarbazine
CELL_CYCLE_CHECKPOINTS,-2.125457181,0.022409881,dacarbazine
CELL_CYCLE,-2.089175818,0.027091057,dacarbazine
G2_M_CHECKPOINTS,-3.077424231,0,procarbazine
METABOLISM_OF_RNA,-2.940742558,0,procarbazine
MITOTIC_G2_G2_M_PHASES,-2.131260042,0.023365516,procarbazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.113512798,0.026800389,procarbazine
GPCR_LIGAND_BINDING,2.03252252,0.038229967,procarbazine
CELL_CYCLE_CHECKPOINTS,-1.853538638,0.118287925,procarbazine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.763477382,0.14580082,procarbazine
PHASE_II_CONJUGATION_OF_COMPOUNDS,-1.750479863,0.128510338,procarbazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.90616504,0.095377855,procarbazine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.64659016,0.192264818,procarbazine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,2.02210045,0.111242819,troglitazone
GPCR_LIGAND_BINDING,-1.89390612,0.30659645,troglitazone
SENSORY_PERCEPTION,-1.87859448,0.182519295,troglitazone
CELLULAR_RESPONSE_TO_STARVATION,1.702017602,0.330081153,troglitazone
UNFOLDED_PROTEIN_RESPONSE_UPR,1.691124252,0.235251208,troglitazone
INTERFERON_ALPHA_BETA_SIGNALING,1.618942818,0.261694173,troglitazone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.610038944,0.219203064,troglitazone
REGULATED_NECROSIS,1.602153115,0.189355947,troglitazone
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.822080485,0.213988138,troglitazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.787498462,0.228598673,troglitazone
CELL_CYCLE,-6.100298315,0,BRD-K59333713
HOST_INTERACTIONS_OF_HIV_FACTORS,-3.32305981,0,BRD-K59333713
DNA_REPLICATION_PRE_INITIATION,-3.308065806,0,BRD-K59333713
HIV_INFECTION,-3.286204544,0,BRD-K59333713
NUCLEOTIDE_EXCISION_REPAIR,-3.244363924,0,BRD-K59333713
TRANSLATION,-3.185479804,0,BRD-K59333713
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,-3.171939723,0,BRD-K59333713
MITOTIC_G2_G2_M_PHASES,-3.150930006,0,BRD-K59333713
RRNA_PROCESSING,-3.070532056,0,BRD-K59333713
SNRNP_ASSEMBLY,-3.06243439,0,BRD-K59333713
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-3.03581354,0,alisertib
HOMOLOGY_DIRECTED_REPAIR,-2.96398314,0,alisertib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.837027182,0,alisertib
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-2.769933309,0,alisertib
DISEASES_OF_DNA_REPAIR,-2.684860596,0,alisertib
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.650792784,0,alisertib
DNA_STRAND_ELONGATION,-2.578719925,0,alisertib
HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,-2.484164678,0,alisertib
DNA_DAMAGE_BYPASS,-2.460485027,0,alisertib
DNA_REPAIR,-2.425152702,0,alisertib
EUKARYOTIC_TRANSLATION_INITIATION,-2.686198928,0,fluspirilene
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.561964999,0,fluspirilene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.556217924,0,fluspirilene
NONSENSE_MEDIATED_DECAY_NMD,-2.554850097,0,fluspirilene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.532713337,0,fluspirilene
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.458243095,0,fluspirilene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.363762549,0.000331424,fluspirilene
CELLULAR_RESPONSE_TO_STARVATION,-2.331447136,0.000289996,fluspirilene
RRNA_PROCESSING,-2.32155953,0.000515548,fluspirilene
SELENOAMINO_ACID_METABOLISM,-2.31610969,0.000463994,fluspirilene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.474062284,0.001399526,etoposide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.472986221,0.000699763,etoposide
SELENOAMINO_ACID_METABOLISM,2.439415635,0.000933017,etoposide
CELLULAR_RESPONSE_TO_STARVATION,2.245724155,0.004198577,etoposide
EUKARYOTIC_TRANSLATION_ELONGATION,2.093704265,0.01035649,etoposide
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-2.10462621,0.056001636,etoposide
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.841238872,0.039653229,etoposide
NONSENSE_MEDIATED_DECAY_NMD,1.813029982,0.040786178,etoposide
CELL_CYCLE,-1.92425102,0.180074226,etoposide
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,-1.89595974,0.166073817,etoposide
EUKARYOTIC_TRANSLATION_ELONGATION,3.482016017,0,tanespimycin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.477910881,0,tanespimycin
EUKARYOTIC_TRANSLATION_INITIATION,3.347971594,0,tanespimycin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.232907959,0,tanespimycin
SELENOAMINO_ACID_METABOLISM,3.120220144,0,tanespimycin
TRANSLATION,3.055693452,0,tanespimycin
NONSENSE_MEDIATED_DECAY_NMD,2.991327336,0,tanespimycin
CELLULAR_RESPONSE_TO_STARVATION,2.708908285,0,tanespimycin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.699608957,0,tanespimycin
INFLUENZA_INFECTION,2.574640315,0.00048516,tanespimycin
HOMOLOGY_DIRECTED_REPAIR,-2.348792979,0.005202384,dasatinib
MITOCHONDRIAL_TRANSLATION,-2.317758997,0.003715989,dasatinib
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.249956649,0.004459187,dasatinib
RRNA_PROCESSING,-2.210485285,0.00668878,dasatinib
RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,2.108286166,0.12982986,dasatinib
HATS_ACETYLATE_HISTONES,2.087072216,0.076455362,dasatinib
GPCR_LIGAND_BINDING,-2.073540709,0.021998654,dasatinib
DNA_REPLICATION,-2.063421269,0.020190206,dasatinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,2.037105173,0.074531956,dasatinib
SARS_COV_2_INFECTION,2.002433018,0.0721277,dasatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.091703837,0.039804042,pazopanib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.858921003,0.14084507,pazopanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.914601016,0.176077203,pazopanib
GPCR_LIGAND_BINDING,-1.893056084,0.108355202,pazopanib
HIV_LIFE_CYCLE,1.632041827,0.307205552,pazopanib
SARS_COV_2_HOST_INTERACTIONS,1.604050307,0.273270055,pazopanib
INFLUENZA_INFECTION,1.555835789,0.268830374,pazopanib
SARS_COV_2_INFECTION,1.524159557,0.263829353,pazopanib
MITOCHONDRIAL_PROTEIN_IMPORT,1.518243152,0.2357624,pazopanib
SENSORY_PERCEPTION,-1.793416551,0.195265103,pazopanib
EUKARYOTIC_TRANSLATION_INITIATION,3.756828058,0,tropisetron
GPCR_LIGAND_BINDING,-2.714744475,0,tropisetron
NERVOUS_SYSTEM_DEVELOPMENT,2.716727296,0,tropisetron
METABOLISM_OF_RNA,2.812548085,0,tropisetron
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.862515929,0,tropisetron
SARS_COV_1_INFECTION,2.986296755,0,tropisetron
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.018847553,0,tropisetron
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.129486699,0,tropisetron
SARS_COV_1_HOST_INTERACTIONS,3.23029056,0,tropisetron
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.262751552,0,tropisetron
HIV_TRANSCRIPTION_INITIATION,1.662138422,1,regorafenib
SARS_COV_1_INFECTION,1.651488589,1,regorafenib
VESICLE_MEDIATED_TRANSPORT,1.622911602,0.821457291,regorafenib
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.596928699,0.722359518,regorafenib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.594742378,0.581429832,regorafenib
MEMBRANE_TRAFFICKING,1.559279087,0.57814063,regorafenib
SIGNALING_BY_ROBO_RECEPTORS,1.510214736,0.626394318,regorafenib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.488187157,0.608502501,regorafenib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.481365028,0.562538001,regorafenib
EUKARYOTIC_TRANSLATION_INITIATION,1.470549579,0.535887026,regorafenib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.716988669,0,homatropine
RESPIRATORY_ELECTRON_TRANSPORT,2.646890072,0,homatropine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.394891357,0.012313905,homatropine
BIOLOGICAL_OXIDATIONS,2.226312917,0.014818853,homatropine
DRUG_ADME,2.049750585,0.039896912,homatropine
TRANSLATION,1.939419674,0.072270407,homatropine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.029291302,0.232543357,homatropine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.779187311,0.147618576,homatropine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.904920379,0.38709865,homatropine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.881144514,0.342894889,homatropine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.459124703,0.01869859,tocainide
NEUTROPHIL_DEGRANULATION,-2.447609147,0.010907511,tocainide
INNATE_IMMUNE_SYSTEM,-2.367459521,0.012465727,tocainide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.184000516,0.037007626,tocainide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.078020332,0.0570307,tocainide
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.077411461,0.047785286,tocainide
HEMOSTASIS,-1.981495852,0.077465588,tocainide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.890810013,0.486879946,tocainide
ESR_MEDIATED_SIGNALING,-1.837745355,0.157964131,tocainide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.790525194,0.182311254,tocainide
RESPIRATORY_ELECTRON_TRANSPORT,3.583495955,0,alimemazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.312733208,0,alimemazine
TRANSLATION,2.473936569,0.001186856,alimemazine
MITOCHONDRIAL_TRANSLATION,2.074576463,0.029671389,alimemazine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.966285996,0.051272161,alimemazine
EUKARYOTIC_TRANSLATION_INITIATION,1.942715518,0.047869842,alimemazine
TP53_REGULATES_METABOLIC_GENES,1.765963075,0.121737472,alimemazine
DISEASES_OF_METABOLISM,1.664407035,0.18900675,alimemazine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.62530386,0.207567853,alimemazine
SIGNALING_BY_ALK_IN_CANCER,-2.056376015,1,alimemazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.813218485,0,clonidine
GPCR_LIGAND_BINDING,2.742158284,0,clonidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.611857094,0,clonidine
SIGNALING_BY_GPCR,2.567268567,0,clonidine
G_ALPHA_I_SIGNALLING_EVENTS,2.538815162,0,clonidine
INNATE_IMMUNE_SYSTEM,-2.387977578,0.020560788,clonidine
NEUTROPHIL_DEGRANULATION,-2.351967689,0.013707192,clonidine
SARS_COV_INFECTIONS,-2.10682009,0.060159343,clonidine
SARS_COV_1_INFECTION,-2.063221473,0.059397832,clonidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.053675013,0.051173517,clonidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.798067564,0,eugenol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.445770435,0,eugenol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.448264522,0,eugenol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.55200388,0,eugenol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.568106436,0,eugenol
NEURONAL_SYSTEM,-2.681364629,0,eugenol
SIGNALING_BY_GPCR,-2.710832544,0,eugenol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.85227498,0,eugenol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.85974093,0,eugenol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.915026632,0,eugenol
RESPIRATORY_ELECTRON_TRANSPORT,3.642162526,0,oxprenolol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.41935181,0,oxprenolol
TRANSLATION,3.041868128,0,oxprenolol
RRNA_PROCESSING,2.697924086,0.000327267,oxprenolol
EUKARYOTIC_TRANSLATION_INITIATION,2.37249842,0.003141759,oxprenolol
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.217633218,0.00763622,oxprenolol
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.048142828,0.022067118,oxprenolol
DNA_REPLICATION,1.897373015,0.050235421,oxprenolol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.993647746,0.333655321,oxprenolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.749880807,0.105598018,oxprenolol
RESPIRATORY_ELECTRON_TRANSPORT,2.919415871,0.001189368,hydroxyfasudil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.574705218,0.001189368,hydroxyfasudil
DRUG_ADME,2.032197995,0.095149447,hydroxyfasudil
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.755552267,0.330941669,hydroxyfasudil
SIGNALING_BY_ALK_IN_CANCER,-1.909347511,1,hydroxyfasudil
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.735669104,0.293773917,hydroxyfasudil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.865689806,0.757861791,hydroxyfasudil
SIGNALING_BY_WNT,1.64609016,0.393680836,hydroxyfasudil
BIOLOGICAL_OXIDATIONS,1.630160605,0.363097085,hydroxyfasudil
INTERLEUKIN_1_FAMILY_SIGNALING,1.559743855,0.43991752,hydroxyfasudil
RESPIRATORY_ELECTRON_TRANSPORT,3.473917595,0,mephenytoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.470923347,0,mephenytoin
TRANSLATION,2.099996596,0.053742613,mephenytoin
MITOCHONDRIAL_TRANSLATION,2.078594218,0.044688151,mephenytoin
RRNA_PROCESSING,1.937706838,0.094984228,mephenytoin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.99459299,0.400369232,mephenytoin
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.955163284,0.286423993,mephenytoin
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.940141348,0.215923627,mephenytoin
METABOLISM_OF_NUCLEOTIDES,1.721292343,0.285361594,mephenytoin
PROTEIN_LOCALIZATION,1.699081161,0.282148721,mephenytoin
SYNTHESIS_OF_DNA,1.825833063,0.203247967,mepivacaine
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.93353883,0.546503197,mepivacaine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.714577959,0.187613508,mepivacaine
DNA_REPLICATION,1.613576677,0.218110354,mepivacaine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.543085238,0.23929408,mepivacaine
DNA_REPLICATION_PRE_INITIATION,1.538804544,0.195488643,mepivacaine
TELOMERE_MAINTENANCE,1.524988375,0.174102247,mepivacaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.763389655,1,mepivacaine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.491589887,0.176776925,mepivacaine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.68215341,1,mepivacaine
METABOLISM_OF_RNA,-3.177123166,0,sirolimus
SIGNALING_BY_GPCR,2.592400222,0,sirolimus
CARDIAC_CONDUCTION,2.689833742,0,sirolimus
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.735600679,0,sirolimus
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.596756181,0,sirolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.907541745,0,sirolimus
GPCR_LIGAND_BINDING,3.098277632,0,sirolimus
MUSCLE_CONTRACTION,2.749870549,0,sirolimus
MRNA_SPLICING,-2.62638484,0.002384531,sirolimus
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.61994751,0.001589687,sirolimus
METABOLISM_OF_RNA,-3.724898222,0,bexarotene
CELL_CYCLE,-3.299932949,0,bexarotene
M_PHASE,-3.242627696,0,bexarotene
CELL_CYCLE_MITOTIC,-3.157753484,0,bexarotene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.114663857,0,bexarotene
MITOTIC_METAPHASE_AND_ANAPHASE,-2.965000724,0,bexarotene
CELL_CYCLE_CHECKPOINTS,-2.874769756,0,bexarotene
MRNA_SPLICING,-2.826629471,0,bexarotene
SEPARATION_OF_SISTER_CHROMATIDS,-2.764949682,0,bexarotene
CHROMATIN_ORGANIZATION,-2.709851835,0,bexarotene
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.695381773,0.630187823,geldanamycin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.671889858,0.347679525,geldanamycin
RSV_HOST_INTERACTIONS,1.6684815,0.235971658,geldanamycin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.663120817,0.181463002,geldanamycin
CELLULAR_RESPONSE_TO_HEAT_STRESS,1.551870459,0.253390512,geldanamycin
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.502804525,0.268856222,geldanamycin
MUSCLE_CONTRACTION,1.499533987,0.233608525,geldanamycin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.626587481,1,geldanamycin
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.604623259,1,geldanamycin
MITOTIC_METAPHASE_AND_ANAPHASE,-1.599828787,1,geldanamycin
UNFOLDED_PROTEIN_RESPONSE_UPR,2.681495256,0,bortezomib
CELL_CYCLE_MITOTIC,-2.177112488,0.022871056,bortezomib
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,2.151060006,0.03043548,bortezomib
CELL_CYCLE,-2.123198809,0.02202398,bortezomib
ONCOGENIC_MAPK_SIGNALING,2.096591539,0.031357767,bortezomib
SIGNALING_BY_INSULIN_RECEPTOR,2.009785834,0.042425215,bortezomib
CELL_CYCLE_CHECKPOINTS,-2.003792287,0.047718622,bortezomib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-1.998906866,0.038118426,bortezomib
SIGNALING_BY_HEDGEHOG,1.874224144,0.085588259,bortezomib
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-1.954772493,0.047605679,bortezomib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.794192954,0,vismodegib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.310398091,0.000633034,vismodegib
GPCR_LIGAND_BINDING,2.151622861,0.00601382,vismodegib
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.999488039,0.023422247,vismodegib
S_PHASE,-2.102122173,0.282828283,vismodegib
SARS_COV_2_INFECTION,-2.082622529,0.20414673,vismodegib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.002113492,0.267942584,vismodegib
SARS_COV_INFECTIONS,-1.868366183,0.466985646,vismodegib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.837111183,0.456494772,vismodegib
STIMULI_SENSING_CHANNELS,-1.796775582,0.458114984,vismodegib
EUKARYOTIC_TRANSLATION_ELONGATION,-3.566689913,0,fexofenadine
SARS_COV_2_HOST_INTERACTIONS,-2.609491789,0,fexofenadine
CELLULAR_RESPONSES_TO_STIMULI,-2.616904868,0,fexofenadine
SEPARATION_OF_SISTER_CHROMATIDS,-2.621419667,0,fexofenadine
M_PHASE,-2.633824707,0,fexofenadine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.666147211,0,fexofenadine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.670543368,0,fexofenadine
CELL_CYCLE_CHECKPOINTS,-2.673754903,0,fexofenadine
INFECTIOUS_DISEASE,-2.764043041,0,fexofenadine
NERVOUS_SYSTEM_DEVELOPMENT,-2.769421617,0,fexofenadine
VESICLE_MEDIATED_TRANSPORT,2.817978226,0,PD-0325901
DNA_REPLICATION,-2.794862839,0,PD-0325901
TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,2.794087781,0,PD-0325901
SYNTHESIS_OF_DNA,-2.733536236,0,PD-0325901
S_PHASE,-2.72226021,0,PD-0325901
MEMBRANE_TRAFFICKING,2.699593246,0,PD-0325901
CELL_CYCLE,-2.610500572,0,PD-0325901
DNA_STRAND_ELONGATION,-2.601998366,0,PD-0325901
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.573246614,9.29E-05,PD-0325901
CELL_CYCLE_MITOTIC,-2.576693437,0.000106198,PD-0325901
ISG15_ANTIVIRAL_MECHANISM,3.162690484,0,vandetanib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,3.000893762,0,vandetanib
SARS_COV_2_HOST_INTERACTIONS,2.682765121,0,vandetanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.092727049,0.011042219,vandetanib
INFLUENZA_INFECTION,2.156649431,0.030451059,vandetanib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.156050851,0.024360847,vandetanib
SARS_COV_2_INFECTION,2.03548864,0.04324933,vandetanib
GPCR_LIGAND_BINDING,-2.011732135,0.017790242,vandetanib
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,1.96420475,0.055228008,vandetanib
SARS_COV_1_INFECTION,1.939024318,0.054944302,vandetanib
EUKARYOTIC_TRANSLATION_INITIATION,2.780212267,0,camptothecin
INTERFERON_GAMMA_SIGNALING,2.717673847,0,camptothecin
GPCR_LIGAND_BINDING,-2.410591374,0,camptothecin
SIGNALING_BY_GPCR,-2.327966753,0.001180769,camptothecin
RHO_GTPASES_ACTIVATE_FORMINS,-2.327033837,0.000787179,camptothecin
G_ALPHA_S_SIGNALLING_EVENTS,-2.288454355,0.000590384,camptothecin
RESPIRATORY_ELECTRON_TRANSPORT,2.387504665,0.003529708,camptothecin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.253526521,0.000629743,camptothecin
MITOTIC_SPINDLE_CHECKPOINT,-2.18699748,0.000674725,camptothecin
SEPARATION_OF_SISTER_CHROMATIDS,-2.198831431,0.000787179,camptothecin
KEAP1_NFE2L2_PATHWAY,2.37470447,0.013954403,levonorgestrel
HIV_INFECTION,2.297442368,0.010465802,levonorgestrel
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.148726092,0.025583071,levonorgestrel
CELL_CYCLE_MITOTIC,2.019589124,0.052329009,levonorgestrel
METABOLISM_OF_RNA,2.001505708,0.046049528,levonorgestrel
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.947824357,0.060469078,levonorgestrel
HOST_INTERACTIONS_OF_HIV_FACTORS,1.86617275,0.081732929,levonorgestrel
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.8626081,0.071516313,levonorgestrel
DNA_REPLICATION_PRE_INITIATION,1.853852705,0.065120545,levonorgestrel
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.821813664,0.069772013,levonorgestrel
NEURONAL_SYSTEM,3.355647538,0,dantrolene
RRNA_PROCESSING,-2.515655403,0,dantrolene
INFLUENZA_INFECTION,-2.523096761,0,dantrolene
NONSENSE_MEDIATED_DECAY_NMD,-2.59031654,0,dantrolene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.641456039,0,dantrolene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.651770921,0,dantrolene
TRANSLATION,-2.515190867,0,dantrolene
SELENOAMINO_ACID_METABOLISM,-2.730876319,0,dantrolene
EUKARYOTIC_TRANSLATION_INITIATION,-2.734223509,0,dantrolene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.677685395,0,dantrolene
METABOLISM_OF_RNA,-3.409269081,0,loratadine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.571659768,0,loratadine
M_PHASE,-2.607172805,0,loratadine
INFECTIOUS_DISEASE,-2.607916837,0,loratadine
CELL_CYCLE_CHECKPOINTS,-2.725341652,0,loratadine
CELL_CYCLE_MITOTIC,-2.790024966,0,loratadine
INFLUENZA_INFECTION,-2.798152185,0,loratadine
NONSENSE_MEDIATED_DECAY_NMD,-2.809302013,0,loratadine
SELENOAMINO_ACID_METABOLISM,-2.814192071,0,loratadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.64150848,0,loratadine
HIV_LIFE_CYCLE,2.412994484,0.005068575,tivozanib
HIV_INFECTION,2.253275814,0.012671437,tivozanib
CELL_CYCLE_MITOTIC,2.223516263,0.0135162,tivozanib
UB_SPECIFIC_PROCESSING_PROTEASES,2.168015938,0.011404293,tivozanib
VOLTAGE_GATED_POTASSIUM_CHANNELS,-2.099978931,0.010324616,tivozanib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.090658217,0.01419201,tivozanib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.076914763,0.00700599,tivozanib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.06544115,0.014360962,tivozanib
KEAP1_NFE2L2_PATHWAY,2.014215258,0.020274299,tivozanib
GPCR_LIGAND_BINDING,-1.973421698,0.017207694,tivozanib
CELLULAR_RESPONSE_TO_STARVATION,2.707387834,0,pomalidomide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.580936525,0.000508736,pomalidomide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.576032473,0.000339157,pomalidomide
EUKARYOTIC_TRANSLATION_ELONGATION,2.462443377,0.000508736,pomalidomide
SELENOAMINO_ACID_METABOLISM,2.430603084,0.000406989,pomalidomide
GPCR_LIGAND_BINDING,-2.687114217,0.002973525,pomalidomide
RESPIRATORY_ELECTRON_TRANSPORT,2.419910837,0.000678314,pomalidomide
RRNA_PROCESSING,2.409964116,0.000726765,pomalidomide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.258525139,0.002670863,pomalidomide
STIMULI_SENSING_CHANNELS,-2.535262949,0.010902924,pomalidomide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.041794901,0,montelukast
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.617548825,0.001730261,montelukast
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.192416495,0.018456121,montelukast
NEUTROPHIL_DEGRANULATION,-2.156839439,0.018167744,montelukast
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.04222304,0.039449959,montelukast
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.861349502,0.110159973,montelukast
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.824971493,0.117163412,montelukast
HEMOSTASIS,-1.765524839,0.139718605,montelukast
TRANSLATION,-1.72013345,0.16302907,montelukast
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.718359656,0.148456425,montelukast
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.29780246,0.16622265,risperidone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.141665471,0.255200658,risperidone
HCMV_EARLY_EVENTS,-2.104530616,0.204030155,risperidone
RESPIRATORY_ELECTRON_TRANSPORT,1.96021218,0.20081923,risperidone
L1CAM_INTERACTIONS,-2.044104086,0.226356139,risperidone
HEMOSTASIS,-1.962205058,0.296071874,risperidone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.939456028,0.278341458,risperidone
ISG15_ANTIVIRAL_MECHANISM,-1.883441335,0.31987384,risperidone
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.874817066,0.294067424,risperidone
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.855715854,0.289205683,risperidone
METABOLISM_OF_RNA,-2.063539752,0.128212629,carvedilol
CELL_CYCLE,-2.055711858,0.067804756,carvedilol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.000641658,0.05917506,carvedilol
SEPARATION_OF_SISTER_CHROMATIDS,-1.957194696,0.056709432,carvedilol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.029324466,0.07936882,carvedilol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.918530752,0.061640687,carvedilol
MRNA_SPLICING,-1.91329037,0.054243805,carvedilol
CELL_CYCLE_CHECKPOINTS,-1.881360354,0.053891572,carvedilol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.860831534,0.052394584,carvedilol
MITOTIC_METAPHASE_AND_ANAPHASE,-1.86006918,0.046846922,carvedilol
SENSORY_PERCEPTION,2.249499929,0.019533206,BRD-K28761384
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.209700288,0.016798558,BRD-K28761384
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.194550252,0.012501252,BRD-K28761384
PROTEIN_UBIQUITINATION,-2.080646372,0.19889262,BRD-K28761384
NEURONAL_SYSTEM,1.941157495,0.086336773,BRD-K28761384
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.93028509,0.324698194,BRD-K28761384
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.920625979,0.229645094,BRD-K28761384
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.867085202,0.25430698,BRD-K28761384
HATS_ACETYLATE_HISTONES,-1.838421276,0.250173368,BRD-K28761384
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.808464107,0.179705499,BRD-K28761384
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.218997298,0.162411482,BRD-K14965640
GPCR_LIGAND_BINDING,1.833284301,0.789403241,BRD-K14965640
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.848990109,1,BRD-K14965640
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.617591374,1,BRD-K14965640
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.328152364,1,BRD-K14965640
MAPK1_MAPK3_SIGNALING,1.673328358,1,BRD-K14965640
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.090143666,1,BRD-K14965640
TRANSLATION,-1.849405356,1,BRD-K14965640
INFLUENZA_INFECTION,-1.581845201,1,BRD-K14965640
SARS_COV_1_INFECTION,-1.509494942,1,BRD-K14965640
RESPIRATORY_ELECTRON_TRANSPORT,3.167913214,0,dopamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.793788551,0,dopamine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.521298128,0.004039322,dopamine
COMPLEX_I_BIOGENESIS,2.292859848,0.00817731,dopamine
PROTEIN_LOCALIZATION,2.285829831,0.006132983,dopamine
GPCR_LIGAND_BINDING,-2.335673455,0.016662201,dopamine
ECM_PROTEOGLYCANS,-2.313973664,0.015820676,dopamine
COMPLEX_IV_ASSEMBLY,2.21575594,0.010597794,dopamine
DISEASES_OF_METABOLISM,2.136670458,0.015373343,dopamine
TRANSLATION,2.08493732,0.018083538,dopamine
G2_M_CHECKPOINTS,3.597341447,0,pantoprazole
CELL_CYCLE_CHECKPOINTS,3.297503145,0,pantoprazole
S_PHASE,3.058195417,0,pantoprazole
CELL_CYCLE,2.998621163,0,pantoprazole
CELL_CYCLE_MITOTIC,2.67417635,0,pantoprazole
MITOTIC_METAPHASE_AND_ANAPHASE,2.586536138,0.001010046,pantoprazole
SYNTHESIS_OF_DNA,2.482663336,0.002597262,pantoprazole
M_PHASE,2.448497292,0.003030139,pantoprazole
METABOLISM_OF_RNA,2.405936913,0.003366821,pantoprazole
SEPARATION_OF_SISTER_CHROMATIDS,2.364539705,0.004242195,pantoprazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.303737924,0.001529857,raloxifene
GPCR_LIGAND_BINDING,-2.237352554,0.002294785,raloxifene
RESPIRATORY_ELECTRON_TRANSPORT,2.031937686,0.154290731,raloxifene
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,2.013795064,0.081315385,raloxifene
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1.938729484,0.083400395,raloxifene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.036916919,0.023202825,raloxifene
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.879416644,0.08652791,raloxifene
INTERLEUKIN_1_SIGNALING,1.801964593,0.100080474,raloxifene
CIRCADIAN_CLOCK,1.771963832,0.102165484,raloxifene
DNA_REPLICATION,1.678918261,0.163226487,raloxifene
M_PHASE,4.417659631,0,calcipotriol
CELL_CYCLE_MITOTIC,3.857702279,0,calcipotriol
ISG15_ANTIVIRAL_MECHANISM,3.174718794,0,calcipotriol
CELL_CYCLE_CHECKPOINTS,3.158887934,0,calcipotriol
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,3.099677334,0,calcipotriol
S_PHASE,3.085150626,0,calcipotriol
MITOTIC_METAPHASE_AND_ANAPHASE,2.862714674,0,calcipotriol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.577162428,0.000734312,calcipotriol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.607268959,0.000790798,calcipotriol
RRNA_PROCESSING,2.676249949,0.000856698,calcipotriol
S_PHASE,2.672348407,0,papaverine
MRNA_SPLICING,2.099989497,0.028921826,papaverine
G2_M_CHECKPOINTS,2.013308771,0.052334732,papaverine
CELL_CYCLE_CHECKPOINTS,1.944695964,0.068172875,papaverine
METABOLISM_OF_RNA,1.861828058,0.100813221,papaverine
CELL_CYCLE_MITOTIC,1.833601111,0.095028856,papaverine
MITOTIC_METAPHASE_AND_ANAPHASE,1.830218513,0.081453305,papaverine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.783851665,0.088831322,papaverine
INTERLEUKIN_1_FAMILY_SIGNALING,1.762090668,0.086306401,papaverine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.758451593,0.080981112,papaverine
SARS_COV_1_INFECTION,2.517327802,0.001818575,canertinib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,2.239660928,0.015457891,canertinib
VESICLE_MEDIATED_TRANSPORT,2.194419843,0.012123836,canertinib
GPCR_LIGAND_BINDING,-2.109056834,0.029607678,canertinib
NEURONAL_SYSTEM,-2.100582021,0.015701041,canertinib
METABOLISM_OF_VITAMINS_AND_COFACTORS,2.072770602,0.017731111,canertinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.075072614,0.014953373,canertinib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,2.004489465,0.02145919,canertinib
MEMBRANE_TRAFFICKING,2.002272131,0.017882659,canertinib
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.874700678,0.03481273,canertinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.87262225,0,cabozantinib
MEMBRANE_TRAFFICKING,2.803872026,0,cabozantinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.603647581,0,cabozantinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.565157806,0.002186113,cabozantinib
SARS_COV_2_HOST_INTERACTIONS,2.509935958,0.003497781,cabozantinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.490342074,0.002914818,cabozantinib
MRNA_SPLICING,2.388014502,0.002498415,cabozantinib
MITOTIC_PROPHASE,2.313647452,0.004372227,cabozantinib
RHO_GTPASE_CYCLE,2.304901882,0.00485803,cabozantinib
SIGNALING_BY_ALK_IN_CANCER,2.274851783,0.004769702,cabozantinib
MRNA_SPLICING,2.457279291,0,enoximone
METABOLISM_OF_RNA,2.424687565,0.003119913,enoximone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.260489827,0.006239826,enoximone
S_PHASE,2.134034521,0.00935974,enoximone
G2_M_CHECKPOINTS,1.952102645,0.036190993,enoximone
CELL_CYCLE_CHECKPOINTS,1.93022332,0.033279074,enoximone
HIV_INFECTION,1.900500719,0.032090536,enoximone
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.886761442,0.03197911,enoximone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.854096262,0.03605233,enoximone
INTERLEUKIN_1_FAMILY_SIGNALING,1.833025671,0.032900903,enoximone
STIMULI_SENSING_CHANNELS,-2.559043571,0.239635577,febuxostat
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.544252194,0.129802604,febuxostat
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.400083481,0.233929968,febuxostat
ION_CHANNEL_TRANSPORT,-2.396046111,0.179013482,febuxostat
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.372515465,0.168886026,febuxostat
TCR_SIGNALING,-2.341153293,0.1692664,febuxostat
SARS_COV_2_INFECTION,-2.255710661,0.247786447,febuxostat
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.182540675,0.317017899,febuxostat
GPCR_LIGAND_BINDING,1.857157178,0.326267776,febuxostat
SARS_COV_INFECTIONS,-2.145091529,0.33472906,febuxostat
EUKARYOTIC_TRANSLATION_ELONGATION,-3.435269543,0,TTNPB
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.433826604,0,TTNPB
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.551181559,0,TTNPB
SARS_COV_1_INFECTION,-2.567326267,0,TTNPB
SARS_COV_2_HOST_INTERACTIONS,-2.621055536,0,TTNPB
NERVOUS_SYSTEM_DEVELOPMENT,-2.661772152,0,TTNPB
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.674613437,0,TTNPB
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.881595491,0,TTNPB
SARS_COV_1_HOST_INTERACTIONS,-2.890709232,0,TTNPB
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.997417796,0,TTNPB
MUSCLE_CONTRACTION,2.844830326,0.000512266,flecainide
NEURONAL_SYSTEM,2.235528032,0.012294382,flecainide
CARDIAC_CONDUCTION,2.21953638,0.009220787,flecainide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.121968761,0.014087313,flecainide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.918182116,0.965636101,flecainide
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.910670667,0.512099469,flecainide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.849433032,0.077659514,flecainide
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.889121631,0.400396281,flecainide
DEUBIQUITINATION,-1.844651064,0.414820091,flecainide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.759118732,0.112186237,flecainide
MUSCLE_CONTRACTION,2.049050496,0.072625698,beclomethasone-dipropionate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.855122388,0.371668993,beclomethasone-dipropionate
G_ALPHA_I_SIGNALLING_EVENTS,1.703791667,0.251920391,beclomethasone-dipropionate
SIGNALING_BY_GPCR,1.664231714,0.211068436,beclomethasone-dipropionate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.611369124,0.206813024,beclomethasone-dipropionate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.816349206,0.385326121,beclomethasone-dipropionate
RHO_GTPASE_EFFECTORS,1.59293135,0.181564246,beclomethasone-dipropionate
GPCR_LIGAND_BINDING,1.540700331,0.198396764,beclomethasone-dipropionate
ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1.501423787,0.204259777,beclomethasone-dipropionate
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.4841849,0.195748953,beclomethasone-dipropionate
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.429115771,0.008478057,danazol
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.248831512,0.028462049,danazol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.063743377,0.093258628,danazol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.033209063,0.089927963,danazol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.974259194,0.10755021,danazol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.906271381,0.49352612,danazol
HEMOSTASIS,-1.795505671,0.260599327,danazol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.707399414,0.367670844,danazol
NEUTROPHIL_DEGRANULATION,-1.697022733,0.342452949,danazol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.66260719,1,danazol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.477107343,0.000755485,pizotifen
MITOCHONDRIAL_TRANSLATION,-2.344466186,0.024421594,pizotifen
TRANSLATION,-2.338845245,0.014652956,pizotifen
GPCR_LIGAND_BINDING,2.223297494,0.007177103,pizotifen
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.193169542,0.024421594,pizotifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.166361694,0.009569471,pizotifen
NEUTROPHIL_DEGRANULATION,-2.059325118,0.034190231,pizotifen
ADAPTIVE_IMMUNE_SYSTEM,-1.992122043,0.038586118,pizotifen
SENSORY_PERCEPTION,2.10357032,0.015487433,pizotifen
SIGNALING_BY_GPCR,2.094529081,0.013145431,pizotifen
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.878208699,0,palbociclib
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.433739679,0.00241424,palbociclib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.209647194,0.000701758,palbociclib
GPCR_LIGAND_BINDING,-2.183231463,0.000701758,palbociclib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.136761142,0.000935678,palbociclib
SARS_COV_1_INFECTION,2.261862117,0.011266455,palbociclib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.261037592,0.008449841,palbociclib
SIGNALING_BY_GPCR,-2.103021138,0.001578956,palbociclib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.061620069,0.001964923,palbociclib
G_ALPHA_I_SIGNALLING_EVENTS,-1.968886699,0.006900624,palbociclib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,3.248491974,0,valsartan
SARS_COV_2_HOST_INTERACTIONS,2.807470383,0,valsartan
CELL_CYCLE_MITOTIC,2.503864494,0,valsartan
TRANSLATION,2.402535805,0.001756835,valsartan
TOLL_LIKE_RECEPTOR_CASCADES,2.246342755,0.007027339,valsartan
TRNA_PROCESSING,2.238132968,0.005856116,valsartan
DNA_REPLICATION_PRE_INITIATION,2.233524837,0.005019528,valsartan
MITOTIC_PROPHASE,2.217960677,0.006148922,valsartan
SARS_COV_2_INFECTION,2.051773871,0.014054678,valsartan
CELLULAR_RESPONSE_TO_HEAT_STRESS,2.048339148,0.013351945,valsartan
MEMBRANE_TRAFFICKING,2.669223735,0,axitinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.610586211,0,axitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.341854881,0,axitinib
VESICLE_MEDIATED_TRANSPORT,2.455938941,0.002298256,axitinib
SENSORY_PERCEPTION,-2.226208802,0.000310426,axitinib
SARS_COV_2_HOST_INTERACTIONS,2.251645593,0.006894769,axitinib
GPCR_LIGAND_BINDING,-2.07197158,0.003311215,axitinib
TRNA_PROCESSING,1.966491885,0.04826338,axitinib
VISUAL_PHOTOTRANSDUCTION,-1.971060079,0.012572271,axitinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.839229526,0.111465426,axitinib
TRANSLATION,-2.834878892,0,tegafur
EUKARYOTIC_TRANSLATION_ELONGATION,-2.589198723,0.004613588,tegafur
SARS_COV_1_INFECTION,-2.57566617,0.003075725,tegafur
INFLUENZA_INFECTION,-2.534773007,0.002306794,tegafur
SELENOAMINO_ACID_METABOLISM,-2.464269705,0.00246058,tegafur
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.451034654,0.002563104,tegafur
SARS_COV_INFECTIONS,-2.425819349,0.002636336,tegafur
EUKARYOTIC_TRANSLATION_INITIATION,-2.423293252,0.002306794,tegafur
INNATE_IMMUNE_SYSTEM,-2.318076933,0.004100967,tegafur
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.31580178,0.004306015,tegafur
TRNA_PROCESSING,-2.713422176,0.003148432,pefloxacin
NONSENSE_MEDIATED_DECAY_NMD,-2.43947191,0.014167944,pefloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.392545314,0.009445296,pefloxacin
INFLUENZA_INFECTION,-2.375262313,0.009445296,pefloxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.242164341,0.011964042,pefloxacin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.21562434,0.012593728,pefloxacin
SELENOAMINO_ACID_METABOLISM,-2.159885035,0.014561498,pefloxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.159885035,0.014561498,pefloxacin
TRANSLATION,-2.158837018,0.01329338,pefloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-2.030587508,0.021724181,pefloxacin
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.363907777,0.014286971,synephrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.303775382,0.015817718,synephrine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.275314842,0.018709129,synephrine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.200306497,0.047708278,synephrine
MITOTIC_G2_G2_M_PHASES,1.991516806,0.197551621,synephrine
NONSENSE_MEDIATED_DECAY_NMD,1.691188755,0.920096674,synephrine
CELL_CYCLE_MITOTIC,1.664358598,0.724685196,synephrine
METABOLISM_OF_RNA,1.658511716,0.566232333,synephrine
HEMOSTASIS,-2.587736914,0.875179027,synephrine
TRANSPORT_OF_SMALL_MOLECULES,-2.567758408,0.739861001,synephrine
TRANSLATION,-3.087151245,0,olanzapine
MITOCHONDRIAL_TRANSLATION,-2.424328406,0.011970854,olanzapine
INFLUENZA_INFECTION,-2.360675983,0.00897814,olanzapine
METABOLISM_OF_RNA,-2.24061176,0.014215389,olanzapine
RHO_GTPASE_CYCLE,-2.205719088,0.014963567,olanzapine
RRNA_PROCESSING,-2.122878871,0.015462353,olanzapine
NEUTROPHIL_DEGRANULATION,-2.098563132,0.015391097,olanzapine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.038147996,0.02061647,olanzapine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.043289295,0.02281944,olanzapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.019043611,0.020948994,olanzapine
HCMV_EARLY_EVENTS,-2.666077512,0.009097352,erythromycin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.336070733,0.051172602,erythromycin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.250828317,0.067472024,erythromycin
DEVELOPMENTAL_CELL_LINEAGES,-2.047260068,0.215493515,erythromycin
ISG15_ANTIVIRAL_MECHANISM,-1.990147498,0.2328922,erythromycin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.974284266,0.209997198,erythromycin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.936956675,0.224834545,erythromycin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.934325933,0.201563195,erythromycin
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.885219328,0.231982465,erythromycin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.868510922,0.22811609,erythromycin
TRANSLATION,2.866579013,0,docetaxel
INFLUENZA_INFECTION,2.575750723,0.004385438,docetaxel
TRNA_PROCESSING,2.309380268,0.014618126,docetaxel
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.171238864,0.010963595,docetaxel
RESPIRATORY_ELECTRON_TRANSPORT,2.164451661,0.008770876,docetaxel
DOWNSTREAM_TCR_SIGNALING,1.857910364,0.064319756,docetaxel
COPII_MEDIATED_VESICLE_TRANSPORT,1.814595724,0.073925954,docetaxel
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.807040915,0.067974288,docetaxel
CELLULAR_RESPONSE_TO_STARVATION,1.801409948,0.062370673,docetaxel
NEUTROPHIL_DEGRANULATION,1.729047798,0.087708759,docetaxel
MUSCLE_CONTRACTION,3.779349602,0,ondansetron
CARDIAC_CONDUCTION,3.633163048,0,ondansetron
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.131755801,0.120485467,ondansetron
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.080943759,0.088006776,ondansetron
SIGNALING_BY_ROBO_RECEPTORS,-2.073507313,0.062861983,ondansetron
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.943931126,0.149559134,ondansetron
BIOLOGICAL_OXIDATIONS,1.790875848,0.169947907,ondansetron
NEURONAL_SYSTEM,1.773329626,0.140186824,ondansetron
INFLUENZA_INFECTION,-1.900728308,0.171194133,ondansetron
NONSENSE_MEDIATED_DECAY_NMD,-1.871652781,0.180553584,ondansetron
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.127727739,0.202103056,quinethazone
RHOG_GTPASE_CYCLE,-2.080868207,0.149008185,quinethazone
SIGNALING_BY_INSULIN_RECEPTOR,-2.034110071,0.153385182,quinethazone
DEVELOPMENTAL_CELL_LINEAGES,-2.032977845,0.116180711,quinethazone
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.027193027,0.095913314,quinethazone
SENSORY_PERCEPTION,1.833773197,0.24820333,quinethazone
MEMBRANE_TRAFFICKING,-1.888605858,0.233883856,quinethazone
TCR_SIGNALING,-1.871222093,0.227386327,quinethazone
RHOC_GTPASE_CYCLE,-1.870812436,0.199105764,quinethazone
COLLAGEN_FORMATION,-1.8641386,0.1844682,quinethazone
METABOLISM_OF_RNA,3.830127432,0,rucaparib
ISG15_ANTIVIRAL_MECHANISM,2.695159806,0,rucaparib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.697021478,0,rucaparib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.363882324,0,rucaparib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.755547113,0,rucaparib
INFLUENZA_INFECTION,2.760622838,0,rucaparib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.787007317,0,rucaparib
MRNA_SPLICING,2.719067162,0,rucaparib
S_PHASE,2.815413357,0,rucaparib
CELL_CYCLE_MITOTIC,2.853000781,0,rucaparib
SIGNALING_BY_ROBO_RECEPTORS,-2.182705068,0.044668837,zonisamide
SARS_COV_1_HOST_INTERACTIONS,-2.144917184,0.033229257,zonisamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.132193387,0.027600257,zonisamide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.127486544,0.021517306,zonisamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.079922403,0.025493921,zonisamide
NONSENSE_MEDIATED_DECAY_NMD,-2.078921497,0.021971257,zonisamide
EUKARYOTIC_TRANSLATION_INITIATION,-1.963880504,0.057275721,zonisamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.95989969,0.051750482,zonisamide
NERVOUS_SYSTEM_DEVELOPMENT,-1.924992687,0.064521653,zonisamide
RRNA_PROCESSING,-1.915422246,0.064170597,zonisamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.62097673,0.00227309,tetryzoline
RESPIRATORY_ELECTRON_TRANSPORT,2.518817968,0.001704817,tetryzoline
TRANSLATION,2.161189503,0.017427022,tetryzoline
DRUG_ADME,2.127733836,0.015627492,tetryzoline
INTERFERON_GAMMA_SIGNALING,-2.154127251,0.116206146,tetryzoline
BACTERIAL_INFECTION_PATHWAYS,-2.119329502,0.07683051,tetryzoline
DISEASES_OF_METABOLISM,1.853058338,0.097288244,tetryzoline
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.978861766,0.190475639,tetryzoline
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.76583397,0.135248844,tetryzoline
RRNA_PROCESSING,1.69530264,0.166909737,tetryzoline
RESPIRATORY_ELECTRON_TRANSPORT,3.383671588,0,dipivefrine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.842770946,0,dipivefrine
CIRCADIAN_CLOCK,2.018386313,0.065016347,dipivefrine
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.970983966,0.067416279,dipivefrine
TRANSLATION,1.884524312,0.09241921,dipivefrine
RRNA_PROCESSING,1.638392984,0.315700181,dipivefrine
NUCLEOTIDE_EXCISION_REPAIR,1.628544477,0.284625733,dipivefrine
ADIPOGENESIS,1.587851807,0.305827732,dipivefrine
BIOLOGICAL_OXIDATIONS,1.497340638,0.426315241,dipivefrine
MUSCLE_CONTRACTION,1.48518387,0.406199445,dipivefrine
METABOLISM_OF_RNA,-2.827305426,0,enzastaurin
MRNA_SPLICING,-2.629080139,0.001508177,enzastaurin
CELL_CYCLE,-2.576655747,0.001508177,enzastaurin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.497385645,0.001508177,enzastaurin
RESPIRATORY_ELECTRON_TRANSPORT,-2.48240164,0.001206542,enzastaurin
KERATINIZATION,2.343609598,0.002950006,enzastaurin
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.343609598,0.002950006,enzastaurin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.345338937,0.005781346,enzastaurin
VIRAL_INFECTION_PATHWAYS,-2.291571997,0.007971794,enzastaurin
TRANSLATION,-2.281976382,0.007917931,enzastaurin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.392791969,0,aminolevulinic-acid
MUSCLE_CONTRACTION,1.816563072,0.087747709,aminolevulinic-acid
NEURONAL_SYSTEM,1.699613632,0.110463349,aminolevulinic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.561689606,0.178002495,aminolevulinic-acid
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.784590292,1,aminolevulinic-acid
METABOLISM_OF_RNA,-1.762888976,1,aminolevulinic-acid
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.756992221,0.984952774,aminolevulinic-acid
CHROMATIN_ORGANIZATION,-1.733733545,0.881726283,aminolevulinic-acid
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.707113386,0.866027254,aminolevulinic-acid
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.699772131,0.762191439,aminolevulinic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.967846146,0,voapaxar
GPCR_LIGAND_BINDING,2.805555342,0,voapaxar
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.511286298,0.000497095,voapaxar
MUSCLE_CONTRACTION,2.343894304,0.001864105,voapaxar
NEURONAL_SYSTEM,2.161306297,0.006661067,voapaxar
SIGNALING_BY_GPCR,1.990875037,0.014498592,voapaxar
METABOLISM_OF_RNA,-1.808164039,1,voapaxar
EUKARYOTIC_TRANSLATION_ELONGATION,1.566972817,0.156087694,voapaxar
CHROMATIN_ORGANIZATION,-1.7721094,1,voapaxar
SENSORY_PERCEPTION,1.552496439,0.146767171,voapaxar
METABOLISM_OF_RNA,-4.344228753,0,ibrutinib
MITOTIC_SPINDLE_CHECKPOINT,-3.081484613,0,ibrutinib
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,-3.048142583,0,ibrutinib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-3.008546054,0,ibrutinib
HOST_INTERACTIONS_OF_HIV_FACTORS,-3.007938927,0,ibrutinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.994439049,0,ibrutinib
DNA_REPLICATION_PRE_INITIATION,-2.984971195,0,ibrutinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.977955607,0,ibrutinib
RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,-2.963768739,0,ibrutinib
REGULATION_OF_RAS_BY_GAPS,-2.947570703,0,ibrutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.214874467,0.001524268,hydroxyurea
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.170593295,0.03343949,hydroxyurea
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.097473309,0.005334938,hydroxyurea
CELL_CYCLE_MITOTIC,2.073785923,0.040605096,hydroxyurea
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.071829154,0.027070064,hydroxyurea
MITOTIC_SPINDLE_CHECKPOINT,2.069324757,0.020302548,hydroxyurea
CELL_CYCLE_CHECKPOINTS,2.007956171,0.02388535,hydroxyurea
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.917657106,0.032643312,hydroxyurea
THE_PHOTOTRANSDUCTION_CASCADE,-2.02641447,0.012702233,hydroxyurea
SENSORY_PERCEPTION,-2.019629723,0.010098275,hydroxyurea
EUKARYOTIC_TRANSLATION_ELONGATION,-3.480086556,0,phenazone
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.593411394,0,phenazone
SARS_COV_1_INFECTION,-2.649970087,0,phenazone
TRANSLATION,-2.732106389,0,phenazone
RRNA_PROCESSING,-2.749833377,0,phenazone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.910872818,0,phenazone
SIGNALING_BY_ROBO_RECEPTORS,-2.994713755,0,phenazone
INFLUENZA_INFECTION,-3.021260257,0,phenazone
CELLULAR_RESPONSE_TO_STARVATION,-3.049050977,0,phenazone
SARS_COV_1_HOST_INTERACTIONS,-2.754157993,0,phenazone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.083105656,0,ranolazine
INFLUENZA_INFECTION,-3.000613515,0,ranolazine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.783586894,0,ranolazine
METABOLISM_OF_RNA,-2.704454439,0.000614879,ranolazine
NEUTROPHIL_DEGRANULATION,-2.701435977,0.000491903,ranolazine
NONSENSE_MEDIATED_DECAY_NMD,-2.515720753,0.004509112,ranolazine
MRNA_SPLICING,-2.491038675,0.004919031,ranolazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.433315181,0.00553391,ranolazine
PKR_MEDIATED_SIGNALING,-2.431032258,0.004919031,ranolazine
TRANSLATION,-2.316303651,0.014511141,ranolazine
ECM_PROTEOGLYCANS,-2.1165887,0.057434821,minaprine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.052343792,0.063588552,minaprine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.931207258,0.141877684,minaprine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.895662605,0.14999719,minaprine
SIGNALING_BY_PDGF,-1.852175402,0.181329936,minaprine
SIGNALING_BY_ALK_IN_CANCER,1.53665576,1,minaprine
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,1.492710235,0.644973024,minaprine
PROTEIN_LOCALIZATION,1.481590618,0.454141359,minaprine
SENSORY_PERCEPTION,-1.673077879,0.638962389,minaprine
BIOLOGICAL_OXIDATIONS,1.261260822,0.951986699,minaprine
METABOLISM_OF_RNA,-2.891348081,0,metoclopramide
TRANSLATION,-2.870367943,0,metoclopramide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.856811897,0,metoclopramide
VIRAL_INFECTION_PATHWAYS,-2.633899076,0,metoclopramide
MRNA_SPLICING,-2.538493551,0.000282847,metoclopramide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.515788557,0.000235706,metoclopramide
EUKARYOTIC_TRANSLATION_INITIATION,-2.499771586,0.000202033,metoclopramide
INFECTIOUS_DISEASE,-2.320201145,0.003358805,metoclopramide
RESPIRATORY_ELECTRON_TRANSPORT,-2.315075484,0.003142741,metoclopramide
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.287935613,0.004101277,metoclopramide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.852017454,0,lorazepam
MRNA_SPLICING,2.832151392,0,lorazepam
METABOLISM_OF_RNA,2.732073972,0,lorazepam
M_PHASE,2.587320451,0,lorazepam
G2_M_CHECKPOINTS,2.516282527,0.0012772,lorazepam
CELL_CYCLE_CHECKPOINTS,2.440656135,0.004257332,lorazepam
MITOTIC_PROPHASE,2.41294256,0.004561427,lorazepam
SENSORY_PERCEPTION,-2.173089227,0.002337978,lorazepam
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.333705369,0.004789499,lorazepam
CELL_CYCLE_MITOTIC,2.300475184,0.005676443,lorazepam
SENSORY_PERCEPTION,-2.008831176,0.033664448,halcinonide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.93591401,0.261205751,halcinonide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.994012919,0.021320817,halcinonide
S_PHASE,1.818290693,0.235653014,halcinonide
TRANSLATION,1.732680361,0.244170593,halcinonide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.881591285,0.046382129,halcinonide
GPCR_LIGAND_BINDING,-1.878270945,0.035908745,halcinonide
VISUAL_PHOTOTRANSDUCTION,-1.865495223,0.034562167,halcinonide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.559315811,0.445753292,halcinonide
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.551149311,0.3781805,halcinonide
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.985635764,0,benazepril
KEAP1_NFE2L2_PATHWAY,2.576201252,0,benazepril
HIV_LIFE_CYCLE,2.556241472,0,benazepril
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.461469854,0,benazepril
HIV_INFECTION,2.450474086,0,benazepril
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.441173367,0,benazepril
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,2.392649549,0.001341979,benazepril
MITOTIC_PROPHASE,2.3521159,0.002348462,benazepril
CELL_CYCLE_CHECKPOINTS,2.342632034,0.003131283,benazepril
SARS_COV_2_HOST_INTERACTIONS,2.331416681,0.002818155,benazepril
METABOLISM_OF_RNA,3.596285092,0,vildagliptin
S_PHASE,2.906393834,0.002915271,vildagliptin
G2_M_CHECKPOINTS,2.462823809,0.001943514,vildagliptin
CELL_CYCLE_CHECKPOINTS,2.335143907,0.001457636,vildagliptin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.17442844,0.004664434,vildagliptin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.120879339,0.008745813,vildagliptin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.07182487,0.008329346,vildagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.127893351,0.009711639,vildagliptin
MITOTIC_METAPHASE_AND_ANAPHASE,2.036010409,0.010932266,vildagliptin
SEPARATION_OF_SISTER_CHROMATIDS,1.976642699,0.016843788,vildagliptin
ISG15_ANTIVIRAL_MECHANISM,3.436682809,0,telmisartan
CELL_CYCLE_CHECKPOINTS,2.919895599,0,telmisartan
INFLUENZA_INFECTION,2.721205449,0,telmisartan
MITOTIC_PROPHASE,2.590430397,0.002348874,telmisartan
METABOLISM_OF_RNA,2.584442492,0.001879099,telmisartan
M_PHASE,2.426765259,0.003523311,telmisartan
CELL_CYCLE_MITOTIC,2.399036072,0.003131832,telmisartan
HIV_LIFE_CYCLE,2.517727416,0.004697749,telmisartan
DNA_REPLICATION_PRE_INITIATION,2.430059182,0.004026642,telmisartan
G2_M_CHECKPOINTS,2.374346596,0.003758199,telmisartan
METABOLISM_OF_RNA,2.568065216,0,acalabrutinib
G2_M_CHECKPOINTS,2.557982027,0,acalabrutinib
CELL_CYCLE_CHECKPOINTS,2.466525227,0,acalabrutinib
CELL_CYCLE,2.403446578,0,acalabrutinib
S_PHASE,2.326278092,0.006437604,acalabrutinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.214895972,0.014752842,acalabrutinib
CELL_CYCLE_MITOTIC,2.192543432,0.012645293,acalabrutinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.095482619,0.016094009,acalabrutinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.002692761,0.017882233,acalabrutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.020607582,0.019469241,acalabrutinib
G2_M_CHECKPOINTS,2.987259658,0,pioglitazone
CELL_CYCLE_CHECKPOINTS,2.885425825,0,pioglitazone
NUCLEOTIDE_EXCISION_REPAIR,2.530107198,0.001787968,pioglitazone
UB_SPECIFIC_PROCESSING_PROTEASES,2.513871528,0.002681952,pioglitazone
DNA_REPLICATION_PRE_INITIATION,2.365759398,0.005363904,pioglitazone
FCERI_MEDIATED_NF_KB_ACTIVATION,2.341070841,0.00446992,pioglitazone
HIV_INFECTION,2.317862616,0.004597632,pioglitazone
REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,2.288928221,0.004693416,pioglitazone
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.284444381,0.004171925,pioglitazone
S_PHASE,2.275067399,0.003754733,pioglitazone
S_PHASE,2.653682779,0,raltitrexed
CELL_CYCLE_CHECKPOINTS,2.500445298,0,raltitrexed
DNA_REPLICATION,2.475850941,0.002959799,raltitrexed
ISG15_ANTIVIRAL_MECHANISM,2.435114515,0.002219849,raltitrexed
G2_M_CHECKPOINTS,2.42507378,0.00177588,raltitrexed
MITOTIC_METAPHASE_AND_ANAPHASE,2.11586708,0.013319096,raltitrexed
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.061087737,0.01649031,raltitrexed
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.059998176,0.010115365,raltitrexed
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.972019583,0.029967967,raltitrexed
SEPARATION_OF_SISTER_CHROMATIDS,1.884088928,0.049329986,raltitrexed
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,3.058815735,0,diethylcarbamazine
M_PHASE,2.394340489,0,diethylcarbamazine
SYNTHESIS_OF_DNA,2.408096614,0,diethylcarbamazine
DNA_REPLICATION_PRE_INITIATION,2.430723526,0,diethylcarbamazine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.486764183,0,diethylcarbamazine
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,2.609763679,0,diethylcarbamazine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,2.609763679,0,diethylcarbamazine
HIV_INFECTION,2.365426782,0,diethylcarbamazine
CELL_CYCLE,2.647210504,0,diethylcarbamazine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.736457213,0,diethylcarbamazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,3.490277874,0,cladribine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.658559975,0,cladribine
MITOTIC_PROPHASE,2.310250698,0.018015882,cladribine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.179995418,0.005349327,cladribine
SYNTHESIS_OF_DNA,2.105328071,0.036031765,cladribine
HIV_INFECTION,2.092166157,0.032428588,cladribine
INTERLEUKIN_1_SIGNALING,2.08833805,0.027023824,cladribine
S_PHASE,2.073380886,0.025736975,cladribine
TOLL_LIKE_RECEPTOR_CASCADES,2.012241846,0.032653787,cladribine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.93489549,0.039034412,cladribine
CELL_CYCLE,-3.325955566,0,flumetasone
CELL_CYCLE_MITOTIC,-3.077334238,0,flumetasone
CELL_CYCLE_CHECKPOINTS,-2.754274341,0.000490196,flumetasone
GPCR_LIGAND_BINDING,2.478502288,0.000684211,flumetasone
METABOLISM_OF_RNA,-2.477180846,0.001470588,flumetasone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.411716532,0.001176471,flumetasone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.380664431,0.00122549,flumetasone
M_PHASE,-2.312365715,0.003151261,flumetasone
DNA_REPLICATION,-2.299777297,0.002941176,flumetasone
SIGNALING_BY_GPCR,2.243456709,0.006842105,flumetasone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.842842009,0.577985425,irbesartan
GPCR_LIGAND_BINDING,1.927493609,0.430225162,irbesartan
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.7470935,0.548160555,irbesartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.887479819,0.30262331,irbesartan
GASTRULATION,-1.67397416,0.537533302,irbesartan
HEMOSTASIS,-1.554892827,0.754877762,irbesartan
ESR_MEDIATED_SIGNALING,-1.526596371,0.703044194,irbesartan
HCMV_INFECTION,-1.521553927,0.601296819,irbesartan
SIGNALING_BY_GPCR,1.79348432,0.469597805,irbesartan
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-1.442728787,0.76251763,irbesartan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.819758023,0,amantadine
EUKARYOTIC_TRANSLATION_INITIATION,-2.809022293,0,amantadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.760814253,0,amantadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.682412688,0,amantadine
NONSENSE_MEDIATED_DECAY_NMD,-2.639211247,0,amantadine
SELENOAMINO_ACID_METABOLISM,-2.637149274,0,amantadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.610217512,0,amantadine
SIGNALING_BY_ROBO_RECEPTORS,-2.559149103,0,amantadine
INFLUENZA_INFECTION,-2.552973483,0,amantadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.866133659,0.00078998,amantadine
TRANSLATION,-2.23499598,0.065483596,molsidomine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-2.079288113,0.095606051,molsidomine
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.060472475,0.06810294,molsidomine
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,-2.027736318,0.062209417,molsidomine
DNA_REPLICATION,-2.01478918,0.05553009,molsidomine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.979677379,0.052823434,molsidomine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.964733436,0.050890109,molsidomine
GPCR_LIGAND_BINDING,2.054418816,0.110630725,molsidomine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.93741701,0.051732041,molsidomine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.877720283,0.06490152,molsidomine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.85733079,0,oxybuprocaine
NERVOUS_SYSTEM_DEVELOPMENT,-2.898766066,0,oxybuprocaine
SARS_COV_1_INFECTION,-2.905309838,0,oxybuprocaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.928521713,0,oxybuprocaine
SARS_COV_1_HOST_INTERACTIONS,-3.022481501,0,oxybuprocaine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.215708038,0,oxybuprocaine
SIGNALING_BY_ROBO_RECEPTORS,-3.236226049,0,oxybuprocaine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.237181371,0,oxybuprocaine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.337544871,0,oxybuprocaine
RRNA_PROCESSING,-3.32307349,0,oxybuprocaine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-2.879817101,0,rofecoxib
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.743563728,0.001606608,rofecoxib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.554594083,0.00910411,rofecoxib
DRUG_ADME,-2.515471648,0.00843469,rofecoxib
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-2.103951276,0.069726769,rofecoxib
NEURONAL_SYSTEM,2.047599444,0.08879344,rofecoxib
COMPLEMENT_CASCADE,-2.080382796,0.063728767,rofecoxib
INTEGRATION_OF_ENERGY_METABOLISM,-2.062778708,0.060821573,rofecoxib
ADIPOGENESIS,-2.05689396,0.056833743,rofecoxib
BIOLOGICAL_OXIDATIONS,-2.038655842,0.056409777,rofecoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.192839311,0.001381351,candesartan
RESPIRATORY_ELECTRON_TRANSPORT,1.902320026,0.435562277,candesartan
GPCR_LIGAND_BINDING,-1.973726088,0.03384309,candesartan
TRANSLATION,1.830833533,0.326671708,candesartan
SIGNALING_BY_GPCR,-1.936122364,0.033152415,candesartan
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.660108043,0.512693097,candesartan
HIV_INFECTION,1.646914678,0.411742465,candesartan
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.621462794,0.371589068,candesartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.848066044,0.060606758,candesartan
MITOCHONDRIAL_TRANSLATION,1.587386473,0.364102841,candesartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.205675869,0.001218673,amlodipine
MITOTIC_PROPHASE,2.131731682,0.062000158,amlodipine
SARS_COV_2_HOST_INTERACTIONS,2.116970715,0.037888986,amlodipine
S_PHASE,2.100481653,0.027555626,amlodipine
GPCR_LIGAND_BINDING,-2.098137307,0.004570024,amlodipine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.083377338,0.022388946,amlodipine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.043656431,0.026177845,amlodipine
G2_M_CHECKPOINTS,1.943192268,0.043629741,amlodipine
SIGNALING_BY_GPCR,-1.996326019,0.007718262,amlodipine
SUMOYLATION,1.935687798,0.03936518,amlodipine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.93372995,0,roscovitine
S_PHASE,2.34107425,0,roscovitine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.246704943,0.006153846,roscovitine
MYD88_INDEPENDENT_TLR4_CASCADE,2.199459463,0.004615385,roscovitine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.194447207,0.003692308,roscovitine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.082884501,0.01025641,roscovitine
INTERLEUKIN_1_FAMILY_SIGNALING,2.066499193,0.012307692,roscovitine
METABOLISM_OF_RNA,2.023056061,0.013846154,roscovitine
MRNA_SPLICING,1.966233141,0.014769231,roscovitine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.980472566,0.015726496,roscovitine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.09046835,0.010472543,vemurafenib
METABOLISM_OF_RNA,2.04202604,0.136246787,vemurafenib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.974476039,0.093669666,vemurafenib
TRANSLATION,1.966237925,0.06433876,vemurafenib
RRNA_PROCESSING,1.946257911,0.051092545,vemurafenib
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.934712114,0.042009426,vemurafenib
SIGNALING_BY_GPCR,-1.977767396,0.02408685,vemurafenib
G_ALPHA_Q_SIGNALLING_EVENTS,-1.96566877,0.019083301,vemurafenib
S_PHASE,1.808875196,0.077584976,vemurafenib
MITOTIC_METAPHASE_AND_ANAPHASE,1.768128029,0.081099278,vemurafenib
C_TYPE_LECTIN_RECEPTORS_CLRS,2.007486393,0.174956428,trifluridine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.90490256,0.138758547,trifluridine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.990420438,0.059644438,trifluridine
INTERLEUKIN_1_FAMILY_SIGNALING,1.753398621,0.21115431,trifluridine
MRNA_SPLICING,1.717578576,0.145998123,trifluridine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.719284109,0.182497654,trifluridine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.942630044,0.05107055,trifluridine
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.714225043,0.126692586,trifluridine
RESPIRATORY_ELECTRON_TRANSPORT,1.692020179,0.119797752,trifluridine
MEMBRANE_TRAFFICKING,1.598849054,0.162136345,trifluridine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.561624519,0.006032091,valproic-acid
NEDDYLATION,2.366997862,0.012064181,valproic-acid
CELL_CYCLE_CHECKPOINTS,2.112413649,0.022117666,valproic-acid
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.081257173,0.018096272,valproic-acid
DNA_REPLICATION,2.052014028,0.016889854,valproic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.116733248,0.013634733,valproic-acid
HIV_INFECTION,2.002527916,0.024128363,valproic-acid
THE_PHOTOTRANSDUCTION_CASCADE,-2.041457793,0.013993541,valproic-acid
MITOTIC_METAPHASE_AND_ANAPHASE,1.917182147,0.03446909,valproic-acid
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.909524732,0.031668476,valproic-acid
S_PHASE,2.49450696,0,nisoldipine
CELL_CYCLE_CHECKPOINTS,2.427563474,0.002997684,nisoldipine
G2_M_CHECKPOINTS,2.367878544,0.003996911,nisoldipine
MRNA_SPLICING,2.285525357,0.007494209,nisoldipine
CELL_CYCLE,2.278091207,0.005995367,nisoldipine
DNA_REPLICATION,2.209201042,0.005995367,nisoldipine
SYNTHESIS_OF_DNA,2.185248151,0.005995367,nisoldipine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.180315303,0.005995367,nisoldipine
TRANSLATION,2.173315489,0.005329215,nisoldipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.157693982,0.004796294,nisoldipine
POTASSIUM_CHANNELS,2.83831497,0,nifedipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.65332296,0,nifedipine
METABOLISM_OF_RNA,-2.617590907,0,nifedipine
MRNA_SPLICING,-2.582140813,0,nifedipine
GPCR_LIGAND_BINDING,2.461115306,0.000483643,nifedipine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.394012635,0.003884007,nifedipine
NEURONAL_SYSTEM,2.367506593,0.001289715,nifedipine
CELL_CYCLE,-2.254240138,0.014603865,nifedipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.250501281,0.003546715,nifedipine
CHROMATIN_ORGANIZATION,-2.227817711,0.014500292,nifedipine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.414442946,0.016923302,parachlorophenol
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.782501693,0.697277034,parachlorophenol
G_ALPHA_Q_SIGNALLING_EVENTS,1.848440851,0.684453544,parachlorophenol
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-1.536738672,1,parachlorophenol
SIGNALING_BY_NOTCH,-1.517598398,0.807658404,parachlorophenol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.515431768,0.611367005,parachlorophenol
S_PHASE,1.755342125,0.824227483,parachlorophenol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.729595213,0.719240332,parachlorophenol
SIGNALING_BY_NOTCH1,-1.418211447,0.756258173,parachlorophenol
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,-1.383720819,0.73580638,parachlorophenol
CELL_CYCLE_CHECKPOINTS,-2.682156219,0.005229952,fluticasone-propionate
ECM_PROTEOGLYCANS,-2.66739153,0.002614976,fluticasone-propionate
G2_M_CHECKPOINTS,-2.61923201,0.001743317,fluticasone-propionate
COLLAGEN_DEGRADATION,-2.517106957,0.001743317,fluticasone-propionate
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.503580626,0.002091981,fluticasone-propionate
CELL_CYCLE,-2.329316932,0.009297692,fluticasone-propionate
COLLAGEN_FORMATION,-2.313892019,0.009463722,fluticasone-propionate
CELL_CYCLE_MITOTIC,-2.267930825,0.010653606,fluticasone-propionate
S_PHASE,-2.270859585,0.011985306,fluticasone-propionate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.166922749,0.019002158,fluticasone-propionate
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.261036762,0.02072878,dioxybenzone
NEURONAL_SYSTEM,2.008380513,0.061149902,dioxybenzone
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.056163298,1,dioxybenzone
SIGNALING_BY_WNT,-2.992760322,0.991552167,dioxybenzone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.999618932,1,dioxybenzone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.469536879,0.833527287,dioxybenzone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.705963247,1,dioxybenzone
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.67207732,1,dioxybenzone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.433709812,0.748136228,dioxybenzone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.547193209,1,dioxybenzone
CELL_CYCLE,-2.891708204,0,latanoprost
GPCR_LIGAND_BINDING,2.406179509,0.000580626,latanoprost
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.286994766,0.001451564,latanoprost
CELL_CYCLE_MITOTIC,-2.440474904,0.00930711,latanoprost
MITOTIC_METAPHASE_AND_ANAPHASE,-2.429685805,0.006980333,latanoprost
SARS_COV_1_INFECTION,-2.369369628,0.007562027,latanoprost
M_PHASE,-2.350192791,0.007445688,latanoprost
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.168060748,0.004451464,latanoprost
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.280416248,0.006980333,latanoprost
PROGRAMMED_CELL_DEATH,-2.284832158,0.008143721,latanoprost
TRANSLATION,-2.591393235,0.017529656,flurbiprofen
EUKARYOTIC_TRANSLATION_INITIATION,-2.505669359,0.014608047,flurbiprofen
INFLUENZA_INFECTION,-2.504249558,0.009738698,flurbiprofen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.348659448,0.027755289,flurbiprofen
SELENOAMINO_ACID_METABOLISM,-2.320873253,0.02804745,flurbiprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.317950042,0.02385981,flurbiprofen
SENSORY_PERCEPTION,2.173179466,0.024802073,flurbiprofen
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.266837225,0.030050839,flurbiprofen
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.111733588,0.073040234,flurbiprofen
NEUTROPHIL_DEGRANULATION,-2.029838316,0.108099546,flurbiprofen
CELL_CYCLE_MITOTIC,4.04313816,0,seocalcitol
MITOTIC_METAPHASE_AND_ANAPHASE,2.462070374,0,seocalcitol
MITOTIC_PROMETAPHASE,2.578849638,0,seocalcitol
HIV_INFECTION,2.609772213,0,seocalcitol
MITOTIC_PROPHASE,2.672638036,0,seocalcitol
SEPARATION_OF_SISTER_CHROMATIDS,2.440794644,0,seocalcitol
METABOLISM_OF_RNA,2.922281603,0,seocalcitol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.290997517,0,seocalcitol
M_PHASE,3.329632919,0,seocalcitol
MRNA_SPLICING,2.910523237,0,seocalcitol
C_TYPE_LECTIN_RECEPTORS_CLRS,2.265246412,0.012334093,imexon
POTASSIUM_CHANNELS,-2.060062093,0.02042921,imexon
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.987487481,0.089422175,imexon
HIV_INFECTION,1.911670928,0.084282969,imexon
HIV_LIFE_CYCLE,1.885354503,0.080171605,imexon
TOLL_LIKE_RECEPTOR_CASCADES,1.816889487,0.091272289,imexon
MYD88_INDEPENDENT_TLR4_CASCADE,1.773982442,0.095589221,imexon
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.941608199,0.041588034,imexon
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.939463932,0.028211766,imexon
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.629544392,0.144154712,imexon
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.769490121,0,timolol
TRANSLATION,-2.496967787,0.011095922,timolol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.431300634,0.013737809,timolol
INFLUENZA_INFECTION,-2.320888162,0.027739806,timolol
NEUTROPHIL_DEGRANULATION,-2.272038337,0.034872899,timolol
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.14122385,0.077671456,timolol
SARS_COV_1_INFECTION,-2.063847768,0.112770802,timolol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.018733291,0.136717614,timolol
KEAP1_NFE2L2_PATHWAY,-1.994001101,0.144775367,timolol
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.993067079,0.131565936,timolol
TRANSLATION,-2.582987921,0.006042296,loxapine
GPCR_LIGAND_BINDING,2.427533418,0.001277076,loxapine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.318668768,0.010574018,loxapine
G_ALPHA_I_SIGNALLING_EVENTS,2.195901571,0.006385382,loxapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.190669572,0.004469768,loxapine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.975732036,0.084592145,loxapine
POTENTIAL_THERAPEUTICS_FOR_SARS,-1.907513512,0.098187311,loxapine
SIGNALING_BY_GPCR,1.958176203,0.039589371,loxapine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.879941369,0.063342993,loxapine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.62439053,0.43081571,loxapine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.600145702,0,lamotrigine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.422220995,0.000982933,lamotrigine
GPCR_LIGAND_BINDING,2.324338698,0.000873718,lamotrigine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.183730628,0.179117831,lamotrigine
SIGNALING_BY_GPCR,1.969615752,0.036204688,lamotrigine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.019138223,0.263588172,lamotrigine
SARS_COV_2_INFECTION,-2.002591741,0.198115177,lamotrigine
NEUTROPHIL_DEGRANULATION,-1.98834707,0.162834392,lamotrigine
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.974057001,0.137595061,lamotrigine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.839429928,0.242894635,lamotrigine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.851594235,0,zafirlukast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.783347036,0,zafirlukast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.758837533,0,zafirlukast
SIGNALING_BY_ROBO_RECEPTORS,-2.71206834,0,zafirlukast
VIRAL_INFECTION_PATHWAYS,-2.693477574,0,zafirlukast
CELL_CYCLE_CHECKPOINTS,-2.544390814,8.12E-05,zafirlukast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.559545755,0.00039177,zafirlukast
SARS_COV_1_INFECTION,-2.56167006,8.70E-05,zafirlukast
INFLUENZA_INFECTION,-2.582984315,9.37E-05,zafirlukast
RRNA_PROCESSING,-2.590357679,0.000101492,zafirlukast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.354383744,0,isradipine
SARS_COV_1_HOST_INTERACTIONS,-2.32477318,0.000530577,isradipine
EUKARYOTIC_TRANSLATION_INITIATION,-2.302904069,0.00176859,isradipine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.301824363,0.001326442,isradipine
CELLULAR_RESPONSE_TO_STARVATION,-2.29083412,0.001061154,isradipine
NONSENSE_MEDIATED_DECAY_NMD,-2.282706562,0.000884295,isradipine
INFLUENZA_INFECTION,-2.226125622,0.003031868,isradipine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.223938057,0.002652885,isradipine
SELENOAMINO_ACID_METABOLISM,-2.199902161,0.004244616,isradipine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.125558619,0.010293193,isradipine
NEUTROPHIL_DEGRANULATION,-2.4647006,0.04418995,sotalol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.408230082,0.037119558,sotalol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.330680541,0.045957548,sotalol
INNATE_IMMUNE_SYSTEM,-2.294358518,0.043306151,sotalol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.042472923,0.174285163,sotalol
MEMBRANE_TRAFFICKING,-1.86912551,0.363241389,sotalol
VESICLE_MEDIATED_TRANSPORT,-1.853999302,0.336601162,sotalol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.764701937,0.444329947,sotalol
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.730633555,0.457807881,sotalol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.732059551,1,sotalol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.612152311,0.001099058,resveratrol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.496933396,0.001648586,resveratrol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.379252157,0.004396231,resveratrol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.073458466,0.03544461,resveratrol
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,2.007773566,0.274246729,resveratrol
EUKARYOTIC_TRANSLATION_ELONGATION,1.998212109,0.150345975,resveratrol
NONSENSE_MEDIATED_DECAY_NMD,1.991206597,0.108392755,resveratrol
BIOLOGICAL_OXIDATIONS,-1.819132298,0.1219954,resveratrol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.895183546,0.182667911,resveratrol
SELENOAMINO_ACID_METABOLISM,1.887481978,0.155537074,resveratrol
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.62114122,0.006568144,fluoxetine
INFLUENZA_INFECTION,2.123987004,0.049261084,fluoxetine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.113932415,0.032840722,fluoxetine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.105334705,0.027914614,fluoxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.061197744,0.019078245,fluoxetine
MRNA_SPLICING,1.956397005,0.056486043,fluoxetine
METABOLISM_OF_RNA,1.909279102,0.051450465,fluoxetine
SENSORY_PERCEPTION,-2.005964763,0.020491449,fluoxetine
HOST_INTERACTIONS_OF_HIV_FACTORS,1.866075017,0.052545156,fluoxetine
VISUAL_PHOTOTRANSDUCTION,-1.99188991,0.017193974,fluoxetine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.290172127,0.010604113,pimozide
DISEASES_OF_METABOLISM,2.072674675,0.031812339,pimozide
MITOTIC_SPINDLE_CHECKPOINT,-2.040828108,0.31194485,pimozide
CELL_CYCLE,-2.00204969,0.212795093,pimozide
SIGNALING_BY_PDGF,-1.979681336,0.168921809,pimozide
GLYCOSAMINOGLYCAN_METABOLISM,1.833942855,0.102169788,pimozide
METABOLISM_OF_STEROIDS,1.763970914,0.114751653,pimozide
METABOLISM_OF_RNA,-1.881581911,0.29339051,pimozide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.88048121,0.23726363,pimozide
CELL_CYCLE_CHECKPOINTS,-1.875450672,0.206803587,pimozide
RESPIRATORY_ELECTRON_TRANSPORT,3.139362127,0,fluphenazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.668869121,0.000374226,fluphenazine
TRANSLATION,2.52950453,0.000997935,fluphenazine
COMPLEX_IV_ASSEMBLY,2.430047534,0.001496903,fluphenazine
MITOCHONDRIAL_TRANSLATION,2.40202285,0.002095664,fluphenazine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.360380248,0.002120612,fluphenazine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.302731309,0.02677351,fluphenazine
INTERFERON_GAMMA_SIGNALING,-2.104361097,0.083812728,fluphenazine
ECM_PROTEOGLYCANS,-2.087147802,0.065187677,fluphenazine
GPCR_LIGAND_BINDING,-2.04218544,0.071299022,fluphenazine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.791997405,0,letrozole
RRNA_PROCESSING,2.353896911,0.001869394,letrozole
HEMOSTASIS,-2.613194353,0.001786829,letrozole
EUKARYOTIC_TRANSLATION_INITIATION,2.317645133,0.00327144,letrozole
EUKARYOTIC_TRANSLATION_ELONGATION,2.294878672,0.00218096,letrozole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.285145492,0.00163572,letrozole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.491431999,0.003573657,letrozole
SELENOAMINO_ACID_METABOLISM,2.255240014,0.002617152,letrozole
CELLULAR_RESPONSE_TO_STARVATION,2.146906289,0.008100708,letrozole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.117943966,0.009480499,letrozole
MUSCLE_CONTRACTION,2.714973281,0,BMS-754807
GPCR_LIGAND_BINDING,2.286710489,0.004917918,BMS-754807
CELL_CYCLE,-2.157300043,0.054377504,BMS-754807
CELL_CYCLE_MITOTIC,-2.083584709,0.067202387,BMS-754807
S_PHASE,-2.026623559,0.075239313,BMS-754807
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.947928886,0.050818482,BMS-754807
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.924453998,0.042007213,BMS-754807
EUKARYOTIC_TRANSLATION_ELONGATION,1.919160544,0.034917215,BMS-754807
SELENOAMINO_ACID_METABOLISM,1.914686144,0.030327159,BMS-754807
SYNTHESIS_OF_DNA,-1.956041992,0.112089477,BMS-754807
RESPIRATORY_ELECTRON_TRANSPORT,2.984618881,0,phenothiazine
RRNA_PROCESSING,2.71087285,0,phenothiazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.56382235,0.001333729,phenothiazine
TRANSLATION,2.510529638,0.001333729,phenothiazine
DNA_REPLICATION,2.304724632,0.006135151,phenothiazine
SYNTHESIS_OF_DNA,2.166039504,0.01622703,phenothiazine
CELL_CYCLE_CHECKPOINTS,2.106549485,0.02019646,phenothiazine
SEPARATION_OF_SISTER_CHROMATIDS,2.104165437,0.018005335,phenothiazine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.099993455,0.016745702,phenothiazine
EUKARYOTIC_TRANSLATION_INITIATION,2.075343185,0.016671606,phenothiazine
MITOCHONDRIAL_TRANSLATION,-2.722837607,0,everolimus
SYNTHESIS_OF_DNA,-2.356227695,0.002468002,everolimus
S_PHASE,-2.23327664,0.006816388,everolimus
DNA_REPLICATION,-2.216807928,0.005464863,everolimus
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,2.023633792,0.256063014,everolimus
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.859695169,0.076719619,everolimus
TRANSLATION,-1.851068345,0.06675359,everolimus
DNA_REPAIR,-1.802089118,0.081998122,everolimus
DNA_DOUBLE_STRAND_BREAK_REPAIR,-1.795375959,0.075626646,everolimus
RNA_POLYMERASE_II_TRANSCRIPTION,1.824227826,0.563589673,everolimus
INFLUENZA_INFECTION,-3.420129553,0,mifepristone
TRANSLATION,-3.378837659,0,mifepristone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.362542303,0,mifepristone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.247323591,0,mifepristone
SELENOAMINO_ACID_METABOLISM,-3.189427766,0,mifepristone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.112847643,0,mifepristone
NONSENSE_MEDIATED_DECAY_NMD,-3.066010965,0,mifepristone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.015580755,0,mifepristone
EUKARYOTIC_TRANSLATION_INITIATION,-3.002791879,0,mifepristone
RRNA_PROCESSING,-2.931376596,0,mifepristone
GPCR_LIGAND_BINDING,2.379055841,0.004065316,mocetinostat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.344229582,0.002845721,mocetinostat
CELL_CYCLE_CHECKPOINTS,-2.280522278,0.045114902,mocetinostat
G2_M_CHECKPOINTS,-2.267144253,0.023363074,mocetinostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.24019176,0.019334958,mocetinostat
CELL_CYCLE,-2.235662694,0.015709653,mocetinostat
NEURONAL_SYSTEM,2.161783522,0.01273799,mocetinostat
G_ALPHA_Q_SIGNALLING_EVENTS,2.141634885,0.011586151,mocetinostat
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.051084124,0.023741446,mocetinostat
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.033525738,0.02263026,mocetinostat
GPCR_LIGAND_BINDING,-3.227092882,0,rolipram
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.577494765,0,rolipram
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.604806966,0,rolipram
INFLUENZA_INFECTION,2.684426693,0,rolipram
RRNA_PROCESSING,2.738985004,0,rolipram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.819821686,0,rolipram
SELENOAMINO_ACID_METABOLISM,2.869591986,0,rolipram
RESPIRATORY_ELECTRON_TRANSPORT,2.748621465,0,rolipram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.943993332,0,rolipram
EUKARYOTIC_TRANSLATION_ELONGATION,2.979857665,0,rolipram
CELL_CYCLE_CHECKPOINTS,-3.388891592,0,A-443654
METABOLISM_OF_RNA,-3.338415743,0,A-443654
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-3.28876357,0,A-443654
MITOTIC_METAPHASE_AND_ANAPHASE,-3.247826808,0,A-443654
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-3.054702527,0,A-443654
G2_M_CHECKPOINTS,-2.93096565,0,A-443654
HIV_INFECTION,-2.903724345,0,A-443654
CELL_CYCLE,-2.863796652,0,A-443654
M_PHASE,-2.639398344,0.000575705,A-443654
CELL_CYCLE_MITOTIC,-2.579809472,0.001036269,A-443654
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.583933118,0,equilin
NERVOUS_SYSTEM_DEVELOPMENT,-2.602300859,0,equilin
SARS_COV_2_INFECTION,-2.660034633,0,equilin
SARS_COV_2_HOST_INTERACTIONS,-2.867774089,0,equilin
TRANSLATION,-3.028777886,0,equilin
SARS_COV_1_INFECTION,-3.062633923,0,equilin
RRNA_PROCESSING,-3.091204571,0,equilin
INFLUENZA_INFECTION,-3.290593781,0,equilin
SIGNALING_BY_ROBO_RECEPTORS,-3.313783544,0,equilin
SARS_COV_1_HOST_INTERACTIONS,-3.34772411,0,equilin
GPCR_LIGAND_BINDING,2.525748764,0.001768578,nelarabine
SIGNALING_BY_NOTCH,-1.871404507,0.746172604,nelarabine
RRNA_PROCESSING,-1.858743984,0.424744405,nelarabine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.620091307,0.241410932,nelarabine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.809596844,0.469619121,nelarabine
SARS_COV_1_INFECTION,-1.794178652,0.405959641,nelarabine
SIGNALING_BY_GPCR,1.481722416,0.327186978,nelarabine
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.76147974,0.434136788,nelarabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.756417878,0.378652158,nelarabine
NONSENSE_MEDIATED_DECAY_NMD,-1.754800715,0.329627898,nelarabine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.370495997,0.00423767,aclidinium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.300103649,0.005297087,aclidinium
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.432059708,0.009790769,aclidinium
SIGNALING_BY_ROBO_RECEPTORS,-2.201793221,0.014831845,aclidinium
SELENOAMINO_ACID_METABOLISM,-2.187269641,0.01271301,aclidinium
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.14635159,0.016526912,aclidinium
EUKARYOTIC_TRANSLATION_INITIATION,-2.145436345,0.013772427,aclidinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.127089723,0.014075118,aclidinium
NONSENSE_MEDIATED_DECAY_NMD,-2.112722899,0.013375145,aclidinium
CELLULAR_RESPONSE_TO_STARVATION,-2.034706859,0.028133419,aclidinium
CELLULAR_RESPONSE_TO_STARVATION,2.748777955,0,milnacipran
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.449545521,0.000934281,milnacipran
STIMULI_SENSING_CHANNELS,-2.53759967,0.006261623,milnacipran
RESPIRATORY_ELECTRON_TRANSPORT,2.404231121,0.001868562,milnacipran
GPCR_LIGAND_BINDING,-2.439583693,0.007827029,milnacipran
EUKARYOTIC_TRANSLATION_ELONGATION,2.304991981,0.003970694,milnacipran
RRNA_PROCESSING,2.254956756,0.004858261,milnacipran
SELENOAMINO_ACID_METABOLISM,2.239399246,0.004204265,milnacipran
SIGNALING_BY_GPCR,-2.393543162,0.011131774,milnacipran
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.206466768,0.004938343,milnacipran
RESPIRATORY_ELECTRON_TRANSPORT,2.637696428,0.000507516,econazole
DISEASES_OF_METABOLISM,2.207209421,0.013449162,econazole
ION_CHANNEL_TRANSPORT,-2.305643644,0.126535752,econazole
COMPLEX_I_BIOGENESIS,2.074477755,0.026221637,econazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.044245546,0.02398011,econazole
ECM_PROTEOGLYCANS,-2.202243987,0.159834634,econazole
RAB_REGULATION_OF_TRAFFICKING,2.015989049,0.023142709,econazole
GPCR_LIGAND_BINDING,-2.166750115,0.134971468,econazole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.158140168,0.108221367,econazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.986324675,0.025037434,econazole
SIGNALING_BY_GPCR,-2.45331788,0,BRD-K72166146
GPCR_LIGAND_BINDING,-2.450394585,0,BRD-K72166146
PROTEIN_LOCALIZATION,2.526170211,0.00160828,BRD-K72166146
ION_CHANNEL_TRANSPORT,-2.234772973,0.016258925,BRD-K72166146
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.138013526,0.017087976,BRD-K72166146
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.145059606,0.034081208,BRD-K72166146
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.122765418,0.033518399,BRD-K72166146
MITOTIC_METAPHASE_AND_ANAPHASE,-2.084971543,0.042731789,BRD-K72166146
CELL_CYCLE_MITOTIC,-2.083636139,0.037520596,BRD-K72166146
M_PHASE,-2.049962838,0.045806394,BRD-K72166146
CELL_CYCLE,5.995064415,0,azathioprine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.50103775,0,azathioprine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.535828576,0,azathioprine
INFLUENZA_INFECTION,2.538425373,0,azathioprine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.632652747,0,azathioprine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.680183696,0,azathioprine
DNA_REPLICATION,2.74261444,0,azathioprine
VIRAL_INFECTION_PATHWAYS,2.789067876,0,azathioprine
SYNTHESIS_OF_DNA,2.811179865,0,azathioprine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.845167295,0,azathioprine
SENSORY_PERCEPTION,-2.079872575,0.020993282,AZD-8330
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.012445825,0.023932342,AZD-8330
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.993561371,0.01931382,AZD-8330
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.95013077,0.02309261,AZD-8330
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.739735916,0.464477212,AZD-8330
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.679230195,0.333612601,AZD-8330
GPCR_LIGAND_BINDING,-1.872954569,0.046521113,AZD-8330
INTERLEUKIN_1_FAMILY_SIGNALING,1.566949877,0.427613941,AZD-8330
NEURONAL_SYSTEM,-1.834456141,0.057801504,AZD-8330
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.521004495,0.399044906,AZD-8330
MEMBRANE_TRAFFICKING,2.847982855,0.005099439,cobimetinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.146777674,0.006065164,cobimetinib
METABOLISM_OF_STEROIDS,2.031721588,0.081591025,cobimetinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.008565057,0.023123439,cobimetinib
SIGNALING_BY_GPCR,-1.990670901,0.018448208,cobimetinib
GPCR_LIGAND_BINDING,-1.949522019,0.023312976,cobimetinib
G_ALPHA_Q_SIGNALLING_EVENTS,-1.948440118,0.01880201,cobimetinib
POTASSIUM_CHANNELS,-1.947177661,0.015921057,cobimetinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.722873775,0.277069522,cobimetinib
G_ALPHA_I_SIGNALLING_EVENTS,-1.912918664,0.019278558,cobimetinib
CELLULAR_RESPONSE_TO_STARVATION,3.146625178,0,AT-7519
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.514911111,0.007995474,AT-7519
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.39658164,0.011993211,AT-7519
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.373862046,0.010993777,AT-7519
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.30519715,0.012792759,AT-7519
KEAP1_NFE2L2_PATHWAY,2.15717588,0.021321265,AT-7519
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.134633766,0.020559791,AT-7519
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.012964175,0.040976806,AT-7519
INNATE_IMMUNE_SYSTEM,1.933208172,0.058633478,AT-7519
RESPIRATORY_ELECTRON_TRANSPORT,1.884679269,0.068361305,AT-7519
KEAP1_NFE2L2_PATHWAY,2.235454205,0.037509017,BRD-K63750851
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.12164301,0.034383265,BRD-K63750851
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.937959723,0.075018033,BRD-K63750851
MITOTIC_PROPHASE,1.866906792,0.089083914,BRD-K63750851
M_PHASE,1.820518895,0.100024044,BRD-K63750851
SARS_COV_2_HOST_INTERACTIONS,1.81902883,0.08335337,BRD-K63750851
NEDDYLATION,1.817173263,0.07323189,BRD-K63750851
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.754376575,0.100024044,BRD-K63750851
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,1.720692511,0.106275547,BRD-K63750851
HIV_INFECTION,1.69920409,0.106275547,BRD-K63750851
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.314669583,0,imatinib
GPCR_LIGAND_BINDING,-2.355738443,0,imatinib
METABOLISM_OF_RNA,2.913009896,0.008071429,imatinib
ISG15_ANTIVIRAL_MECHANISM,2.820099709,0.004035714,imatinib
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,2.779277712,0.002690476,imatinib
M_PHASE,2.765920204,0.002017857,imatinib
TRNA_PROCESSING,2.601996506,0.001614286,imatinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.600611622,0.001345238,imatinib
G_ALPHA_S_SIGNALLING_EVENTS,-2.191958199,0.000155914,imatinib
SIGNALING_BY_GPCR,-2.183955142,0.000233871,imatinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.142953594,0,saxagliptin
MRNA_SPLICING,2.729914443,0.005959388,saxagliptin
MITOTIC_METAPHASE_AND_ANAPHASE,2.627164601,0.003972925,saxagliptin
INFLUENZA_INFECTION,2.434753859,0.002979694,saxagliptin
MITOTIC_PROPHASE,2.400369929,0.002383755,saxagliptin
M_PHASE,2.384137647,0.001986463,saxagliptin
SEPARATION_OF_SISTER_CHROMATIDS,2.281494681,0.006810729,saxagliptin
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.203007359,0.007449235,saxagliptin
S_PHASE,2.193261456,0.006621542,saxagliptin
CELL_CYCLE_CHECKPOINTS,2.176444203,0.010726898,saxagliptin
DEUBIQUITINATION,-2.35833297,0.024252618,diclofenac
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.319338709,0.014551571,diclofenac
GPCR_LIGAND_BINDING,2.245775119,0.023177894,diclofenac
CELL_CYCLE,-2.190504799,0.032875771,diclofenac
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.182851288,0.025465249,diclofenac
MUSCLE_CONTRACTION,2.119366823,0.030076077,diclofenac
SIGNALING_BY_GPCR,2.072819677,0.029432247,diclofenac
UB_SPECIFIC_PROCESSING_PROTEASES,-2.101129285,0.048181868,diclofenac
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.094781084,0.040959977,diclofenac
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.032543236,0.060978011,diclofenac
G_ALPHA_Q_SIGNALLING_EVENTS,1.947245374,0.241845806,hesperidin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.897756023,0.193266952,hesperidin
GPCR_LIGAND_BINDING,1.884604816,0.142358177,hesperidin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.848830235,0.143290145,hesperidin
TRANSLATION,-1.932052104,1,hesperidin
SYNTHESIS_OF_DNA,-1.786365797,1,hesperidin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.676757515,1,hesperidin
MITOTIC_METAPHASE_AND_ANAPHASE,-1.589087021,1,hesperidin
DNA_REPLICATION,-1.540011236,1,hesperidin
NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,1.750681437,0.247437616,hesperidin
EUKARYOTIC_TRANSLATION_INITIATION,-3.189980176,0,doxapram
SARS_COV_INFECTIONS,-2.508615409,0,doxapram
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.688800204,0,doxapram
SIGNALING_BY_ROBO_RECEPTORS,-2.727239413,0,doxapram
SARS_COV_1_INFECTION,-2.738074981,0,doxapram
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.762906663,0,doxapram
SARS_COV_1_HOST_INTERACTIONS,-2.809186661,0,doxapram
RRNA_PROCESSING,-2.822091432,0,doxapram
INFLUENZA_INFECTION,-2.876696372,0,doxapram
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.781780109,0,doxapram
G2_M_CHECKPOINTS,2.656691288,0.012634659,escitalopram
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.593620949,0.006317329,escitalopram
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.459105165,0.004211553,escitalopram
UB_SPECIFIC_PROCESSING_PROTEASES,2.362798028,0.003158665,escitalopram
HIV_INFECTION,2.217352193,0.010107727,escitalopram
KEAP1_NFE2L2_PATHWAY,2.208555891,0.008423106,escitalopram
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.153033292,0.005364666,escitalopram
S_PHASE,2.174176069,0.009927232,escitalopram
CELL_CYCLE_CHECKPOINTS,2.074740264,0.013424325,escitalopram
DNA_REPLICATION_PRE_INITIATION,2.069590638,0.011932733,escitalopram
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.751031395,0,nadolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.089842103,0.095195838,nadolol
SENSORY_PERCEPTION,2.012278285,0.124500204,nadolol
G_ALPHA_I_SIGNALLING_EVENTS,1.927552952,0.173225214,nadolol
SIGNALING_BY_GPCR,1.881498038,0.193512852,nadolol
GPCR_LIGAND_BINDING,1.86684132,0.182762138,nadolol
RESPIRATORY_ELECTRON_TRANSPORT,-1.479209155,1,nadolol
AQUAPORIN_MEDIATED_TRANSPORT,1.765281544,0.314346914,nadolol
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.760322914,0.283636781,nadolol
SARS_COV_2_INFECTION,-1.405883026,1,nadolol
RESPIRATORY_ELECTRON_TRANSPORT,2.412374833,0.006259765,methimazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.307701159,0.006828834,methimazole
ION_CHANNEL_TRANSPORT,-2.243020537,0.347071113,methimazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.217211451,0.207562136,methimazole
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.123659829,0.270851575,methimazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.898537771,0.103950032,methimazole
COLLAGEN_FORMATION,-2.056122253,0.312704268,methimazole
CELLULAR_RESPONSE_TO_STARVATION,1.815842517,0.134442674,methimazole
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.018856579,0.314405597,methimazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.007505626,0.280605861,methimazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.360647115,0.01250906,nicotine
M_PHASE,1.812103952,0.414614518,nicotine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.114172097,0.117049065,nicotine
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.697837459,0.39095445,nicotine
CELL_CYCLE_MITOTIC,1.675685598,0.298943076,nicotine
MITOTIC_PROMETAPHASE,1.593592714,0.34307098,nicotine
MITOTIC_METAPHASE_AND_ANAPHASE,1.478840154,0.483566715,nicotine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-1.860295231,0.552483501,nicotine
MRNA_SPLICING,1.369972759,0.66173078,nicotine
DISEASES_OF_METABOLISM,1.361229207,0.590053114,nicotine
NEUTROPHIL_DEGRANULATION,-3.91693469,0.124050539,diphenoxylate
SENSORY_PERCEPTION,2.022981421,0.115962046,diphenoxylate
GPCR_LIGAND_BINDING,2.000208201,0.07369201,diphenoxylate
VESICLE_MEDIATED_TRANSPORT,-2.03662004,1,diphenoxylate
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.922729553,1,diphenoxylate
INNATE_IMMUNE_SYSTEM,-1.695027932,1,diphenoxylate
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.728556605,0.496766443,diphenoxylate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.427176147,1,diphenoxylate
TRANSLATION,-1.423281362,1,diphenoxylate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.704105967,0.446079807,diphenoxylate
HEMOSTASIS,-2.04418443,0.253605865,fenoldopam
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-1.849142513,0.386086541,fenoldopam
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-1.76379146,0.432770207,fenoldopam
ESR_MEDIATED_SIGNALING,-1.723469996,0.409743804,fenoldopam
GASTRULATION,-1.662304545,0.458004622,fenoldopam
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.639187305,0.423307302,fenoldopam
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.598073212,0.443945448,fenoldopam
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.583558638,0.41021695,fenoldopam
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.569435629,0.386507114,fenoldopam
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.553523576,0.374352538,fenoldopam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.450380166,0.03092249,raclopride
HEMOSTASIS,-2.370112187,0.038653113,raclopride
MUSCLE_CONTRACTION,2.051017701,0.068343541,raclopride
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.195083192,0.139151205,raclopride
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.137782377,0.161570011,raclopride
INFLUENZA_INFECTION,-2.114231684,0.150901752,raclopride
NONSENSE_MEDIATED_DECAY_NMD,-2.113302687,0.127297584,raclopride
METABOLISM_OF_RNA,-2.092790711,0.127665709,raclopride
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.903507874,0.125455801,raclopride
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.029093878,0.170266961,raclopride
NONSENSE_MEDIATED_DECAY_NMD,-2.835081574,0,clofibrate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.784206174,0,clofibrate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.739821819,0,clofibrate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.735964851,0,clofibrate
EUKARYOTIC_TRANSLATION_INITIATION,-2.734713231,0,clofibrate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.724765154,0,clofibrate
SELENOAMINO_ACID_METABOLISM,-2.718353895,0,clofibrate
SIGNALING_BY_ROBO_RECEPTORS,-2.630072957,0,clofibrate
INFLUENZA_INFECTION,-2.629986298,0,clofibrate
RRNA_PROCESSING,-2.593721097,0,clofibrate
TOLL_LIKE_RECEPTOR_CASCADES,2.036216213,0.077257364,nalbuphine
HIV_INFECTION,1.903225695,0.096571704,nalbuphine
THE_PHOTOTRANSDUCTION_CASCADE,-2.004023176,0.066322558,nalbuphine
VOLTAGE_GATED_POTASSIUM_CHANNELS,-1.981305074,0.040622567,nalbuphine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.94140419,0.042833319,nalbuphine
SENSORY_PERCEPTION,-1.930578286,0.034197569,nalbuphine
VISUAL_PHOTOTRANSDUCTION,-1.871502219,0.047254823,nalbuphine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.583731353,0.375985836,nalbuphine
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.557554184,0.324480927,nalbuphine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.531496494,0.300531144,nalbuphine
CELL_CYCLE_CHECKPOINTS,3.63861712,0,sitagliptin
G2_M_CHECKPOINTS,3.433190794,0,sitagliptin
MITOTIC_METAPHASE_AND_ANAPHASE,2.923555711,0,sitagliptin
SEPARATION_OF_SISTER_CHROMATIDS,2.875849374,0,sitagliptin
CELL_CYCLE,2.591094503,0,sitagliptin
S_PHASE,2.406978164,0.003789169,sitagliptin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.382537297,0.003247859,sitagliptin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.313312733,0.003789169,sitagliptin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.188499265,0.002304451,sitagliptin
INFLUENZA_INFECTION,2.213808767,0.005052225,sitagliptin
M_PHASE,3.746398096,0,tamibarotene
ISG15_ANTIVIRAL_MECHANISM,3.290049792,0,tamibarotene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.170694179,0,tamibarotene
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,3.067537936,0,tamibarotene
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.68864831,0.000716569,tamibarotene
SUMOYLATION,2.690535481,0.00077169,tamibarotene
G2_M_CHECKPOINTS,2.735102735,0.000835998,tamibarotene
INFLUENZA_INFECTION,2.74137514,0.000911997,tamibarotene
HIV_LIFE_CYCLE,2.753478179,0.001003197,tamibarotene
S_PHASE,2.661415626,0.000668798,tamibarotene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.489451461,0,dabrafenib
ISG15_ANTIVIRAL_MECHANISM,2.402856886,0.040770665,dabrafenib
GPCR_LIGAND_BINDING,-2.118037432,0.003570858,dabrafenib
INFLUENZA_INFECTION,2.144788893,0.053511498,dabrafenib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.057375279,0.008007379,dabrafenib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.998091709,0.084938885,dabrafenib
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.849718744,0.149067744,dabrafenib
SIGNALING_BY_ALK_IN_CANCER,1.84104213,0.124350528,dabrafenib
MITF_M_DEPENDENT_GENE_EXPRESSION,1.758224377,0.159685105,dabrafenib
SIGNALING_BY_GPCR,-1.895416328,0.03716939,dabrafenib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.162533949,1,phenazopyridine
EUKARYOTIC_TRANSLATION_INITIATION,-2.139903038,1,phenazopyridine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.100384051,1,phenazopyridine
SELENOAMINO_ACID_METABOLISM,-2.092603753,1,phenazopyridine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.081950612,1,phenazopyridine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.007375395,1,phenazopyridine
INFLUENZA_INFECTION,-1.958175885,0.88276892,phenazopyridine
KEAP1_NFE2L2_PATHWAY,-1.919886304,0.784989654,phenazopyridine
TRANSLATION,-1.905324176,0.701925058,phenazopyridine
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.903576509,0.632200156,phenazopyridine
ECM_PROTEOGLYCANS,1.714092013,0.812180062,naltrexone
SYNTHESIS_OF_DNA,1.704020925,0.42805689,naltrexone
DNA_REPLICATION,1.614350441,0.453190142,naltrexone
METABOLISM_OF_NUCLEOTIDES,1.515933174,0.572919415,naltrexone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.766416602,1,naltrexone
REPRODUCTION,-1.72123985,1,naltrexone
DISEASES_OF_METABOLISM,1.407157392,0.786057312,naltrexone
EXTRACELLULAR_MATRIX_ORGANIZATION,1.388912251,0.712240751,naltrexone
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.380245268,0.638650362,naltrexone
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.688009209,1,naltrexone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.916026079,0.170063513,bumetanide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.72640556,0.207033842,bumetanide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.5440704,0.337388483,bumetanide
GPCR_LIGAND_BINDING,1.50047476,0.310961545,bumetanide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.451012596,0.325174582,bumetanide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.44545183,0.278646739,bumetanide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.053006363,1,bumetanide
EUKARYOTIC_TRANSLATION_ELONGATION,-1.998263982,1,bumetanide
NONSENSE_MEDIATED_DECAY_NMD,-1.972554046,1,bumetanide
SELENOAMINO_ACID_METABOLISM,-1.969864007,1,bumetanide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.25785441,0.000423845,dienestrol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.25785441,0.000423845,dienestrol
CELLULAR_RESPONSE_TO_STARVATION,-2.209538329,0.001412815,dienestrol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.199573843,0.001059612,dienestrol
EUKARYOTIC_TRANSLATION_INITIATION,-2.193655463,0.000847689,dienestrol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.13056061,0.002260505,dienestrol
SELENOAMINO_ACID_METABOLISM,-2.097502262,0.003269658,dienestrol
NONSENSE_MEDIATED_DECAY_NMD,-2.088511653,0.003390757,dienestrol
INFLUENZA_INFECTION,-2.075553354,0.003767508,dienestrol
GPCR_LIGAND_BINDING,-2.069904894,0.003560295,dienestrol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.804146917,0,estriol
SARS_COV_2_INFECTION,-2.486927013,0,estriol
NERVOUS_SYSTEM_DEVELOPMENT,-2.765629113,0,estriol
SARS_COV_2_HOST_INTERACTIONS,-2.857042177,0,estriol
TRANSLATION,-3.105631329,0,estriol
RRNA_PROCESSING,-3.175335804,0,estriol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.2070325,0,estriol
SIGNALING_BY_ROBO_RECEPTORS,-3.44945577,0,estriol
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.457435772,0,estriol
SARS_COV_1_HOST_INTERACTIONS,-3.471594657,0,estriol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.598859715,0,rabeprazole
SELENOAMINO_ACID_METABOLISM,-2.586749733,0,rabeprazole
NONSENSE_MEDIATED_DECAY_NMD,-2.564492417,0,rabeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.517749222,0,rabeprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.512797339,0,rabeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.501492231,0,rabeprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.454511223,0,rabeprazole
CELLULAR_RESPONSE_TO_STARVATION,-2.445468864,0,rabeprazole
INFLUENZA_INFECTION,-2.40667145,0.000219688,rabeprazole
SIGNALING_BY_ROBO_RECEPTORS,-2.417326901,0.000244098,rabeprazole
NONSENSE_MEDIATED_DECAY_NMD,-3.047486442,0,triclosan
SIGNALING_BY_ROBO_RECEPTORS,-2.617353175,0,triclosan
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.646001513,0,triclosan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.709276743,0,triclosan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.786837536,0,triclosan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.817034728,0,triclosan
SELENOAMINO_ACID_METABOLISM,-2.843866191,0,triclosan
CELLULAR_RESPONSE_TO_STARVATION,-2.659859653,0,triclosan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.928776974,0,triclosan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.94462978,0,triclosan
NEURONAL_SYSTEM,2.2934629,0.016336652,amoxapine
PROTEIN_UBIQUITINATION,-2.166528677,0.136674309,amoxapine
TRANSLATION,-2.126039677,0.09877303,amoxapine
CHROMOSOME_MAINTENANCE,-2.091664193,0.088819159,amoxapine
EUKARYOTIC_TRANSLATION_INITIATION,-2.078301097,0.072644118,amoxapine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.02952295,0.090733365,amoxapine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.011490096,0.088244897,amoxapine
RRNA_PROCESSING,-1.982271139,0.092210038,amoxapine
METABOLISM_OF_RNA,-1.966519671,0.09245615,amoxapine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.878430845,0.18174525,amoxapine
INFLUENZA_INFECTION,2.263907748,0.045738411,tacrolimus
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.96486567,0.105198346,tacrolimus
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.941686604,0.080804527,tacrolimus
TRANSLATION,1.916961009,0.070894538,tacrolimus
CELLULAR_RESPONSE_TO_STARVATION,1.914239356,0.059459935,tacrolimus
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.757863155,0.107485267,tacrolimus
GOLGI_TO_ER_RETROGRADE_TRANSPORT,1.643027293,0.175766181,tacrolimus
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.603020833,0.193244788,tacrolimus
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.860706789,0.308230996,tacrolimus
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.562962772,0.213954125,tacrolimus
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.082206712,0.143357529,tibolone
ESR_MEDIATED_SIGNALING,-3.116518844,0.588904563,tibolone
EPH_EPHRIN_SIGNALING,1.787792007,0.658718771,tibolone
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.014804535,0.986613714,tibolone
METABOLISM_OF_RNA,1.746025967,0.588249775,tibolone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.974742331,0.917586686,tibolone
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.957777211,0.779248957,tibolone
GPCR_LIGAND_BINDING,1.715456209,0.546437162,tibolone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.945547288,0.674233317,tibolone
SIGNALING_BY_NUCLEAR_RECEPTORS,-2.891293353,0.741898716,tibolone
MUSCLE_CONTRACTION,2.537449962,0.009361549,ethotoin
RESPIRATORY_ELECTRON_TRANSPORT,2.105579928,0.180989957,ethotoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.042521597,0.177349354,ethotoin
MEMBRANE_TRAFFICKING,-1.852775562,0.848454074,ethotoin
GASTRULATION,1.724361403,0.692364598,ethotoin
LEISHMANIA_INFECTION,1.683552888,0.65998924,ethotoin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,-1.765908472,0.824977432,ethotoin
DEATH_RECEPTOR_SIGNALING,-1.755056249,0.599409464,ethotoin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.591454011,0.794951578,ethotoin
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.578555134,0.630734397,ethotoin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.190818508,0,metyrapone
RESPIRATORY_ELECTRON_TRANSPORT,2.987190727,0,metyrapone
RRNA_PROCESSING,2.625507983,0,metyrapone
TRANSLATION,2.408425569,0.003982504,metyrapone
MITOCHONDRIAL_TRANSLATION,1.926144813,0.076954235,metyrapone
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.919120259,0.068008918,metyrapone
FATTY_ACID_METABOLISM,1.760619793,0.151422688,metyrapone
BIOLOGICAL_OXIDATIONS,1.722191215,0.166805657,metyrapone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.720060836,0.150450159,metyrapone
CELL_CYCLE_CHECKPOINTS,1.715653584,0.138346069,metyrapone
ASPARAGINE_N_LINKED_GLYCOSYLATION,-2.132648758,0.085629732,anastrozole
GPCR_LIGAND_BINDING,2.119316347,0.033716065,anastrozole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-2.090636575,0.073569206,anastrozole
METABOLISM_OF_RNA,-2.00746285,0.112162888,anastrozole
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.983554742,0.103419007,anastrozole
MUSCLE_CONTRACTION,1.938654751,0.056363725,anastrozole
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-1.941379831,0.123258572,anastrozole
VESICLE_MEDIATED_TRANSPORT,-1.933941282,0.1101528,anastrozole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.860981557,0.059031494,anastrozole
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,-1.899543487,0.126463226,anastrozole
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.121775278,0.084318537,clofarabine
C_TYPE_LECTIN_RECEPTORS_CLRS,2.039828195,0.072273031,clofarabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.046488974,0.025994544,clofarabine
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.965474857,0.072273031,clofarabine
GPCR_LIGAND_BINDING,-2.020171781,0.016607626,clofarabine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.863438544,0.093352666,clofarabine
SARS_COV_2_HOST_INTERACTIONS,1.851083716,0.080704885,clofarabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.99289493,0.017329696,clofarabine
MYD88_INDEPENDENT_TLR4_CASCADE,1.811743464,0.091345081,clofarabine
G_ALPHA_S_SIGNALLING_EVENTS,-1.903121298,0.03718664,clofarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.76081031,0,indometacin
MRNA_SPLICING,-2.584611759,0,indometacin
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.642142544,0.003074524,indometacin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.371905024,0.004300977,indometacin
ISG15_ANTIVIRAL_MECHANISM,-2.281917552,0.007419186,indometacin
METABOLISM_OF_RNA,-2.271169312,0.006967584,indometacin
RHO_GTPASE_EFFECTORS,-2.222155109,0.010752444,indometacin
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-2.116987315,0.022487968,indometacin
GPCR_LIGAND_BINDING,2.310281061,0.030745243,indometacin
DEVELOPMENTAL_CELL_LINEAGES,2.303820469,0.021668076,indometacin
MEMBRANE_TRAFFICKING,2.998419236,0,floxuridine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.723976893,0,floxuridine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.383501415,0.006130973,floxuridine
S_PHASE,2.140389844,0.013794689,floxuridine
MITOTIC_PROPHASE,2.11454424,0.014714335,floxuridine
TOLL_LIKE_RECEPTOR_CASCADES,2.016617159,0.021458405,floxuridine
SARS_COV_1_INFECTION,1.920383613,0.035472058,floxuridine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.938376803,0.026242681,floxuridine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.847807941,0.058627428,floxuridine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.916066396,0.01940865,floxuridine
EUKARYOTIC_TRANSLATION_ELONGATION,2.460730191,0.008649814,ciclopirox
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.442044134,0.004324907,ciclopirox
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.257759714,0.012843663,ciclopirox
SELENOAMINO_ACID_METABOLISM,2.210489895,0.01415424,ciclopirox
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.189893817,0.012581547,ciclopirox
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2.081585181,0.021362418,ciclopirox
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.045278354,0.142426113,ciclopirox
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-1.941742547,0.238085442,ciclopirox
ADIPOGENESIS,-1.923486048,0.188130014,ciclopirox
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-1.879400588,0.21417061,ciclopirox
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.000510032,0,cabergoline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.758238863,0,cabergoline
EUKARYOTIC_TRANSLATION_INITIATION,-2.671054054,0,cabergoline
SELENOAMINO_ACID_METABOLISM,-2.638788984,0,cabergoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.633738103,0,cabergoline
NONSENSE_MEDIATED_DECAY_NMD,-2.633496401,0,cabergoline
METABOLISM_OF_RNA,-2.59950579,0,cabergoline
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.578684888,0,cabergoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.56107043,0,cabergoline
SIGNALING_BY_ROBO_RECEPTORS,-2.501751306,0,cabergoline
EXTRACELLULAR_MATRIX_ORGANIZATION,1.787119405,0.275867898,esmolol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.05540866,1,esmolol
DISEASES_OF_METABOLISM,1.604921926,0.417605173,esmolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.826867665,1,esmolol
METABOLISM_OF_RNA,-1.772739283,1,esmolol
HEMOSTASIS,-1.756605915,1,esmolol
TRANSPORT_OF_SMALL_MOLECULES,-1.74656647,0.839410412,esmolol
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.705689945,0.805440084,esmolol
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.496074883,0.498658271,esmolol
GLYCOSAMINOGLYCAN_METABOLISM,1.494603848,0.376529254,esmolol
CELL_CYCLE,-2.590711122,0.004439444,repaglinide
CELL_CYCLE_MITOTIC,-2.529659033,0.002219722,repaglinide
NEUTROPHIL_DEGRANULATION,-2.324541627,0.010851975,repaglinide
M_PHASE,-2.217329896,0.023677036,repaglinide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.182166996,0.024268961,repaglinide
CELL_CYCLE_CHECKPOINTS,-2.165090731,0.022937128,repaglinide
DEUBIQUITINATION,-2.110772545,0.027482273,repaglinide
CHROMOSOME_MAINTENANCE,-2.091046467,0.029041364,repaglinide
MITOTIC_PROMETAPHASE,-2.088384654,0.026636665,repaglinide
INNATE_IMMUNE_SYSTEM,-2.087235212,0.024416943,repaglinide
RESPIRATORY_ELECTRON_TRANSPORT,2.580828085,0,benzylpenicillin
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-2.247484376,0.025389821,benzylpenicillin
DISEASES_OF_METABOLISM,2.293069049,0.006880472,benzylpenicillin
ECM_PROTEOGLYCANS,-2.216345282,0.020044595,benzylpenicillin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.19331055,0.01469937,benzylpenicillin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.154118864,0.019710519,benzylpenicillin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.150980689,0.016570199,benzylpenicillin
CHROMATIN_ORGANIZATION,-2.142371874,0.015144805,benzylpenicillin
GPCR_LIGAND_BINDING,-2.140441131,0.013363064,benzylpenicillin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.070720364,0.029540159,benzylpenicillin
CELL_CYCLE_MITOTIC,-3.247069243,0,amsacrine
CELL_CYCLE_CHECKPOINTS,-2.820921303,0,amsacrine
RHO_GTPASES_ACTIVATE_FORMINS,-2.853606965,0,amsacrine
M_PHASE,-2.858878687,0,amsacrine
RHO_GTPASE_EFFECTORS,-2.86867933,0,amsacrine
MITOTIC_PROMETAPHASE,-2.796733598,0,amsacrine
SEPARATION_OF_SISTER_CHROMATIDS,-2.988258171,0,amsacrine
MITOTIC_METAPHASE_AND_ANAPHASE,-3.039532643,0,amsacrine
CELL_CYCLE,-3.080126917,0,amsacrine
MITOTIC_SPINDLE_CHECKPOINT,-3.085068812,0,amsacrine
CELL_CYCLE_MITOTIC,2.678060884,0,moxifloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.567347312,0,moxifloxacin
M_PHASE,2.458538709,0.002374451,moxifloxacin
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.398994858,0.001780838,moxifloxacin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.318555016,0.001424671,moxifloxacin
HIV_LIFE_CYCLE,2.189944327,0.010685029,moxifloxacin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.184754748,0.010176218,moxifloxacin
S_PHASE,2.130525741,0.013356286,moxifloxacin
TOLL_LIKE_RECEPTOR_CASCADES,2.11282035,0.014246705,moxifloxacin
METABOLISM_OF_RNA,2.055371732,0.017096047,moxifloxacin
NUCLEAR_ENVELOPE_BREAKDOWN,2.317140405,0.034793287,dronedarone
CELL_CYCLE_CHECKPOINTS,2.239056697,0.034793287,dronedarone
GLUCOSE_METABOLISM,2.148197711,0.044071497,dronedarone
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,1.925750967,0.118297176,dronedarone
MITOTIC_SPINDLE_CHECKPOINT,1.920593663,0.100204666,dronedarone
TRNA_PROCESSING,1.857784392,0.111338518,dronedarone
MITOTIC_PROMETAPHASE,1.845117895,0.104379861,dronedarone
SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,1.804549116,0.118297176,dronedarone
TRNA_PROCESSING_IN_THE_NUCLEUS,1.740530267,0.151544094,dronedarone
MITOTIC_PROPHASE,1.686668401,0.196930004,dronedarone
EUKARYOTIC_TRANSLATION_INITIATION,2.624251126,0,baricitinib
NONSENSE_MEDIATED_DECAY_NMD,2.842938301,0,baricitinib
EUKARYOTIC_TRANSLATION_ELONGATION,2.787982001,0,baricitinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.787029607,0,baricitinib
CELLULAR_RESPONSE_TO_STARVATION,2.758170567,0,baricitinib
SELENOAMINO_ACID_METABOLISM,2.702001704,0,baricitinib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.657954378,0,baricitinib
RRNA_PROCESSING,2.644358283,0,baricitinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.623423177,0,baricitinib
SIGNALING_BY_ROBO_RECEPTORS,2.445195682,0.000120908,baricitinib
EUKARYOTIC_TRANSLATION_INITIATION,-3.253760597,0,etodolac
METABOLISM_OF_RNA,-2.524602828,0,etodolac
VIRAL_INFECTION_PATHWAYS,-2.534007362,0,etodolac
SARS_COV_1_INFECTION,-2.565092649,0,etodolac
NERVOUS_SYSTEM_DEVELOPMENT,-2.641956833,0,etodolac
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.694539227,0,etodolac
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.700388458,0,etodolac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.712989701,0,etodolac
SARS_COV_1_HOST_INTERACTIONS,-2.778088358,0,etodolac
CELLULAR_RESPONSE_TO_STARVATION,-2.94236874,0,etodolac
METABOLISM_OF_RNA,-3.335545083,0,bendroflumethiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.746579679,0,bendroflumethiazide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.864902859,0,bendroflumethiazide
SIGNALING_BY_ROBO_RECEPTORS,-2.900056448,0,bendroflumethiazide
GPCR_LIGAND_BINDING,3.037850049,0,bendroflumethiazide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.052824475,0,bendroflumethiazide
CELLULAR_RESPONSE_TO_STARVATION,-3.054616645,0,bendroflumethiazide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.172931316,0,bendroflumethiazide
TRANSLATION,-3.143596981,0,bendroflumethiazide
INFLUENZA_INFECTION,-3.183007588,0,bendroflumethiazide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.402366768,0.010279991,talniflumate
CILIUM_ASSEMBLY,2.056918021,0.11593545,talniflumate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.011096513,0.103180647,talniflumate
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1.988068233,0.093376582,talniflumate
NEURONAL_SYSTEM,1.972671039,0.081783037,talniflumate
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.182960531,0.655986552,talniflumate
OPIOID_SIGNALLING,1.897259315,0.116887301,talniflumate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.122451112,0.493087615,talniflumate
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.834027166,0.157137,talniflumate
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.683235658,0.341524133,talniflumate
S_PHASE,3.336482965,0,alitretinoin
ISG15_ANTIVIRAL_MECHANISM,2.379141213,0,alitretinoin
G2_M_CHECKPOINTS,2.380923098,0,alitretinoin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.5296682,0,alitretinoin
MRNA_SPLICING,2.613700992,0,alitretinoin
DNA_REPLICATION,2.618599927,0,alitretinoin
METABOLISM_OF_RNA,2.50224476,0,alitretinoin
CELL_CYCLE_CHECKPOINTS,2.653141844,0,alitretinoin
SEPARATION_OF_SISTER_CHROMATIDS,2.658992097,0,alitretinoin
M_PHASE,2.75121229,0,alitretinoin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.180398004,0.054568259,felbamate
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.978018044,0.368885271,felbamate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.568329914,1,felbamate
RAC3_GTPASE_CYCLE,-1.5463653,0.771014209,felbamate
OPIOID_SIGNALLING,1.703025468,1,felbamate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.695244103,1,felbamate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.48405822,0.772710984,felbamate
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.406175982,0.895896793,felbamate
EUKARYOTIC_TRANSLATION_INITIATION,1.579269718,1,felbamate
RRNA_PROCESSING,1.573954142,1,felbamate
S_PHASE,-2.352549064,0.040276648,gabexate
TRANSLATION,-2.306189045,0.023799837,gabexate
MITOCHONDRIAL_TRANSLATION,-2.289074061,0.021969081,gabexate
CELL_CYCLE,-2.088313487,0.036615134,gabexate
SENSORY_PERCEPTION,2.180175585,0.028030545,gabexate
SYNTHESIS_OF_DNA,-1.985818719,0.056387307,gabexate
CELL_CYCLE_MITOTIC,-1.941222908,0.063466233,gabexate
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.916131209,0.060153435,gabexate
CHROMOSOME_MAINTENANCE,-1.888907819,0.058126526,gabexate
DNA_REPLICATION,-1.739359968,0.129780309,gabexate
CELL_CYCLE,4.937648926,0,salmeterol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.297848353,0,salmeterol
M_PHASE,3.064296606,0,salmeterol
CELL_CYCLE_CHECKPOINTS,3.040619114,0,salmeterol
ISG15_ANTIVIRAL_MECHANISM,3.031572747,0,salmeterol
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.962936084,0,salmeterol
G2_M_CHECKPOINTS,2.890687007,0,salmeterol
S_PHASE,2.804114033,0,salmeterol
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,2.669098917,0.002223878,salmeterol
MITOTIC_METAPHASE_AND_ANAPHASE,2.547026076,0.00200149,salmeterol
TRANSLATION,2.67262636,0.010967668,gestrinone
VOLTAGE_GATED_POTASSIUM_CHANNELS,-2.248910637,0.002948133,gestrinone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.149136734,0.041128756,gestrinone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.149028716,0.027419171,gestrinone
HIV_INFECTION,2.098304686,0.026048212,gestrinone
POTASSIUM_CHANNELS,-2.112893897,0.007738849,gestrinone
S_PHASE,2.002247051,0.033999772,gestrinone
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.759074378,0.100536959,gestrinone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.748264063,0.094008585,gestrinone
METABOLISM_OF_RNA,1.735821822,0.090483263,gestrinone
VESICLE_MEDIATED_TRANSPORT,2.138946223,0.039059675,amuvatinib
MEMBRANE_TRAFFICKING,2.02605963,0.074864376,amuvatinib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.003944758,0.054249548,amuvatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.794627162,0.113924051,amuvatinib
INTERLEUKIN_1_FAMILY_SIGNALING,1.790693774,0.093743219,amuvatinib
TRANSLATION,1.770097651,0.086799277,amuvatinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.717759903,0.108809093,amuvatinib
S_PHASE,1.69794969,0.107414105,amuvatinib
MRNA_SPLICING,1.687075137,0.102712477,amuvatinib
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1.62356495,0.133453888,amuvatinib
METABOLISM_OF_STEROIDS,2.821620786,0,romidepsin
MEMBRANE_TRAFFICKING,2.391169461,0.006644682,romidepsin
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.214564584,0.015061279,romidepsin
SIGNALING_BY_INSULIN_RECEPTOR,2.19181789,0.015282768,romidepsin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.9632292,0.044652262,romidepsin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.934297512,0.043411921,romidepsin
CELLULAR_RESPONSE_TO_STARVATION,1.931438326,0.037589914,romidepsin
SIGNALING_BY_GPCR,-2.028350781,0.078040947,romidepsin
VESICLE_MEDIATED_TRANSPORT,1.910211672,0.037542452,romidepsin
METABOLISM_OF_LIPIDS,1.883372171,0.038391495,romidepsin
NEUTROPHIL_DEGRANULATION,-2.639825999,0.005735354,rutin
TRANSLATION,-2.313060866,0.017206063,rutin
INFLUENZA_INFECTION,-2.227626415,0.021029633,rutin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.14685601,0.022941417,rutin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.819409058,0.13822204,rutin
RESPIRATORY_ELECTRON_TRANSPORT,-1.754217723,0.167281169,rutin
MITOTIC_METAPHASE_AND_ANAPHASE,-1.751872772,0.144612864,rutin
CELL_CYCLE_CHECKPOINTS,-1.693865343,0.170268333,rutin
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.663865512,0.181300924,rutin
SENSORY_PERCEPTION,1.891014439,0.450751857,rutin
NEURONAL_SYSTEM,2.093682389,0.059609154,ramipril
PLATELET_HOMEOSTASIS,2.013437256,0.054370773,ramipril
APOPTOSIS,-2.041897883,0.544247102,ramipril
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.017119917,0.321416403,ramipril
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.932694775,0.401995585,ramipril
SARS_COV_1_INFECTION,-1.900043232,0.385227012,ramipril
SARS_COV_INFECTIONS,-1.890320583,0.330869826,ramipril
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.87931702,0.295081866,ramipril
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.86861217,0.274149285,ramipril
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.861900309,0.252710271,ramipril
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.494694424,0.011819689,milrinone
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.273836291,0.044323832,milrinone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.229337902,0.038742313,milrinone
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.103701583,0.071903106,milrinone
RESPIRATORY_ELECTRON_TRANSPORT,2.07676044,0.077362202,milrinone
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-2.056398014,0.081949841,milrinone
ISG15_ANTIVIRAL_MECHANISM,-2.010155103,0.09390086,milrinone
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.991494504,0.090899034,milrinone
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.966117756,0.093818778,milrinone
RHO_GTPASE_CYCLE,-1.960927863,0.085583301,milrinone
CARDIAC_CONDUCTION,2.188797489,0.052640363,BRD-K89997465
MUSCLE_CONTRACTION,2.173848227,0.03075973,BRD-K89997465
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.192596212,0.185064119,BRD-K89997465
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.129914899,0.145494488,BRD-K89997465
PROTEIN_LOCALIZATION,-2.088547699,0.123781921,BRD-K89997465
NEURONAL_SYSTEM,2.000689653,0.065536195,BRD-K89997465
APOPTOSIS,-2.047983509,0.127231582,BRD-K89997465
PROGRAMMED_CELL_DEATH,-2.00140161,0.140989638,BRD-K89997465
HIV_INFECTION,-1.9876892,0.127434503,BRD-K89997465
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.982748197,0.113577885,BRD-K89997465
SIGNALING_BY_INTERLEUKINS,-2.135460892,0.103436556,desloratadine
SARS_COV_1_INFECTION,-2.085113497,0.068957704,desloratadine
TRANSLATION,-2.07223191,0.04806143,desloratadine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.924155631,0.108138218,desloratadine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.868734025,0.112839879,desloratadine
EUKARYOTIC_TRANSLATION_INITIATION,-1.867053089,0.095078046,desloratadine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.838026497,0.097167674,desloratadine
SIGNALING_BY_ROBO_RECEPTORS,-1.835325755,0.087372545,desloratadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.996602714,0.175662377,desloratadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.794289921,0.099257301,desloratadine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.283934707,0.019311876,alvimopan
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.123438353,0.0160442,alvimopan
S_PHASE,2.047850819,0.080466149,alvimopan
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.04670144,0.053644099,alvimopan
TOLL_LIKE_RECEPTOR_CASCADES,2.008867008,0.049889012,alvimopan
SYNTHESIS_OF_DNA,2.001995225,0.041198668,alvimopan
DNA_REPLICATION,1.982978752,0.040769515,alvimopan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.948898946,0.040462978,alvimopan
HIV_INFECTION,1.946878496,0.036209767,alvimopan
TRANSLATION,1.946619341,0.032186459,alvimopan
SIGNALING_BY_ALK_IN_CANCER,2.153093851,0.058979006,doramapimod
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.039907764,0.058979006,doramapimod
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.970961801,0.064340734,doramapimod
VESICLE_MEDIATED_TRANSPORT,1.893695384,0.061123697,doramapimod
MEMBRANE_TRAFFICKING,1.893695384,0.061123697,doramapimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.916632151,0.1081871,doramapimod
GPCR_LIGAND_BINDING,-1.884991142,0.07599646,doramapimod
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.590182395,0.356554901,doramapimod
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.564842065,0.353108076,doramapimod
SUMOYLATION,1.538708309,0.351193173,doramapimod
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.624302314,0.005707675,epirubicin
KEAP1_NFE2L2_PATHWAY,2.270221257,0.019976861,epirubicin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.266922997,0.013317907,epirubicin
FATTY_ACID_METABOLISM,2.127398608,0.025684535,epirubicin
SENSORY_PERCEPTION,-2.052353149,0.020605927,epirubicin
SARS_COV_2_INFECTION,1.907640482,0.066209024,epirubicin
INTERFERON_GAMMA_SIGNALING,1.83721141,0.078956164,epirubicin
NEUTROPHIL_DEGRANULATION,1.758218964,0.113338108,epirubicin
SARS_COV_1_INFECTION,1.707720051,0.143405322,epirubicin
VISUAL_PHOTOTRANSDUCTION,-1.875873038,0.084085478,epirubicin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.536373969,0.117428662,moxonidine
LATE_SARS_COV_2_INFECTION_EVENTS,-2.43449533,0.180439164,moxonidine
ION_CHANNEL_TRANSPORT,-2.237728811,0.444892331,moxonidine
ADIPOGENESIS,1.840753655,0.912633648,moxonidine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.010617098,0.656956084,moxonidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.893775364,0.637551713,moxonidine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.647413213,0.779993635,moxonidine
REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1.703555326,1,moxonidine
RAB_REGULATION_OF_TRAFFICKING,1.692729683,1,moxonidine
HEMOSTASIS,-1.405592581,1,moxonidine
SENSORY_PERCEPTION,2.022322054,0.143159368,diclofenamide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.276095349,0.210418018,diclofenamide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.878701676,0.190481493,diclofenamide
SIGNALING_BY_WNT,-3.012492,1,diclofenamide
MUSCLE_CONTRACTION,1.622365808,0.546656699,diclofenamide
G_ALPHA_I_SIGNALLING_EVENTS,1.618263264,0.418343487,diclofenamide
PROTEIN_LOCALIZATION,-1.856368226,1,diclofenamide
CARDIAC_CONDUCTION,1.544028327,0.492150095,diclofenamide
GPCR_LIGAND_BINDING,1.517463056,0.468051601,diclofenamide
SIGNALING_BY_GPCR,1.394814217,0.698413203,diclofenamide
TRANSLATION,-2.670293335,0.006046931,cisapride
NEUTROPHIL_DEGRANULATION,-2.547394241,0.006046931,cisapride
SIGNALING_BY_INTERLEUKINS,-2.016897275,0.069539711,cisapride
INNATE_IMMUNE_SYSTEM,-1.959164667,0.068027978,cisapride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.913781262,0.062283394,cisapride
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.851215719,0.085160951,cisapride
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.738319453,0.143830583,cisapride
SARS_COV_1_INFECTION,-1.66047755,0.195013538,cisapride
SARS_COV_2_INFECTION,-1.613237955,0.221384878,cisapride
INFLUENZA_INFECTION,-1.577948425,0.233713899,cisapride
SENSORY_PERCEPTION,2.349138105,0.013923244,mexiletine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.157376567,0.05997705,mexiletine
SIGNALING_BY_GPCR,2.047242369,0.094963662,mexiletine
DISEASES_OF_METABOLISM,-1.895764909,0.185998978,mexiletine
G_ALPHA_I_SIGNALLING_EVENTS,2.023627818,0.087823537,mexiletine
RHO_GTPASE_EFFECTORS,-1.805059949,0.155237609,mexiletine
GPCR_LIGAND_BINDING,1.878227478,0.200066301,mexiletine
RHO_GTPASE_CYCLE,1.737733296,0.415555272,mexiletine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.731782541,0.369807472,mexiletine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.72764883,0.332283565,mexiletine
METABOLISM_OF_RNA,-2.726041093,0,H-89
METABOLISM_OF_STEROIDS,2.492602867,0.000802417,H-89
CHOLESTEROL_BIOSYNTHESIS,2.459916161,0.000802417,H-89
SENSORY_PERCEPTION,2.326444899,0.00213978,H-89
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.307497173,0.002407252,H-89
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.470714636,0.008879306,H-89
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.18724473,0.006258856,H-89
HIV_LIFE_CYCLE,-2.248358533,0.041892109,H-89
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.139543505,0.066594793,H-89
MRNA_SPLICING,-2.122876443,0.060379279,H-89
SENSORY_PERCEPTION,2.266833268,0.006082786,phenoxybenzamine
GPCR_LIGAND_BINDING,2.187801163,0.009124179,phenoxybenzamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.068071031,0.019431122,phenoxybenzamine
SIGNALING_BY_FGFR,-3.151681921,1,phenoxybenzamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.892090686,0.074387404,phenoxybenzamine
SIGNALING_BY_GPCR,1.887445118,0.062348557,phenoxybenzamine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.847101647,0.073246882,phenoxybenzamine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-3.034165995,1,phenoxybenzamine
SIGNALING_BY_INSULIN_RECEPTOR,-3.00306264,1,phenoxybenzamine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.810786337,0.084217621,phenoxybenzamine
METABOLISM_OF_RNA,-3.273008126,0,nilutamide
GPCR_LIGAND_BINDING,2.704214338,0,nilutamide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.77509816,0.001164394,nilutamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.554578105,0.000313668,nilutamide
SIGNALING_BY_GPCR,2.524186802,0.000418224,nilutamide
SENSORY_PERCEPTION,2.46296999,0.000313668,nilutamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.386688755,0.000250935,nilutamide
NEUTROPHIL_DEGRANULATION,-2.502257237,0.002328788,nilutamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.492658936,0.001746591,nilutamide
MRNA_SPLICING,-2.466560222,0.00186303,nilutamide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.380583567,0.005197087,enalaprilat
GPCR_LIGAND_BINDING,2.189358662,0.027840225,enalaprilat
NEUTROPHIL_DEGRANULATION,-2.00792582,0.102642462,enalaprilat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.067644318,0.046632377,enalaprilat
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.919755893,0.138588979,enalaprilat
BIOLOGICAL_OXIDATIONS,-1.868827836,0.14356952,enalaprilat
SIGNALING_BY_GPCR,1.964660773,0.076328617,enalaprilat
VISUAL_PHOTOTRANSDUCTION,-1.746488624,0.22659298,enalaprilat
INFLUENZA_INFECTION,-1.699987661,0.244263075,enalaprilat
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.675221366,0.241664532,enalaprilat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.480193017,0.001909315,cyclophosphamide
METABOLISM_OF_RNA,-2.274006405,0.04252462,cyclophosphamide
GPCR_LIGAND_BINDING,2.214574111,0.010310299,cyclophosphamide
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.14593594,0.06925438,cyclophosphamide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.124934179,0.0558895,cyclophosphamide
M_PHASE,-2.115470658,0.046169587,cyclophosphamide
CELL_CYCLE_MITOTIC,-2.032269176,0.077759304,cyclophosphamide
MITOTIC_SPINDLE_CHECKPOINT,-2.008311293,0.077556806,cyclophosphamide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.998062715,0.071510789,cyclophosphamide
SEPARATION_OF_SISTER_CHROMATIDS,-1.963826723,0.082011766,cyclophosphamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.439031828,0,simvastatin
TRANSLATION,2.388303844,0.020648379,simvastatin
GPCR_LIGAND_BINDING,-2.218129969,0.000970205,simvastatin
SIGNALING_BY_GPCR,-2.180873207,0.001293607,simvastatin
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.171217308,0.041296758,simvastatin
MYD88_INDEPENDENT_TLR4_CASCADE,2.128940384,0.039002494,simvastatin
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.103969098,0.032693267,simvastatin
G_ALPHA_I_SIGNALLING_EVENTS,-2.095817514,0.003072316,simvastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.07741979,0.002716574,simvastatin
G_ALPHA_Q_SIGNALLING_EVENTS,-2.017630096,0.004312023,simvastatin
RESPIRATORY_ELECTRON_TRANSPORT,3.144460783,0,nabumetone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.066813473,0,nabumetone
RRNA_PROCESSING,2.377831537,0.005865908,nabumetone
SYNTHESIS_OF_DNA,2.263116874,0.011312823,nabumetone
DNA_REPLICATION,2.261107459,0.009050259,nabumetone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.151451119,0.015502758,nabumetone
FATTY_ACID_METABOLISM,1.908597252,0.056564116,nabumetone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.976269302,0.407976381,nabumetone
TRANSLATION,1.792276842,0.094744895,nabumetone
SIGNALING_BY_ALK_IN_CANCER,-1.897793699,0.395430411,nabumetone
TRANSLATION,-4.063253529,0,CCT-018159
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.819412862,0,CCT-018159
CELLULAR_RESPONSE_TO_STARVATION,-3.181316902,0,CCT-018159
RRNA_PROCESSING,-3.288225419,0,CCT-018159
SELENOAMINO_ACID_METABOLISM,-3.400577978,0,CCT-018159
NONSENSE_MEDIATED_DECAY_NMD,-3.442321875,0,CCT-018159
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.400577978,0,CCT-018159
METABOLISM_OF_RNA,-3.499298876,0,CCT-018159
EUKARYOTIC_TRANSLATION_ELONGATION,-3.561710149,0,CCT-018159
INFLUENZA_INFECTION,-3.584261913,0,CCT-018159
EUKARYOTIC_TRANSLATION_ELONGATION,-2.957157306,0,piribedil
NONSENSE_MEDIATED_DECAY_NMD,-2.920319507,0,piribedil
SELENOAMINO_ACID_METABOLISM,-2.862305172,0,piribedil
METABOLISM_OF_RNA,-2.831962575,0,piribedil
VIRAL_INFECTION_PATHWAYS,-2.781271171,0,piribedil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.771872745,0,piribedil
EUKARYOTIC_TRANSLATION_INITIATION,-2.735693011,0,piribedil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.723667266,0,piribedil
CELLULAR_RESPONSE_TO_STARVATION,-2.712901678,0,piribedil
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.681031706,0.000125082,piribedil
METABOLISM_OF_STEROIDS,2.324642069,0.022619017,brexpiprazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.218311398,0.017906722,brexpiprazole
ECM_PROTEOGLYCANS,-2.070095093,0.136251185,brexpiprazole
PROTEIN_LOCALIZATION,1.778755858,0.157704815,brexpiprazole
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.929145919,0.282090416,brexpiprazole
KEAP1_NFE2L2_PATHWAY,1.752673173,0.137363407,brexpiprazole
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.87269973,0.309845287,brexpiprazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.840508665,0.30959297,brexpiprazole
UB_SPECIFIC_PROCESSING_PROTEASES,1.530061418,0.339850735,brexpiprazole
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.510036174,0.311325641,brexpiprazole
RESPIRATORY_ELECTRON_TRANSPORT,3.832081344,0,cyclobenzaprine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.035931557,0,cyclobenzaprine
PROTEIN_LOCALIZATION,2.372061579,0.004320988,cyclobenzaprine
GPCR_LIGAND_BINDING,-2.428335337,0.006884607,cyclobenzaprine
G2_M_CHECKPOINTS,2.293090409,0.00462963,cyclobenzaprine
DISEASES_OF_METABOLISM,2.135178064,0.013703704,cyclobenzaprine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,2.088378503,0.014814815,cyclobenzaprine
ION_CHANNEL_TRANSPORT,-2.308253133,0.021944685,cyclobenzaprine
NEUTROPHIL_DEGRANULATION,2.025668779,0.020634921,cyclobenzaprine
NEURONAL_SYSTEM,-2.188974577,0.057371725,cyclobenzaprine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.713141958,0,tioconazole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.714821458,0,tioconazole
SIGNALING_BY_ROBO_RECEPTORS,2.782805624,0,tioconazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.908373174,0,tioconazole
INFLUENZA_INFECTION,3.083709301,0,tioconazole
RRNA_PROCESSING,3.147663654,0,tioconazole
TRANSLATION,3.196573079,0,tioconazole
EUKARYOTIC_TRANSLATION_INITIATION,3.249890119,0,tioconazole
METABOLISM_OF_RNA,2.831356301,0,tioconazole
RESPIRATORY_ELECTRON_TRANSPORT,3.41452606,0,tioconazole
METABOLISM_OF_RNA,2.247677183,0.082448378,crizotinib
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,2.213127906,0.041224189,crizotinib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.030971436,0.090904621,crizotinib
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.994297585,0.079277286,crizotinib
DUAL_INCISION_IN_TC_NER,1.94756699,0.083716814,crizotinib
ESR_MEDIATED_SIGNALING,1.923286819,0.079277286,crizotinib
KEAP1_NFE2L2_PATHWAY,1.906523449,0.077012221,crizotinib
INTERLEUKIN_1_FAMILY_SIGNALING,1.870330561,0.086412242,crizotinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.795174183,0.113454605,crizotinib
UB_SPECIFIC_PROCESSING_PROTEASES,1.776564976,0.114159292,crizotinib
METABOLISM_OF_RNA,2.963143477,0,talmapimod
MITOTIC_PROPHASE,2.506015084,0,talmapimod
SEPARATION_OF_SISTER_CHROMATIDS,2.399325023,0,talmapimod
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.382248072,0,talmapimod
MITOTIC_METAPHASE_AND_ANAPHASE,2.330565443,0.001951673,talmapimod
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.254927902,0.003252788,talmapimod
CELL_CYCLE_CHECKPOINTS,2.223505507,0.004182156,talmapimod
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.130692401,0.001895222,talmapimod
MITOTIC_SPINDLE_CHECKPOINT,2.185055153,0.004879182,talmapimod
MRNA_SPLICING,2.12322435,0.004337051,talmapimod
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.668869299,0,glycopyrrolate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.643866955,0,glycopyrrolate
EUKARYOTIC_TRANSLATION_INITIATION,-2.633445511,0,glycopyrrolate
NONSENSE_MEDIATED_DECAY_NMD,-2.62848026,0,glycopyrrolate
SELENOAMINO_ACID_METABOLISM,-2.622053446,0,glycopyrrolate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.611908038,0,glycopyrrolate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.564741123,0,glycopyrrolate
SIGNALING_BY_ROBO_RECEPTORS,-2.541850096,0,glycopyrrolate
RRNA_PROCESSING,-2.507905425,0,glycopyrrolate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.485091248,0,glycopyrrolate
GPCR_LIGAND_BINDING,2.005951283,0.163688311,ifenprodil
TRANSLATION,-2.136634189,1,ifenprodil
NEUTROPHIL_DEGRANULATION,-2.07285407,1,ifenprodil
INFLUENZA_INFECTION,-2.069580468,0.814516636,ifenprodil
MITOCHONDRIAL_TRANSLATION,-2.049433087,0.644568841,ifenprodil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.886143274,0.22196135,ifenprodil
EUKARYOTIC_TRANSLATION_INITIATION,-1.863826177,0.797786024,ifenprodil
NONSENSE_MEDIATED_DECAY_NMD,-1.748695459,0.790741556,ifenprodil
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.808926942,0.271504345,ifenprodil
INNATE_IMMUNE_SYSTEM,-1.720032674,0.709101201,ifenprodil
MUSCLE_CONTRACTION,3.646204404,0,trimipramine
RRNA_PROCESSING,-2.566652638,0,trimipramine
SIGNALING_BY_ROBO_RECEPTORS,-2.567816571,0,trimipramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.602376113,0,trimipramine
INFLUENZA_INFECTION,-2.660813108,0,trimipramine
NONSENSE_MEDIATED_DECAY_NMD,-2.674759572,0,trimipramine
SELENOAMINO_ACID_METABOLISM,-2.718914468,0,trimipramine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.724156851,0,trimipramine
NEURONAL_SYSTEM,2.559150812,0,trimipramine
SIGNALING_BY_GPCR,2.790175505,0,trimipramine
ESR_MEDIATED_SIGNALING,-1.936732371,0.511939429,physostigmine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.875158491,0.358182877,physostigmine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.803822304,0.352358765,physostigmine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.585178427,0.793680839,physostigmine
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.468893571,1,physostigmine
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.706738049,1,physostigmine
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.701994821,1,physostigmine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.437253262,0.976703553,physostigmine
CELLULAR_RESPONSE_TO_STARVATION,1.698151043,0.871665231,physostigmine
MAPK_FAMILY_SIGNALING_CASCADES,-1.379197165,1,physostigmine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.417212015,0.005452512,metoprolol
TRANSLATION,-2.34107459,0.008178768,metoprolol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.273847568,0.01363128,metoprolol
NONSENSE_MEDIATED_DECAY_NMD,-2.190473828,0.033055853,metoprolol
SIGNALING_BY_ROBO_RECEPTORS,-2.157402714,0.039258086,metoprolol
EUKARYOTIC_TRANSLATION_INITIATION,-2.151222817,0.034986951,metoprolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.150954094,0.029988815,metoprolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.140769071,0.028796078,metoprolol
SELENOAMINO_ACID_METABOLISM,-2.105434163,0.033169447,metoprolol
INFLUENZA_INFECTION,-2.08131679,0.038303896,metoprolol
FOXO_MEDIATED_TRANSCRIPTION,2.3197152,0.024832997,PD-407824
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.823555023,0.310976851,PD-407824
CELL_JUNCTION_ORGANIZATION,1.762933798,0.297995966,PD-407824
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.74727462,0.24550804,PD-407824
NEURONAL_SYSTEM,1.694338549,0.262552506,PD-407824
SIGNALING_BY_VEGF,1.620676771,0.320007032,PD-407824
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.51883249,1,PD-407824
G2_M_CHECKPOINTS,-2.246789177,1,PD-407824
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.170713821,1,PD-407824
VISUAL_PHOTOTRANSDUCTION,-2.123446622,0.89740163,PD-407824
MUSCLE_CONTRACTION,3.230305778,0,daunorubicin
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.475853309,0,daunorubicin
G2_M_CHECKPOINTS,-2.480358147,0,daunorubicin
HOMOLOGY_DIRECTED_REPAIR,-2.481437691,0,daunorubicin
DISEASES_OF_METABOLISM,2.490006718,0,daunorubicin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.504485683,0,daunorubicin
DNA_REPAIR,-2.529949008,0,daunorubicin
MITOTIC_SPINDLE_CHECKPOINT,-2.464466322,0,daunorubicin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.536065637,0,daunorubicin
CELL_CYCLE_MITOTIC,-2.675650782,0,daunorubicin
NEUTROPHIL_DEGRANULATION,-2.3503879,0.012484608,diazepam
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.844065941,0.3121152,diazepam
TRANSLATION,-1.83522252,0.224722944,diazepam
MITOCHONDRIAL_TRANSLATION,-1.777977362,0.247819469,diazepam
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.856355941,0.512777089,diazepam
BIOLOGICAL_OXIDATIONS,-1.642199871,0.419482829,diazepam
GPCR_LIGAND_BINDING,1.818558465,0.353261653,diazepam
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.584951645,0.456936653,diazepam
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.576690438,0.413418877,diazepam
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.569323449,0.377659393,diazepam
NEUTROPHIL_DEGRANULATION,-2.736922925,0,clotrimazole
INNATE_IMMUNE_SYSTEM,-2.209999712,0.024116516,clotrimazole
TRANSLATION,-2.183588252,0.019650494,clotrimazole
BIOLOGICAL_OXIDATIONS,-2.075753748,0.032155354,clotrimazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.108819723,0.074720719,clotrimazole
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.951087181,0.064310709,clotrimazole
SENSORY_PERCEPTION,2.071117324,0.050915888,clotrimazole
GPCR_LIGAND_BINDING,1.961076203,0.086623135,clotrimazole
HIV_LIFE_CYCLE,-1.709994143,0.245184578,clotrimazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.907463614,0.101335843,clotrimazole
METABOLISM_OF_RNA,4.775878078,0,filgotinib
MEMBRANE_TRAFFICKING,2.590978321,0,filgotinib
MRNA_SPLICING,2.403726424,0.006534305,filgotinib
CELL_CYCLE_MITOTIC,2.378943846,0.004900729,filgotinib
MITOTIC_METAPHASE_AND_ANAPHASE,2.369708019,0.003920583,filgotinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.357428361,0.003267153,filgotinib
CELL_CYCLE_CHECKPOINTS,2.31308114,0.004200625,filgotinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.294790935,0.003675547,filgotinib
M_PHASE,2.233597554,0.003564166,filgotinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.253905287,0.004356203,filgotinib
GASTRULATION,-2.459665131,0.052625584,topiramate
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.071349177,0.615426966,topiramate
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.913569619,0.915100429,topiramate
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.855580171,0.82519839,topiramate
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.810465832,0.75605422,topiramate
SARS_COV_1_HOST_INTERACTIONS,1.829168203,0.786343578,topiramate
SIGNALING_BY_WNT,-1.728516255,0.761121869,topiramate
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,-1.613442049,0.834909063,topiramate
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.560964644,0.818985648,topiramate
SELECTIVE_AUTOPHAGY,-1.517887469,0.798479537,topiramate
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.487999362,0.110687887,lidocaine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.405286809,0.086969054,lidocaine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.353219879,0.090482956,lidocaine
ION_CHANNEL_TRANSPORT,-2.118270824,0.34919393,lidocaine
HEMOSTASIS,-2.055132509,0.395840969,lidocaine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.8815512,0.686089206,lidocaine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.830976611,0.692740519,lidocaine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.723441719,0.828841442,lidocaine
ESR_MEDIATED_SIGNALING,-1.720522843,0.744068576,lidocaine
INTERFERON_GAMMA_SIGNALING,-1.681605286,0.748460952,lidocaine
TRNA_PROCESSING,-2.719449372,0,BRD-K33211335
GPCR_LIGAND_BINDING,2.370193393,0.002236317,BRD-K33211335
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.239030969,0.005311253,BRD-K33211335
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.183258116,0.008386189,BRD-K33211335
MITOTIC_METAPHASE_AND_ANAPHASE,-2.089099017,0.106207602,BRD-K33211335
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.02093583,0.105607559,BRD-K33211335
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-1.997823978,0.08550612,BRD-K33211335
NEUTROPHIL_DEGRANULATION,-1.987676647,0.072005154,BRD-K33211335
SENSORY_PERCEPTION,2.089531209,0.015374679,BRD-K33211335
RHO_GTPASE_CYCLE,-1.977040406,0.064804639,BRD-K33211335
NEURONAL_SYSTEM,1.723269571,1,gavestinel
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.856560405,1,gavestinel
DISEASES_OF_GLYCOSYLATION,1.622486768,0.975282691,gavestinel
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.603668774,0.715666377,gavestinel
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.717848604,1,gavestinel
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.678387715,1,gavestinel
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.592692789,1,gavestinel
METABOLISM_OF_STEROIDS,1.501841398,0.750652363,gavestinel
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.501971758,0.93795303,gavestinel
RESPIRATORY_ELECTRON_TRANSPORT,1.477669586,0.700686189,gavestinel
INFLUENZA_INFECTION,-2.493224997,0.005581247,ritonavir
NEUTROPHIL_DEGRANULATION,-2.28304224,0.013953118,ritonavir
BIOLOGICAL_OXIDATIONS,-2.200683976,0.019534365,ritonavir
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.15108014,0.038185085,ritonavir
GPCR_LIGAND_BINDING,2.103395527,0.030200931,ritonavir
TRANSLATION,-1.993210809,0.065579652,ritonavir
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.970696955,0.059161218,ritonavir
CELLULAR_RESPONSE_TO_STARVATION,-1.959465358,0.051626535,ritonavir
METABOLISM_OF_RNA,-1.957889436,0.045048637,ritonavir
NONSENSE_MEDIATED_DECAY_NMD,-1.849943778,0.077090974,ritonavir
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.96709652,0,tropicamide
INNATE_IMMUNE_SYSTEM,-2.593296978,0.003482318,tropicamide
NEUTROPHIL_DEGRANULATION,-2.440120062,0.013597624,tropicamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.404125841,0.011193166,tropicamide
METABOLISM_OF_RNA,2.078505018,0.159573101,tropicamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.078186573,0.07978655,tropicamide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.213419079,0.04616559,tropicamide
EUKARYOTIC_TRANSLATION_INITIATION,1.911960182,0.219789365,tropicamide
RRNA_PROCESSING,1.865853451,0.233588926,tropicamide
VISUAL_PHOTOTRANSDUCTION,-1.933064067,0.244093925,tropicamide
RESPIRATORY_ELECTRON_TRANSPORT,2.777229896,0,amyleine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.673701406,0.000744952,amyleine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.005212849,0.100320244,amyleine
CIRCADIAN_CLOCK,1.980392231,0.086414467,amyleine
TRANSLATION,1.926979672,0.094459952,amyleine
MITOCHONDRIAL_TRANSLATION,1.916650412,0.08616615,amyleine
DNA_REPLICATION,1.901719294,0.08109338,amyleine
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1.89768869,0.072819088,amyleine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-2.013523957,0.422924226,amyleine
SEPARATION_OF_SISTER_CHROMATIDS,1.81295528,0.108266402,amyleine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.353207715,0.14945429,amiodarone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.092164532,0.426041776,amiodarone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.726118189,1,amiodarone
G_ALPHA_Q_SIGNALLING_EVENTS,1.681286379,1,amiodarone
TCR_SIGNALING,-1.625811225,1,amiodarone
HEMOSTASIS,-1.585620453,1,amiodarone
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.572210378,1,amiodarone
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.570108956,1,amiodarone
INFLUENZA_INFECTION,-1.55591793,1,amiodarone
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.486713095,1,amiodarone
SIGNALING_BY_INTERLEUKINS,-2.489244776,0.011292346,hypericin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.268518606,0.035288582,hypericin
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.250542351,0.026348808,hypericin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.197368039,0.028230866,hypericin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-2.13555207,0.030489335,hypericin
MRNA_SPLICING_MINOR_PATHWAY,-1.932281619,0.072929737,hypericin
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,-1.876949381,0.085902491,hypericin
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.002983045,0.179179795,hypericin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.925298423,0.168114907,hypericin
SEPARATION_OF_SISTER_CHROMATIDS,-1.690354991,0.205026662,hypericin
CELL_CYCLE_CHECKPOINTS,-4.055511347,0,paclitaxel
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.989301593,0,paclitaxel
DNA_REPAIR,-2.994528882,0,paclitaxel
SYNTHESIS_OF_DNA,-3.019467882,0,paclitaxel
DNA_REPLICATION_PRE_INITIATION,-3.026814434,0,paclitaxel
S_PHASE,-3.035384432,0,paclitaxel
DNA_REPLICATION,-3.14055124,0,paclitaxel
SEPARATION_OF_SISTER_CHROMATIDS,-3.177646455,0,paclitaxel
MITOTIC_G2_G2_M_PHASES,-3.109008278,0,paclitaxel
MITOTIC_METAPHASE_AND_ANAPHASE,-3.492014309,0,paclitaxel
RAB_REGULATION_OF_TRAFFICKING,2.533395042,0,midostaurin
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.287101034,0.009328358,midostaurin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.190499456,0.002210611,midostaurin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.225153117,0.010883085,midostaurin
NEDDYLATION,2.165640749,0.017490672,midostaurin
KEAP1_NFE2L2_PATHWAY,2.083048457,0.023320896,midostaurin
MEMBRANE_TRAFFICKING,2.059519966,0.022543532,midostaurin
VESICLE_MEDIATED_TRANSPORT,2.014357057,0.025986141,midostaurin
GPCR_LIGAND_BINDING,-2.04856684,0.015474277,midostaurin
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.983566428,0.02681903,midostaurin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.650915178,0,fulvestrant
GPCR_LIGAND_BINDING,2.576723764,0,fulvestrant
KERATINIZATION,-2.367043017,0.003914226,fulvestrant
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.367043017,0.003914226,fulvestrant
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.414719931,0.001654305,fulvestrant
MITOTIC_G2_G2_M_PHASES,-2.339320895,0.004349139,fulvestrant
METABOLISM_OF_RNA,-2.329599491,0.00358804,fulvestrant
CELL_CYCLE,-2.26076261,0.008611296,fulvestrant
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.201809257,0.008436953,fulvestrant
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.138190756,0.022832982,fulvestrant
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.233678423,0.021405516,trovafloxacin
METABOLISM_OF_STEROIDS,2.13367364,0.020386205,trovafloxacin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.900903508,0.065235857,trovafloxacin
KEAP1_NFE2L2_PATHWAY,1.805310056,0.085112407,trovafloxacin
ORC1_REMOVAL_FROM_CHROMATIN,1.781277582,0.078283028,trovafloxacin
G1_S_DNA_DAMAGE_CHECKPOINTS,1.722596092,0.091228269,trovafloxacin
SNRNP_ASSEMBLY,1.703878441,0.08707822,trovafloxacin
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1.632884462,0.113653095,trovafloxacin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.609071725,0.113596466,trovafloxacin
ECM_PROTEOGLYCANS,-1.852785113,1,trovafloxacin
RESPIRATORY_ELECTRON_TRANSPORT,4.208995788,0,AMD-11070
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.043782523,0,AMD-11070
GPCR_LIGAND_BINDING,-2.445458432,0,AMD-11070
NEURONAL_SYSTEM,-2.414784394,0,AMD-11070
PROTEIN_LOCALIZATION,2.293772855,0.006976822,AMD-11070
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.168491861,0.006832668,AMD-11070
SIGNALING_BY_GPCR,-2.164025698,0.005347306,AMD-11070
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.150808877,0.005347306,AMD-11070
G2_M_CHECKPOINTS,2.184874836,0.014490323,AMD-11070
TRANSLATION,2.140734555,0.014168316,AMD-11070
METABOLISM_OF_RNA,-2.651757066,0,ilomastat
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.422587787,0.001381116,ilomastat
MITOTIC_METAPHASE_AND_ANAPHASE,-2.403538586,0.00230186,ilomastat
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.394354862,0.002071674,ilomastat
M_PHASE,-2.318067975,0.003314678,ilomastat
MRNA_SPLICING,-2.280828069,0.00460372,ilomastat
CELL_CYCLE,-2.277617327,0.004143348,ilomastat
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.253015232,0.004661266,ilomastat
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.289827492,0.012370975,ilomastat
SEPARATION_OF_SISTER_CHROMATIDS,-2.233442884,0.005677921,ilomastat
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.290966372,0.016755219,atorvastatin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.153389019,0.035904041,atorvastatin
M_PHASE,-2.078076712,0.056648598,atorvastatin
GPCR_LIGAND_BINDING,-2.069182766,0.046076853,atorvastatin
SEPARATION_OF_SISTER_CHROMATIDS,-1.999826283,0.072765524,atorvastatin
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.954205952,0.091156371,atorvastatin
CELL_CYCLE_MITOTIC,-1.943003296,0.084801926,atorvastatin
SIGNALING_BY_NOTCH,-1.926260532,0.086169699,atorvastatin
PROTEIN_LOCALIZATION,1.848617048,0.306932683,atorvastatin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.901444779,0.094680286,atorvastatin
CELLULAR_RESPONSE_TO_STARVATION,2.628655558,0,tipiracil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.507739122,0.000279649,tipiracil
RESPIRATORY_ELECTRON_TRANSPORT,2.537550757,0.000419473,tipiracil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.349980264,0.001677893,tipiracil
RRNA_PROCESSING,2.362367796,0.001887629,tipiracil
SELENOAMINO_ACID_METABOLISM,2.334252632,0.001957541,tipiracil
EUKARYOTIC_TRANSLATION_ELONGATION,2.27304523,0.00215729,tipiracil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.105040705,0.010486829,tipiracil
TRANSLATION,1.988534139,0.021066873,tipiracil
SARS_COV_2_INFECTION,-3.475788117,0.404633538,tipiracil
SIGNALING_BY_ALK_IN_CANCER,2.241511242,0.077358859,ponatinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.228117514,0.043367845,ponatinib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.086841826,0.08048447,ponatinib
MITF_M_DEPENDENT_GENE_EXPRESSION,2.064617394,0.069740184,ponatinib
SUMOYLATION,1.996340547,0.090017582,ponatinib
SARS_COV_2_HOST_INTERACTIONS,1.96262796,0.088689197,ponatinib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.941015709,0.086065917,ponatinib
ISG15_ANTIVIRAL_MECHANISM,1.939322514,0.075600703,ponatinib
GPCR_LIGAND_BINDING,-1.89150783,0.403879467,ponatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.868159214,0.252103107,ponatinib
MRNA_SPLICING,2.169885657,0.035349568,lonafarnib
METABOLISM_OF_RNA,2.066593934,0.047721917,lonafarnib
INTERLEUKIN_1_FAMILY_SIGNALING,1.923057111,0.067164179,lonafarnib
TRANSLATION,1.665705421,0.192655145,lonafarnib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.914089457,0.206040214,lonafarnib
VISUAL_PHOTOTRANSDUCTION,-1.905011235,0.112085876,lonafarnib
POTASSIUM_CHANNELS,-1.903456978,0.075273358,lonafarnib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.62305403,0.205027494,lonafarnib
RESPIRATORY_ELECTRON_TRANSPORT,1.594831387,0.191476826,lonafarnib
C_TYPE_LECTIN_RECEPTORS_CLRS,1.558492189,0.203512513,lonafarnib
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,-2.586888322,0.001349859,PLX-4720
BIOLOGICAL_OXIDATIONS,-2.523019355,0.000674929,PLX-4720
DRUG_ADME,-2.485543816,0.000449953,PLX-4720
EUKARYOTIC_TRANSLATION_ELONGATION,2.308541332,0.008826219,PLX-4720
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.295353184,0.004780869,PLX-4720
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.292776336,0.003187246,PLX-4720
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.248382999,0.011811265,PLX-4720
NONSENSE_MEDIATED_DECAY_NMD,2.195597021,0.007171303,PLX-4720
CELLULAR_RESPONSE_TO_STARVATION,2.186972584,0.005737042,PLX-4720
INFLUENZA_INFECTION,2.158177785,0.007232596,PLX-4720
NEUTROPHIL_DEGRANULATION,-2.067832713,0.204448496,etomidate
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.043187165,0.116007293,etomidate
GPCR_LIGAND_BINDING,2.043747361,0.111582224,etomidate
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.017014683,0.072754626,etomidate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.900638168,0.192962625,etomidate
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.839176643,0.19698268,etomidate
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.758374205,0.25820237,etomidate
CELL_CYCLE_CHECKPOINTS,-1.664680366,0.344576117,etomidate
SIGNALING_BY_GPCR,1.834174788,0.223164448,etomidate
ADIPOGENESIS,-1.63770924,0.340309936,etomidate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.465294542,0.056507745,piretanide
HEMOSTASIS,-2.290750504,0.123677329,piretanide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.232824315,0.12225575,piretanide
MITOTIC_G2_G2_M_PHASES,1.897850832,0.310798247,piretanide
PTEN_REGULATION,1.879035955,0.17882853,piretanide
INNATE_IMMUNE_SYSTEM,-1.996176753,0.338246832,piretanide
G2_M_CHECKPOINTS,1.740515996,0.325142781,piretanide
SIGNALING_BY_GPCR,1.64848762,0.451852836,piretanide
ESR_MEDIATED_SIGNALING,-1.788982564,0.538422853,piretanide
GPCR_LIGAND_BINDING,1.600130257,0.492878204,piretanide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.534152441,0.00330437,ciprofibrate
NEURONAL_SYSTEM,2.328976598,0.007269615,ciprofibrate
CARDIAC_CONDUCTION,2.147879597,0.021368262,ciprofibrate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.90491827,0.08938322,ciprofibrate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.812534618,0.130720894,ciprofibrate
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.130059914,1,ciprofibrate
SENSORY_PERCEPTION,1.775759541,0.136250208,ciprofibrate
SIGNALING_BY_WNT,-1.949477222,1,ciprofibrate
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.862443035,1,ciprofibrate
GPCR_LIGAND_BINDING,1.632654331,0.271524839,ciprofibrate
RESPIRATORY_ELECTRON_TRANSPORT,2.206617697,0.03233391,aminoglutethimide
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.071062294,0.133802468,aminoglutethimide
G_ALPHA_I_SIGNALLING_EVENTS,1.927183322,0.1252939,aminoglutethimide
HOMOLOGY_DIRECTED_REPAIR,1.773687236,0.223306065,aminoglutethimide
CARDIAC_CONDUCTION,1.7517609,0.192487807,aminoglutethimide
MUSCLE_CONTRACTION,1.73875935,0.167125896,aminoglutethimide
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.727811824,0.679914763,aminoglutethimide
ESR_MEDIATED_SIGNALING,-1.648924061,0.709979021,aminoglutethimide
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.558597928,0.40030054,aminoglutethimide
G2_M_CHECKPOINTS,1.558328288,0.343547792,aminoglutethimide
NEUTROPHIL_DEGRANULATION,-2.509229591,0.007362264,tripelennamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.405470222,0.003735299,tripelennamine
TRANSLATION,-2.392802863,0.008589308,tripelennamine
SENSORY_PERCEPTION,2.325717357,0.003361769,tripelennamine
GPCR_LIGAND_BINDING,2.241213612,0.004731379,tripelennamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.123283326,0.011579427,tripelennamine
G_ALPHA_I_SIGNALLING_EVENTS,2.069053694,0.016435315,tripelennamine
HIV_INFECTION,-1.908778795,0.135792875,tripelennamine
SIGNALING_BY_GPCR,1.997148012,0.029010822,tripelennamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.76316429,0.210438055,tripelennamine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.813351443,0,linagliptin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.588078571,0,linagliptin
MITOTIC_PROPHASE,2.568377915,0,linagliptin
CELL_CYCLE,2.514852181,0,linagliptin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.413516078,0.00199971,linagliptin
CELL_CYCLE_CHECKPOINTS,2.377605235,0.00333285,linagliptin
SEPARATION_OF_SISTER_CHROMATIDS,2.35539826,0.005713458,linagliptin
MRNA_SPLICING,2.273493801,0.006249094,linagliptin
S_PHASE,2.270853463,0.005554751,linagliptin
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.181871988,0.004614716,linagliptin
MEMBRANE_TRAFFICKING,2.981539661,0,bosutinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.26542703,0.000844552,bosutinib
SIGNALING_BY_ALK_IN_CANCER,2.607888142,0.00870322,bosutinib
VESICLE_MEDIATED_TRANSPORT,2.591860505,0.005802147,bosutinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.099723639,0.004645038,bosutinib
CLATHRIN_MEDIATED_ENDOCYTOSIS,2.138003526,0.051131419,bosutinib
SARS_COV_1_INFECTION,2.117693249,0.050478677,bosutinib
GPCR_LIGAND_BINDING,-2.032330983,0.010556904,bosutinib
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2.078038602,0.0572962,bosutinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.019713226,0.00992349,bosutinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.353156258,0.016647749,R-547
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.094869918,0.033295498,R-547
KEAP1_NFE2L2_PATHWAY,1.963892575,0.058267121,R-547
POTASSIUM_CHANNELS,-1.918498422,0.127486508,R-547
SENSORY_PERCEPTION,-1.911196494,0.071173449,R-547
TRANSLATION,1.638450525,0.267404465,R-547
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.601683325,0.268028755,R-547
S_PHASE,1.55498336,0.282318073,R-547
VISUAL_PHOTOTRANSDUCTION,-1.789398905,0.1514717,R-547
HEDGEHOG_OFF_STATE,1.434522616,0.444138155,R-547
CELL_CYCLE_MITOTIC,4.921128011,0,calcitriol
DNA_REPLICATION_PRE_INITIATION,2.613259087,0,calcitriol
MITOTIC_METAPHASE_AND_ANAPHASE,2.623250822,0,calcitriol
MEMBRANE_TRAFFICKING,2.695782061,0,calcitriol
G2_M_CHECKPOINTS,2.735467427,0,calcitriol
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.736334854,0,calcitriol
DNA_REPLICATION,2.764535121,0,calcitriol
TRNA_PROCESSING,2.85226372,0,calcitriol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.201000007,0,calcitriol
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.892794949,0,calcitriol
ISG15_ANTIVIRAL_MECHANISM,3.022314921,0,zolpidem
S_PHASE,3.016695466,0,zolpidem
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.978213371,0,zolpidem
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.818650219,0,zolpidem
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.770704874,0,zolpidem
CELL_CYCLE,2.68971101,0,zolpidem
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.673962917,0,zolpidem
CELL_CYCLE_MITOTIC,2.644707373,0,zolpidem
DNA_REPLICATION,2.550020279,0,zolpidem
G2_M_CHECKPOINTS,2.517677274,0,zolpidem
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.859591653,0,thalidomide
METABOLISM_OF_RNA,-2.855406842,0,thalidomide
MRNA_SPLICING,-2.766715627,0,thalidomide
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,-2.302096708,0.007647094,thalidomide
SIGNALING_BY_FGFR,-2.182514947,0.021968015,thalidomide
MUSCLE_CONTRACTION,2.159800689,0.028935905,thalidomide
SIGNALING_BY_FGFR2,-2.11226062,0.034527788,thalidomide
NUCLEOTIDE_EXCISION_REPAIR,-2.098922878,0.032971885,thalidomide
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,-2.067568387,0.041363826,thalidomide
ESR_MEDIATED_SIGNALING,-2.067409056,0.036767846,thalidomide
GPCR_LIGAND_BINDING,2.411850091,0.002001201,cinacalcet
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.25134053,0.004252552,cinacalcet
SIGNALING_BY_GPCR,2.201885798,0.003502101,cinacalcet
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,1.834299679,0.02726636,cinacalcet
MAPK_FAMILY_SIGNALING_CASCADES,1.77322792,0.029317591,cinacalcet
EXTRACELLULAR_MATRIX_ORGANIZATION,1.669973011,0.043692882,cinacalcet
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.804041894,1,cinacalcet
SIGNALING_BY_INTERLEUKINS,1.485244545,0.08991109,cinacalcet
G_ALPHA_I_SIGNALLING_EVENTS,1.456859282,0.088740744,cinacalcet
TRANSPORT_OF_SMALL_MOLECULES,-2.744950097,1,cinacalcet
CARDIAC_CONDUCTION,2.272623156,0.005786415,verapamil
NEUTROPHIL_DEGRANULATION,-2.26773146,0.071354976,verapamil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.214475986,0.055300106,verapamil
DEUBIQUITINATION,-2.194736024,0.045191485,verapamil
INNATE_IMMUNE_SYSTEM,-2.184438025,0.036123456,verapamil
PROGRAMMED_CELL_DEATH,-2.124132462,0.043526535,verapamil
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.074145754,0.055300106,verapamil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.044764663,0.058613016,verapamil
NEURONAL_SYSTEM,1.954674617,0.095765171,verapamil
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.93928153,0.090977594,verapamil
MUSCLE_CONTRACTION,2.198420734,0.006588053,alprenolol
CARDIAC_CONDUCTION,2.03020943,0.019764159,alprenolol
NEURONAL_SYSTEM,1.881606165,0.039528318,alprenolol
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.80722339,0.04611637,alprenolol
TRANSPORT_OF_SMALL_MOLECULES,1.660499896,0.092044511,alprenolol
NERVOUS_SYSTEM_DEVELOPMENT,1.632210179,0.090664157,alprenolol
NEUTROPHIL_DEGRANULATION,-2.75420828,0.797891699,alprenolol
VESICLE_MEDIATED_TRANSPORT,-2.629566457,0.585618372,alprenolol
INNATE_IMMUNE_SYSTEM,-2.390235024,0.571040137,alprenolol
INTERFERON_SIGNALING,-1.732911175,0.449347431,alprenolol
GPCR_LIGAND_BINDING,2.624684476,0,BRD-K71860425
CARDIAC_CONDUCTION,2.279354787,0.007501141,BRD-K71860425
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.157888927,0.016741678,BRD-K71860425
NEURONAL_SYSTEM,1.966276984,0.053160264,BRD-K71860425
MEMBRANE_TRAFFICKING,-1.967919962,0.455652726,BRD-K71860425
CHROMATIN_ORGANIZATION,-1.961291409,0.236517287,BRD-K71860425
HATS_ACETYLATE_HISTONES,-1.882800018,0.293008292,BRD-K71860425
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.831845851,0.100058705,BRD-K71860425
PROTEIN_LOCALIZATION,-1.856690182,0.26538357,BRD-K71860425
SIGNALING_BY_ALK_IN_CANCER,-1.849379801,0.22099778,BRD-K71860425
METABOLISM_OF_RNA,-3.27328751,0,donepezil
MITOTIC_METAPHASE_AND_ANAPHASE,-2.973897154,0,donepezil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.897707811,0,donepezil
MRNA_SPLICING,-2.606071807,0.002582223,donepezil
RHO_GTPASES_ACTIVATE_FORMINS,-2.589356674,0.002478934,donepezil
SEPARATION_OF_SISTER_CHROMATIDS,-2.580167168,0.002065779,donepezil
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.579671006,0.001770667,donepezil
CELL_CYCLE_CHECKPOINTS,-2.484484565,0.004648002,donepezil
MITOTIC_SPINDLE_CHECKPOINT,-2.455151736,0.005508743,donepezil
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.388819075,0.008882849,donepezil
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.69604875,0.025083074,probenecid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.096256164,0.043582498,probenecid
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.094532994,0.022098168,probenecid
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.154495668,0.342802015,probenecid
HEMOSTASIS,-2.111534211,0.304712902,probenecid
GPCR_LIGAND_BINDING,1.907356236,0.094940276,probenecid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.012852685,0.399238932,probenecid
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.874020913,0.676685604,probenecid
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.867073352,0.582484725,probenecid
ION_CHANNEL_TRANSPORT,-1.823575201,0.601197495,probenecid
NEUTROPHIL_DEGRANULATION,-3.85096342,0.064109589,cilastatin
INNATE_IMMUNE_SYSTEM,-1.8370652,1,cilastatin
SENSORY_PERCEPTION,1.796898381,0.949241379,cilastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.792725454,0.490677881,cilastatin
VESICLE_MEDIATED_TRANSPORT,-1.55514077,1,cilastatin
GPCR_LIGAND_BINDING,1.757006877,0.425702271,cilastatin
MITOCHONDRIAL_TRANSLATION,-1.497988584,1,cilastatin
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.49646856,1,cilastatin
SARS_COV_1_INFECTION,-1.476835458,1,cilastatin
NONSENSE_MEDIATED_DECAY_NMD,-1.441172969,1,cilastatin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.145879036,0.004554413,lacidipine
MRNA_SPLICING,2.15550207,0.045035824,lacidipine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.082461006,0.039406346,lacidipine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.921805729,0.073183214,lacidipine
POTASSIUM_CHANNELS,-1.96576352,0.02732648,lacidipine
METABOLISM_OF_RNA,1.849640984,0.087256909,lacidipine
RESPIRATORY_ELECTRON_TRANSPORT,1.788860285,0.090071648,lacidipine
GPCR_LIGAND_BINDING,-1.911239264,0.036435306,lacidipine
S_PHASE,1.604027915,0.215796656,lacidipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.844642402,0.056930166,lacidipine
TRANSLATION,2.354473667,0.025627654,navitoclax
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.216335238,0.007330738,navitoclax
MITOCHONDRIAL_TRANSLATION,1.960285032,0.1185279,navitoclax
SENSORY_PERCEPTION,-2.025993984,0.039652629,navitoclax
GPCR_LIGAND_BINDING,-2.021317753,0.027767947,navitoclax
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.806107983,0.266954729,navitoclax
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.705562422,0.350778514,navitoclax
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.647036706,0.394665872,navitoclax
TNF_SIGNALING,1.622948258,0.372668802,navitoclax
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.893735966,0.069475404,navitoclax
NEUTROPHIL_DEGRANULATION,-3.27958703,0,tolterodine
INNATE_IMMUNE_SYSTEM,-2.850537758,0,tolterodine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.25098209,0.016049684,tolterodine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.167308207,0.028957543,tolterodine
SENSORY_PERCEPTION,2.143500256,0.017303898,tolterodine
GPCR_LIGAND_BINDING,2.113413426,0.017892466,tolterodine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.066103382,0.021365016,tolterodine
TRANSLATION,-2.000163493,0.071621716,tolterodine
BIOLOGICAL_OXIDATIONS,-1.819220111,0.154558459,tolterodine
G_ALPHA_I_SIGNALLING_EVENTS,1.887146607,0.089556499,tolterodine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.363393949,0.359966463,cirazoline
METABOLISM_OF_VITAMINS_AND_COFACTORS,-3.32440484,0.269974847,cirazoline
GPCR_LIGAND_BINDING,1.990102068,0.165489665,cirazoline
ADIPOGENESIS,-3.297172914,0.226407478,cirazoline
VISUAL_PHOTOTRANSDUCTION,-3.273685277,0.211051765,cirazoline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.270314175,0.173555259,cirazoline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.168916858,0.298186504,cirazoline
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.87086562,0.243131292,cirazoline
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.793926787,0.291368734,cirazoline
SIGNALING_BY_GPCR,1.78611052,0.235111969,cirazoline
TOLL_LIKE_RECEPTOR_CASCADES,2.571274669,0,paroxetine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.507727557,0.003550479,paroxetine
RESPIRATORY_ELECTRON_TRANSPORT,2.358754063,0.004733971,paroxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.17881553,0.002547724,paroxetine
C_TYPE_LECTIN_RECEPTORS_CLRS,2.194824332,0.014201914,paroxetine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.170550128,0.011361531,paroxetine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.153292748,0.010651436,paroxetine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.07251455,0.015216337,paroxetine
TCR_SIGNALING,2.039438249,0.017752393,paroxetine
DNA_REPLICATION_PRE_INITIATION,2.037435486,0.0165689,paroxetine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.36896264,0.004279519,dichloroacetic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.340498193,0.003056799,dichloroacetic-acid
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.463367794,0.039148736,dichloroacetic-acid
GPCR_LIGAND_BINDING,2.323590048,0.002649226,dichloroacetic-acid
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-2.264780944,0.078297472,dichloroacetic-acid
G_ALPHA_I_SIGNALLING_EVENTS,2.134657643,0.011462997,dichloroacetic-acid
INFLUENZA_INFECTION,-2.159893745,0.10812508,dichloroacetic-acid
TRANSLATION,-2.159070663,0.08109381,dichloroacetic-acid
SIGNALING_BY_GPCR,2.065918265,0.018096251,dichloroacetic-acid
VISUAL_PHOTOTRANSDUCTION,-2.012731266,0.179524917,dichloroacetic-acid
KEAP1_NFE2L2_PATHWAY,2.40359012,0,semaxanib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.128827118,0.016012335,semaxanib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.067071317,0.014233187,semaxanib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.05521424,0.01067489,semaxanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.008899044,0.012809868,semaxanib
MRNA_SPLICING,2.000227876,0.011564464,semaxanib
INTERLEUKIN_1_FAMILY_SIGNALING,1.933886781,0.019062304,semaxanib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.747731569,0.067385245,semaxanib
HIV_INFECTION,1.735504422,0.062863243,semaxanib
CELL_CYCLE_CHECKPOINTS,1.733598135,0.058178152,semaxanib
TRANSLATION,-3.39859206,0,meclofenamic-acid
SIGNALING_BY_ROBO_RECEPTORS,-2.778021023,0,meclofenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,-3.018061676,0,meclofenamic-acid
SELENOAMINO_ACID_METABOLISM,-3.045271185,0,meclofenamic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.126920572,0,meclofenamic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.150438267,0,meclofenamic-acid
CELLULAR_RESPONSE_TO_STARVATION,-2.956867485,0,meclofenamic-acid
RRNA_PROCESSING,-3.227107724,0,meclofenamic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-3.241705431,0,meclofenamic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.281884162,0,meclofenamic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-3.232075572,0,nicergoline
SARS_COV_1_HOST_INTERACTIONS,-2.513988517,0,nicergoline
METABOLISM_OF_RNA,-2.527441464,0,nicergoline
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.534000488,0,nicergoline
VIRAL_INFECTION_PATHWAYS,-2.59810201,0,nicergoline
NERVOUS_SYSTEM_DEVELOPMENT,-2.612312987,0,nicergoline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.71657714,0,nicergoline
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.772578246,0,nicergoline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.861862174,0,nicergoline
CELLULAR_RESPONSE_TO_STARVATION,-2.901211006,0,nicergoline
TRANSLATION,-2.492931627,0.012529481,sibutramine
INFLUENZA_INFECTION,-2.463590135,0.007517689,sibutramine
METABOLISM_OF_RNA,-2.426975904,0.005847091,sibutramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.231026714,0.019637805,sibutramine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.221500447,0.019420696,sibutramine
GPCR_LIGAND_BINDING,2.182023206,0.016364837,sibutramine
MITOCHONDRIAL_TRANSLATION,-2.02094,0.044604953,sibutramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.106256017,0.022789551,sibutramine
SIGNALING_BY_GPCR,1.977793593,0.054185795,sibutramine
NONSENSE_MEDIATED_DECAY_NMD,-1.794303081,0.141165487,sibutramine
TRANSLATION,-2.895192563,0,disulfiram
NEUTROPHIL_DEGRANULATION,-2.662437405,0,disulfiram
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.57159848,0.00280923,disulfiram
EUKARYOTIC_TRANSLATION_ELONGATION,-2.505647416,0.003160383,disulfiram
SARS_COV_1_HOST_INTERACTIONS,-2.468038073,0.002528307,disulfiram
SARS_COV_1_INFECTION,-2.46276597,0.002106922,disulfiram
INFLUENZA_INFECTION,-2.442144975,0.001805933,disulfiram
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.36760466,0.003687114,disulfiram
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.335964442,0.004213845,disulfiram
SELENOAMINO_ACID_METABOLISM,-2.291282261,0.005363075,disulfiram
GPCR_LIGAND_BINDING,2.772401066,0,L-2167
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.726480374,0,L-2167
SIGNALING_BY_GPCR,2.419900714,0.000397453,L-2167
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.302943429,0.000447135,L-2167
G_ALPHA_Q_SIGNALLING_EVENTS,2.295578102,0.000357708,L-2167
G_ALPHA_I_SIGNALLING_EVENTS,2.198533889,0.001092997,L-2167
SENSORY_PERCEPTION,2.170941139,0.001107192,L-2167
G_ALPHA_S_SIGNALLING_EVENTS,2.024013437,0.006185369,L-2167
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.164028763,0.605351356,L-2167
POTASSIUM_CHANNELS,1.844508134,0.03365106,L-2167
TRANSLATION,2.811320569,0,tiaprofenic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.658910796,0.000743971,tiaprofenic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.613483451,0.00049598,tiaprofenic-acid
MITOCHONDRIAL_TRANSLATION,2.339556486,0.003347868,tiaprofenic-acid
DNA_REPLICATION,2.263926395,0.007737296,tiaprofenic-acid
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.167101081,0.013639464,tiaprofenic-acid
RRNA_PROCESSING,2.153991774,0.012541221,tiaprofenic-acid
PTEN_REGULATION,1.74923325,0.136332638,tiaprofenic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.977087628,1,tiaprofenic-acid
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.653777659,0.201698733,tiaprofenic-acid
MITOTIC_G2_G2_M_PHASES,-3.34698794,0,pyrazolanthrone
M_PHASE,-3.252996026,0,pyrazolanthrone
MITOTIC_METAPHASE_AND_ANAPHASE,-2.866226327,0,pyrazolanthrone
CELL_CYCLE_MITOTIC,-2.725558761,0,pyrazolanthrone
SEPARATION_OF_SISTER_CHROMATIDS,-2.697134734,0,pyrazolanthrone
MITOTIC_PROMETAPHASE,-2.69169965,0,pyrazolanthrone
CELL_CYCLE_CHECKPOINTS,-2.618484939,0,pyrazolanthrone
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-2.550430117,0.001828082,pyrazolanthrone
CELL_CYCLE,-2.450133607,0.004468646,pyrazolanthrone
DNA_REPLICATION,-2.380009252,0.005118631,pyrazolanthrone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.681197295,0,allopurinol
SIGNALING_BY_ROBO_RECEPTORS,-2.617134218,0,allopurinol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.578125582,0,allopurinol
EUKARYOTIC_TRANSLATION_INITIATION,-2.50938034,0,allopurinol
SELENOAMINO_ACID_METABOLISM,-2.480716401,0,allopurinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.475576465,0,allopurinol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.428784576,0,allopurinol
NERVOUS_SYSTEM_DEVELOPMENT,-2.378562713,0.000136623,allopurinol
NONSENSE_MEDIATED_DECAY_NMD,-2.36297088,0.000121442,allopurinol
RRNA_PROCESSING,-2.30813212,0.000218596,allopurinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.0250046,0.039285696,decitabine
CELL_CYCLE_CHECKPOINTS,1.935529939,0.35029191,decitabine
GPCR_LIGAND_BINDING,-1.957836966,0.052744684,decitabine
KEAP1_NFE2L2_PATHWAY,1.810212649,0.375312761,decitabine
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1.603079791,0.673894912,decitabine
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.557436208,0.634278565,decitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.829183143,0.133619867,decitabine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.495029075,0.71059216,decitabine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,1.464655155,0.698915763,decitabine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.770433149,0.178422535,decitabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.720237296,0,pitavastatin
SELENOAMINO_ACID_METABOLISM,-2.646251456,0,pitavastatin
NONSENSE_MEDIATED_DECAY_NMD,-2.545597561,0,pitavastatin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.497405213,0,pitavastatin
EUKARYOTIC_TRANSLATION_INITIATION,-2.478527059,0,pitavastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.451766616,0,pitavastatin
RRNA_PROCESSING,-2.380470493,0,pitavastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.328019088,0.000133925,pitavastatin
METABOLISM_OF_STEROIDS,2.50021927,0.001045645,pitavastatin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.440975363,0.000784233,pitavastatin
METABOLISM_OF_RNA,-2.86688662,0,tacrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.756956988,0,tacrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.752855976,0,tacrine
CELL_CYCLE,-2.716474973,0,tacrine
CELL_CYCLE_CHECKPOINTS,-2.68914242,0,tacrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.681005666,0,tacrine
RRNA_PROCESSING,-2.643921071,0,tacrine
SIGNALING_BY_ROBO_RECEPTORS,-2.619416965,0,tacrine
TRANSLATION,-2.612677475,0,tacrine
SELENOAMINO_ACID_METABOLISM,-2.605378596,0,tacrine
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.20144799,0.127565895,orphenadrine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.196461851,0.066174808,orphenadrine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.071686557,0.106836437,orphenadrine
RESPIRATORY_ELECTRON_TRANSPORT,1.926235869,0.299151632,orphenadrine
SIGNALING_BY_INTERLEUKINS,-1.832676362,0.362366871,orphenadrine
DEVELOPMENTAL_CELL_LINEAGES,-1.828924896,0.295952877,orphenadrine
GPCR_LIGAND_BINDING,-1.823106075,0.254334503,orphenadrine
INTERFERON_SIGNALING,-1.812885257,0.23394674,orphenadrine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.792356762,0.235398941,orphenadrine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.78391342,0.218456595,orphenadrine
POTASSIUM_CHANNELS,-2.093652719,0.021014995,albendazole
INTERLEUKIN_1_FAMILY_SIGNALING,1.913175486,0.131128684,albendazole
MRNA_SPLICING,1.855398929,0.089719626,albendazole
METABOLISM_OF_RNA,1.846656201,0.066714594,albendazole
TRANSLATION,1.789164687,0.064701653,albendazole
SENSORY_PERCEPTION,-1.968700094,0.042905615,albendazole
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.95263494,0.034149367,albendazole
VISUAL_PHOTOTRANSDUCTION,-1.850728789,0.073552483,albendazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.462080224,0.31263839,albendazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.787988437,0.101222226,albendazole
GPCR_LIGAND_BINDING,2.878290443,0,NPI-2358
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.599595462,0,NPI-2358
G_ALPHA_I_SIGNALLING_EVENTS,2.597967986,0,NPI-2358
G2_M_CHECKPOINTS,-2.488354525,0.002651989,NPI-2358
UB_SPECIFIC_PROCESSING_PROTEASES,-2.314638148,0.014585939,NPI-2358
SIGNALING_BY_GPCR,2.216649848,0.001385531,NPI-2358
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.286948708,0.015911934,NPI-2358
KEAP1_NFE2L2_PATHWAY,-2.219866473,0.023867901,NPI-2358
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.119695722,0.044023017,NPI-2358
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.118673307,0.037127846,NPI-2358
DEVELOPMENTAL_CELL_LINEAGES,-3.206987467,0.103983055,ibudilast
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.201573665,0.051991528,ibudilast
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.121211174,0.065890253,ibudilast
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.075657647,0.101409217,ibudilast
SIGNALING_BY_MET,-3.050395528,0.12519148,ibudilast
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.998472858,0.245887324,ibudilast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.753403483,1,ibudilast
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.709244096,0.740667155,ibudilast
DISEASES_OF_GLYCOSYLATION,1.631526284,0.758548573,ibudilast
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.913911059,0.556978544,ibudilast
CELL_CYCLE,-2.876920077,0,nitazoxanide
CELL_CYCLE_MITOTIC,-2.818329005,0,nitazoxanide
S_PHASE,-2.643496027,0,nitazoxanide
SENSORY_PERCEPTION,2.512399508,0.00129815,nitazoxanide
CHROMOSOME_MAINTENANCE,-2.50540501,0.001052759,nitazoxanide
CELL_CYCLE_CHECKPOINTS,-2.337523494,0.007579868,nitazoxanide
DNA_REPLICATION,-2.27606102,0.009474835,nitazoxanide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.246056365,0.009926018,nitazoxanide
M_PHASE,-2.211568797,0.011317164,nitazoxanide
SYNTHESIS_OF_DNA,-2.203180851,0.010527594,nitazoxanide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.221390209,0.040327502,linifanib
DNA_REPLICATION_PRE_INITIATION,2.17420885,0.024816924,linifanib
DEVELOPMENTAL_CELL_LINEAGES,2.083133446,0.033089232,linifanib
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.034937153,0.031021155,linifanib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.017577945,0.02791904,linifanib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.996849989,0.026367982,linifanib
DOWNSTREAM_TCR_SIGNALING,1.979443927,0.024816924,linifanib
KEAP1_NFE2L2_PATHWAY,1.977183634,0.021714809,linifanib
C_TYPE_LECTIN_RECEPTORS_CLRS,1.966026893,0.02102545,linifanib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.963014417,0.019543328,linifanib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,4.093416005,0,digoxin
MRNA_SPLICING,4.002881357,0,digoxin
METABOLISM_OF_RNA,3.168885788,0,digoxin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,3.010603049,0,digoxin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.862680535,0.001166114,digoxin
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.60385631,0.000971762,digoxin
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,2.529890555,0.001665877,digoxin
KEAP1_NFE2L2_PATHWAY,2.4159289,0.002186464,digoxin
HIV_INFECTION,2.408425982,0.001943523,digoxin
HIV_LIFE_CYCLE,2.385058473,0.002332228,digoxin
GPCR_LIGAND_BINDING,2.198761462,0.022635847,mefenamic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.172457693,0.015198355,mefenamic-acid
DNA_DOUBLE_STRAND_BREAK_REPAIR,2.144052054,0.015521724,mefenamic-acid
HOMOLOGY_DIRECTED_REPAIR,1.934221798,0.064350481,mefenamic-acid
SIGNALING_BY_GPCR,1.921469583,0.05678364,mefenamic-acid
GLYCOSAMINOGLYCAN_METABOLISM,-3.18508286,1,mefenamic-acid
RSV_HOST_INTERACTIONS,-3.109643189,1,mefenamic-acid
DISEASES_OF_GLYCOSYLATION,-3.061611927,1,mefenamic-acid
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.83474567,0.097226354,mefenamic-acid
G_ALPHA_Q_SIGNALLING_EVENTS,1.800446699,0.108744459,mefenamic-acid
SELENOAMINO_ACID_METABOLISM,-2.810936301,0,oxymetazoline
INFLUENZA_INFECTION,-2.778444046,0,oxymetazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.771047598,0,oxymetazoline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.744046334,0,oxymetazoline
CELLULAR_RESPONSE_TO_STARVATION,-2.585708722,0.00057742,oxymetazoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.579683797,0.000481183,oxymetazoline
TRANSLATION,-2.568706085,0.000412443,oxymetazoline
EUKARYOTIC_TRANSLATION_INITIATION,-2.397990795,0.001804437,oxymetazoline
SARS_COV_1_INFECTION,-2.291191068,0.00256631,oxymetazoline
SIGNALING_BY_INTERLEUKINS,-1.985460403,0.022519374,oxymetazoline
METABOLISM_OF_RNA,-2.907884487,0,VX-745
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.483181604,0,VX-745
GPCR_LIGAND_BINDING,2.469708991,0,VX-745
INFLUENZA_INFECTION,-2.385405979,0.007769424,VX-745
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.250736399,0.001758982,VX-745
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.279065138,0.014243943,VX-745
SELENOAMINO_ACID_METABOLISM,-2.275238249,0.010682957,VX-745
EUKARYOTIC_TRANSLATION_INITIATION,-2.226256895,0.010100251,VX-745
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.187696658,0.011006683,VX-745
EUKARYOTIC_TRANSLATION_ELONGATION,-2.090112054,0.018313641,VX-745
TRANSLATION,-2.168850079,0.064308682,glimepiride
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.003238687,0.09807074,glimepiride
SARS_COV_INFECTIONS,-1.862602839,0.172561629,glimepiride
NEUTROPHIL_DEGRANULATION,-1.849530931,0.145498392,glimepiride
SENSORY_PERCEPTION,1.952205173,0.268842785,glimepiride
INFLUENZA_INFECTION,-1.664224934,0.356913183,glimepiride
SARS_COV_1_INFECTION,-1.650047368,0.327974277,glimepiride
NONSENSE_MEDIATED_DECAY_NMD,-1.622523447,0.31924667,glimepiride
TOLL_LIKE_RECEPTOR_CASCADES,-1.610452823,0.299437299,glimepiride
GPCR_LIGAND_BINDING,1.868190756,0.267819272,glimepiride
GPCR_LIGAND_BINDING,2.734249482,0,practolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.506295621,0,practolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.483370461,0,practolol
MITOTIC_METAPHASE_AND_ANAPHASE,-2.312390469,0.017124963,practolol
NEUTROPHIL_DEGRANULATION,-2.283401728,0.009785693,practolol
THE_PHOTOTRANSDUCTION_CASCADE,2.257186249,0.002188554,practolol
MEMBRANE_TRAFFICKING,-2.225461254,0.015494014,practolol
SIGNALING_BY_GPCR,2.203689358,0.002751325,practolol
SENSORY_PERCEPTION,2.153638345,0.00396024,practolol
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.136811015,0.02201781,practolol
EUKARYOTIC_TRANSLATION_ELONGATION,3.255080141,0,ketotifen
TRANSLATION,2.786017184,0,ketotifen
METABOLISM_OF_RNA,2.806848285,0,ketotifen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.821079266,0,ketotifen
CELLULAR_RESPONSE_TO_STARVATION,2.8440635,0,ketotifen
NEURONAL_SYSTEM,-2.847922519,0,ketotifen
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.851000875,0,ketotifen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.878138578,0,ketotifen
RRNA_PROCESSING,2.915849221,0,ketotifen
SIGNALING_BY_GPCR,-2.972134321,0,ketotifen
TRANSLATION,3.696112774,0,dexamethasone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.221227076,0,dexamethasone
EUKARYOTIC_TRANSLATION_INITIATION,3.152963486,0,dexamethasone
EUKARYOTIC_TRANSLATION_ELONGATION,3.132331834,0,dexamethasone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.797929267,0,dexamethasone
CELLULAR_RESPONSE_TO_STARVATION,2.759104018,0,dexamethasone
NONSENSE_MEDIATED_DECAY_NMD,2.671466548,0.000726644,dexamethasone
INFLUENZA_INFECTION,2.55441016,0.001271627,dexamethasone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.529539338,0.001130335,dexamethasone
SELENOAMINO_ACID_METABOLISM,2.503395007,0.001017301,dexamethasone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.59575084,0,alfacalcidol
SELENOAMINO_ACID_METABOLISM,3.156607669,0,alfacalcidol
INFLUENZA_INFECTION,3.118513269,0,alfacalcidol
TRANSLATION,2.929269624,0,alfacalcidol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.883692264,0,alfacalcidol
TRNA_PROCESSING,2.381006596,0,alfacalcidol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.336852066,0,alfacalcidol
RRNA_PROCESSING,2.315507059,0,alfacalcidol
SIGNALING_BY_ROBO_RECEPTORS,2.266667538,0.000835422,alfacalcidol
CELLULAR_RESPONSE_TO_STARVATION,2.245161093,0.00075188,alfacalcidol
RESPIRATORY_ELECTRON_TRANSPORT,2.47633585,0.012023318,BRD-K20152659
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.296879862,0.027386446,BRD-K20152659
TRANSLATION,2.13677715,0.052991661,BRD-K20152659
DRUG_ADME,2.062075988,0.057444741,BRD-K20152659
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-3.293819419,0.322156514,BRD-K20152659
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-3.263751935,0.269914917,BRD-K20152659
CIRCADIAN_CLOCK,1.784913636,0.232985183,BRD-K20152659
MITOCHONDRIAL_TRANSLATION,1.776615692,0.203505789,BRD-K20152659
ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1.775891475,0.175578611,BRD-K20152659
DNA_REPLICATION,1.744027747,0.186361428,BRD-K20152659
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.379499023,0,triprolidine
RESPIRATORY_ELECTRON_TRANSPORT,3.30377947,0,triprolidine
TRANSLATION,2.75332558,0.00110349,triprolidine
BIOLOGICAL_OXIDATIONS,2.38047686,0.008276178,triprolidine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.20138031,0.226627157,triprolidine
FATTY_ACID_METABOLISM,2.036672172,0.068857803,triprolidine
EUKARYOTIC_TRANSLATION_INITIATION,1.990510357,0.073382113,triprolidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.112761399,0.243503647,triprolidine
RRNA_PROCESSING,1.947574624,0.080712443,triprolidine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.889212689,0.099727947,triprolidine
CELL_CYCLE,-3.717273763,0,MLN-8054
CHROMOSOME_MAINTENANCE,-2.55926398,0,MLN-8054
VIRAL_INFECTION_PATHWAYS,-2.571140556,0,MLN-8054
G_ALPHA_I_SIGNALLING_EVENTS,2.587025793,0,MLN-8054
DNA_REPLICATION_PRE_INITIATION,-2.588990268,0,MLN-8054
SARS_COV_2_HOST_INTERACTIONS,-2.5951409,0,MLN-8054
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.611716884,0,MLN-8054
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,-2.624187037,0,MLN-8054
INFLUENZA_INFECTION,-2.677656757,0,MLN-8054
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.682184125,0,MLN-8054
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.227110496,0,BVD-523
RRNA_PROCESSING,2.698200039,0,BVD-523
SIGNALING_BY_GPCR,-2.756037546,0,BVD-523
NONSENSE_MEDIATED_DECAY_NMD,2.774913166,0,BVD-523
NEURONAL_SYSTEM,-2.792644485,0,BVD-523
METABOLISM_OF_RNA,2.809542152,0,BVD-523
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.866622731,0,BVD-523
TRANSLATION,2.8921565,0,BVD-523
EUKARYOTIC_TRANSLATION_INITIATION,2.857817218,0,BVD-523
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.05565484,0,BVD-523
CELL_CYCLE_MITOTIC,-2.164523907,0.117345885,D-serine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.118994164,0.088898398,D-serine
M_PHASE,-2.111641027,0.063216638,D-serine
GPCR_LIGAND_BINDING,-2.034833545,0.090676366,D-serine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.025419045,0.077993528,D-serine
CELL_CYCLE,-2.025030697,0.06538971,D-serine
SEPARATION_OF_SISTER_CHROMATIDS,-2.015746978,0.06028158,D-serine
MITOTIC_PROMETAPHASE,-1.993212725,0.062377042,D-serine
RRNA_PROCESSING,-1.931008168,0.091795827,D-serine
SIGNALING_BY_GPCR,-1.904869101,0.102529485,D-serine
RESPIRATORY_ELECTRON_TRANSPORT,2.936440277,0,ivacaftor
GPCR_LIGAND_BINDING,-2.611158766,0.003228172,ivacaftor
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.531176448,0.000815349,ivacaftor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.482756463,0.006994373,ivacaftor
COMPLEX_I_BIOGENESIS,2.152555538,0.017937667,ivacaftor
RAB_REGULATION_OF_TRAFFICKING,2.134809648,0.017122319,ivacaftor
ION_CHANNEL_TRANSPORT,-2.293756437,0.042324924,ivacaftor
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.048560579,0.022992828,ivacaftor
SIGNALING_BY_GPCR,-2.239335137,0.055416955,ivacaftor
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-2.197554024,0.066285135,ivacaftor
RESPIRATORY_ELECTRON_TRANSPORT,4.15804487,0,imipramine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.382451434,0,imipramine
GPCR_LIGAND_BINDING,-2.431273535,0.001925959,imipramine
SIGNALING_BY_GPCR,-2.285769533,0.006259366,imipramine
DISEASES_OF_METABOLISM,2.184416948,0.015914403,imipramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.046583281,0.031731767,imipramine
G_ALPHA_I_SIGNALLING_EVENTS,-2.087453914,0.034025273,imipramine
ION_CHANNEL_TRANSPORT,-2.08208883,0.027204169,imipramine
PROTEIN_LOCALIZATION,2.021876801,0.029810394,imipramine
TRANSLATION,1.979471618,0.032605119,imipramine
NONSENSE_MEDIATED_DECAY_NMD,2.684379131,0,xanthinol
EUKARYOTIC_TRANSLATION_ELONGATION,2.579978263,0,xanthinol
CELLULAR_RESPONSE_TO_STARVATION,2.54916141,0,xanthinol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.538928118,0,xanthinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.519705435,0,xanthinol
SELENOAMINO_ACID_METABOLISM,2.427600872,0.000502621,xanthinol
EUKARYOTIC_TRANSLATION_INITIATION,2.391129202,0.001005242,xanthinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.25252132,0.002513104,xanthinol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.416245011,0.038608552,xanthinol
RRNA_PROCESSING,2.196293509,0.003797579,xanthinol
MAPK6_MAPK4_SIGNALING,2.261818137,0.05209038,prochlorperazine
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.229504153,0.02604519,prochlorperazine
G2_M_CHECKPOINTS,2.165793381,0.032246426,prochlorperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.083792832,0.007139543,prochlorperazine
SYNTHESIS_OF_DNA,2.135205181,0.039067785,prochlorperazine
FCERI_MEDIATED_NF_KB_ACTIVATION,2.123307401,0.032742525,prochlorperazine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.103094375,0.032246426,prochlorperazine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,2.101577857,0.027639794,prochlorperazine
S_PHASE,2.059292167,0.032556488,prochlorperazine
SENSORY_PERCEPTION,-2.019790886,0.010434717,prochlorperazine
GPCR_LIGAND_BINDING,-2.470727268,0,fostamatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.454301174,0,fostamatinib
SIGNALING_BY_GPCR,-2.161791456,0.001072667,fostamatinib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.348959941,0.027694361,fostamatinib
ISG15_ANTIVIRAL_MECHANISM,2.328654937,0.015825349,fostamatinib
G_ALPHA_S_SIGNALLING_EVENTS,-2.10217596,0.003057102,fostamatinib
G_ALPHA_Q_SIGNALLING_EVENTS,-2.098980048,0.002703122,fostamatinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.01004702,0.005899671,fostamatinib
SIGNALING_BY_NTRKS,1.907158612,0.145065701,fostamatinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.910896761,0.019124129,fostamatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.429595807,0,tandutinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.202894899,0.001257575,tandutinib
MYD88_INDEPENDENT_TLR4_CASCADE,2.28997907,0.04414643,tandutinib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,2.17786322,0.047299746,tandutinib
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.172294909,0.031533164,tandutinib
TRNA_PROCESSING,2.158174429,0.025226531,tandutinib
GPCR_LIGAND_BINDING,-2.114895304,0.004611107,tandutinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.039223588,0.04036245,tandutinib
REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,2.014597895,0.039942008,tandutinib
TOLL_LIKE_RECEPTOR_CASCADES,1.813821973,0.106311811,tandutinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.00770252,0.178881442,tubocurarine
GPCR_LIGAND_BINDING,1.747662223,0.258845281,tubocurarine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.796151052,0.28524338,tubocurarine
METABOLISM_OF_RNA,-1.778345191,0.206680585,tubocurarine
G_ALPHA_I_SIGNALLING_EVENTS,1.589971268,0.371459787,tubocurarine
SIGNALING_BY_GPCR,1.444963767,0.541221951,tubocurarine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.417145547,0.466215648,tubocurarine
VESICLE_MEDIATED_TRANSPORT,-1.414323833,0.610372487,tubocurarine
MEMBRANE_TRAFFICKING,-1.414323833,0.610372487,tubocurarine
NERVOUS_SYSTEM_DEVELOPMENT,1.32469684,0.581225313,tubocurarine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.652041171,0,tiagabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.549486658,0,tiagabine
GPCR_LIGAND_BINDING,2.340121455,0.000657633,tiagabine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.287843442,0.064891371,tiagabine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.233885506,0.054346524,tiagabine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.175036539,0.067595179,tiagabine
INNATE_IMMUNE_SYSTEM,-2.123115189,0.082330928,tiagabine
NEUTROPHIL_DEGRANULATION,-2.07967349,0.08565661,tiagabine
HEMOSTASIS,-2.067488067,0.078140026,tiagabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.011934936,0.103362685,tiagabine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-2.273038773,0.034785827,propofol
INFLUENZA_INFECTION,-2.124160218,0.053628149,propofol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.976838972,0.091795931,propofol
DISEASES_OF_METABOLISM,-1.656404453,0.364526475,propofol
TOLL_LIKE_RECEPTOR_CASCADES,-1.647824125,0.305245629,propofol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.840560699,1,propofol
KEAP1_NFE2L2_PATHWAY,-1.438199969,0.656340909,propofol
G_ALPHA_I_SIGNALLING_EVENTS,1.692613018,1,propofol
CELLULAR_RESPONSES_TO_STIMULI,-1.338004431,0.860949209,propofol
DNA_REPLICATION,-1.319201171,0.812212816,propofol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.566124403,0,carprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.267928633,0.003527556,carprofen
GPCR_LIGAND_BINDING,2.120259212,0.017402612,carprofen
THE_PHOTOTRANSDUCTION_CASCADE,2.085682862,0.018696049,carprofen
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.904097603,0.066600266,carprofen
SIGNALING_BY_GPCR,1.783550222,0.149568393,carprofen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.933573533,1,carprofen
NEUTROPHIL_DEGRANULATION,-1.5613571,1,carprofen
FATTY_ACID_METABOLISM,-1.533603799,1,carprofen
RHOG_GTPASE_CYCLE,-1.3685915,1,carprofen
TRANSLATION,2.099033246,0.070455022,radezolid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.078832914,0.02259976,radezolid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.948840058,0.111553785,radezolid
POTASSIUM_CHANNELS,-2.0494895,0.017132076,radezolid
CELL_CYCLE_CHECKPOINTS,1.676719167,0.383588453,radezolid
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.584439024,0.478507025,radezolid
RESPIRATORY_ELECTRON_TRANSPORT,1.570796731,0.408639128,radezolid
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.497667251,0.5059062,radezolid
GPCR_LIGAND_BINDING,-1.80606065,0.131467419,radezolid
MITOTIC_METAPHASE_AND_ANAPHASE,1.493653259,0.44705389,radezolid
MEMBRANE_TRAFFICKING,2.912053958,0,PCI-24781
METABOLISM_OF_STEROIDS,2.783928605,0,PCI-24781
NEUTROPHIL_DEGRANULATION,2.602127584,0,PCI-24781
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.266868551,0.002853946,PCI-24781
GPCR_LIGAND_BINDING,-2.193044818,0.004280919,PCI-24781
VESICLE_MEDIATED_TRANSPORT,2.189868153,0.016945793,PCI-24781
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.128220157,0.005470063,PCI-24781
HEDGEHOG_OFF_STATE,2.127892222,0.021088098,PCI-24781
SIGNALING_BY_GPCR,-2.064522551,0.011237411,PCI-24781
SIGNALING_BY_NTRKS,1.989913532,0.043305916,PCI-24781
NEURONAL_SYSTEM,2.532508887,0.001142148,flumazenil
CARDIAC_CONDUCTION,2.303669788,0.007995034,flumazenil
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.183763535,0.014467205,flumazenil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.133061575,0.015704531,flumazenil
SIGNALING_BY_INSULIN_RECEPTOR,-2.177414675,0.384506352,flumazenil
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.864638229,0.095483551,flumazenil
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.837688054,1,flumazenil
INTRINSIC_PATHWAY_FOR_APOPTOSIS,-1.78787753,1,flumazenil
SARS_COV_INFECTIONS,-1.776542616,1,flumazenil
PLATELET_HOMEOSTASIS,1.705309531,0.234996896,flumazenil
RESPIRATORY_ELECTRON_TRANSPORT,3.293592861,0,zardaverine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.78121624,0,zardaverine
COMPLEX_I_BIOGENESIS,2.591529396,0.001026036,zardaverine
GPCR_LIGAND_BINDING,-2.314512656,0.053304534,zardaverine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.227081672,0.065212994,zardaverine
ION_CHANNEL_TRANSPORT,-2.196363769,0.055572812,zardaverine
DISEASES_OF_METABOLISM,2.010922851,0.047518276,zardaverine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-2.108088719,0.087328705,zardaverine
ECM_PROTEOGLYCANS,-2.078571089,0.085060427,zardaverine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-2.048705706,0.08997503,zardaverine
METABOLISM_OF_RNA,-3.430998582,0,levocetirizine
GPCR_LIGAND_BINDING,2.814549097,0,levocetirizine
CELL_CYCLE_CHECKPOINTS,-2.952217543,0,levocetirizine
SIGNALING_BY_GPCR,2.549301552,0,levocetirizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.98448657,0,levocetirizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.999107477,0,levocetirizine
CELL_CYCLE,-2.968620982,0,levocetirizine
MRNA_SPLICING,-2.812345915,0.00064838,levocetirizine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.774324949,0.001037409,levocetirizine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.636894099,0.002161268,levocetirizine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.499334018,0.038817596,bupropion
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.322976695,0.071506097,bupropion
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.238621735,0.083083275,bupropion
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.059918178,0.185915853,bupropion
HEMOSTASIS,-2.013224751,0.184690034,bupropion
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.957444558,0.21179425,bupropion
G_ALPHA_S_SIGNALLING_EVENTS,1.855840049,0.366744276,bupropion
MITOTIC_SPINDLE_CHECKPOINT,-1.911200919,0.227068341,bupropion
NEUTROPHIL_DEGRANULATION,-1.80200298,0.338632446,bupropion
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.793883421,0.312583796,bupropion
TRANSLATION,4.418578839,0,megestrol-acetate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.514879298,0,megestrol-acetate
GPCR_LIGAND_BINDING,-2.58272431,0,megestrol-acetate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.604767727,0,megestrol-acetate
SARS_COV_1_INFECTION,2.669488699,0,megestrol-acetate
MITOTIC_METAPHASE_AND_ANAPHASE,2.683364697,0,megestrol-acetate
RESPIRATORY_ELECTRON_TRANSPORT,2.751632288,0,megestrol-acetate
M_PHASE,2.79201058,0,megestrol-acetate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.155202608,0,megestrol-acetate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.267669155,0,megestrol-acetate
RESPIRATORY_ELECTRON_TRANSPORT,2.791045345,0,diphemanil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.353284488,0.016984972,diphemanil
TRANSLATION,2.152825678,0.054998956,diphemanil
SIGNALING_BY_ALK_IN_CANCER,-2.022010299,0.185375901,diphemanil
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.846990693,0.24415897,diphemanil
EUKARYOTIC_TRANSLATION_INITIATION,1.772561659,0.27879618,diphemanil
SIGNALING_BY_WNT,1.734010333,0.278230015,diphemanil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.652199025,0.346632078,diphemanil
DNA_REPLICATION,1.617440094,0.345462195,diphemanil
METABOLISM_OF_NUCLEOTIDES,1.59038556,0.347383114,diphemanil
RESPIRATORY_ELECTRON_TRANSPORT,3.056354665,0,nimodipine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.339057112,0.009219316,nimodipine
GLYCOSAMINOGLYCAN_METABOLISM,2.240700062,0.017937555,nimodipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.08101265,0.029298006,nimodipine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.951241305,0.326773548,nimodipine
G_ALPHA_Q_SIGNALLING_EVENTS,1.778421749,0.147760608,nimodipine
NONSENSE_MEDIATED_DECAY_NMD,-1.936938596,0.248921543,nimodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.717772876,0.169689269,nimodipine
SARS_COV_2_HOST_INTERACTIONS,-1.882730413,0.28349398,nimodipine
INFLUENZA_INFECTION,-1.857030342,0.281906208,nimodipine
MUSCLE_CONTRACTION,2.148981861,0.085986088,SU-11652
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.08837131,0.071207229,SU-11652
DNA_REPAIR,-2.020514771,0.169387766,SU-11652
MEIOSIS,-2.012931935,0.09018754,SU-11652
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-2.006684965,0.064092668,SU-11652
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,-1.994892764,0.054936573,SU-11652
CILIUM_ASSEMBLY,-1.954004207,0.061528961,SU-11652
NUCLEOTIDE_EXCISION_REPAIR,-1.92799392,0.065618684,SU-11652
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.823221316,0.210038934,SU-11652
NEUTROPHIL_DEGRANULATION,-1.910230652,0.064485072,SU-11652
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.380360397,0.002172315,glibenclamide
GPCR_LIGAND_BINDING,2.324090939,0.00152062,glibenclamide
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.42489113,0.040684839,glibenclamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.235787,0.00289642,glibenclamide
S_PHASE,-2.340039978,0.034872719,glibenclamide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.296585052,0.027123226,glibenclamide
SIGNALING_BY_ALK_IN_CANCER,-2.157464901,0.037052264,glibenclamide
SYNTHESIS_OF_DNA,-2.028127943,0.07323271,glibenclamide
SIGNALING_BY_GPCR,2.040573534,0.01325112,glibenclamide
G_ALPHA_I_SIGNALLING_EVENTS,2.031871078,0.011469822,glibenclamide
RESPIRATORY_ELECTRON_TRANSPORT,3.325793822,0,loperamide
METABOLISM_OF_STEROIDS,2.455826611,0.001951038,loperamide
ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,2.359384779,0.002601384,loperamide
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.224103446,0.004598876,loperamide
METABOLISM_OF_LIPIDS,2.025133447,0.018172528,loperamide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.064897819,0.386686759,loperamide
HEMOSTASIS,-2.059783772,0.203639772,loperamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.996390358,0.235291647,loperamide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.983992266,0.19677551,loperamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.807608142,0.063362289,loperamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.536214451,0,nilotinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.295228996,0.001106925,nilotinib
GPCR_LIGAND_BINDING,-2.289943844,0.00073795,nilotinib
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.228728076,0.04423775,nilotinib
SIGNALING_BY_NUCLEAR_RECEPTORS,2.1765171,0.037602087,nilotinib
ESR_MEDIATED_SIGNALING,1.981689108,0.076678766,nilotinib
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.84766456,0.150408348,nilotinib
FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,1.737142443,0.231805808,nilotinib
KEAP1_NFE2L2_PATHWAY,1.72771712,0.206442831,nilotinib
SIGNALING_BY_GPCR,-1.92778078,0.07176561,nilotinib
METABOLISM_OF_RNA,-3.43852067,0,exemestane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.158188512,0,exemestane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.007516537,0,exemestane
CELL_CYCLE,-2.992961946,0,exemestane
CELL_CYCLE_MITOTIC,-2.981377118,0,exemestane
GPCR_LIGAND_BINDING,2.961268077,0,exemestane
M_PHASE,-2.949047385,0,exemestane
MRNA_SPLICING,-2.880777538,0,exemestane
MITOTIC_METAPHASE_AND_ANAPHASE,-2.88008467,0,exemestane
CELL_CYCLE_CHECKPOINTS,-2.606725822,0,exemestane
NONSENSE_MEDIATED_DECAY_NMD,2.40368248,0.004880437,E-7438
EUKARYOTIC_TRANSLATION_ELONGATION,2.335595851,0.007320655,E-7438
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.30123321,0.006913952,E-7438
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.286264971,0.006100546,E-7438
SELENOAMINO_ACID_METABOLISM,2.182363779,0.017813594,E-7438
CELLULAR_RESPONSE_TO_STARVATION,2.128792183,0.023182074,E-7438
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.113305102,0.02265917,E-7438
SIGNALING_BY_ROBO_RECEPTORS,2.106044223,0.020589342,E-7438
EUKARYOTIC_TRANSLATION_INITIATION,2.085818685,0.020741856,E-7438
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.074553885,0.019765768,E-7438
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.238362778,0.00381562,pilaralisib
SIGNALING_BY_NTRKS,1.948194575,0.178928344,pilaralisib
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1.918690999,0.111152456,pilaralisib
MYD88_INDEPENDENT_TLR4_CASCADE,1.911908273,0.075908994,pilaralisib
TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1.798872978,0.138262811,pilaralisib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.919769036,0.06639179,pilaralisib
MITOCHONDRIAL_TRANSLATION,1.642693572,0.246162024,pilaralisib
GPCR_LIGAND_BINDING,-1.876222681,0.07071616,pilaralisib
SARS_COV_2_HOST_INTERACTIONS,1.630735324,0.221401233,pilaralisib
METABOLISM_OF_RNA,1.619050708,0.205264117,pilaralisib
SIGNALING_BY_MET,2.149239815,0.073219931,sonidegib
SIGNALING_BY_EGFR,2.133702741,0.042390486,sonidegib
S_PHASE,1.850833404,0.151578102,sonidegib
EUKARYOTIC_TRANSLATION_ELONGATION,1.81917208,0.13487882,sonidegib
SIGNALING_BY_FGFR1,1.751467554,0.158386271,sonidegib
GLYCOSAMINOGLYCAN_METABOLISM,-1.907836637,0.370614693,sonidegib
SELENOAMINO_ACID_METABOLISM,1.732992591,0.146118721,sonidegib
EUKARYOTIC_TRANSLATION_INITIATION,1.708552962,0.143136707,sonidegib
SIGNALING_BY_FGFR2_IN_DISEASE,1.661003496,0.164263134,sonidegib
SIGNALING_BY_PDGF,1.644327655,0.164209611,sonidegib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.17062319,0.004066128,idelalisib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.182668333,0.080388535,idelalisib
GPCR_LIGAND_BINDING,-1.997498346,0.021686016,idelalisib
RHO_GTPASE_CYCLE,1.917714651,0.175585484,idelalisib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.856834353,0.165008045,idelalisib
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.840973499,0.137506704,idelalisib
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.924718637,0.039983593,idelalisib
INFLUENZA_INFECTION,1.77887227,0.159084679,idelalisib
CELL_CYCLE_CHECKPOINTS,1.647790389,0.252448205,idelalisib
MITOTIC_PROPHASE,1.593069297,0.285893059,idelalisib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.289499643,0.035516224,istaroxime
VISUAL_PHOTOTRANSDUCTION,-2.092722299,0.0137296,istaroxime
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2.123631215,0.04820059,istaroxime
SENSORY_PERCEPTION,-2.074169429,0.008771689,istaroxime
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.937610117,0.093018682,istaroxime
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.910924917,0.084985251,istaroxime
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.977274691,0.022374163,istaroxime
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.834160273,0.09640118,istaroxime
HIV_INFECTION,1.799989108,0.098092429,istaroxime
RESPIRATORY_ELECTRON_TRANSPORT,1.767735886,0.103649389,istaroxime
SENSORY_PERCEPTION,2.226069166,0.021714427,methotrexate
MITOCHONDRIAL_TRANSLATION,-2.095665931,0.368335523,methotrexate
GPCR_LIGAND_BINDING,1.939059095,0.174132997,methotrexate
TRANSLATION,-1.842688404,0.729340986,methotrexate
NEUTROPHIL_DEGRANULATION,-1.833286332,0.51371505,methotrexate
NEURONAL_SYSTEM,1.807193502,0.336016831,methotrexate
NONSENSE_MEDIATED_DECAY_NMD,-1.594458804,0.867237743,methotrexate
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.589273166,0.701120254,methotrexate
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.758092365,0.364343022,methotrexate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.749441351,0.310349265,methotrexate
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.555951468,0.014914016,sumatriptan
DEVELOPMENTAL_CELL_LINEAGES,-2.227364635,0.10865926,sumatriptan
SIGNALING_BY_MET,-2.173076244,0.112920408,sumatriptan
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.143270373,0.102800183,sumatriptan
HEMOSTASIS,-2.080609409,0.121868818,sumatriptan
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-2.06476098,0.118957033,sumatriptan
L1CAM_INTERACTIONS,-2.032796457,0.126616953,sumatriptan
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.892858213,0.250342414,sumatriptan
ION_CHANNEL_TRANSPORT,-1.789751299,0.385397115,sumatriptan
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.765322073,0.392451682,sumatriptan
NEUTROPHIL_DEGRANULATION,-2.831701998,0,phenelzine
GPCR_LIGAND_BINDING,2.806397115,0,phenelzine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.611643628,0,phenelzine
SENSORY_PERCEPTION,2.55506698,0,phenelzine
VESICLE_MEDIATED_TRANSPORT,-2.576239321,0.000758786,phenelzine
SIGNALING_BY_GPCR,2.314904681,0.000497647,phenelzine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.310299238,0.000398118,phenelzine
INNATE_IMMUNE_SYSTEM,-2.495361738,0.001517573,phenelzine
G_ALPHA_I_SIGNALLING_EVENTS,2.202878917,0.00254353,phenelzine
MEMBRANE_TRAFFICKING,-2.312197105,0.017452089,phenelzine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.861241125,0.003996542,glipizide
STIMULI_SENSING_CHANNELS,-2.561008077,0.067941208,glipizide
CELLULAR_RESPONSE_TO_STARVATION,2.085900864,0.077233716,glipizide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.53305082,0.058615944,glipizide
ECM_PROTEOGLYCANS,-2.383465608,0.142543318,glipizide
RESPIRATORY_ELECTRON_TRANSPORT,1.95632686,0.124581342,glipizide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.913782706,0.112380653,glipizide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.907403029,0.088650874,glipizide
HEMOSTASIS,-2.298640189,0.198761337,glipizide
EUKARYOTIC_TRANSLATION_ELONGATION,1.823140165,0.127603531,glipizide
METABOLISM_OF_RNA,3.933386731,0,GW-501516
CELL_CYCLE_MITOTIC,3.501700768,0,GW-501516
M_PHASE,3.428023407,0,GW-501516
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.36055068,0,GW-501516
MITOTIC_METAPHASE_AND_ANAPHASE,3.310945531,0,GW-501516
INFLUENZA_INFECTION,3.221634621,0,GW-501516
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,3.208327528,0,GW-501516
CELL_CYCLE_CHECKPOINTS,3.15598551,0,GW-501516
ISG15_ANTIVIRAL_MECHANISM,3.128887975,0,GW-501516
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.870982601,0,GW-501516
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.6920001,0,aripiprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.639480379,0,aripiprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.595171982,0,aripiprazole
CELL_CYCLE,-2.556160132,0,aripiprazole
SIGNALING_BY_ROBO_RECEPTORS,-2.550081575,0,aripiprazole
METABOLISM_OF_RNA,-2.549733246,0,aripiprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.485783261,0,aripiprazole
CELL_CYCLE_CHECKPOINTS,-2.481354296,0,aripiprazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.663831815,0.000504665,aripiprazole
NONSENSE_MEDIATED_DECAY_NMD,-2.389796678,0.000684622,aripiprazole
CELL_CYCLE_CHECKPOINTS,2.946485706,0,lomerizine
G2_M_CHECKPOINTS,2.303264447,0,lomerizine
SARS_COV_2_INFECTION,2.328312479,0,lomerizine
HOST_INTERACTIONS_OF_HIV_FACTORS,2.383181402,0,lomerizine
MITOTIC_PROPHASE,2.403007626,0,lomerizine
HIV_INFECTION,2.423096497,0,lomerizine
CELL_CYCLE_MITOTIC,2.396917545,0,lomerizine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.50266263,0,lomerizine
ISG15_ANTIVIRAL_MECHANISM,2.544689546,0,lomerizine
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.601416554,0,lomerizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.959402907,0.09985102,foretinib
SENSORY_PERCEPTION,-1.948303788,0.057166615,foretinib
MEMBRANE_TRAFFICKING,1.698318424,0.772366149,foretinib
VOLTAGE_GATED_POTASSIUM_CHANNELS,-1.932745595,0.044462923,foretinib
THE_PHOTOTRANSDUCTION_CASCADE,-1.924304762,0.036586633,foretinib
VESICLE_MEDIATED_TRANSPORT,1.644459828,0.509959701,foretinib
TOLL_LIKE_RECEPTOR_CASCADES,1.608833158,0.392784494,foretinib
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1.55724608,0.397322971,foretinib
INTERLEUKIN_1_FAMILY_SIGNALING,1.539620863,0.354496258,foretinib
POTASSIUM_CHANNELS,-1.811545706,0.087503032,foretinib
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.400705198,0.00666325,hexachlorophene
MEMBRANE_TRAFFICKING,2.172055875,0.029984623,hexachlorophene
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.022992611,0.039979498,hexachlorophene
VESICLE_MEDIATED_TRANSPORT,1.949478154,0.039979498,hexachlorophene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.06818158,0.017442338,hexachlorophene
SIGNALING_BY_GPCR,-2.015278548,0.016744644,hexachlorophene
GPCR_LIGAND_BINDING,-2.00172725,0.013023612,hexachlorophene
HIV_LIFE_CYCLE,1.757438564,0.125269093,hexachlorophene
RESPIRATORY_ELECTRON_TRANSPORT,1.745860459,0.121049035,hexachlorophene
POTASSIUM_CHANNELS,-1.945816769,0.019709842,hexachlorophene
NEDDYLATION,2.431772678,0.010777521,avanafil
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.326083364,0.007185014,avanafil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.862238904,0.067060132,avanafil
TRANSLATION,1.754598258,0.105080831,avanafil
HIV_INFECTION,1.684248699,0.12214524,avanafil
S_PHASE,1.664453371,0.114361475,avanafil
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.618607831,0.121632025,avanafil
SENSORY_PERCEPTION,-1.848460132,0.303647767,avanafil
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.531911769,0.160764691,avanafil
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.510839126,0.16126365,avanafil
METABOLISM_OF_RNA,-3.221995648,0,bisoprolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.022994082,0,bisoprolol
GPCR_LIGAND_BINDING,3.012764291,0,bisoprolol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.987322614,0,bisoprolol
SIGNALING_BY_GPCR,2.803750093,0,bisoprolol
G_ALPHA_I_SIGNALLING_EVENTS,2.641794283,0,bisoprolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.505071012,0,bisoprolol
MRNA_SPLICING,-2.757090318,0.001499659,bisoprolol
VIRAL_INFECTION_PATHWAYS,-2.462475315,0.018558282,bisoprolol
HIV_INFECTION,-2.4175397,0.02204499,bisoprolol
GPCR_LIGAND_BINDING,2.456088144,0.000878933,FR-180204
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.370673724,0.000878933,FR-180204
SIGNALING_BY_GPCR,2.233958355,0.0026368,FR-180204
BIOLOGICAL_OXIDATIONS,-2.063016224,0.213895855,FR-180204
RRNA_PROCESSING,-1.855298335,0.352500369,FR-180204
G_ALPHA_I_SIGNALLING_EVENTS,1.939724322,0.082839457,FR-180204
G_ALPHA_Q_SIGNALLING_EVENTS,1.895651455,0.098088948,FR-180204
G_ALPHA_S_SIGNALLING_EVENTS,1.870848559,0.103128165,FR-180204
POTASSIUM_CHANNELS,1.849108614,0.106476482,FR-180204
S_PHASE,-1.63780901,0.728957073,FR-180204
NONSENSE_MEDIATED_DECAY_NMD,-2.353319683,0.026558717,selegiline
GPCR_LIGAND_BINDING,2.248491337,0.011489254,selegiline
NEUTROPHIL_DEGRANULATION,-2.207607071,0.039838075,selegiline
EUKARYOTIC_TRANSLATION_INITIATION,-2.097260727,0.06688862,selegiline
TRANSLATION,-2.06863193,0.05901937,selegiline
INFLUENZA_INFECTION,-2.066478357,0.04780569,selegiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.024068314,0.056807979,selegiline
SIGNALING_BY_GPCR,1.997705359,0.048935713,selegiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.967513197,0.048031466,selegiline
INNATE_IMMUNE_SYSTEM,-1.76407549,0.253291465,selegiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.352798048,0.003688373,tadalafil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.776596875,0.087252475,tadalafil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.677465489,0.061262376,tadalafil
ECM_PROTEOGLYCANS,-2.350658448,0.262376238,tadalafil
HEMOSTASIS,-2.325369184,0.235303218,tadalafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.897816684,0.236424737,tadalafil
ESR_MEDIATED_SIGNALING,-2.194799868,0.393564356,tadalafil
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.151751947,0.389851485,tadalafil
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.104673205,0.397807638,tadalafil
GPCR_LIGAND_BINDING,1.775394477,0.428834884,tadalafil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.543325681,0,retinol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.483713704,0,retinol
GPCR_LIGAND_BINDING,2.407496847,0.000281026,retinol
SENSORY_PERCEPTION,2.248918527,0.001475385,retinol
G_ALPHA_I_SIGNALLING_EVENTS,2.180369484,0.00185477,retinol
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.12510912,0.057154067,retinol
SIGNALING_BY_GPCR,2.131564791,0.003653334,retinol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.991357305,0.060881507,retinol
METABOLISM_OF_RNA,-1.981465589,0.04390095,retinol
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.931836104,0.041623071,retinol
METABOLISM_OF_RNA,-3.226384904,0,pilocarpine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.617103925,0,pilocarpine
S_PHASE,-2.646087032,0,pilocarpine
EUKARYOTIC_TRANSLATION_INITIATION,-2.65844402,0,pilocarpine
RRNA_PROCESSING,-2.676134405,0,pilocarpine
NEURONAL_SYSTEM,2.703390534,0,pilocarpine
SEPARATION_OF_SISTER_CHROMATIDS,-2.718016839,0,pilocarpine
GPCR_LIGAND_BINDING,2.802228689,0,pilocarpine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.852515814,0,pilocarpine
TRANSLATION,-2.671162289,0,pilocarpine
RESPIRATORY_ELECTRON_TRANSPORT,3.272957004,0,BRD-K98297262
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.109982896,0,BRD-K98297262
TRANSLATION,2.681913003,0.000526177,BRD-K98297262
APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,2.557549909,0.003157064,BRD-K98297262
UCH_PROTEINASES,2.377875982,0.005998421,BRD-K98297262
CIRCADIAN_CLOCK,2.355397534,0.005261773,BRD-K98297262
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.336099306,0.004735596,BRD-K98297262
DNA_REPLICATION,2.187837369,0.012430939,BRD-K98297262
METABOLISM_OF_RNA,2.182295802,0.011400509,BRD-K98297262
SYNTHESIS_OF_DNA,2.143159324,0.012312549,BRD-K98297262
RESPIRATORY_ELECTRON_TRANSPORT,3.76092037,0,citalopram
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.00451029,0,citalopram
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.462732659,0.001055426,citalopram
MITOCHONDRIAL_TRANSLATION,2.441527675,0.003055653,citalopram
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.162836531,0.043800173,citalopram
HEMOSTASIS,-2.117991476,0.048549589,citalopram
INTERFERON_SIGNALING,-1.954000396,0.164118719,citalopram
TRANSLATION,1.643489559,0.365220039,citalopram
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.797507954,0.431247002,citalopram
PI_METABOLISM,-1.771568015,0.432020981,citalopram
RESPIRATORY_ELECTRON_TRANSPORT,2.910147914,0,dipyridamole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.520163863,0.000921181,dipyridamole
ECM_PROTEOGLYCANS,-2.401218158,0.014866672,dipyridamole
ION_CHANNEL_TRANSPORT,-2.171329954,0.061944466,dipyridamole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.136808768,0.056162983,dipyridamole
COMPLEX_I_BIOGENESIS,2.059827269,0.044216679,dipyridamole
PROTEIN_LOCALIZATION,1.995279141,0.051279065,dipyridamole
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.036279563,0.105925037,dipyridamole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.962563258,0.050480708,dipyridamole
GPCR_LIGAND_BINDING,-1.995773979,0.122650043,dipyridamole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.405573604,0,pramipexole
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.127870245,0.000886211,pramipexole
NEUTROPHIL_DEGRANULATION,-2.665258036,0.22982394,pramipexole
HEMOSTASIS,-2.659130666,0.180786955,pramipexole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.400873103,0.499468274,pramipexole
INNATE_IMMUNE_SYSTEM,-1.949210975,0.691539643,pramipexole
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.903389467,0.620347395,pramipexole
VISUAL_PHOTOTRANSDUCTION,-1.817705012,0.595311946,pramipexole
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.718661233,0.610106739,pramipexole
SIGNALING_BY_HEDGEHOG,1.694409954,1,pramipexole
RESPIRATORY_ELECTRON_TRANSPORT,3.567152285,0,cholic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.90553471,0,cholic-acid
DISEASES_OF_METABOLISM,2.495859665,0.001078458,cholic-acid
COMPLEX_I_BIOGENESIS,2.470807693,0.000808843,cholic-acid
NEURONAL_SYSTEM,-2.27466295,0.020210567,cholic-acid
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.175524491,0.026466219,cholic-acid
PROTEIN_LOCALIZATION,2.121103106,0.018333783,cholic-acid
SIGNALING_BY_INTERLEUKINS,-2.107237775,0.039458726,cholic-acid
GPCR_LIGAND_BINDING,-2.072055908,0.041624144,cholic-acid
SIGNALING_BY_GPCR,-2.062418725,0.035609094,cholic-acid
CELLULAR_RESPONSE_TO_STARVATION,2.72779369,0,emedastine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.474529934,0.001020893,emedastine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.460252701,0.001020893,emedastine
RESPIRATORY_ELECTRON_TRANSPORT,2.387107659,0.00076567,emedastine
STIMULI_SENSING_CHANNELS,-2.513996926,0.017797032,emedastine
SELENOAMINO_ACID_METABOLISM,2.285338789,0.004287752,emedastine
GPCR_LIGAND_BINDING,-2.440735768,0.018785756,emedastine
EUKARYOTIC_TRANSLATION_ELONGATION,2.21800405,0.005785062,emedastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.375315532,0.022740652,emedastine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.126017197,0.00991725,emedastine
M_PHASE,4.762771795,0,benzbromarone
SEPARATION_OF_SISTER_CHROMATIDS,2.732673843,0,benzbromarone
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,2.762929372,0,benzbromarone
MRNA_SPLICING,2.914127566,0,benzbromarone
CLEC7A_DECTIN_1_SIGNALING,2.937684613,0,benzbromarone
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.943426115,0,benzbromarone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,3.126233477,0,benzbromarone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.130115636,0,benzbromarone
HOST_INTERACTIONS_OF_HIV_FACTORS,3.143230751,0,benzbromarone
S_PHASE,3.16765968,0,benzbromarone
SENSORY_PERCEPTION,-2.169041801,0.002324721,pemetrexed
MRNA_SPLICING,2.058627822,0.126979429,pemetrexed
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.974310192,0.092348675,pemetrexed
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.961277884,0.069261507,pemetrexed
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.019171576,0.015885593,pemetrexed
S_PHASE,1.879641552,0.072147403,pemetrexed
GPCR_LIGAND_BINDING,-1.988800338,0.01446493,pemetrexed
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.87200192,0.062335356,pemetrexed
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.864157172,0.057717922,pemetrexed
VISUAL_PHOTOTRANSDUCTION,-1.953232263,0.014916959,pemetrexed
CELL_CYCLE_MITOTIC,4.071270994,0,anagrelide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.50018343,0,anagrelide
MITOTIC_SPINDLE_CHECKPOINT,2.510649093,0,anagrelide
TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,2.534476593,0,anagrelide
MYD88_INDEPENDENT_TLR4_CASCADE,2.556202799,0,anagrelide
INFLUENZA_INFECTION,2.566128069,0,anagrelide
METABOLISM_OF_RNA,2.583027818,0,anagrelide
S_PHASE,2.660181626,0,anagrelide
ISG15_ANTIVIRAL_MECHANISM,2.667615758,0,anagrelide
G2_M_CHECKPOINTS,2.66380812,0,anagrelide
METABOLISM_OF_RNA,-2.923645134,0,razoxane
GPCR_LIGAND_BINDING,2.540887047,0.000804087,razoxane
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.511620049,0.000692955,razoxane
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.391806366,0.001608175,razoxane
SIGNALING_BY_GPCR,2.309955882,0.001340146,razoxane
G_ALPHA_I_SIGNALLING_EVENTS,2.262493293,0.001407153,razoxane
CELL_CYCLE,-2.213258864,0.008315459,razoxane
CELL_CYCLE_CHECKPOINTS,-2.202213336,0.00692955,razoxane
SENSORY_PERCEPTION,2.068472698,0.010774772,razoxane
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.049694955,0.010721166,razoxane
NEUTROPHIL_DEGRANULATION,-2.173548568,0.166220463,ezetimibe
GPCR_LIGAND_BINDING,2.011033058,0.136818422,ezetimibe
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.913894217,0.416870368,ezetimibe
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.867829318,0.357945654,ezetimibe
SIGNALING_BY_INTERLEUKINS,-1.835772296,0.315291196,ezetimibe
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.888262339,0.206616652,ezetimibe
TRANSLATION,-1.775571755,0.361463547,ezetimibe
INFLUENZA_INFECTION,-1.70555301,0.440176412,ezetimibe
SIGNALING_BY_GPCR,1.825123445,0.229882729,ezetimibe
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.648337265,0.476046361,ezetimibe
SENSORY_PERCEPTION,2.2086641,0.016453085,alosetron
GPCR_LIGAND_BINDING,2.182965612,0.010529974,alosetron
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.164959287,0.008994353,alosetron
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.139001732,0.008720135,alosetron
SIGNALING_BY_GPCR,2.105962949,0.009213727,alosetron
MITOCHONDRIAL_TRANSLATION,-1.994356406,0.373104765,alosetron
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.897685432,0.321136601,alosetron
G_ALPHA_I_SIGNALLING_EVENTS,1.925866724,0.043107082,alosetron
TRANSLATION,-1.751489695,0.433512203,alosetron
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.743602399,0.337126805,alosetron
GPCR_LIGAND_BINDING,2.216366212,0.010326007,aloisine
SIGNALING_BY_GPCR,2.061959508,0.033711375,aloisine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.258015504,0.532222174,aloisine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.910146303,0.083215466,aloisine
SENSORY_PERCEPTION,1.734473906,0.247216751,aloisine
SIGNALING_BY_WNT,-3.040025623,1,aloisine
CARDIAC_CONDUCTION,1.703719546,0.251833083,aloisine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.701349084,0.21320167,aloisine
G_ALPHA_I_SIGNALLING_EVENTS,1.660465345,0.237932022,aloisine
TRANSLATION,-2.163246576,1,aloisine
TRANSLATION,-2.64901521,0.00749837,methantheline
NEUTROPHIL_DEGRANULATION,-2.290181087,0.013747012,methantheline
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.149127232,0.032492936,methantheline
CELL_CYCLE,-2.114208934,0.02999348,methantheline
GPCR_LIGAND_BINDING,2.168151194,0.042761014,methantheline
RHO_GTPASES_ACTIVATE_FORMINS,-1.965305456,0.058987177,methantheline
RHO_GTPASE_EFFECTORS,-1.943919336,0.059570383,methantheline
MITOTIC_SPINDLE_CHECKPOINT,-1.94305287,0.051417394,methantheline
METABOLISM_OF_RNA,-1.936032277,0.047177244,methantheline
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.985116121,0.106177773,methantheline
CHROMATIN_ORGANIZATION,-2.310991976,0.046809584,triflupromazine
METABOLISM_OF_RNA,-2.235214107,0.043152585,triflupromazine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.197409945,0.041933586,triflupromazine
RESPIRATORY_ELECTRON_TRANSPORT,2.130916922,0.054666092,triflupromazine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.049025368,0.084476671,triflupromazine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.02311345,0.064915984,triflupromazine
ISG15_ANTIVIRAL_MECHANISM,-2.024789254,0.079576293,triflupromazine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.007992286,0.077284573,triflupromazine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.005657874,0.067915691,triflupromazine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.977389978,0.074237074,triflupromazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.348155948,0.11905059,proxymetacaine
INFLUENZA_INFECTION,-2.149136251,0.20216138,proxymetacaine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.926485126,0.445503781,proxymetacaine
GPCR_LIGAND_BINDING,1.862408072,0.618072101,proxymetacaine
NEUTROPHIL_DEGRANULATION,-1.7165709,0.874347967,proxymetacaine
TRANSLATION,-1.702387151,0.736765917,proxymetacaine
CHROMOSOME_MAINTENANCE,-1.664651715,0.713929169,proxymetacaine
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.751243125,0.741320798,proxymetacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.751028811,0.495189127,proxymetacaine
SIGNALING_BY_GPCR,1.739405492,0.404855512,proxymetacaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.579930918,0,oxaprozin
GPCR_LIGAND_BINDING,2.488655347,0,oxaprozin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.277036236,0.000977211,oxaprozin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.174402963,0.13909038,oxaprozin
SIGNALING_BY_GPCR,2.123401686,0.006596178,oxaprozin
G_ALPHA_I_SIGNALLING_EVENTS,2.077099349,0.008061995,oxaprozin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.954358522,0.434187536,oxaprozin
ESR_MEDIATED_SIGNALING,-1.918488551,0.362136214,oxaprozin
HCMV_EARLY_EVENTS,-1.891855031,0.328929952,oxaprozin
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.805649612,0.434563456,oxaprozin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.192425457,0.044772556,lofexidine
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-2.020876554,0.255115954,lofexidine
ECM_PROTEOGLYCANS,-1.941346296,0.267662641,lofexidine
BIOLOGICAL_OXIDATIONS,1.770238643,0.337906084,lofexidine
METABOLISM_OF_STEROIDS,1.641161961,0.44800715,lofexidine
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.772838888,0.708539256,lofexidine
CELL_CYCLE,-1.749476278,0.619754025,lofexidine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.74921181,0.497267,lofexidine
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.740319664,0.442270692,lofexidine
AUTOPHAGY,1.509926122,0.640965603,lofexidine
MUSCLE_CONTRACTION,2.700063316,0,mibefradil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.597892713,0,mibefradil
EXTRACELLULAR_MATRIX_ORGANIZATION,2.44890722,0.00097046,mibefradil
CARDIAC_CONDUCTION,2.441791158,0.000909807,mibefradil
METABOLISM_OF_STEROIDS,2.387864527,0.00160126,mibefradil
GPCR_LIGAND_BINDING,2.36582898,0.001576998,mibefradil
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.24773747,0.02172298,mibefradil
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.268730573,0.003639226,mibefradil
METABOLISM_OF_RNA,-2.132548381,0.050505929,mibefradil
SIGNALING_BY_GPCR,2.120672971,0.008370221,mibefradil
TRANSLATION,-3.107552511,0,pergolide
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.638000273,0,pergolide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.54790414,0.001017368,pergolide
EUKARYOTIC_TRANSLATION_INITIATION,-2.547732136,0.000763026,pergolide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.502772648,0.001831262,pergolide
MITOCHONDRIAL_TRANSLATION,-2.403842939,0.003052104,pergolide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.361792334,0.003433617,pergolide
SELENOAMINO_ACID_METABOLISM,-2.361792334,0.003433617,pergolide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.268169449,0.010295539,pergolide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.279753824,0.005765085,pergolide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.283382332,0.019093389,butorphanol-(+)-tartrate
C_TYPE_LECTIN_RECEPTORS_CLRS,2.175750474,0.02227562,butorphanol-(+)-tartrate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.107163259,0.010074609,butorphanol-(+)-tartrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.004555015,0.048794216,butorphanol-(+)-tartrate
HIV_INFECTION,1.932274098,0.055689051,butorphanol-(+)-tartrate
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.925593216,0.047097026,butorphanol-(+)-tartrate
HIV_LIFE_CYCLE,1.857795726,0.057280166,butorphanol-(+)-tartrate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.844411405,0.052734121,butorphanol-(+)-tartrate
METABOLISM_OF_RNA,1.815961421,0.054097935,butorphanol-(+)-tartrate
MITOTIC_METAPHASE_AND_ANAPHASE,1.797898401,0.054451516,butorphanol-(+)-tartrate
SUMOYLATION,2.5623639,0.009846354,lapatinib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-2.252463921,0.002945909,lapatinib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.398445516,0.007384765,lapatinib
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.363412282,0.004923177,lapatinib
SARS_COV_2_INFECTION,2.235274,0.009846354,lapatinib
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,2.201282389,0.009846354,lapatinib
RESOLUTION_OF_SISTER_CHROMATID_COHESION,2.098478988,0.018051648,lapatinib
RHO_GTPASE_CYCLE,2.054881462,0.019692707,lapatinib
NEURONAL_SYSTEM,-2.072789479,0.011783634,lapatinib
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,2.022756437,0.022154296,lapatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.909535151,0.174649823,cediranib
VISUAL_PHOTOTRANSDUCTION,-1.901613872,0.093562405,cediranib
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.606694152,1,cediranib
SIGNALING_BY_FGFR,1.595354264,0.736618522,cediranib
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1.577399068,0.534409516,cediranib
KEAP1_NFE2L2_PATHWAY,1.566163603,0.418861512,cediranib
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1.564441289,0.33797791,cediranib
INTERLEUKIN_1_FAMILY_SIGNALING,1.563578312,0.282450675,cediranib
TRANSLATION,1.510483016,0.338390581,cediranib
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1.505108932,0.302109884,cediranib
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.688588871,0.017360446,venlafaxine
HEMOSTASIS,-2.496552825,0.037614301,venlafaxine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.482991278,0.027005139,venlafaxine
HCMV_EARLY_EVENTS,-2.448777299,0.025558435,venlafaxine
L1CAM_INTERACTIONS,-2.135577918,0.148142476,venlafaxine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.010324517,0.25622733,venlafaxine
ION_CHANNEL_TRANSPORT,-1.944030109,0.302843344,venlafaxine
HCMV_INFECTION,-1.872416046,0.368186135,venlafaxine
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.823993397,0.404219778,venlafaxine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.801388384,0.398711587,venlafaxine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.046248922,0.068232044,piperine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.915787068,0.234622468,piperine
TRANSPORT_OF_SMALL_MOLECULES,-2.716549398,0.466451811,piperine
HEMOSTASIS,-2.67236745,0.385151934,piperine
MEMBRANE_TRAFFICKING,-2.655665114,0.317697974,piperine
VESICLE_MEDIATED_TRANSPORT,-2.538620827,0.304251074,piperine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-2.461126581,0.280281505,piperine
GPCR_LIGAND_BINDING,1.501722166,1,piperine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.391578189,0.383655617,piperine
NERVOUS_SYSTEM_DEVELOPMENT,1.397405147,1,piperine
METABOLISM_OF_RNA,-3.115241161,0,alfuzosin
EUKARYOTIC_TRANSLATION_INITIATION,-3.09379534,0,alfuzosin
SELENOAMINO_ACID_METABOLISM,-3.049685983,0,alfuzosin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.047236698,0,alfuzosin
NONSENSE_MEDIATED_DECAY_NMD,-2.998135198,0,alfuzosin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.984064137,0,alfuzosin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.984064137,0,alfuzosin
INFLUENZA_INFECTION,-2.862996564,0,alfuzosin
RRNA_PROCESSING,-2.842994721,0,alfuzosin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.468927677,0.002757344,alfuzosin
UB_SPECIFIC_PROCESSING_PROTEASES,2.450408048,0.03048589,alectinib
METABOLISM_OF_RNA,2.441161646,0.016936606,alectinib
GPCR_LIGAND_BINDING,-2.188276479,0.00644608,alectinib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.278406245,0.032744104,alectinib
G2_M_CHECKPOINTS,2.274294873,0.025404908,alectinib
NEURONAL_SYSTEM,-2.14263544,0.006066899,alectinib
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.241644596,0.023711248,alectinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.230374313,0.017420509,alectinib
G2_M_DNA_DAMAGE_CHECKPOINT,2.232400697,0.020323927,alectinib
SIGNALING_BY_ALK_IN_CANCER,2.220121775,0.01651319,alectinib
RESPIRATORY_ELECTRON_TRANSPORT,3.489113038,0,moracizine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.480039306,0,moracizine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.025584523,0.057552881,moracizine
MITOCHONDRIAL_TRANSLATION,1.983901178,0.054212759,moracizine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.979118375,0.044809029,moracizine
CIRCADIAN_CLOCK,1.874663482,0.070742083,moracizine
SIGNALING_BY_WNT,1.693741699,0.169869091,moracizine
ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,-2.125096595,1,moracizine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.104487228,1,moracizine
SARS_COV_2_HOST_INTERACTIONS,-2.053818677,1,moracizine
RESPIRATORY_ELECTRON_TRANSPORT,3.419055986,0,BRD-K34685430
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.785694962,0,BRD-K34685430
TRANSLATION,2.605492974,0,BRD-K34685430
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.362986624,0.027165794,BRD-K34685430
RRNA_PROCESSING,2.258385714,0.009965609,BRD-K34685430
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.296185822,0.02585132,BRD-K34685430
MITOCHONDRIAL_TRANSLATION,2.11354576,0.026840707,BRD-K34685430
METABOLISM_OF_RNA,2.103072961,0.024803293,BRD-K34685430
NEURONAL_SYSTEM,-2.110897118,0.104865808,BRD-K34685430
CIRCADIAN_CLOCK,1.939059476,0.063969718,BRD-K34685430
CELL_CYCLE,-2.985972041,0,trazodone
INFLUENZA_INFECTION,-2.63342108,0,trazodone
NONSENSE_MEDIATED_DECAY_NMD,-2.64285042,0,trazodone
INFECTIOUS_DISEASE,-2.647940312,0,trazodone
CELL_CYCLE_MITOTIC,-2.720703669,0,trazodone
TRANSLATION,-2.754727553,0,trazodone
SELENOAMINO_ACID_METABOLISM,-2.764450825,0,trazodone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.803811533,0,trazodone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.633694097,0,trazodone
EUKARYOTIC_TRANSLATION_INITIATION,-2.814964809,0,trazodone
ECM_PROTEOGLYCANS,-2.077698039,0.121077981,adenosine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.037014037,0.094461701,adenosine
FATTY_ACID_METABOLISM,1.643937422,0.684905194,adenosine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.82895784,0.459609234,adenosine
GASTRULATION,-1.76990373,0.564160767,adenosine
METABOLISM_OF_LIPIDS,1.443660549,0.936037099,adenosine
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.369829595,0.866833137,adenosine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.367573197,0.657794364,adenosine
EUKARYOTIC_TRANSLATION_INITIATION,-1.67704254,0.912468718,adenosine
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.343103017,0.586307384,adenosine
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,2.190368986,0.025668103,pyrimethamine
MUSCLE_CONTRACTION,2.098123918,0.025482102,pyrimethamine
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.084502187,0.242124261,pyrimethamine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.0788103,0.126325702,pyrimethamine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.073689846,0.088164813,pyrimethamine
CELL_CYCLE_CHECKPOINTS,-2.044953408,0.091125571,pyrimethamine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.043402808,0.075005885,pyrimethamine
VIRAL_INFECTION_PATHWAYS,-2.009076651,0.080269456,pyrimethamine
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,-1.980922578,0.087788843,pyrimethamine
APOPTOSIS,-1.96898543,0.085697514,pyrimethamine
RESPIRATORY_ELECTRON_TRANSPORT,3.820980599,0,loxoprofen
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.314524208,0,loxoprofen
COMPLEX_I_BIOGENESIS,2.697548038,0.000506078,loxoprofen
NEURONAL_SYSTEM,-2.388230255,0.005498511,loxoprofen
PROTEIN_LOCALIZATION,2.252107775,0.009488962,loxoprofen
GPCR_LIGAND_BINDING,-2.204595811,0.025843,loxoprofen
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.174963946,0.026026284,loxoprofen
SIGNALING_BY_GPCR,-2.117423197,0.037664798,loxoprofen
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.075538727,0.026569095,loxoprofen
TRANSLATION,2.060838163,0.023659146,loxoprofen
RESPIRATORY_ELECTRON_TRANSPORT,4.223696932,0,ambrisentan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.14876042,0,ambrisentan
PROTEIN_LOCALIZATION,2.459475362,0.001864294,ambrisentan
TRANSLATION,2.354638601,0.003262514,ambrisentan
DISEASES_OF_METABOLISM,2.351719676,0.002610011,ambrisentan
GPCR_LIGAND_BINDING,-2.23475426,0.02319973,ambrisentan
ION_CHANNEL_TRANSPORT,-2.228729617,0.013318363,ambrisentan
METABOLISM_OF_STEROIDS,2.009505698,0.028275118,ambrisentan
NEURONAL_SYSTEM,-2.074265644,0.046972292,ambrisentan
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.928943157,0.042878751,ambrisentan
EUKARYOTIC_TRANSLATION_ELONGATION,3.127943558,0,amlexanox
SARS_COV_1_HOST_INTERACTIONS,2.583802511,0,amlexanox
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.592264363,0,amlexanox
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.662169324,0,amlexanox
INFLUENZA_INFECTION,2.672477649,0,amlexanox
CELLULAR_RESPONSE_TO_STARVATION,2.8091946,0,amlexanox
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.844106075,0,amlexanox
RRNA_PROCESSING,2.830608925,0,amlexanox
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.95042934,0,amlexanox
EUKARYOTIC_TRANSLATION_INITIATION,2.970383192,0,amlexanox
G_ALPHA_Q_SIGNALLING_EVENTS,2.070998513,0.083785991,BRD-K14643723
SIGNALING_BY_GPCR,2.061024199,0.0461533,BRD-K14643723
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.3156551,0.49913216,BRD-K14643723
GPCR_LIGAND_BINDING,2.012878885,0.044023148,BRD-K14643723
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.99312483,0.042248021,BRD-K14643723
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.942299674,0.053395818,BRD-K14643723
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-3.142837945,0.812224151,BRD-K14643723
TRNA_PROCESSING,-2.517326137,1,BRD-K14643723
SENSORY_PERCEPTION,1.83567668,0.100945551,BRD-K14643723
NEUTROPHIL_DEGRANULATION,-1.78499605,1,BRD-K14643723
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.058710823,0.030153509,guanaben-acetate
METABOLISM_OF_RNA,-1.714171367,0.13629386,guanaben-acetate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.706011254,0.095486111,guanaben-acetate
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.502014392,1,guanaben-acetate
NEURONAL_SYSTEM,-1.41510936,0.284950658,guanaben-acetate
SARS_COV_2_INFECTION,1.371210711,1,guanaben-acetate
HEMOSTASIS,1.34335583,1,guanaben-acetate
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-1.271804696,0.404298246,guanaben-acetate
NERVOUS_SYSTEM_DEVELOPMENT,1.317115279,1,guanaben-acetate
MAPK1_MAPK3_SIGNALING,-1.150942772,0.512006579,guanaben-acetate
MUSCLE_CONTRACTION,2.544222252,0.002119143,VX-702
GPCR_LIGAND_BINDING,2.416660856,0.001765952,VX-702
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.06064969,0.017894985,VX-702
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.055955642,0.013951024,VX-702
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.03635965,0.012291029,VX-702
SIGNALING_BY_GPCR,1.832700609,0.035554509,VX-702
CELL_CELL_COMMUNICATION,1.823297265,0.032695348,VX-702
G_ALPHA_I_SIGNALLING_EVENTS,1.709052367,0.055362609,VX-702
G_ALPHA_Q_SIGNALLING_EVENTS,1.673064145,0.061769092,VX-702
SENSORY_PERCEPTION,1.5317066,0.116552861,VX-702
EUKARYOTIC_TRANSLATION_ELONGATION,-3.718970998,0,estrone
METABOLISM_OF_RNA,-2.381438382,0,estrone
VIRAL_INFECTION_PATHWAYS,-2.394406166,0,estrone
SARS_COV_INFECTIONS,-2.401661011,0,estrone
SARS_COV_2_INFECTION,-2.601535065,0,estrone
NERVOUS_SYSTEM_DEVELOPMENT,-2.679052063,0,estrone
GPCR_LIGAND_BINDING,2.812424935,0,estrone
MUSCLE_CONTRACTION,2.855761177,0,estrone
SARS_COV_2_HOST_INTERACTIONS,-2.858569452,0,estrone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.046528016,0,estrone
RRNA_PROCESSING,2.606968839,0,ibuprofen
RESPIRATORY_ELECTRON_TRANSPORT,2.59706582,0,ibuprofen
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.587029555,0,ibuprofen
METABOLISM_OF_RNA,2.391983121,0.000922824,ibuprofen
TRANSLATION,2.284787474,0.003937382,ibuprofen
EUKARYOTIC_TRANSLATION_INITIATION,2.200379365,0.007587664,ibuprofen
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.336936608,0.117438115,ibuprofen
THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,2.01293142,0.040076928,ibuprofen
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1.888685184,0.08997534,ibuprofen
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,1.860719067,0.084038505,ibuprofen
RESPIRATORY_ELECTRON_TRANSPORT,4.163411719,0,clozapine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.310369871,0,clozapine
PROTEIN_LOCALIZATION,2.435543001,0.005387741,clozapine
ION_CHANNEL_TRANSPORT,-2.403120741,0.043512217,clozapine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.202339807,0.020608108,clozapine
TRANSLATION,2.132715923,0.021981982,clozapine
DISEASES_OF_METABOLISM,2.102605286,0.021281576,clozapine
FATTY_ACID_METABOLISM,1.930776744,0.049182376,clozapine
METABOLISM_OF_STEROIDS,1.864545621,0.06586513,clozapine
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.84497108,0.064652888,clozapine
NEUTROPHIL_DEGRANULATION,-2.211538655,0.679412034,mesoridazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.189203116,0.394770583,mesoridazine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.186101726,0.266568978,mesoridazine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.053632657,0.426962176,mesoridazine
RHOG_GTPASE_CYCLE,-1.952460485,0.522859236,mesoridazine
INNATE_IMMUNE_SYSTEM,-1.889103961,0.539350368,mesoridazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.765343654,0.496760932,mesoridazine
GPCR_LIGAND_BINDING,1.76612906,0.989410739,mesoridazine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.795654953,0.600748368,mesoridazine
MEMBRANE_TRAFFICKING,-1.780415747,0.547257075,mesoridazine
G_ALPHA_I_SIGNALLING_EVENTS,2.452390454,0.002538275,loteprednol
GPCR_LIGAND_BINDING,2.445257289,0.001269137,loteprednol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.309770524,0.001903706,loteprednol
CELL_CYCLE,-2.370941926,0.026395127,loteprednol
SENSORY_PERCEPTION,2.14185026,0.009201247,loteprednol
CELL_CYCLE_MITOTIC,-2.1126756,0.079185381,loteprednol
M_PHASE,-2.047300582,0.077585676,loteprednol
SIGNALING_BY_GPCR,2.058729659,0.015737305,loteprednol
MITOTIC_METAPHASE_AND_ANAPHASE,-1.971963639,0.096582169,loteprednol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.998019747,0.023161759,loteprednol
METABOLISM_OF_RNA,3.894513257,0,nocodazole
HIV_INFECTION,2.789997023,0,nocodazole
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.72694564,0,nocodazole
KEAP1_NFE2L2_PATHWAY,2.624524754,0,nocodazole
HIV_LIFE_CYCLE,2.594032091,0,nocodazole
SIGNALING_BY_ALK_IN_CANCER,2.506806724,0,nocodazole
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.460021251,0,nocodazole
ISG15_ANTIVIRAL_MECHANISM,2.458633175,0,nocodazole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.245367685,0,nocodazole
POTASSIUM_CHANNELS,-2.08132998,0.003007114,nocodazole
RESPIRATORY_ELECTRON_TRANSPORT,3.474395365,0,nateglinide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.05897894,0,nateglinide
GPCR_LIGAND_BINDING,-2.566127385,0.001890033,nateglinide
SIGNALING_BY_GPCR,-2.504630096,0.001417525,nateglinide
MITOCHONDRIAL_TRANSLATION,2.419175722,0.003017837,nateglinide
COMPLEX_I_BIOGENESIS,2.417485533,0.002263378,nateglinide
DISEASES_OF_METABOLISM,2.364880234,0.002489715,nateglinide
CELLULAR_RESPONSE_TO_STARVATION,2.272028672,0.005847059,nateglinide
TRANSLATION,2.21981305,0.007598482,nateglinide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.18409206,0.022050388,nateglinide
NEUTROPHIL_DEGRANULATION,-2.569727142,0.008283602,didanosine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.298983518,0.004895626,didanosine
CELL_CYCLE,-2.242965373,0.030373207,didanosine
BIOLOGICAL_OXIDATIONS,-2.140088407,0.043258811,didanosine
SENSORY_PERCEPTION,2.074421037,0.032870631,didanosine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.979027978,0.075933019,didanosine
CELL_CYCLE_MITOTIC,-1.953169089,0.067373297,didanosine
GPCR_LIGAND_BINDING,2.031351701,0.034036256,didanosine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.74494803,0.179478044,didanosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.890124737,0.08742189,didanosine
RESPIRATORY_ELECTRON_TRANSPORT,2.924988873,0,pentobarbital
EUKARYOTIC_TRANSLATION_ELONGATION,2.368048783,0.009765051,pentobarbital
RRNA_PROCESSING,2.334026229,0.007195301,pentobarbital
SELENOAMINO_ACID_METABOLISM,2.292512162,0.007709251,pentobarbital
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.27633569,0.006989721,pentobarbital
EUKARYOTIC_TRANSLATION_INITIATION,2.064903257,0.022442487,pentobarbital
TRANSLATION,2.030062749,0.023348018,pentobarbital
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.94250561,0.032892805,pentobarbital
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.911370558,0.035976505,pentobarbital
SIGNALING_BY_ROBO_RECEPTORS,1.750769806,0.077812041,pentobarbital
GPCR_LIGAND_BINDING,-2.918383459,0,vardenafil
CELLULAR_RESPONSE_TO_STARVATION,2.573819089,0,vardenafil
EUKARYOTIC_TRANSLATION_ELONGATION,2.411760796,0.001597361,vardenafil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.401197696,0.001331134,vardenafil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.345259816,0.002995052,vardenafil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.531752542,0.024677093,vardenafil
COLLAGEN_FORMATION,-2.514897457,0.020062678,vardenafil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.495799001,0.017454529,vardenafil
ECM_PROTEOGLYCANS,-2.480081433,0.014926632,vardenafil
RRNA_PROCESSING,2.185455228,0.010063374,vardenafil
EUKARYOTIC_TRANSLATION_ELONGATION,-2.666256652,0,tetracaine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.641351057,0,tetracaine
NONSENSE_MEDIATED_DECAY_NMD,-2.511651149,0.000555209,tetracaine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.488438536,0.000370139,tetracaine
SELENOAMINO_ACID_METABOLISM,-2.480433267,0.000555209,tetracaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.474088292,0.000666251,tetracaine
RRNA_PROCESSING,-2.469298883,0.000555209,tetracaine
EUKARYOTIC_TRANSLATION_INITIATION,-2.385007411,0.000493519,tetracaine
SIGNALING_BY_ROBO_RECEPTORS,-2.389618555,0.000555209,tetracaine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.411318174,0.000634525,tetracaine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.343292939,0.001054819,mazindol
GPCR_LIGAND_BINDING,-2.244241633,0.00843855,mazindol
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.173500738,0.016525494,mazindol
PROTEIN_LOCALIZATION,2.204683973,0.040982177,mazindol
SIGNALING_BY_GPCR,-1.979033694,0.08148475,mazindol
G_ALPHA_S_SIGNALLING_EVENTS,-1.972618221,0.068352256,mazindol
MITOTIC_METAPHASE_AND_ANAPHASE,-1.935812609,0.084385502,mazindol
NEURONAL_SYSTEM,-1.85040104,0.157770751,mazindol
CHROMATIN_ORGANIZATION,-1.838215756,0.154662803,mazindol
METABOLISM_OF_STEROIDS,1.699277939,0.486458442,mazindol
MITOTIC_METAPHASE_AND_ANAPHASE,-3.267203585,0,quetiapine
SEPARATION_OF_SISTER_CHROMATIDS,-2.960527321,0,quetiapine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.829632512,0,quetiapine
M_PHASE,-2.817644804,0,quetiapine
CELL_CYCLE,-2.727530572,0.000735565,quetiapine
CELL_CYCLE_MITOTIC,-2.711219773,0.00061297,quetiapine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.710688285,0.000525403,quetiapine
MITOTIC_SPINDLE_CHECKPOINT,-2.680737363,0.000459728,quetiapine
RHO_GTPASES_ACTIVATE_FORMINS,-2.586426975,0.001838911,quetiapine
CELL_CYCLE_CHECKPOINTS,-2.50688578,0.004597278,quetiapine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.243982888,0.016950262,levamisole
MITOTIC_METAPHASE_AND_ANAPHASE,-2.136899025,0.038743455,levamisole
SEPARATION_OF_SISTER_CHROMATIDS,-2.068425549,0.052868674,levamisole
CELL_CYCLE_MITOTIC,-2.033130633,0.052364202,levamisole
RHO_GTPASES_ACTIVATE_FORMINS,-2.026380654,0.044070681,levamisole
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.996819315,0.050850785,levamisole
M_PHASE,-1.930429502,0.084924271,levamisole
RHO_GTPASE_EFFECTORS,-1.927691521,0.076578861,levamisole
MITOTIC_SPINDLE_CHECKPOINT,-1.909589573,0.080850058,levamisole
CELL_CYCLE,-1.852184958,0.119741492,levamisole
ION_CHANNEL_TRANSPORT,-2.985870462,0.187784782,BMS-927711
DISEASES_OF_METABOLISM,-2.91363362,0.520763982,BMS-927711
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.8979301,0.479786891,BMS-927711
AURKA_ACTIVATION_BY_TPX2,1.485487454,1,BMS-927711
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.48321659,0.9366439,BMS-927711
CELL_CELL_COMMUNICATION,1.482105468,0.629410211,BMS-927711
INTERFERON_ALPHA_BETA_SIGNALING,1.433235608,0.606882759,BMS-927711
TRNA_PROCESSING,1.39503143,0.586574092,BMS-927711
ISG15_ANTIVIRAL_MECHANISM,1.32885598,0.671069016,BMS-927711
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.320624935,0.598295482,BMS-927711
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.71843966,0,SNS-314
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.019832593,0.043822132,SNS-314
GPCR_LIGAND_BINDING,2.013965302,0.023736988,SNS-314
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.779867712,0.240267842,SNS-314
SIGNALING_BY_GPCR,1.966337278,0.027023648,SNS-314
NEUTROPHIL_DEGRANULATION,-1.724721378,0.217490157,SNS-314
G_ALPHA_Q_SIGNALLING_EVENTS,1.922507828,0.030127716,SNS-314
SIGNALING_BY_VEGF,-1.672808918,0.224837797,SNS-314
RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,-1.624943982,0.258343038,SNS-314
METABOLISM_OF_RNA,-1.605111597,0.248350247,SNS-314
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.558168075,1,moexipril
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.210942195,1,moexipril
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.124118617,1,moexipril
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.693157161,1,moexipril
VISUAL_PHOTOTRANSDUCTION,-1.914322487,0.965639001,moexipril
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.87975948,0.793123244,moexipril
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.637472742,1,moexipril
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.583315399,1,moexipril
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.693623149,0.843273344,moexipril
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.506251807,1,moexipril
TRANSPORT_OF_SMALL_MOLECULES,-2.970574861,0.098670072,DPPE
MHC_CLASS_II_ANTIGEN_PRESENTATION,1.852616391,0.13389908,DPPE
RAC1_GTPASE_CYCLE,1.560129514,0.320061995,DPPE
VESICLE_MEDIATED_TRANSPORT,-2.752564631,0.524698664,DPPE
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.723353922,0.5663251,DPPE
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.719299421,0.44761267,DPPE
RSV_HOST_INTERACTIONS,1.385278413,0.534732456,DPPE
DNA_REPLICATION,1.320439859,0.535812287,DPPE
RHOA_GTPASE_CYCLE,1.25445626,0.577234616,DPPE
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,1.246001778,0.495570574,DPPE
TRANSLATION,-2.837896572,0,lansoprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.319081529,0.015689382,lansoprazole
SELENOAMINO_ACID_METABOLISM,-2.267918811,0.019968304,lansoprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.255889368,0.017115689,lansoprazole
INFLUENZA_INFECTION,-2.12688655,0.022820919,lansoprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.092529771,0.023771791,lansoprazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.088162006,0.020783337,lansoprazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.939244739,0.0431458,lansoprazole
SIGNALING_BY_ROBO_RECEPTORS,-1.881980418,0.053248811,lansoprazole
MITOCHONDRIAL_TRANSLATION,-1.865213708,0.054199683,lansoprazole
MUSCLE_CONTRACTION,2.178250246,0.02789624,noretynodrel
GPCR_LIGAND_BINDING,2.154463656,0.015940709,noretynodrel
CARDIAC_CONDUCTION,2.052400789,0.030932566,noretynodrel
G_ALPHA_Q_SIGNALLING_EVENTS,2.035632042,0.026899946,noretynodrel
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.998324208,0.028579414,noretynodrel
SIGNALING_BY_GPCR,1.992046737,0.024670145,noretynodrel
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.852192386,0.061404261,noretynodrel
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.115289923,1,noretynodrel
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.704470162,0.135567189,noretynodrel
EXTRACELLULAR_MATRIX_ORGANIZATION,1.689275738,0.133977862,noretynodrel
TRANSLATION,-3.215671478,0,alprazolam
NEUTROPHIL_DEGRANULATION,-2.852442582,0,alprazolam
EUKARYOTIC_TRANSLATION_INITIATION,-2.701923222,0,alprazolam
INNATE_IMMUNE_SYSTEM,-2.681386248,0,alprazolam
INFLUENZA_INFECTION,-2.655703947,0,alprazolam
EUKARYOTIC_TRANSLATION_ELONGATION,-2.508215696,0.001492272,alprazolam
CELLULAR_RESPONSE_TO_STARVATION,-2.407562548,0.002984544,alprazolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.386515592,0.002611476,alprazolam
NONSENSE_MEDIATED_DECAY_NMD,-2.376284183,0.002321312,alprazolam
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.347877595,0.002984544,alprazolam
CELL_CYCLE_CHECKPOINTS,3.684642205,0,fludarabine
ISG15_ANTIVIRAL_MECHANISM,3.362981273,0,fludarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.083579399,0,fludarabine
METABOLISM_OF_RNA,3.070338838,0,fludarabine
S_PHASE,2.741879576,0,fludarabine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.659171878,0,fludarabine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.651311014,0,fludarabine
MITOTIC_PROPHASE,2.628538789,0,fludarabine
DNA_REPLICATION,2.627595906,0,fludarabine
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,2.492722359,0,fludarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.369726612,0,melatonin
METABOLISM_OF_RNA,-3.357758468,0,melatonin
MRNA_SPLICING,-3.186955354,0,melatonin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.922208534,0,melatonin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.854376743,0,melatonin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.768295264,0,melatonin
GPCR_LIGAND_BINDING,2.762211733,0,melatonin
SIGNALING_BY_GPCR,2.46263416,0,melatonin
G_ALPHA_Q_SIGNALLING_EVENTS,2.186935076,0.001560787,melatonin
CHROMATIN_ORGANIZATION,-2.418429243,0.005479058,melatonin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.741833495,0,melperone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.171519418,0.01539028,melperone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.33312289,0.061553724,melperone
HEMOSTASIS,-2.317547696,0.048244811,melperone
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.3033818,0.040342643,melperone
NEUTROPHIL_DEGRANULATION,-2.201980247,0.060888278,melperone
RESPIRATORY_ELECTRON_TRANSPORT,1.925355443,0.072054492,melperone
INNATE_IMMUNE_SYSTEM,-1.971160055,0.212110806,melperone
ISG15_ANTIVIRAL_MECHANISM,-1.912927142,0.257384877,melperone
INTERFERON_SIGNALING,-1.859238345,0.299242598,melperone
NEUTROPHIL_DEGRANULATION,-3.895951337,0.085287764,nitrazepam
SELENOAMINO_ACID_METABOLISM,-2.49998421,1,nitrazepam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.466207962,1,nitrazepam
NONSENSE_MEDIATED_DECAY_NMD,-2.462542504,1,nitrazepam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.456814342,0.897330659,nitrazepam
EUKARYOTIC_TRANSLATION_ELONGATION,-2.431546123,0.750360027,nitrazepam
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.324237694,0.677133158,nitrazepam
INFLUENZA_INFECTION,-2.282707649,0.606383081,nitrazepam
EUKARYOTIC_TRANSLATION_INITIATION,-1.938842209,0.595578529,nitrazepam
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-1.915010796,0.541964975,nitrazepam
GPCR_LIGAND_BINDING,1.941730573,0.264176132,finasteride
CARDIAC_CONDUCTION,1.936970806,0.136908798,finasteride
NEURONAL_SYSTEM,1.861778432,0.163904899,finasteride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.813699836,0.177724332,finasteride
TRANSLATION,-1.941131352,1,finasteride
NEUTROPHIL_DEGRANULATION,-1.93493745,1,finasteride
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.823093357,1,finasteride
SARS_COV_1_INFECTION,-1.766243376,1,finasteride
MITOTIC_METAPHASE_AND_ANAPHASE,-1.736981366,1,finasteride
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.7794637,0.183573487,finasteride
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.543084203,0.022691552,fenofibrate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.391985688,0.051571709,fenofibrate
SENSORY_PERCEPTION,2.11151825,0.060447012,fenofibrate
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.032156073,0.785265226,fenofibrate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.846951178,0.363410347,fenofibrate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.986752237,0.725613949,fenofibrate
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.905387745,0.795854617,fenofibrate
G_ALPHA_S_SIGNALLING_EVENTS,1.778225641,0.397396618,fenofibrate
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.732714541,0.40747112,fenofibrate
NEURONAL_SYSTEM,1.720320549,0.355544952,fenofibrate
CELL_CYCLE,-3.813152882,0,MK-1775
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.43503757,0,MK-1775
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.436281713,0,MK-1775
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.452228238,0,MK-1775
MITOTIC_G2_G2_M_PHASES,-2.510910225,0,MK-1775
MITOTIC_PROPHASE,-2.528347669,0,MK-1775
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.569160725,0,MK-1775
RHO_GTPASES_ACTIVATE_FORMINS,-2.588015716,0,MK-1775
SYNTHESIS_OF_DNA,-2.617554297,0,MK-1775
DNA_REPLICATION,-2.6811674,0,MK-1775
RHO_GTPASE_CYCLE,-2.197978837,0.039419921,gemfibrozil
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-2.191895274,0.020307232,gemfibrozil
NEUTROPHIL_DEGRANULATION,-1.839770259,0.284699429,gemfibrozil
EXTRACELLULAR_MATRIX_ORGANIZATION,1.792710806,0.60028561,gemfibrozil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.819229963,0.246374506,gemfibrozil
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.743546147,0.416570997,gemfibrozil
RHO_GTPASE_EFFECTORS,-1.73023167,0.357885101,gemfibrozil
RHOA_GTPASE_CYCLE,-1.673514025,0.431827316,gemfibrozil
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.660521958,0.397782839,gemfibrozil
MEMBRANE_TRAFFICKING,-1.627287646,0.4216737,gemfibrozil
EUKARYOTIC_TRANSLATION_ELONGATION,-3.13589099,0,propranolol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.495773888,0,propranolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.50987496,0,propranolol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.524199354,0,propranolol
INFLUENZA_INFECTION,-2.641452938,0,propranolol
SARS_COV_1_HOST_INTERACTIONS,-2.779568002,0,propranolol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.807844072,0,propranolol
SARS_COV_1_INFECTION,-2.563556292,0,propranolol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.870269362,0,propranolol
EUKARYOTIC_TRANSLATION_INITIATION,-2.874011025,0,propranolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.910607458,0.085037326,pindolol
MUSCLE_CONTRACTION,1.842922738,0.073677377,pindolol
DEVELOPMENTAL_CELL_LINEAGES,1.765766362,0.079627826,pindolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.680602503,0.108406362,pindolol
GPCR_LIGAND_BINDING,1.596465854,0.137617657,pindolol
EUKARYOTIC_TRANSLATION_INITIATION,-2.566720023,1,pindolol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.492212765,1,pindolol
SELENOAMINO_ACID_METABOLISM,-2.456167512,1,pindolol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.399787202,1,pindolol
TRANSLATION,-2.389852285,0.834053952,pindolol
METABOLISM_OF_RNA,-2.905101398,0,mycophenolate-mofetil
CELL_CYCLE,-2.659303583,0.000795356,mycophenolate-mofetil
CELL_CYCLE_MITOTIC,-2.64490009,0.000530237,mycophenolate-mofetil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.602287419,0.000795356,mycophenolate-mofetil
M_PHASE,-2.492209226,0.001272569,mycophenolate-mofetil
CELL_CYCLE_CHECKPOINTS,-2.412222204,0.002120949,mycophenolate-mofetil
DNA_REPLICATION_PRE_INITIATION,-2.4096387,0.001817956,mycophenolate-mofetil
MRNA_SPLICING,-2.389472424,0.001988389,mycophenolate-mofetil
DNA_REPLICATION,-2.297834011,0.004294921,mycophenolate-mofetil
MITOTIC_METAPHASE_AND_ANAPHASE,-2.299620554,0.004772135,mycophenolate-mofetil
CELLULAR_RESPONSE_TO_STARVATION,2.656624296,0,rimonabant
GPCR_LIGAND_BINDING,-2.768899853,0.001002386,rimonabant
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.506525849,0.000498039,rimonabant
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.50288865,0.000332026,rimonabant
RESPIRATORY_ELECTRON_TRANSPORT,2.494999752,0.000249019,rimonabant
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.479360118,0.000199215,rimonabant
SELENOAMINO_ACID_METABOLISM,2.449950142,0.000830064,rimonabant
EUKARYOTIC_TRANSLATION_ELONGATION,2.336127897,0.001707561,rimonabant
SIGNALING_BY_GPCR,-2.439626879,0.022052498,rimonabant
METABOLISM_OF_STEROIDS,2.148768455,0.007719598,rimonabant
HEMOSTASIS,-2.607357713,0,phenytoin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.548635748,0.001056324,phenytoin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.535648306,0.001056324,phenytoin
EUKARYOTIC_TRANSLATION_INITIATION,-2.171463849,0.076055351,phenytoin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.126971564,0.0938016,phenytoin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.107901415,0.094717081,phenytoin
NONSENSE_MEDIATED_DECAY_NMD,-2.105421242,0.083600525,phenytoin
CELLULAR_RESPONSE_TO_STARVATION,-2.052185476,0.108537324,phenytoin
SELENOAMINO_ACID_METABOLISM,-2.048246384,0.098472901,phenytoin
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.022548182,0.108907038,phenytoin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.562575885,0,LY-215490
GPCR_LIGAND_BINDING,-2.665070432,0,LY-215490
EUKARYOTIC_TRANSLATION_INITIATION,2.893544053,0,LY-215490
INFLUENZA_INFECTION,2.920006584,0,LY-215490
METABOLISM_OF_RNA,3.126889375,0,LY-215490
RRNA_PROCESSING,3.13614162,0,LY-215490
TRANSLATION,3.032114866,0,LY-215490
RESPIRATORY_ELECTRON_TRANSPORT,3.24586211,0,LY-215490
CELLULAR_RESPONSE_TO_STARVATION,3.284102883,0,LY-215490
SELENOAMINO_ACID_METABOLISM,3.305524946,0,LY-215490
RESPIRATORY_ELECTRON_TRANSPORT,3.520371826,0,ampalex
NEURONAL_SYSTEM,-2.629236051,0,ampalex
GPCR_LIGAND_BINDING,-2.748281682,0,ampalex
NONSENSE_MEDIATED_DECAY_NMD,2.847091246,0,ampalex
TRANSLATION,2.868011806,0,ampalex
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.951456731,0,ampalex
METABOLISM_OF_RNA,2.950239232,0,ampalex
CELLULAR_RESPONSE_TO_STARVATION,3.15975761,0,ampalex
RRNA_PROCESSING,3.191347531,0,ampalex
EUKARYOTIC_TRANSLATION_ELONGATION,3.213923582,0,ampalex
G2_M_CHECKPOINTS,2.828947866,0,GDC-0199
CELL_CYCLE_CHECKPOINTS,2.681416315,0,GDC-0199
CELL_CYCLE_MITOTIC,2.45473113,0.005332165,GDC-0199
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.280569714,0.009997809,GDC-0199
VOLTAGE_GATED_POTASSIUM_CHANNELS,-2.115633763,0.005513335,GDC-0199
S_PHASE,2.168215207,0.012797195,GDC-0199
M_PHASE,2.155639,0.010664329,GDC-0199
HIV_LIFE_CYCLE,2.143177015,0.01028346,GDC-0199
KEAP1_NFE2L2_PATHWAY,2.113662675,0.012997151,GDC-0199
TOLL_LIKE_RECEPTOR_CASCADES,2.081729276,0.0151078,GDC-0199
GPCR_LIGAND_BINDING,-2.451623638,0.001126597,doxofylline
SIGNALING_BY_GPCR,-2.379949856,0.002253195,doxofylline
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.369299289,0.001877662,doxofylline
PROTEIN_LOCALIZATION,2.093279881,0.090315636,doxofylline
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.012191934,0.071426091,doxofylline
NERVOUS_SYSTEM_DEVELOPMENT,-2.023268356,0.05942801,doxofylline
MITOTIC_METAPHASE_AND_ANAPHASE,-2.02094141,0.048894325,doxofylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.995473464,0.052574543,doxofylline
SEPARATION_OF_SISTER_CHROMATIDS,-1.89978043,0.108475231,doxofylline
G_ALPHA_Q_SIGNALLING_EVENTS,-1.861444872,0.135754981,doxofylline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.628736187,0.001314871,aniracetam
RESPIRATORY_ELECTRON_TRANSPORT,-2.475465181,0.001314871,aniracetam
TP53_REGULATES_METABOLIC_GENES,-2.215176241,0.019723059,aniracetam
CELL_CYCLE_CHECKPOINTS,-2.188008969,0.020051776,aniracetam
APOPTOSIS,-2.125345031,0.026034438,aniracetam
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.112019983,0.025639976,aniracetam
PROGRAMMED_CELL_DEATH,-2.050450113,0.046583986,aniracetam
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.955496316,0.112703005,aniracetam
G2_M_CHECKPOINTS,-1.978506774,0.070509935,aniracetam
MITOTIC_METAPHASE_AND_ANAPHASE,-1.977959998,0.062675498,aniracetam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.769618148,0.05282916,granisetron
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.554002982,0.194182857,granisetron
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.394244814,0.441670811,granisetron
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.379747292,0.365877625,granisetron
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.289501545,0.455473024,granisetron
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.844876504,1,granisetron
HEMOSTASIS,-2.690820516,0.783394564,granisetron
TRANSPORT_OF_SMALL_MOLECULES,-2.408761813,0.768572483,granisetron
DRUG_ADME,-2.274642008,0.704626763,granisetron
VESICLE_MEDIATED_TRANSPORT,-1.96837038,0.711051931,granisetron
TRNA_PROCESSING,-2.24726699,0.037723682,ranitidine
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,-1.838330758,0.345316782,ranitidine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.729850218,0.425600516,ranitidine
TRANSLATION,-1.716580892,0.344591327,ranitidine
METABOLISM_OF_RNA,-1.632869828,0.447460906,ranitidine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.518383198,0.684346284,ranitidine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.725213441,1,ranitidine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.431602258,0.9074411,ranitidine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.404993751,0.896662905,ranitidine
HIV_INFECTION,-1.359400371,0.978558762,ranitidine
CELL_CYCLE,-2.53814298,0,betamethasone
PROTEIN_LOCALIZATION,-2.382997778,0.007077966,betamethasone
SIGNALING_BY_GPCR,2.267580735,0.016562716,betamethasone
GPCR_LIGAND_BINDING,2.22577102,0.010931392,betamethasone
NEUTROPHIL_DEGRANULATION,-2.166940403,0.028901693,betamethasone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.164593307,0.0128085,betamethasone
G_ALPHA_Q_SIGNALLING_EVENTS,2.135016015,0.013084546,betamethasone
CELL_CYCLE_MITOTIC,-2.070627356,0.049103386,betamethasone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.090984781,0.0153702,betamethasone
HIV_LIFE_CYCLE,-2.035568059,0.047422369,betamethasone
RESPIRATORY_ELECTRON_TRANSPORT,3.649992367,0,CS-1657
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.358105859,0,CS-1657
TRANSLATION,2.359226741,0.004761201,CS-1657
BIOLOGICAL_OXIDATIONS,2.293297853,0.007855982,CS-1657
MITOCHONDRIAL_TRANSLATION,2.160417873,0.021996749,CS-1657
RRNA_PROCESSING,1.771487859,0.201160748,CS-1657
INTERLEUKIN_1_FAMILY_SIGNALING,1.723908284,0.225680934,CS-1657
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.715118461,0.206398069,CS-1657
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.983978657,1,CS-1657
PROTEIN_FOLDING,1.576215772,0.393275214,CS-1657
RESPIRATORY_ELECTRON_TRANSPORT,3.059561279,0,tolazoline
TRANSLATION,2.813465192,0,tolazoline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.721808157,0,tolazoline
RRNA_PROCESSING,2.51582435,0.000838311,tolazoline
MITOCHONDRIAL_TRANSLATION,2.24959334,0.008047788,tolazoline
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.086435582,0.112639625,tolazoline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.013727439,0.109270064,tolazoline
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.986816774,0.101407754,tolazoline
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.8855342,0.070790731,tolazoline
BIOLOGICAL_OXIDATIONS,1.809185669,0.097244109,tolazoline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-3.65213218,0,genistein
SARS_COV_2_INFECTION,-2.525638903,0,genistein
SARS_COV_2_HOST_INTERACTIONS,-2.869300405,0,genistein
NERVOUS_SYSTEM_DEVELOPMENT,-2.869346604,0,genistein
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-3.084734444,0,genistein
SARS_COV_1_INFECTION,-3.180607153,0,genistein
RRNA_PROCESSING,-3.185977581,0,genistein
INFLUENZA_INFECTION,-3.336055454,0,genistein
SIGNALING_BY_ROBO_RECEPTORS,-3.363686753,0,genistein
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.394537338,0,genistein
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.065099455,0,terbinafine
SEPARATION_OF_SISTER_CHROMATIDS,-2.491073221,0,terbinafine
INFECTIOUS_DISEASE,-2.529926522,0,terbinafine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.531167744,0,terbinafine
M_PHASE,-2.536270166,0,terbinafine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.538217319,0,terbinafine
SARS_COV_1_INFECTION,-2.553882694,0,terbinafine
TRANSLATION,-2.595098283,0,terbinafine
SARS_COV_1_HOST_INTERACTIONS,-2.601269856,0,terbinafine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.60787325,0,terbinafine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.130578308,0,tolfenamic-acid
NONSENSE_MEDIATED_DECAY_NMD,-2.979384029,0,tolfenamic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.908507151,0,tolfenamic-acid
SELENOAMINO_ACID_METABOLISM,-2.872419281,0,tolfenamic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.862012538,0,tolfenamic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.825334476,0,tolfenamic-acid
CELLULAR_RESPONSE_TO_STARVATION,-2.756952937,0,tolfenamic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.74653677,0,tolfenamic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.732379102,0,tolfenamic-acid
RRNA_PROCESSING,-2.710039511,0,tolfenamic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.932233069,0.175410872,oxiconazole
ION_CHANNEL_TRANSPORT,-3.052183403,0.259392985,oxiconazole
DISEASES_OF_METABOLISM,-3.051268046,0.134922359,oxiconazole
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.60177482,0.577591656,oxiconazole
POTENTIAL_THERAPEUTICS_FOR_SARS,1.575640767,0.432996207,oxiconazole
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.538460381,0.386773072,oxiconazole
NUCLEAR_ENVELOPE_BREAKDOWN,1.501931275,0.378950695,oxiconazole
PROTEIN_LOCALIZATION,1.486886448,0.338442899,oxiconazole
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,1.484206722,0.292577208,oxiconazole
TRNA_PROCESSING_IN_THE_NUCLEUS,1.474364166,0.269832491,oxiconazole
TRANSLATION,2.211655742,0.037685983,rosuvastatin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.144339499,0.037685983,rosuvastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.060987902,0.028464749,rosuvastatin
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.836772112,0.154333072,rosuvastatin
MITOCHONDRIAL_TRANSLATION,1.824865929,0.129209084,rosuvastatin
RESPIRATORY_ELECTRON_TRANSPORT,1.805830923,0.113057948,rosuvastatin
HIV_INFECTION,1.802502307,0.095112242,rosuvastatin
INTERLEUKIN_1_FAMILY_SIGNALING,1.782123261,0.089215796,rosuvastatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.925316381,0.059484027,rosuvastatin
MRNA_SPLICING,1.65914878,0.158146535,rosuvastatin
TRANSLATION,-4.544886716,0,mestranol
SARS_COV_1_HOST_INTERACTIONS,-2.762643245,0,mestranol
VIRAL_INFECTION_PATHWAYS,-2.785493668,0,mestranol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.78999144,0,mestranol
METABOLISM_OF_RNA,-2.817936737,0,mestranol
RRNA_PROCESSING,-2.911018888,0,mestranol
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.026275969,0,mestranol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-3.07741013,0,mestranol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.799937973,0,mestranol
CELLULAR_RESPONSE_TO_STARVATION,-3.708219611,0,mestranol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.029177602,0,phenformin
METABOLISM_OF_RNA,-2.562191422,0,phenformin
VIRAL_INFECTION_PATHWAYS,-2.463196979,0.00577444,phenformin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.454699063,0.003849627,phenformin
SIGNALING_BY_ROBO_RECEPTORS,-2.454525981,0.00288722,phenformin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.433801659,0.002309776,phenformin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.42082636,0.00235255,phenformin
INFLUENZA_INFECTION,-2.396499487,0.002383102,phenformin
TRANSLATION,-2.390505811,0.002085215,phenformin
INFECTIOUS_DISEASE,-2.367112581,0.002851575,phenformin
RESPIRATORY_ELECTRON_TRANSPORT,2.089980727,0.200645943,mometasone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.86228493,0.404257096,mometasone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.713338045,0.584805498,mometasone
LEISHMANIA_INFECTION,1.671677473,0.542139407,mometasone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.649412744,0.482736347,mometasone
EPH_EPHRIN_SIGNALING,1.614544837,0.479540508,mometasone
CHROMOSOME_MAINTENANCE,-1.76417163,1,mometasone
CELL_CYCLE,-1.71872087,1,mometasone
S_PHASE,-1.658717537,1,mometasone
L1CAM_INTERACTIONS,1.489622023,0.731842309,mometasone
GPCR_LIGAND_BINDING,2.554651326,0,remoxipride
SIGNALING_BY_GPCR,2.186683351,0.011035787,remoxipride
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.213428192,0.121727399,remoxipride
G_ALPHA_I_SIGNALLING_EVENTS,2.121104168,0.016185822,remoxipride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.07224897,0.020179726,remoxipride
NEURONAL_SYSTEM,2.055390442,0.018666246,remoxipride
PROTEIN_LOCALIZATION,-2.083074236,0.137604886,remoxipride
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,-2.069200785,0.099381307,remoxipride
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.040301526,0.018182774,remoxipride
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.976731671,0.026125538,remoxipride
SIGNALING_BY_ALK_IN_CANCER,2.399617404,0.030065141,quizartinib
GPCR_LIGAND_BINDING,-2.084601605,0.024547008,quizartinib
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,2.163627175,0.073492567,quizartinib
ISG15_ANTIVIRAL_MECHANISM,2.143318313,0.060130282,quizartinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.061724954,0.016876068,quizartinib
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.079964472,0.081843995,quizartinib
RAC2_GTPASE_CYCLE,2.019085619,0.092199766,quizartinib
INFLUENZA_INFECTION,1.954213617,0.106341518,quizartinib
RAC3_GTPASE_CYCLE,1.928797816,0.102126035,quizartinib
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.897561402,0.111073994,quizartinib
CELL_CYCLE_CHECKPOINTS,2.77647949,0,alogliptin
G2_M_CHECKPOINTS,2.750589708,0,alogliptin
S_PHASE,2.687191919,0,alogliptin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.215154619,0.009962958,alogliptin
DNA_REPLICATION,2.182578634,0.009298761,alogliptin
MITOTIC_METAPHASE_AND_ANAPHASE,2.13902883,0.008855963,alogliptin
HIV_INFECTION,2.129004595,0.009488532,alogliptin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.121411818,0.009132712,alogliptin
SEPARATION_OF_SISTER_CHROMATIDS,2.103193399,0.008855963,alogliptin
TRANSLATION,2.037062377,0.013283944,alogliptin
GPCR_LIGAND_BINDING,3.157356189,0,BRD-K59946561
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.787286145,0,BRD-K59946561
SIGNALING_BY_GPCR,2.652585879,0,BRD-K59946561
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.449208565,0.000132157,BRD-K59946561
G_ALPHA_I_SIGNALLING_EVENTS,2.446837406,0.000105726,BRD-K59946561
TRANSLATION,-2.385764127,0.202528678,BRD-K59946561
PROTEIN_LOCALIZATION,-2.342743906,0.126580424,BRD-K59946561
G_ALPHA_Q_SIGNALLING_EVENTS,2.002203668,0.019559266,BRD-K59946561
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.181442755,0.240033989,BRD-K59946561
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.061651617,0.354894004,BRD-K59946561
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.12028903,0.110925073,diphenhydramine
TRANSLATION,-2.045999138,0.080112553,diphenhydramine
MITOCHONDRIAL_TRANSLATION,-1.772186842,0.245678496,diphenhydramine
SENSORY_PERCEPTION,1.958760404,0.31737913,diphenhydramine
SARS_COV_INFECTIONS,-1.649781701,0.352495233,diphenhydramine
MITOCHONDRIAL_BIOGENESIS,-1.629756973,0.310590205,diphenhydramine
GPCR_LIGAND_BINDING,1.87229971,0.31737913,diphenhydramine
DISEASES_OF_METABOLISM,-1.610910852,0.284707688,diphenhydramine
METABOLISM_OF_NUCLEOTIDES,-1.529604281,0.377849535,diphenhydramine
NEUTROPHIL_DEGRANULATION,-1.490430464,0.397173387,diphenhydramine
TRANSLATION,-3.11085433,0,betaxolol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.518541846,0,betaxolol
GPCR_LIGAND_BINDING,2.490077318,0,betaxolol
INFLUENZA_INFECTION,-2.691220313,0.001847291,betaxolol
EUKARYOTIC_TRANSLATION_INITIATION,-2.508355691,0.002463054,betaxolol
CELLULAR_RESPONSE_TO_STARVATION,-2.446534552,0.005541872,betaxolol
G_ALPHA_I_SIGNALLING_EVENTS,2.370465119,0.000949462,betaxolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.330615962,0.000712096,betaxolol
MITOCHONDRIAL_TRANSLATION,-2.409441137,0.005172414,betaxolol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.313039474,0.007389163,betaxolol
G_ALPHA_I_SIGNALLING_EVENTS,2.17076437,0.007800849,calcifediol
GPCR_LIGAND_BINDING,2.16505272,0.003900424,calcifediol
SIGNALING_BY_GPCR,1.905494669,0.031528431,calcifediol
RHO_GTPASE_EFFECTORS,1.867425665,0.032178502,calcifediol
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.403836617,1,calcifediol
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-1.347429716,1,calcifediol
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.377932636,0.39394287,calcifediol
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.268390323,0.856906891,calcifediol
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.259802845,0.654704837,calcifediol
CELLULAR_RESPONSES_TO_STIMULI,-1.138491887,0.712474416,calcifediol
CARDIAC_CONDUCTION,2.3671184,0.00600504,clemastine
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.256940531,0.012867943,clemastine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.245470931,0.009722446,clemastine
GPCR_LIGAND_BINDING,2.229234447,0.008149697,clemastine
METABOLISM_OF_STEROIDS,2.112409753,0.019902418,clemastine
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,2.078129599,0.021303594,clemastine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.073021083,0.217525818,clemastine
MUSCLE_CONTRACTION,2.052497165,0.022304434,clemastine
SENSORY_PERCEPTION,2.047862965,0.020159777,clemastine
L1CAM_INTERACTIONS,1.886281922,0.059573809,clemastine
APOPTOSIS,-2.555084867,0.044288969,betahistine
NEURONAL_SYSTEM,2.297108752,0.006321658,betahistine
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.529108089,0.031002279,betahistine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.197356045,0.00881705,betahistine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.420355233,0.062496657,betahistine
GPCR_LIGAND_BINDING,2.079888728,0.015748692,betahistine
DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,-2.376552337,0.073814949,betahistine
CARDIAC_CONDUCTION,2.039135302,0.017135021,betahistine
HIV_INFECTION,-2.343440532,0.081196444,betahistine
PROGRAMMED_CELL_DEATH,-2.319297606,0.083410893,betahistine
SENSORY_PERCEPTION,2.385823411,0.001376036,guanfacine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.316085771,0.002408064,guanfacine
GPCR_LIGAND_BINDING,2.177492407,0.009402915,guanfacine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.086109159,0.019264509,guanfacine
SIGNALING_BY_GPCR,2.000167241,0.034125701,guanfacine
G_ALPHA_I_SIGNALLING_EVENTS,1.991556236,0.03004346,guanfacine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.91569535,1,guanfacine
MITOTIC_SPINDLE_CHECKPOINT,-1.787420927,1,guanfacine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.676449938,1,guanfacine
NEUTROPHIL_DEGRANULATION,-1.608725289,1,guanfacine
SIGNALING_BY_GPCR,1.800896877,0.204373757,bromhexine
MEMBRANE_TRAFFICKING,-1.699175649,0.486246057,bromhexine
VESICLE_MEDIATED_TRANSPORT,-1.565061798,0.486908517,bromhexine
HEMOSTASIS,-1.4815191,0.494195584,bromhexine
NEUTROPHIL_DEGRANULATION,-1.410015726,0.528643533,bromhexine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.386235321,0.468492114,bromhexine
G_ALPHA_I_SIGNALLING_EVENTS,1.467834381,0.766998012,bromhexine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.34041118,0.475205047,bromhexine
GPCR_LIGAND_BINDING,1.415468093,0.654738237,bromhexine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.367985226,0.610536779,bromhexine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.190199088,0.152672899,vanoxerine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.081811541,0.112466855,vanoxerine
G_ALPHA_Q_SIGNALLING_EVENTS,2.012165331,0.098703429,vanoxerine
GPCR_LIGAND_BINDING,2.012070713,0.065802286,vanoxerine
SIGNALING_BY_GPCR,1.888192809,0.13566806,vanoxerine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.8426178,0.764669391,vanoxerine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.839770048,0.520218766,vanoxerine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.703829299,0.805121184,vanoxerine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-1.669107525,0.771976811,vanoxerine
G_ALPHA_I_SIGNALLING_EVENTS,1.685798831,0.461507348,vanoxerine
COLLAGEN_FORMATION,-2.614629702,0,haloperidol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.586053293,0.000734735,haloperidol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.461224475,0.006367707,haloperidol
ECM_PROTEOGLYCANS,-2.44279265,0.005877884,haloperidol
RESPIRATORY_ELECTRON_TRANSPORT,2.332239465,0.010947524,haloperidol
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.252835558,0.027626053,haloperidol
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.22969743,0.029879242,haloperidol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.069350802,0.050905988,haloperidol
TRANSLATION,2.034044079,0.043790097,haloperidol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.116948316,0.061297929,haloperidol
EUKARYOTIC_TRANSLATION_INITIATION,2.803050756,0,purvalanol-a
RESPIRATORY_ELECTRON_TRANSPORT,2.06858972,0.056116835,purvalanol-a
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.047578965,0.04107899,purvalanol-a
VISUAL_PHOTOTRANSDUCTION,1.919918959,0.059417825,purvalanol-a
SENSORY_PERCEPTION,1.793812138,0.094848455,purvalanol-a
G_ALPHA_Q_SIGNALLING_EVENTS,1.784028858,0.082524757,purvalanol-a
MUSCLE_CONTRACTION,1.765094024,0.080166907,purvalanol-a
TRANSLATION,1.731600105,0.0850005,purvalanol-a
DEVELOPMENTAL_CELL_LINEAGES,1.716097083,0.084236382,purvalanol-a
CELLULAR_RESPONSE_TO_STARVATION,1.71046642,0.078123437,purvalanol-a
CELL_CYCLE,-3.067725474,0,dorsomorphin
S_PHASE,-2.558244687,0,dorsomorphin
MITOTIC_PROMETAPHASE,-2.61977871,0,dorsomorphin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.656160764,0,dorsomorphin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.661608687,0,dorsomorphin
RHO_GTPASES_ACTIVATE_FORMINS,-2.680306298,0,dorsomorphin
RHO_GTPASE_EFFECTORS,-2.576023793,0,dorsomorphin
M_PHASE,-2.771550115,0,dorsomorphin
CELL_CYCLE_CHECKPOINTS,-2.935416151,0,dorsomorphin
CHROMATIN_ORGANIZATION,-2.936301375,0,dorsomorphin
RESPIRATORY_ELECTRON_TRANSPORT,3.363189979,0,ketorolac
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.104944332,0,ketorolac
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.669480953,0,ketorolac
COMPLEX_I_BIOGENESIS,2.405978544,0.002336003,ketorolac
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.375343181,0.002156311,ketorolac
ECM_PROTEOGLYCANS,-2.343904774,0.017663519,ketorolac
ION_CHANNEL_TRANSPORT,-2.316039144,0.015981279,ketorolac
GPCR_LIGAND_BINDING,-2.298650605,0.015455579,ketorolac
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.276244165,0.015644831,ketorolac
SIGNALING_BY_INTERLEUKINS,-2.257455105,0.014929879,ketorolac
GPCR_LIGAND_BINDING,2.688267732,0,somatostatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.665594182,0,somatostatin
METABOLISM_OF_RNA,-2.64381116,0,somatostatin
RRNA_PROCESSING,-2.642567087,0,somatostatin
SIGNALING_BY_GPCR,2.502424687,0,somatostatin
G_ALPHA_Q_SIGNALLING_EVENTS,2.371216385,0.000152222,somatostatin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.342075591,0.000121778,somatostatin
G_ALPHA_I_SIGNALLING_EVENTS,2.335514526,0.000101482,somatostatin
TRANSLATION,-2.520538958,0.003491264,somatostatin
INFLUENZA_INFECTION,-2.413741579,0.007855343,somatostatin
GPCR_LIGAND_BINDING,2.463386831,0.000605045,acitretin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.353462275,0.000907567,acitretin
SIGNALING_BY_GPCR,2.134007422,0.003428586,acitretin
TRANSLATION,-2.182440341,0.176642903,acitretin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.031475265,0.010285758,acitretin
SARS_COV_1_INFECTION,-2.126332155,0.139708477,acitretin
INFLUENZA_INFECTION,-2.051136245,0.128467565,acitretin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.021176773,0.127664643,acitretin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.985580878,0.130394579,acitretin
SENSORY_PERCEPTION,1.914783378,0.031946353,acitretin
METABOLISM_OF_RNA,4.921750406,0,orciprenaline
GPCR_LIGAND_BINDING,-2.338791055,0,orciprenaline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.359874154,0,orciprenaline
UB_SPECIFIC_PROCESSING_PROTEASES,2.555923838,0,orciprenaline
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.589373356,0,orciprenaline
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.612185836,0,orciprenaline
MITOTIC_METAPHASE_AND_ANAPHASE,2.621862351,0,orciprenaline
MITOTIC_PROMETAPHASE,2.645444761,0,orciprenaline
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.662906356,0,orciprenaline
G2_M_DNA_DAMAGE_CHECKPOINT,2.772321581,0,orciprenaline
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.517819571,1,BRD-K33396764
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.768579686,1,BRD-K33396764
VESICLE_MEDIATED_TRANSPORT,1.750420095,1,BRD-K33396764
MEMBRANE_TRAFFICKING,1.737037427,0.937764448,BRD-K33396764
UB_SPECIFIC_PROCESSING_PROTEASES,-1.352369253,1,BRD-K33396764
SELENOAMINO_ACID_METABOLISM,-1.346771221,1,BRD-K33396764
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.701277824,0.89477382,BRD-K33396764
REPRODUCTION,1.701062225,0.717424931,BRD-K33396764
NONSENSE_MEDIATED_DECAY_NMD,-1.313384461,0.889959432,BRD-K33396764
PKR_MEDIATED_SIGNALING,1.662186395,0.774333148,BRD-K33396764
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.23276349,0.065514846,pravastatin
GPCR_LIGAND_BINDING,2.143818683,0.056539399,pravastatin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2.107892175,0.039406248,pravastatin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.113417707,0.084233374,pravastatin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.925146309,0.122787583,pravastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.893211427,0.122073702,pravastatin
PROTEIN_LOCALIZATION,-1.871520733,0.261168027,pravastatin
SIGNALING_BY_GPCR,1.866745554,0.118732738,pravastatin
G_ALPHA_I_SIGNALLING_EVENTS,1.821261568,0.136065776,pravastatin
CARDIAC_CONDUCTION,1.809605213,0.128865773,pravastatin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.959309017,0,itopride
HEMOSTASIS,-2.745752824,0.000946536,itopride
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.333318978,0.004331218,itopride
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.659031236,0.004417166,itopride
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.170172196,0.010518673,itopride
NEUTROPHIL_DEGRANULATION,-2.429498786,0.022716853,itopride
GPCR_LIGAND_BINDING,2.032479622,0.027843546,itopride
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.222710951,0.099196924,itopride
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.218018447,0.087081269,itopride
ECM_PROTEOGLYCANS,-2.181165153,0.095464869,itopride
G2_M_CHECKPOINTS,2.269917792,0.023248823,nitrendipine
S_PHASE,2.07668645,0.061028159,nitrendipine
ANTIGEN_PROCESSING_CROSS_PRESENTATION,2.015128016,0.050372449,nitrendipine
APOPTOSIS,1.976641842,0.053762902,nitrendipine
INTERLEUKIN_1_SIGNALING,1.894360384,0.063934262,nitrendipine
INTERLEUKIN_1_FAMILY_SIGNALING,1.813185344,0.097838795,nitrendipine
PROGRAMMED_CELL_DEATH,1.807069735,0.085522454,nitrendipine
SENSORY_PERCEPTION,-1.954992945,0.087024401,nitrendipine
KEAP1_NFE2L2_PATHWAY,1.766204112,0.095174867,nitrendipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.923548454,0.061492448,nitrendipine
SENSORY_PERCEPTION,2.371228788,0.001462233,oxcarbazepine
BIOLOGICAL_OXIDATIONS,-2.361960696,0.115789873,oxcarbazepine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.142288422,0.020471257,oxcarbazepine
MITOCHONDRIAL_TRANSLATION,-2.267068306,0.113326258,oxcarbazepine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.111130087,0.018034202,oxcarbazepine
NEUTROPHIL_DEGRANULATION,-2.190271089,0.111683849,oxcarbazepine
GPCR_LIGAND_BINDING,2.069244272,0.019922919,oxcarbazepine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.146992742,0.113942162,oxcarbazepine
KEAP1_NFE2L2_PATHWAY,-2.03347404,0.188220133,oxcarbazepine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.862765682,0.098846925,oxcarbazepine
S_PHASE,-3.391519837,0,BRD-K19136521
SYNTHESIS_OF_DNA,-3.021069537,0,BRD-K19136521
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.896205009,0,BRD-K19136521
CELLULAR_RESPONSE_TO_STARVATION,-2.85259008,0,BRD-K19136521
KEAP1_NFE2L2_PATHWAY,-2.812132441,0,BRD-K19136521
EUKARYOTIC_TRANSLATION_INITIATION,-2.786643575,0,BRD-K19136521
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.764818724,0,BRD-K19136521
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-2.728423386,0,BRD-K19136521
GPCR_LIGAND_BINDING,2.698520836,0,BRD-K19136521
SELENOAMINO_ACID_METABOLISM,-2.692000999,0,BRD-K19136521
CELL_CYCLE_CHECKPOINTS,-2.953493931,0,ALW-II-49-7
DNA_REPLICATION,-2.938695386,0,ALW-II-49-7
SYNTHESIS_OF_DNA,-2.486729329,0,ALW-II-49-7
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.41834539,0.001152007,ALW-II-49-7
GPCR_LIGAND_BINDING,2.331953688,0.003624542,ALW-II-49-7
SIGNALING_BY_GPCR,2.327412495,0.001812271,ALW-II-49-7
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.30094718,0.001449817,ALW-II-49-7
G_ALPHA_S_SIGNALLING_EVENTS,2.295612519,0.001087363,ALW-II-49-7
INFLUENZA_INFECTION,-2.248484937,0.009216052,ALW-II-49-7
BIOLOGICAL_OXIDATIONS,-2.241278018,0.007680044,ALW-II-49-7
NEUTROPHIL_DEGRANULATION,-2.31240694,0.13795342,estropipate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.307803932,0.072222673,estropipate
RESPIRATORY_ELECTRON_TRANSPORT,2.137295549,0.042403637,estropipate
RAC2_GTPASE_CYCLE,-2.161372933,0.123887581,estropipate
INNATE_IMMUNE_SYSTEM,-2.004524231,0.213422056,estropipate
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.967751066,0.207417025,estropipate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.897120094,0.216611911,estropipate
EUKARYOTIC_TRANSLATION_INITIATION,1.896382744,0.14558582,estropipate
SIGNALING_BY_ALK_IN_CANCER,-1.933343956,0.2096351,estropipate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.922733248,0.189888826,estropipate
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.049255983,0.226030983,torasemide
GASTRULATION,-1.894464558,0.294346317,torasemide
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.816884367,0.316555829,torasemide
EUKARYOTIC_TRANSLATION_ELONGATION,1.916812309,0.510801599,torasemide
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.790949826,0.277900033,torasemide
PI3K_AKT_SIGNALING_IN_CANCER,-1.77581549,0.23918801,torasemide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.69214158,0.32302189,torasemide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.843451871,0.497534025,torasemide
RRNA_PROCESSING,1.83660376,0.352419934,torasemide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1.82332369,0.290020875,torasemide
SYNTHESIS_OF_DNA,2.000182889,0.201013822,Y-27632
DNA_REPLICATION,2.000182889,0.201013822,Y-27632
TELOMERE_MAINTENANCE,1.943959755,0.196193347,Y-27632
G_ALPHA_Q_SIGNALLING_EVENTS,1.937790992,0.154014187,Y-27632
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.931287227,0.430956269,Y-27632
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.83496372,0.231961274,Y-27632
METABOLISM_OF_STEROIDS,-1.835911582,0.458498587,Y-27632
SIGNALING_BY_WNT,1.779133091,0.263680002,Y-27632
GASTRULATION,1.763385617,0.24667061,Y-27632
CHROMOSOME_MAINTENANCE,1.749364593,0.234275102,Y-27632
RESPIRATORY_ELECTRON_TRANSPORT,3.433372277,0,myricetin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.89028066,0,myricetin
CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6,2.487642686,0.001487991,myricetin
DNA_REPLICATION,2.482774653,0.001487991,myricetin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.420456704,0.002380786,myricetin
TRANSLATION,2.379034034,0.003471979,myricetin
SYNTHESIS_OF_DNA,2.37154264,0.002975982,myricetin
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,2.342629419,0.003719978,myricetin
APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,2.154770326,0.012399925,myricetin
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.147260504,0.012350326,myricetin
RESPIRATORY_ELECTRON_TRANSPORT,3.132279806,0,naloxone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.715441982,0.0006544,naloxone
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.098124203,0.046680525,naloxone
RRNA_PROCESSING,1.921821766,0.10404958,naloxone
TRANSLATION,1.813924925,0.155223651,naloxone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.674140399,0.272666615,naloxone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.668204441,0.239136412,naloxone
S_PHASE,1.606303567,0.280573947,naloxone
SIGNALING_BY_ALK_IN_CANCER,-1.756303371,1,naloxone
NEURONAL_SYSTEM,-1.730026412,1,naloxone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.686368429,0,BRD-K41170226
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.681101289,0,BRD-K41170226
SELENOAMINO_ACID_METABOLISM,-2.593605127,0,BRD-K41170226
EUKARYOTIC_TRANSLATION_INITIATION,-2.578079653,0,BRD-K41170226
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.570415628,0,BRD-K41170226
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.567531375,0,BRD-K41170226
NONSENSE_MEDIATED_DECAY_NMD,-2.528534513,0,BRD-K41170226
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.524154986,0,BRD-K41170226
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.518029057,0,BRD-K41170226
INFLUENZA_INFECTION,-2.425842816,0,BRD-K41170226
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.087930061,0.130361192,desipramine
MUSCLE_CONTRACTION,2.057925094,0.080956791,desipramine
NEURONAL_SYSTEM,1.997294573,0.083309382,desipramine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.958688104,0.081371954,desipramine
METABOLISM_OF_STEROIDS,1.930675539,0.077884585,desipramine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.891426092,0.083862932,desipramine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.130491944,1,desipramine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.927531995,1,desipramine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.907200397,1,desipramine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.848736,1,desipramine
TRANSLATION,-2.882185454,0,testosterone
NEUTROPHIL_DEGRANULATION,-2.741622365,0.001130856,testosterone
GPCR_LIGAND_BINDING,2.273525826,0.0110093,testosterone
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.220335409,0.023371029,testosterone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.029570372,0.042407108,testosterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.103745098,0.033421089,testosterone
SARS_COV_INFECTIONS,-1.953145163,0.050662359,testosterone
SARS_COV_2_INFECTION,-1.890868651,0.060312332,testosterone
BIOLOGICAL_OXIDATIONS,-1.88241978,0.053634895,testosterone
INNATE_IMMUNE_SYSTEM,-1.784209135,0.077746365,testosterone
METABOLISM_OF_RNA,-3.504659312,0,cytarabine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-3.285476131,0,cytarabine
MRNA_SPLICING,-2.998289329,0,cytarabine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.686614013,0,cytarabine
RESPIRATORY_ELECTRON_TRANSPORT,2.627317619,0,cytarabine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.523454027,0,cytarabine
CHROMATIN_ORGANIZATION,-2.51570272,0.000279441,cytarabine
RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,-2.445047903,0.000698602,cytarabine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.44575441,0.000637524,cytarabine
M_PHASE,-2.392323107,0.001596804,cytarabine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.518545997,0,bezafibrate
SARS_COV_1_INFECTION,-2.593244869,0,bezafibrate
SARS_COV_2_HOST_INTERACTIONS,-2.677151931,0,bezafibrate
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.719863482,0,bezafibrate
SARS_COV_1_HOST_INTERACTIONS,-2.740185842,0,bezafibrate
NERVOUS_SYSTEM_DEVELOPMENT,-2.861264121,0,bezafibrate
METABOLISM_OF_RNA,-2.910706411,0,bezafibrate
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.935708285,0,bezafibrate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.954774916,0,bezafibrate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-3.002936131,0,bezafibrate
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.233292687,0.015258285,sertraline
SENSORY_PERCEPTION,2.214390386,0.00895595,sertraline
INNATE_IMMUNE_SYSTEM,-1.979582635,0.260198834,sertraline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.080908554,0.022555726,sertraline
CELL_CYCLE,-1.942357001,0.164102674,sertraline
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.93634772,0.112358588,sertraline
METABOLISM_OF_RNA,-1.925034721,0.090921752,sertraline
CELL_CYCLE_MITOTIC,-1.911316023,0.081607816,sertraline
TRANSLATION,-1.853402532,0.096588961,sertraline
SARS_COV_INFECTIONS,-1.831163768,0.094195357,sertraline
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.06554162,0.322304969,propafenone
PKR_MEDIATED_SIGNALING,-1.968279306,0.290562813,propafenone
ESR_MEDIATED_SIGNALING,-1.966972933,0.198591951,propafenone
TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,-1.960984963,0.153827372,propafenone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.866629066,0.216823343,propafenone
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.792393469,0.272656981,propafenone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1.872703474,0.58325919,propafenone
PROGRAMMED_CELL_DEATH,-1.758920016,0.277307847,propafenone
EUKARYOTIC_TRANSLATION_ELONGATION,1.859467917,0.327458374,propafenone
G_ALPHA_S_SIGNALLING_EVENTS,1.859364405,0.218305583,propafenone
NEURONAL_SYSTEM,2.135081589,0.10283006,dosulepin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.083945447,0.076373782,dosulepin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.992380481,0.097505526,dosulepin
POTASSIUM_CHANNELS,1.985167188,0.07662337,dosulepin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.768423488,0.271151886,dosulepin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.139486883,1,dosulepin
PTEN_REGULATION,1.742374451,0.270719267,dosulepin
CARDIAC_CONDUCTION,1.734653898,0.243882666,dosulepin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.829888449,1,dosulepin
L1CAM_INTERACTIONS,1.618371708,0.400463182,dosulepin
METABOLISM_OF_RNA,-2.607345556,0,AT-7867
CELL_CYCLE_CHECKPOINTS,-2.480429676,0,AT-7867
GPCR_LIGAND_BINDING,2.228196317,0.01407684,AT-7867
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.204303142,0.007918222,AT-7867
RRNA_PROCESSING,-2.193416629,0.012137993,AT-7867
SEPARATION_OF_SISTER_CHROMATIDS,-2.157084125,0.012316493,AT-7867
MITOTIC_METAPHASE_AND_ANAPHASE,-2.023884364,0.023990387,AT-7867
INFLUENZA_INFECTION,-2.020111449,0.020705989,AT-7867
NEURONAL_SYSTEM,2.045189258,0.033139227,AT-7867
SIGNALING_BY_GPCR,2.022995987,0.030573136,AT-7867
RESPIRATORY_ELECTRON_TRANSPORT,3.554379836,0,propentofylline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.501015849,0.001848336,propentofylline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.471348313,0.008703939,propentofylline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.964238836,0.042306369,propentofylline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.154002565,0.194387965,propentofylline
NEUTROPHIL_DEGRANULATION,-2.101941039,0.20019059,propentofylline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.682772672,0.175900023,propentofylline
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,-2.039812099,0.234522793,propentofylline
PROTEIN_LOCALIZATION,1.569472315,0.261231558,propentofylline
HEMOSTASIS,-1.968303744,0.299608912,propentofylline
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.380437666,0.074755865,BRD-K30697463
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.310339453,0.10270513,BRD-K30697463
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.29786852,0.077898754,BRD-K30697463
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.274664551,0.080312044,BRD-K30697463
METABOLISM_OF_RNA,1.881022894,0.888895069,BRD-K30697463
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.723132906,1,BRD-K30697463
MRNA_SPLICING,1.723040673,0.882196835,BRD-K30697463
CELL_CELL_COMMUNICATION,1.708483861,0.738480312,BRD-K30697463
HEMOSTASIS,-2.494965372,0.775440566,BRD-K30697463
TRANSPORT_OF_SMALL_MOLECULES,-2.343353615,0.682792682,BRD-K30697463
GPCR_LIGAND_BINDING,3.401962398,0,plerixafor
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.241719209,0,plerixafor
MUSCLE_CONTRACTION,2.766762795,0,plerixafor
SIGNALING_BY_GPCR,2.553596367,0.000108624,plerixafor
METABOLISM_OF_RNA,-2.461902695,0.002405093,plerixafor
CELL_CYCLE_MITOTIC,-2.337563708,0.007816553,plerixafor
CARDIAC_CONDUCTION,2.328778961,0.000782093,plerixafor
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION_BY_MLL3_AND_MLL4_COMPLEXES,-2.292668179,0.009620373,plerixafor
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-2.278806879,0.007515916,plerixafor
CELL_CYCLE,-2.276923952,0.006012733,plerixafor
NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,2.164554521,0.062658414,metformin
GPCR_LIGAND_BINDING,-1.941945522,0.446418329,metformin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.900594444,0.31121454,metformin
PARASITE_INFECTION,1.846370271,0.329213468,metformin
MAPK_FAMILY_SIGNALING_CASCADES,-1.881598387,0.240253036,metformin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.822759136,0.259535943,metformin
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.771269732,0.254742403,metformin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.832281751,0.268195152,metformin
POTASSIUM_CHANNELS,-1.81000417,0.247201691,metformin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.790391918,0.239433619,metformin
RESPIRATORY_ELECTRON_TRANSPORT,3.276447703,0,lurasidone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.559721159,0.001201068,lurasidone
ION_CHANNEL_TRANSPORT,-2.626685466,0.003227334,lurasidone
COMPLEX_I_BIOGENESIS,2.373214867,0.002935943,lurasidone
NEURONAL_SYSTEM,-2.486688063,0.010219892,lurasidone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.206923323,0.00680605,lurasidone
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,2.073038385,0.016814947,lurasidone
SIGNALING_BY_INTERLEUKINS,-2.306850644,0.054864682,lurasidone
SIGNALING_BY_GPCR,-2.257157453,0.063470907,lurasidone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.248907404,0.055510149,lurasidone
RESPIRATORY_ELECTRON_TRANSPORT,2.785007561,0,ripasudil
GPCR_LIGAND_BINDING,-2.45912165,0.002308469,ripasudil
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.481560291,0.001095994,ripasudil
SIGNALING_BY_GPCR,-2.380796116,0.006925408,ripasudil
STIMULI_SENSING_CHANNELS,-2.375529399,0.005386428,ripasudil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.208428887,0.013395482,ripasudil
DISEASES_OF_METABOLISM,2.174918054,0.014430587,ripasudil
ION_CHANNEL_TRANSPORT,-2.135380597,0.044438032,ripasudil
CELLULAR_RESPONSE_TO_STARVATION,2.096406012,0.021189216,ripasudil
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.086661574,0.056788342,ripasudil
GPCR_LIGAND_BINDING,-2.83072461,0,KX-2391
METABOLISM_OF_RNA,2.746256259,0,KX-2391
NEURONAL_SYSTEM,-2.691957348,0,KX-2391
POTASSIUM_CHANNELS,-2.625944739,0,KX-2391
SIGNALING_BY_GPCR,-2.61162302,0,KX-2391
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.569656911,0,KX-2391
SENSORY_PERCEPTION,-2.564983714,0,KX-2391
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.500404836,0.000104196,KX-2391
EUKARYOTIC_TRANSLATION_ELONGATION,2.496450557,0.003427412,KX-2391
RESPIRATORY_ELECTRON_TRANSPORT,2.487693061,0.002284942,KX-2391
METABOLISM_OF_RNA,-3.025909813,0,trimebutine
NONSENSE_MEDIATED_DECAY_NMD,-2.933509048,0,trimebutine
EUKARYOTIC_TRANSLATION_INITIATION,-2.876721256,0,trimebutine
NEUTROPHIL_DEGRANULATION,-2.861339519,0,trimebutine
TRANSLATION,-2.726738148,0,trimebutine
SIGNALING_BY_ROBO_RECEPTORS,-2.672272919,0,trimebutine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.669007856,0,trimebutine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.626403648,0.000215526,trimebutine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.639979977,0.000242467,trimebutine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.606386699,0.000387947,trimebutine
INFLUENZA_INFECTION,-3.387254324,0,midazolam
TRANSLATION,-3.354068032,0,midazolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.180366487,0,midazolam
EUKARYOTIC_TRANSLATION_INITIATION,-3.13212808,0,midazolam
SELENOAMINO_ACID_METABOLISM,-3.056511753,0,midazolam
EUKARYOTIC_TRANSLATION_ELONGATION,-2.967285324,0,midazolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.914643669,0,midazolam
NONSENSE_MEDIATED_DECAY_NMD,-2.903404443,0,midazolam
METABOLISM_OF_RNA,-2.824148878,0,midazolam
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.564763624,0.000275687,midazolam
EUKARYOTIC_TRANSLATION_INITIATION,4.066742568,0,pregnenolone
M_PHASE,2.864573081,0,pregnenolone
SEPARATION_OF_SISTER_CHROMATIDS,2.959845415,0,pregnenolone
DNA_REPLICATION,2.992359632,0,pregnenolone
ORC1_REMOVAL_FROM_CHROMATIN,3.020213892,0,pregnenolone
CELL_CYCLE_CHECKPOINTS,3.042904106,0,pregnenolone
MITOTIC_METAPHASE_AND_ANAPHASE,3.060200257,0,pregnenolone
S_PHASE,3.085295058,0,pregnenolone
SELENOAMINO_ACID_METABOLISM,3.188352644,0,pregnenolone
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,3.218324778,0,pregnenolone
EUKARYOTIC_TRANSLATION_INITIATION,-2.704184409,0,ubenimex
EUKARYOTIC_TRANSLATION_ELONGATION,-2.586652275,0,ubenimex
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.483954808,0.000347558,ubenimex
NONSENSE_MEDIATED_DECAY_NMD,-2.480197835,0.000260669,ubenimex
SELENOAMINO_ACID_METABOLISM,-2.448829271,0.000208535,ubenimex
TRANSLATION,-2.409554911,0.000347558,ubenimex
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.401105247,0.000297907,ubenimex
CELLULAR_RESPONSE_TO_STARVATION,-2.367335519,0.000260669,ubenimex
INFLUENZA_INFECTION,-2.313148948,0.000347558,ubenimex
RRNA_PROCESSING,-2.291728317,0.00041707,ubenimex
EUKARYOTIC_TRANSLATION_INITIATION,-2.601184314,0,clofazimine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.421497366,0,clofazimine
TRANSLATION,-2.334579437,0.001499339,clofazimine
NONSENSE_MEDIATED_DECAY_NMD,-2.304337096,0.001967883,clofazimine
NERVOUS_SYSTEM_DEVELOPMENT,-2.292352133,0.001799207,clofazimine
INFLUENZA_INFECTION,-2.272174686,0.001874174,clofazimine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.24930685,0.003052227,clofazimine
SELENOAMINO_ACID_METABOLISM,-2.248558914,0.002670698,clofazimine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.233681349,0.002373954,clofazimine
SIGNALING_BY_ROBO_RECEPTORS,-2.194601321,0.003823315,clofazimine
NEURONAL_SYSTEM,2.274786963,0.021815963,dydrogesterone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.942054614,0.160682957,dydrogesterone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.854740226,0.188512294,dydrogesterone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.986315047,1,dydrogesterone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.661285723,0.431914109,dydrogesterone
DISEASES_OF_GLYCOSYLATION,1.642742369,0.379597752,dydrogesterone
PROTEIN_LOCALIZATION,-1.796433655,1,dydrogesterone
DISEASES_OF_METABOLISM,1.595409771,0.411007145,dydrogesterone
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.713217813,1,dydrogesterone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.551313399,0.445668954,dydrogesterone
CELL_CYCLE,-3.687607138,0,irinotecan
MITOTIC_G2_G2_M_PHASES,-2.762857582,0,irinotecan
CHROMOSOME_MAINTENANCE,-2.778822503,0,irinotecan
RHO_GTPASE_EFFECTORS,-2.860708262,0,irinotecan
METABOLISM_OF_RNA,-2.931322446,0,irinotecan
MRNA_SPLICING,-2.945745329,0,irinotecan
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.94900993,0,irinotecan
RHO_GTPASES_ACTIVATE_FORMINS,-2.738559811,0,irinotecan
CELL_CYCLE_CHECKPOINTS,-2.975251463,0,irinotecan
SEPARATION_OF_SISTER_CHROMATIDS,-3.083788781,0,irinotecan
NEUTROPHIL_DEGRANULATION,-1.985371155,0.253891785,flucytosine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.995826434,0.170055849,flucytosine
SENSORY_PERCEPTION,1.959070152,0.116599475,flucytosine
BIOLOGICAL_OXIDATIONS,-1.7805997,0.406938702,flucytosine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.869305385,0.16694653,flucytosine
POTASSIUM_CHANNELS,1.864034096,0.128797574,flucytosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.848272123,0.116671228,flucytosine
GPCR_LIGAND_BINDING,1.834250019,0.10978289,flucytosine
NEURONAL_SYSTEM,1.78924723,0.131821472,flucytosine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.551794672,0.994211756,flucytosine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.91839326,0.002017701,duloxetine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.54606162,0.008070805,duloxetine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.481784547,0.010761074,duloxetine
SEPARATION_OF_SISTER_CHROMATIDS,-2.381463036,0.018159312,duloxetine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.297854282,0.034704462,duloxetine
RHO_GTPASES_ACTIVATE_FORMINS,-2.250135922,0.039345175,duloxetine
ECM_PROTEOGLYCANS,-2.150874063,0.070907789,duloxetine
CELL_CYCLE_CHECKPOINTS,-2.147253939,0.062296528,duloxetine
GPCR_LIGAND_BINDING,-2.078363071,0.082277375,duloxetine
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.062146975,0.083331064,duloxetine
MITOTIC_METAPHASE_AND_ANAPHASE,-3.042217779,0,diazoxide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.959758847,0,diazoxide
S_PHASE,-2.838680194,0,diazoxide
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-2.823744133,0,diazoxide
SEPARATION_OF_SISTER_CHROMATIDS,-2.805305337,0,diazoxide
CELL_CYCLE_CHECKPOINTS,-2.797972873,0,diazoxide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.516675431,0.001396066,diazoxide
METABOLISM_OF_RNA,-2.450215191,0.001832337,diazoxide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.388215649,0.003664674,diazoxide
RHO_GTPASES_ACTIVATE_FORMINS,-2.390385636,0.00407186,diazoxide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.379044422,0.031417764,phentermine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.218760023,0.647085093,phentermine
PROTEIN_LOCALIZATION,1.834962537,0.371490175,phentermine
HEMOSTASIS,-2.950611156,1,phentermine
NEUTROPHIL_DEGRANULATION,-2.900354628,1,phentermine
ION_CHANNEL_TRANSPORT,-2.280940809,1,phentermine
INNATE_IMMUNE_SYSTEM,-2.267803439,1,phentermine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-2.266487067,0.796923657,phentermine
KERATINIZATION,-2.266487067,0.796923657,phentermine
EUKARYOTIC_TRANSLATION_INITIATION,-2.228886504,0.725830897,phentermine
NEUTROPHIL_DEGRANULATION,-2.708062106,0.002863506,atomoxetine
GPCR_LIGAND_BINDING,2.397149784,0.000661162,atomoxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.31228366,0.001652906,atomoxetine
SENSORY_PERCEPTION,2.305383903,0.001101937,atomoxetine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.29142528,0.000991744,atomoxetine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.108919495,0.06442889,atomoxetine
ESR_MEDIATED_SIGNALING,-2.108392184,0.042952593,atomoxetine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.067731099,0.038657334,atomoxetine
SIGNALING_BY_GPCR,2.096579249,0.009785205,atomoxetine
CELL_CYCLE,-1.977211576,0.054406618,atomoxetine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.001930134,0,zosuquidar
RRNA_PROCESSING,-2.495197886,0,zosuquidar
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.524433495,0,zosuquidar
CELLULAR_RESPONSE_TO_STARVATION,-2.554518725,0,zosuquidar
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.597259368,0,zosuquidar
SARS_COV_1_HOST_INTERACTIONS,-2.620268463,0,zosuquidar
SIGNALING_BY_ROBO_RECEPTORS,-2.695168582,0,zosuquidar
EUKARYOTIC_TRANSLATION_INITIATION,-2.608526614,0,zosuquidar
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.740850369,0,zosuquidar
NONSENSE_MEDIATED_DECAY_NMD,-2.747683615,0,zosuquidar
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,2.057971063,0.048321081,terazosin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.120447454,0.085173961,terazosin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.079138473,0.063396528,terazosin
EXTRACELLULAR_MATRIX_ORGANIZATION,1.609234307,0.432982317,terazosin
INTERFERON_GAMMA_SIGNALING,1.575722559,0.34121465,terazosin
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.796978267,0.550727089,terazosin
MEMBRANE_TRAFFICKING,-1.782659395,0.462165527,terazosin
VESICLE_MEDIATED_TRANSPORT,-1.765191963,0.419868913,terazosin
ANTIGEN_PROCESSING_CROSS_PRESENTATION,1.387103146,0.700019869,terazosin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.671277102,0.686876375,terazosin
RRNA_PROCESSING,-2.381485144,0.060611712,dacomitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.304295391,0.052818778,dacomitinib
METABOLISM_OF_RNA,-2.229444804,0.054839168,dacomitinib
SEPARATION_OF_SISTER_CHROMATIDS,-2.177205755,0.053251718,dacomitinib
SENSORY_PERCEPTION,2.008230691,0.120334931,dacomitinib
RHO_GTPASES_ACTIVATE_FORMINS,-2.102530863,0.06684606,dacomitinib
KERATINIZATION,1.930485033,0.134858113,dacomitinib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.913409889,0.10926965,dacomitinib
TRANSLATION,-1.952888804,0.131036749,dacomitinib
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.807719779,0.22636619,dacomitinib
RESPIRATORY_ELECTRON_TRANSPORT,3.285518509,0,nicardipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.834259587,0.000618926,nicardipine
TRANSLATION,2.744275205,0.000412617,nicardipine
MITOCHONDRIAL_TRANSLATION,2.696091447,0.000309463,nicardipine
RRNA_PROCESSING,2.308366526,0.005941687,nicardipine
NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,-2.126289156,0.091747789,nicardipine
SELENOAMINO_ACID_METABOLISM,2.071085299,0.028264276,nicardipine
METABOLISM_OF_NUCLEOTIDES,1.988585932,0.040495427,nicardipine
G2_M_CHECKPOINTS,1.935614819,0.048276208,nicardipine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.847942258,0.075508941,nicardipine
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-2.11681621,0.09146115,imiquimod
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-2.082500294,0.069464165,imiquimod
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.053152381,0.061745924,imiquimod
ESR_MEDIATED_SIGNALING,-2.044131577,0.049782651,imiquimod
MRNA_SPLICING,-2.006853686,0.056497521,imiquimod
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.913949913,0.118667948,imiquimod
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.850968002,0.181433783,imiquimod
CHROMATIN_ORGANIZATION,-1.845242896,0.168016449,imiquimod
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.683545553,0.459571948,imiquimod
RESPIRATORY_ELECTRON_TRANSPORT,1.595291223,0.373377887,imiquimod
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.042527956,0.101806129,ketoconazole
GPCR_LIGAND_BINDING,2.036377927,0.059919511,ketoconazole
CELL_CYCLE_CHECKPOINTS,-1.837177584,0.160995738,ketoconazole
TRANSLATION,-1.828335838,0.112854856,ketoconazole
METABOLISM_OF_RNA,-1.699950669,0.165730907,ketoconazole
RRNA_PROCESSING,-1.680989095,0.145369681,ketoconazole
EUKARYOTIC_TRANSLATION_INITIATION,-1.634211007,0.151919998,ketoconazole
CELLULAR_RESPONSE_TO_STARVATION,-1.621290231,0.136643442,ketoconazole
SELENOAMINO_ACID_METABOLISM,-1.565309592,0.158924102,ketoconazole
INTERFERON_SIGNALING,-1.548068286,0.157312829,ketoconazole
SIGNALING_BY_PTK6,-2.670126675,0,ziprasidone
RHO_GTPASES_ACTIVATE_FORMINS,-2.235592788,0.016789885,ziprasidone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.213283429,0.018036159,ziprasidone
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.075976478,0.039798245,ziprasidone
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.032697186,0.04104194,ziprasidone
SEPARATION_OF_SISTER_CHROMATIDS,-1.871176918,0.101112416,ziprasidone
MITOTIC_SPINDLE_CHECKPOINT,-1.830806367,0.11162164,ziprasidone
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.825612922,0.098340753,ziprasidone
CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,-1.817904752,0.09024563,ziprasidone
SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,-1.732465693,0.135148207,ziprasidone
NEURONAL_SYSTEM,2.338706219,0.006767483,triamterene
MUSCLE_CONTRACTION,1.951689061,0.076510151,triamterene
CARDIAC_CONDUCTION,1.911127481,0.066170942,triamterene
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.066603974,1,triamterene
APOPTOSIS,-2.058850228,1,triamterene
HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,-1.951174993,1,triamterene
CELL_CYCLE_CHECKPOINTS,-1.950204468,0.981953163,triamterene
PROGRAMMED_CELL_DEATH,-1.922005054,0.845316272,triamterene
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.916396087,0.712397393,triamterene
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.907903711,0.620300752,triamterene
ECM_PROTEOGLYCANS,-2.259284432,0.012715071,bupivacaine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.20726229,0.019464194,bupivacaine
NEUTROPHIL_DEGRANULATION,1.926906942,0.061636614,bupivacaine
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.946048922,0.212977446,bupivacaine
METABOLISM_OF_STEROIDS,1.790208192,0.095158282,bupivacaine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.922757099,0.17200666,bupivacaine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.892181532,0.16609062,bupivacaine
PROTEIN_LOCALIZATION,1.620919672,0.174691141,bupivacaine
METABOLISM_OF_LIPIDS,1.525397661,0.228250115,bupivacaine
AUTOPHAGY,1.470337049,0.24979049,bupivacaine
RESPIRATORY_ELECTRON_TRANSPORT,2.971682156,0,equol
CELLULAR_RESPONSE_TO_STARVATION,2.198596588,0.017073318,equol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.189336884,0.012093601,equol
COMPLEX_I_BIOGENESIS,2.178624448,0.010137283,equol
ION_CHANNEL_TRANSPORT,-2.605894795,0.097314603,equol
GPCR_LIGAND_BINDING,-2.548755593,0.100709298,equol
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.995378411,0.032581583,equol
SIGNALING_BY_GPCR,-2.423673061,0.201795785,equol
TRANSPORT_OF_SMALL_MOLECULES,-2.372050507,0.23310242,equol
NEDDYLATION,1.842645304,0.075407156,equol
NEUTROPHIL_DEGRANULATION,-2.854562088,0,amiloride
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.650827088,0.001704766,amiloride
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.469120136,0.009660338,amiloride
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.234283284,0.040061991,amiloride
INNATE_IMMUNE_SYSTEM,-2.154039397,0.057621077,amiloride
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.834548487,0.645542716,amiloride
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.865357976,0.264238667,amiloride
HEMOSTASIS,-1.709977987,0.479526208,amiloride
SIGNALING_BY_PDGF,-1.613670058,0.629058504,amiloride
DISEASES_OF_GLYCOSYLATION,-1.519937675,0.768470446,amiloride
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.72512562,1,miglitol
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.489200859,1,miglitol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.443956725,1,miglitol
NEUTROPHIL_DEGRANULATION,-2.269036962,1,miglitol
G_ALPHA_Q_SIGNALLING_EVENTS,1.647260366,1,miglitol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.161961192,1,miglitol
G_ALPHA_I_SIGNALLING_EVENTS,-2.082425356,1,miglitol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.926361925,1,miglitol
DISEASES_OF_GLYCOSYLATION,-1.626847527,1,miglitol
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.607551632,1,miglitol
GPCR_LIGAND_BINDING,3.381115005,0,rimexolone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.289421921,0,rimexolone
SIGNALING_BY_GPCR,3.068305231,0,rimexolone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.979375149,0,rimexolone
MUSCLE_CONTRACTION,2.795240644,0,rimexolone
CARDIAC_CONDUCTION,2.626473338,0,rimexolone
G_ALPHA_Q_SIGNALLING_EVENTS,2.593408696,0,rimexolone
G_ALPHA_I_SIGNALLING_EVENTS,2.50450071,0.00018316,rimexolone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.932518052,0.038422878,rimexolone
POTASSIUM_CHANNELS,1.920180456,0.037730941,rimexolone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.252181701,0.044800531,levomepromazine
NEURONAL_SYSTEM,2.170237508,0.045513074,levomepromazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.177784431,0.041067153,levomepromazine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.084386853,0.044620661,levomepromazine
SENSORY_PERCEPTION,1.800100326,0.257312476,levomepromazine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.78168149,0.217971927,levomepromazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.838792055,0.443738592,levomepromazine
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1.757000745,0.206861383,levomepromazine
PROTEIN_LOCALIZATION,-1.818403492,0.383204542,levomepromazine
EPH_EPHRIN_SIGNALING,1.719494184,0.215369055,levomepromazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.763577374,0.043360517,moclobemide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.669277248,0.086721033,moclobemide
NEUTROPHIL_DEGRANULATION,-2.272483361,0.862763098,moclobemide
HEMOSTASIS,-2.205256824,0.731708716,moclobemide
METABOLISM_OF_RNA,-2.158397938,0.627059778,moclobemide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.041993637,0.618721217,moclobemide
INNATE_IMMUNE_SYSTEM,-1.989771059,0.573692988,moclobemide
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.872818432,0.609131872,moclobemide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.610514044,1,moclobemide
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.755444266,0.689321032,moclobemide
GPCR_LIGAND_BINDING,3.046347752,0,xylazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.88743576,0,xylazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.850808056,0,xylazine
SIGNALING_BY_GPCR,2.683786989,0,xylazine
METABOLISM_OF_RNA,-2.558499262,0.00239968,xylazine
SENSORY_PERCEPTION,2.45777671,0.000267725,xylazine
G_ALPHA_I_SIGNALLING_EVENTS,2.392709634,0.000446208,xylazine
NEUTROPHIL_DEGRANULATION,-2.437037422,0.00479936,xylazine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.385143612,0.005599253,xylazine
CELL_CYCLE_MITOTIC,-2.204680925,0.01559792,xylazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.303843929,0,obatoclax
GPCR_LIGAND_BINDING,-2.267274113,0,obatoclax
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.188527884,0.000460794,obatoclax
G_ALPHA_I_SIGNALLING_EVENTS,-2.161082527,0.000345596,obatoclax
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.319709623,0.020710974,obatoclax
SENSORY_PERCEPTION,-2.110923212,0.000552953,obatoclax
TRANS_GOLGI_NETWORK_VESICLE_BUDDING,2.262955394,0.018122102,obatoclax
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,2.248470124,0.012081401,obatoclax
COPII_MEDIATED_VESICLE_TRANSPORT,2.062832242,0.028477589,obatoclax
POTASSIUM_CHANNELS,-2.019683377,0.002649568,obatoclax
GPCR_LIGAND_BINDING,2.489793227,0,AS-604850
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.301534726,0.000388965,AS-604850
SIGNALING_BY_GPCR,2.124495342,0.003630338,AS-604850
NEURONAL_SYSTEM,1.809887049,0.05367714,AS-604850
G_ALPHA_I_SIGNALLING_EVENTS,1.695337623,0.109843655,AS-604850
POTASSIUM_CHANNELS,1.656445585,0.124987351,AS-604850
G_ALPHA_Q_SIGNALLING_EVENTS,1.625703024,0.131358964,AS-604850
CHROMATIN_ORGANIZATION,-1.124345545,1,AS-604850
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.100993073,1,AS-604850
BIOLOGICAL_OXIDATIONS,-1.098445995,1,AS-604850
NEURONAL_SYSTEM,2.334186598,0.011787013,benzydamine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.030726201,0.070722075,benzydamine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,2.010452373,0.057461686,benzydamine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.883022839,0.097611198,benzydamine
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.753799949,0.18358272,benzydamine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.330380068,1,benzydamine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.195235817,1,benzydamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.19432726,1,benzydamine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.982489752,1,benzydamine
HEMOSTASIS,-1.858820487,0.949031324,benzydamine
EUKARYOTIC_TRANSLATION_ELONGATION,3.031404685,0,hydroflumethiazide
EUKARYOTIC_TRANSLATION_INITIATION,2.941541545,0,hydroflumethiazide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.88023772,0,hydroflumethiazide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.863873925,0,hydroflumethiazide
SELENOAMINO_ACID_METABOLISM,2.857536159,0,hydroflumethiazide
GPCR_LIGAND_BINDING,-2.856119273,0,hydroflumethiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.832577261,0,hydroflumethiazide
CELLULAR_RESPONSE_TO_STARVATION,2.771347603,0,hydroflumethiazide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.759735264,0,hydroflumethiazide
NONSENSE_MEDIATED_DECAY_NMD,2.703761048,0.000198831,hydroflumethiazide
MITOTIC_METAPHASE_AND_ANAPHASE,-2.263318519,0.027147351,RAF-265
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.054695684,0.060464554,RAF-265
KERATINIZATION,2.107321127,0.038051903,RAF-265
GPCR_LIGAND_BINDING,2.104577025,0.019835567,RAF-265
SEPARATION_OF_SISTER_CHROMATIDS,-1.974770747,0.063343818,RAF-265
TRANSLATION,-1.876453172,0.085143963,RAF-265
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.856828113,0.075025405,RAF-265
ADIPOGENESIS,-1.797883407,0.090902492,RAF-265
G_ALPHA_I_SIGNALLING_EVENTS,1.933350063,0.079072395,RAF-265
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.72080061,0.120223981,RAF-265
RESPIRATORY_ELECTRON_TRANSPORT,2.297616907,0.014690983,phenethyl-isothiocyanate
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.265626383,0.071404186,phenethyl-isothiocyanate
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.239198358,0.062608018,phenethyl-isothiocyanate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.920116727,0.091002477,phenethyl-isothiocyanate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.176152898,0.153846701,phenethyl-isothiocyanate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.174100792,0.118489556,phenethyl-isothiocyanate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.149956139,0.137220219,phenethyl-isothiocyanate
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.760727924,0.139020226,phenethyl-isothiocyanate
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.608783925,0.226894067,phenethyl-isothiocyanate
TRANSPORT_OF_SMALL_MOLECULES,-2.678909567,0.503451256,phenethyl-isothiocyanate
GPCR_LIGAND_BINDING,2.72448868,0,flupirtine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.551144814,0,flupirtine
SIGNALING_BY_GPCR,2.399594988,0.000226125,flupirtine
NEUTROPHIL_DEGRANULATION,-2.258164074,0.045975157,flupirtine
S_PHASE,-2.186895682,0.035247621,flupirtine
METABOLISM_OF_RNA,-2.088545548,0.037801796,flupirtine
SENSORY_PERCEPTION,2.09646877,0.006105374,flupirtine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.09042563,0.005562674,flupirtine
G_ALPHA_I_SIGNALLING_EVENTS,2.049617193,0.007462124,flupirtine
SYNTHESIS_OF_DNA,-1.920026976,0.08198903,flupirtine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.883064924,0,dazoxiben
NONSENSE_MEDIATED_DECAY_NMD,-2.69800866,0,dazoxiben
SELENOAMINO_ACID_METABOLISM,-2.685949839,0,dazoxiben
EUKARYOTIC_TRANSLATION_INITIATION,-2.680870677,0,dazoxiben
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.657153261,0,dazoxiben
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.617727281,0,dazoxiben
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.613185895,0,dazoxiben
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.577468263,0,dazoxiben
RRNA_PROCESSING,-2.503004921,0.000121945,dazoxiben
INFLUENZA_INFECTION,-2.482513383,0.00010975,dazoxiben
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.554419397,0,linsitinib
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.52036432,0,linsitinib
SELENOAMINO_ACID_METABOLISM,-2.5542503,0,linsitinib
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.584796517,0,linsitinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.590559817,0,linsitinib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.606752536,0,linsitinib
EUKARYOTIC_TRANSLATION_INITIATION,-2.533552694,0,linsitinib
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.620990044,0,linsitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.992287001,0,linsitinib
GPCR_LIGAND_BINDING,3.269154328,0,linsitinib
BIOLOGICAL_OXIDATIONS,2.120040846,0.059688087,diphenidol
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.067215957,0.044473476,diphenidol
EUKARYOTIC_TRANSLATION_INITIATION,-2.057147225,0.248511243,diphenidol
PLATELET_HOMEOSTASIS,1.926332217,0.077048347,diphenidol
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.94278977,0.35550914,diphenidol
CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,-1.928283161,0.272288554,diphenidol
SIGNALING_BY_ALK_IN_CANCER,1.812247816,0.112061457,diphenidol
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.809188795,0.091989875,diphenidol
DNA_REPLICATION_PRE_INITIATION,-1.910929095,0.234417434,diphenidol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.907827839,0.19075539,diphenidol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.954584047,0.379687923,levosimendan
NEUTROPHIL_DEGRANULATION,1.766807969,0.494304368,levosimendan
AUTOPHAGY,1.735183355,0.289220641,levosimendan
UNFOLDED_PROTEIN_RESPONSE_UPR,1.598531817,0.37766001,levosimendan
METABOLISM_OF_STEROIDS,1.569165189,0.328659819,levosimendan
ECM_PROTEOGLYCANS,-1.806251792,0.728154823,levosimendan
SUMOYLATION_OF_RNA_BINDING_PROTEINS,1.471044393,0.421258229,levosimendan
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.450829228,0.387221023,levosimendan
G_ALPHA_I_SIGNALLING_EVENTS,-1.676006948,1,levosimendan
BIOLOGICAL_OXIDATIONS,1.297482994,0.683612424,levosimendan
EUKARYOTIC_TRANSLATION_INITIATION,-3.201913597,0,levetiracetam
SEPARATION_OF_SISTER_CHROMATIDS,-2.590019989,0,levetiracetam
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.660830519,0,levetiracetam
MITOTIC_METAPHASE_AND_ANAPHASE,-2.678942927,0,levetiracetam
CELL_CYCLE,-2.67994387,0,levetiracetam
CELL_CYCLE_CHECKPOINTS,-2.712641304,0,levetiracetam
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.750244501,0,levetiracetam
SARS_COV_1_INFECTION,-2.795923113,0,levetiracetam
RRNA_PROCESSING,-2.82962764,0,levetiracetam
CELLULAR_RESPONSE_TO_STARVATION,-2.868186337,0,levetiracetam
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.263202802,0.107270752,ciglitazone
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.110278009,0.160041041,ciglitazone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.039791756,0.163213026,ciglitazone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.93087329,0.237466302,ciglitazone
PROTEIN_LOCALIZATION,1.697317899,1,ciglitazone
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,-1.687078555,0.675459703,ciglitazone
NEURONAL_SYSTEM,-1.684787693,0.568938693,ciglitazone
RESPIRATORY_ELECTRON_TRANSPORT,1.693629927,0.643852954,ciglitazone
ESR_MEDIATED_SIGNALING,-1.646990415,0.575653413,ciglitazone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.627780309,0.548681246,ciglitazone
GPCR_LIGAND_BINDING,2.063710858,0.03798025,H-7
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.050611481,0.022028545,H-7
G_ALPHA_I_SIGNALLING_EVENTS,2.016968985,0.022534948,H-7
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.969360049,0.028485188,H-7
SIGNALING_BY_GPCR,1.946271438,0.027649622,H-7
EXTRACELLULAR_MATRIX_ORGANIZATION,1.830284176,0.05924919,H-7
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.711181194,0.929434475,H-7
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.694057712,0.51333381,H-7
SIGNALING_BY_ROBO_RECEPTORS,-1.678796539,0.365100927,H-7
KEAP1_NFE2L2_PATHWAY,-1.625361488,0.357117323,H-7
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.167435536,0.09163934,homosalate
SENSORY_PERCEPTION,1.903282528,0.34473847,homosalate
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.63683833,1,homosalate
RHO_GTPASE_EFFECTORS,-1.579234712,0.99506387,homosalate
G_ALPHA_I_SIGNALLING_EVENTS,1.796308172,0.470706198,homosalate
MUSCLE_CONTRACTION,1.751450559,0.47019709,homosalate
CARDIAC_CONDUCTION,1.737099492,0.409147835,homosalate
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.393647204,1,homosalate
PLATELET_HOMEOSTASIS,1.656506183,0.557545382,homosalate
VISUAL_PHOTOTRANSDUCTION,1.651236689,0.492857567,homosalate
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.504823204,0.054831486,prazosin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.50296616,0.029446539,prazosin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.418119279,0.036554324,prazosin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.401685045,0.028431141,prazosin
ISG15_ANTIVIRAL_MECHANISM,-2.380336189,0.027212663,prazosin
HCMV_EARLY_EVENTS,-2.351775683,0.029446539,prazosin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.333841703,0.0275608,prazosin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.169344865,0.063970067,prazosin
HEMOSTASIS,-2.127560138,0.075816375,prazosin
INFLUENZA_INFECTION,-2.096987378,0.083262626,prazosin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.277539882,0.030786897,metergoline
METABOLISM_OF_STEROIDS,2.133251443,0.04518722,metergoline
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.9015426,0.141354892,metergoline
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1.78235259,0.211784057,metergoline
REGULATION_OF_T_CELL_ACTIVATION_BY_CD28_FAMILY,1.77204568,0.180351629,metergoline
OPIOID_SIGNALLING,1.73126465,0.19481816,metergoline
NEURONAL_SYSTEM,1.731200413,0.167128869,metergoline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.522866444,1,metergoline
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.656117409,0.212528902,metergoline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.851385869,1,metergoline
GPCR_LIGAND_BINDING,2.597764058,0,tegaserod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.49472666,0,tegaserod
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.539618705,0.004127483,tegaserod
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.413005882,0.017541802,tegaserod
SIGNALING_BY_GPCR,2.265146155,0.005082061,tegaserod
NEUTROPHIL_DEGRANULATION,-2.214001498,0.063975986,tegaserod
CELL_CYCLE,-2.210110603,0.049529795,tegaserod
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.066373175,0.021757573,tegaserod
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.110384477,0.073881945,tegaserod
CELL_CYCLE_MITOTIC,-1.979890523,0.135519023,tegaserod
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.990094812,0.41665498,tolmetin
BIOLOGICAL_OXIDATIONS,-1.563564031,1,tolmetin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.553429129,0.920710331,tolmetin
HEMOSTASIS,1.771984993,0.966526177,tolmetin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.458199134,0.942498608,tolmetin
METABOLISM_OF_STEROIDS,-1.456641052,0.712476655,tolmetin
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.741133409,0.78827469,tolmetin
NEURONAL_SYSTEM,1.699783551,0.756309096,tolmetin
PLATELET_HOMEOSTASIS,1.697363892,0.61336148,tolmetin
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.362180654,0.853602438,tolmetin
CELLULAR_RESPONSE_TO_HEAT_STRESS,-2.618890771,0.00207037,azelastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.570728661,0.003105555,azelastine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.441192823,0.00621111,azelastine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.384969156,0.007763887,azelastine
METABOLISM_OF_RNA,-2.344205191,0.007039258,azelastine
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.330925164,0.006556172,azelastine
M_PHASE,-2.3215604,0.005619576,azelastine
MITOTIC_PROMETAPHASE,-2.286474382,0.006469906,azelastine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.282992731,0.005981069,azelastine
MITOTIC_SPINDLE_CHECKPOINT,-2.20607334,0.011594072,azelastine
RESPIRATORY_ELECTRON_TRANSPORT,2.876496346,0,etacrynic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.312634471,0.008234454,etacrynic-acid
COLLAGEN_FORMATION,-2.227663922,0.081392889,etacrynic-acid
INTERFERON_GAMMA_SIGNALING,-2.019760951,0.205483687,etacrynic-acid
SIGNALING_BY_MET,-2.013444526,0.143215903,etacrynic-acid
MITOCHONDRIAL_TRANSLATION,1.949665902,0.095857495,etacrynic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.928199956,0.202481491,etacrynic-acid
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.895225505,0.205216825,etacrynic-acid
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.890873892,0.17412741,etacrynic-acid
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-1.847917251,0.205483687,etacrynic-acid
MUSCLE_CONTRACTION,2.226159748,0.024830402,mafenide
SEPARATION_OF_SISTER_CHROMATIDS,1.76322115,0.199598235,mafenide
GPCR_LIGAND_BINDING,1.740012378,0.147072384,mafenide
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.68339738,0.151369953,mafenide
INTERLEUKIN_1_FAMILY_SIGNALING,1.666108564,0.134084173,mafenide
RHO_GTPASES_ACTIVATE_FORMINS,1.571160154,0.182407956,mafenide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.49062289,0.232205192,mafenide
MITOTIC_SPINDLE_CHECKPOINT,1.365518702,0.369352236,mafenide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.313219634,0.411930009,mafenide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.070065336,1,mafenide
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.488312589,0.611420408,stiripentol
HEMOSTASIS,-2.231819634,1,stiripentol
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.903134528,1,stiripentol
CELL_CELL_COMMUNICATION,-1.903012487,1,stiripentol
CELL_JUNCTION_ORGANIZATION,-1.874421244,1,stiripentol
ADAPTIVE_IMMUNE_SYSTEM,-1.825916624,1,stiripentol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.757634107,1,stiripentol
INNATE_IMMUNE_SYSTEM,-1.71884836,0.986312738,stiripentol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.513909538,1,stiripentol
PI3K_AKT_SIGNALING_IN_CANCER,-1.507993217,1,stiripentol
EUKARYOTIC_TRANSLATION_ELONGATION,3.566125903,0,felodipine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.72480444,0,felodipine
METABOLISM_OF_RNA,2.748222817,0,felodipine
SIGNALING_BY_ROBO_RECEPTORS,2.798548521,0,felodipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.859565641,0,felodipine
SIGNALING_BY_GPCR,-2.895326767,0,felodipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.93367817,0,felodipine
NEURONAL_SYSTEM,-2.965249007,0,felodipine
RESPIRATORY_ELECTRON_TRANSPORT,2.969075729,0,felodipine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.061569843,0,felodipine
NONSENSE_MEDIATED_DECAY_NMD,-3.229726742,0,quinidine
INFLUENZA_INFECTION,-2.921545614,0,quinidine
METABOLISM_OF_RNA,-2.928233685,0,quinidine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.929207638,0,quinidine
CELLULAR_RESPONSE_TO_STARVATION,-2.964099543,0,quinidine
GPCR_LIGAND_BINDING,3.042116201,0,quinidine
EUKARYOTIC_TRANSLATION_INITIATION,-3.114947985,0,quinidine
TRANSLATION,-2.953178595,0,quinidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.122126186,0,quinidine
SELENOAMINO_ACID_METABOLISM,-3.122380545,0,quinidine
RESPIRATORY_ELECTRON_TRANSPORT,1.848042833,0.587715407,minoxidil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.1558378,1,minoxidil
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.744082901,0.569478821,minoxidil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.907235195,1,minoxidil
EUKARYOTIC_TRANSLATION_INITIATION,-1.905302788,0.951479729,minoxidil
INFLUENZA_INFECTION,-1.857739158,0.820484275,minoxidil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.836809431,0.69691066,minoxidil
GLYCOSAMINOGLYCAN_METABOLISM,1.649958412,0.66535905,minoxidil
EUKARYOTIC_TRANSLATION_ELONGATION,-1.741755631,0.768902496,minoxidil
NONSENSE_MEDIATED_DECAY_NMD,-1.712792194,0.729672776,minoxidil
INTERLEUKIN_1_FAMILY_SIGNALING,2.003071216,0.15648772,mebendazole
S_PHASE,1.93708764,0.106063899,mebendazole
POTASSIUM_CHANNELS,-1.978377626,0.082138201,mebendazole
SYNTHESIS_OF_DNA,1.880173798,0.105484315,mebendazole
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.783140094,0.128667681,mebendazole
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.782354841,0.103629646,mebendazole
TRANSLATION,1.741219179,0.104904731,mebendazole
MRNA_SPLICING,1.73889552,0.089918341,mebendazole
METABOLISM_OF_RNA,1.702428708,0.090415127,mebendazole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.590020428,0.13639547,mebendazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.420111627,0,droperidol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.230230646,0,droperidol
HEMOSTASIS,-2.999312117,0,droperidol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.879003653,0,droperidol
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.451789281,0.005821465,droperidol
VISUAL_PHOTOTRANSDUCTION,-2.160471983,0.023882934,droperidol
NEUTROPHIL_DEGRANULATION,-2.074741008,0.037103845,droperidol
INNATE_IMMUNE_SYSTEM,-2.024840319,0.041701843,droperidol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.994124189,0.043039038,droperidol
DISEASES_OF_METABOLISM,-1.826601831,0.101875642,droperidol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.493553385,0.028830926,ropivacaine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.284706158,0.135612132,ropivacaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.248692515,0.157324311,ropivacaine
RRNA_PROCESSING,1.736313533,1,ropivacaine
NONSENSE_MEDIATED_DECAY_NMD,1.7264472,0.92002495,ropivacaine
METABOLISM_OF_RNA,1.686250701,0.803787807,ropivacaine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.977514116,1,ropivacaine
EUKARYOTIC_TRANSLATION_INITIATION,1.666239051,0.683092253,ropivacaine
TRANSPORT_OF_SMALL_MOLECULES,-2.52852104,1,ropivacaine
HEMOSTASIS,-2.441420885,1,ropivacaine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.219556543,0.056507071,BRD-K66766661
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.147597038,0.057955971,BRD-K66766661
GPCR_LIGAND_BINDING,1.892505785,0.523507654,BRD-K66766661
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.784184307,0.656498585,BRD-K66766661
COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1.781370501,0.443303104,BRD-K66766661
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.883887388,1,BRD-K66766661
CARDIAC_CONDUCTION,1.73724314,0.470080661,BRD-K66766661
G_ALPHA_S_SIGNALLING_EVENTS,1.72713037,0.404661423,BRD-K66766661
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.82591349,1,BRD-K66766661
SIGNALING_BY_GPCR,1.694821514,0.419600481,BRD-K66766661
INFLUENZA_INFECTION,-2.724042711,0,BRD-K49668410
SENSORY_PERCEPTION,2.19354423,0.027172449,BRD-K49668410
NEUTROPHIL_DEGRANULATION,-2.110941829,0.069802614,BRD-K49668410
NONSENSE_MEDIATED_DECAY_NMD,-2.014052577,0.077946252,BRD-K49668410
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.975409039,0.075910342,BRD-K49668410
METABOLISM_OF_RNA,-1.961647618,0.060495599,BRD-K49668410
EUKARYOTIC_TRANSLATION_ELONGATION,-1.965991087,0.069802614,BRD-K49668410
INNATE_IMMUNE_SYSTEM,-1.947997388,0.056839271,BRD-K49668410
CELL_CYCLE,-1.930271013,0.058459689,BRD-K49668410
CELL_CYCLE_MITOTIC,-1.839822293,0.087641059,BRD-K49668410
EUKARYOTIC_TRANSLATION_ELONGATION,-2.75093761,0,isocarboxazid
NONSENSE_MEDIATED_DECAY_NMD,-2.524205255,0,isocarboxazid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.553373781,0,isocarboxazid
EUKARYOTIC_TRANSLATION_INITIATION,-2.625225764,0,isocarboxazid
SELENOAMINO_ACID_METABOLISM,-2.625887626,0,isocarboxazid
CELLULAR_RESPONSE_TO_STARVATION,-2.522960977,0,isocarboxazid
INFLUENZA_INFECTION,-2.660139635,0,isocarboxazid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.671930354,0,isocarboxazid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.687617819,0,isocarboxazid
GPCR_LIGAND_BINDING,2.654519934,0,isocarboxazid
CELL_CYCLE,-3.49699114,0,rizatriptan
CELL_CYCLE_MITOTIC,-3.239585049,0,rizatriptan
MITOTIC_METAPHASE_AND_ANAPHASE,-2.914980049,0,rizatriptan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.791895649,0,rizatriptan
M_PHASE,-2.782970296,0,rizatriptan
CELL_CYCLE_CHECKPOINTS,-2.768799043,0,rizatriptan
SEPARATION_OF_SISTER_CHROMATIDS,-2.617318972,0,rizatriptan
S_PHASE,-2.587786208,0,rizatriptan
PROGRAMMED_CELL_DEATH,-2.540997083,0,rizatriptan
METABOLISM_OF_RNA,-2.517721517,0.000203635,rizatriptan
CELL_CYCLE,-4.162047695,0,topotecan
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-2.640381125,0,topotecan
DNA_DOUBLE_STRAND_BREAK_REPAIR,-2.645567884,0,topotecan
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.650909392,0,topotecan
DNA_STRAND_ELONGATION,-2.653936228,0,topotecan
RHO_GTPASE_EFFECTORS,-2.720347271,0,topotecan
DNA_REPAIR,-2.75462745,0,topotecan
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.838920676,0,topotecan
CHROMOSOME_MAINTENANCE,-2.859034398,0,topotecan
DNA_REPLICATION_PRE_INITIATION,-2.862494981,0,topotecan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.238502118,0.004679176,memantine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.189061798,0.005459039,memantine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.800656198,0.472596823,memantine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.781611303,0.447641215,memantine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.760655771,0.443273984,memantine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.774231088,1,memantine
G_ALPHA_S_SIGNALLING_EVENTS,1.761514633,0.583012847,memantine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.742763556,0.439134823,memantine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-2.705293701,0.609852666,memantine
VISUAL_PHOTOTRANSDUCTION,-2.703597993,0.531643574,memantine
GPCR_LIGAND_BINDING,2.886878962,0,PD-168393
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.604175442,0.000795746,PD-168393
MUSCLE_CONTRACTION,1.934368055,0.036471709,PD-168393
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.896557087,0.034316562,PD-168393
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.951313152,0.56875839,PD-168393
METABOLISM_OF_RNA,-1.919688132,0.37729517,PD-168393
CELL_CYCLE_MITOTIC,-1.873075848,0.397567746,PD-168393
SIGNALING_BY_GPCR,1.619586189,0.122624516,PD-168393
RHO_GTPASE_EFFECTORS,-1.794125245,0.582555004,PD-168393
CELL_CYCLE,-1.782690635,0.506589156,PD-168393
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.093190312,0.151661694,paricalcitol
ESTROGEN_DEPENDENT_GENE_EXPRESSION,2.000302829,0.156831979,paricalcitol
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.866668529,0.188428165,paricalcitol
C_TYPE_LECTIN_RECEPTORS_CLRS,1.62760426,0.417069657,paricalcitol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.626624305,0.334345097,paricalcitol
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.56602867,0.385473471,paricalcitol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.832021829,0.623188294,paricalcitol
PROTEASOME_ASSEMBLY,1.560357867,0.345670483,paricalcitol
SELENOAMINO_ACID_METABOLISM,-1.815526018,0.372034427,paricalcitol
NEDDYLATION,1.507366533,0.396388517,paricalcitol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.972809738,0,BRD-K82225283
NERVOUS_SYSTEM_DEVELOPMENT,-2.441334175,0,BRD-K82225283
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.513156994,0,BRD-K82225283
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.546201099,0,BRD-K82225283
SIGNALING_BY_ROBO_RECEPTORS,-2.580059509,0,BRD-K82225283
INFLUENZA_INFECTION,-2.600123127,0,BRD-K82225283
CELLULAR_RESPONSE_TO_STARVATION,-2.641395277,0,BRD-K82225283
RRNA_PROCESSING,-2.558511136,0,BRD-K82225283
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.795373063,0,BRD-K82225283
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.716629183,0,BRD-K82225283
TRANSLATION,-2.139889091,0.107257278,vincristine
INFLUENZA_INFECTION,-2.117627919,0.063379301,vincristine
NEUTROPHIL_DEGRANULATION,-2.011587649,0.077355249,vincristine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.976064139,0.076055161,vincristine
SARS_COV_1_INFECTION,-1.812048711,0.151720295,vincristine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,-1.739514428,0.181362307,vincristine
ADIPOGENESIS,-1.658391775,0.251845661,vincristine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.572489669,0.330303663,vincristine
SARS_COV_2_HOST_INTERACTIONS,-1.563965227,0.306170776,vincristine
CELLULAR_RESPONSE_TO_STARVATION,-1.498286704,0.381055857,vincristine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.021413441,0,relcovaptan
ADAPTIVE_IMMUNE_SYSTEM,2.109038934,0.031401457,relcovaptan
ION_CHANNEL_TRANSPORT,-2.178527487,0.53223312,relcovaptan
METABOLISM_OF_RNA,-2.130061828,0.382428374,relcovaptan
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.760194012,0.228945165,relcovaptan
BIOLOGICAL_OXIDATIONS,1.690112808,0.253923596,relcovaptan
REGULATION_OF_TP53_ACTIVITY,-1.780457309,1,relcovaptan
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1.628872714,0.281128676,relcovaptan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.62387348,0.240554188,relcovaptan
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.706673651,1,relcovaptan
GPCR_LIGAND_BINDING,3.226522008,0,levocabastine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.113763401,0,levocabastine
SIGNALING_BY_GPCR,2.660171715,0,levocabastine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.605098031,0,levocabastine
G_ALPHA_I_SIGNALLING_EVENTS,2.158422514,0.003875619,levocabastine
RRNA_PROCESSING,-2.301510357,0.047674716,levocabastine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.28747867,0.025481314,levocabastine
G_ALPHA_Q_SIGNALLING_EVENTS,2.079160927,0.008909469,levocabastine
METABOLISM_OF_RNA,-2.114444512,0.052606583,levocabastine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.094730941,0.047674716,levocabastine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.369731243,0.008680048,budesonide
RESPIRATORY_ELECTRON_TRANSPORT,2.225212724,0.032550182,budesonide
TRANSLATION,2.210892617,0.02459347,budesonide
SIGNALING_BY_ROBO_RECEPTORS,1.867908742,0.244126361,budesonide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.827342377,0.246947377,budesonide
PCP_CE_PATHWAY,1.813470001,0.223692081,budesonide
MITOCHONDRIAL_TRANSLATION,1.743983084,0.289386614,budesonide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.146440254,1,budesonide
SIGNALING_BY_ALK_IN_CANCER,-1.948796665,1,budesonide
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,-1.900850774,1,budesonide
EUKARYOTIC_TRANSLATION_ELONGATION,3.237239472,0,tolazamide
SIGNALING_BY_GPCR,-2.647187472,0,tolazamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.658655969,0,tolazamide
METABOLISM_OF_RNA,2.694959695,0,tolazamide
NEURONAL_SYSTEM,-2.717872624,0,tolazamide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.74741683,0,tolazamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.76177177,0,tolazamide
TRANSLATION,2.773702549,0,tolazamide
RESPIRATORY_ELECTRON_TRANSPORT,2.88836393,0,tolazamide
INFLUENZA_INFECTION,2.603244472,0,tolazamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.089716735,0.116637192,cetirizine
MUSCLE_CONTRACTION,1.640364013,0.848080051,cetirizine
DEVELOPMENTAL_CELL_LINEAGES,1.527090159,0.745699216,cetirizine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.933422873,1,cetirizine
GASTRULATION,1.35073638,1,cetirizine
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1.291168205,1,cetirizine
SIGNALING_BY_ERBB2,1.276824891,0.943431754,cetirizine
PTEN_REGULATION,1.257540814,0.855975091,cetirizine
HEMOSTASIS,-2.441541159,1,cetirizine
NEUTROPHIL_DEGRANULATION,-2.407488647,1,cetirizine
CELL_CYCLE,-3.226465443,0,BMS-387032
HIV_INFECTION,-3.102958861,0,BMS-387032
CELL_CYCLE_MITOTIC,-2.762241146,0.00074162,BMS-387032
CELL_CYCLE_CHECKPOINTS,-2.695844819,0.000556215,BMS-387032
NEDDYLATION,-2.558551379,0.000889944,BMS-387032
MITOTIC_METAPHASE_AND_ANAPHASE,-2.459370092,0.001483239,BMS-387032
M_PHASE,-2.431933038,0.001271348,BMS-387032
G_ALPHA_Q_SIGNALLING_EVENTS,2.410926212,0.004113784,BMS-387032
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.325800188,0.00246827,BMS-387032
GPCR_LIGAND_BINDING,2.256263997,0.003016775,BMS-387032
EUKARYOTIC_TRANSLATION_ELONGATION,-2.84665508,0,agomelatine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.670766539,0,agomelatine
SELENOAMINO_ACID_METABOLISM,-2.634507132,0,agomelatine
EUKARYOTIC_TRANSLATION_INITIATION,-2.613204093,0,agomelatine
NONSENSE_MEDIATED_DECAY_NMD,-2.567737443,0,agomelatine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.566808278,0,agomelatine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.549971014,0,agomelatine
SARS_COV_1_HOST_INTERACTIONS,-2.518470079,0.00013992,agomelatine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.485853567,0.000124373,agomelatine
SARS_COV_1_INFECTION,-2.454616077,0.000223872,agomelatine
RESPIRATORY_ELECTRON_TRANSPORT,3.029308269,0,etoricoxib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.532220144,0.001072012,etoricoxib
GPCR_LIGAND_BINDING,-2.579482336,0.012270023,etoricoxib
STIMULI_SENSING_CHANNELS,-2.5629876,0.007250468,etoricoxib
ION_CHANNEL_TRANSPORT,-2.463800012,0.018219125,etoricoxib
CELLULAR_RESPONSE_TO_STARVATION,2.204186787,0.010958345,etoricoxib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.14860888,0.012506806,etoricoxib
COMPLEX_I_BIOGENESIS,2.107879991,0.014293493,etoricoxib
TRANSLATION,1.985625408,0.026085625,etoricoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.301322898,0.08310152,etoricoxib
MITOTIC_METAPHASE_AND_ANAPHASE,-2.301617298,0.018111364,probucol
M_PHASE,-2.180123804,0.046572078,probucol
SEPARATION_OF_SISTER_CHROMATIDS,-2.119275675,0.055196537,probucol
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.081929956,0.058538515,probucol
CELL_CYCLE_MITOTIC,-2.060914627,0.056662695,probucol
ECM_PROTEOGLYCANS,-2.026843094,0.064252219,probucol
SIGNALING_BY_GPCR,-1.998289689,0.072075836,probucol
CELL_CYCLE,-1.968703953,0.080692594,probucol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.963385362,0.074314088,probucol
METABOLISM_OF_RNA,-1.957817477,0.069858118,probucol
TRANSLATION,2.324084453,0.020923705,naringenin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.15623686,0.006107219,naringenin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.096116564,0.034001021,naringenin
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.99928239,0.031385558,naringenin
HIV_INFECTION,1.9500715,0.032693289,naringenin
SIGNALING_BY_GPCR,-1.953124438,0.039696922,naringenin
HIV_LIFE_CYCLE,1.764281271,0.10357234,naringenin
GPCR_LIGAND_BINDING,-1.948153651,0.027736952,naringenin
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.703795731,0.121183125,naringenin
G_ALPHA_Q_SIGNALLING_EVENTS,-1.901486016,0.031490347,naringenin
GPCR_LIGAND_BINDING,2.319227452,0.005077615,capecitabine
SENSORY_PERCEPTION,2.296665617,0.002901494,capecitabine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.295536827,0.002176121,capecitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.295331134,0.001632091,capecitabine
DISEASES_OF_METABOLISM,-3.497858413,0.124661247,capecitabine
SIGNALING_BY_GPCR,2.016717415,0.017989264,capecitabine
G_ALPHA_I_SIGNALLING_EVENTS,1.982978236,0.020552251,capecitabine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.809715496,0.092744192,capecitabine
VISUAL_PHOTOTRANSDUCTION,1.779038693,0.103093718,capecitabine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.762400077,0.102841852,capecitabine
EUKARYOTIC_TRANSLATION_INITIATION,-2.633735488,0,fenoterol
SELENOAMINO_ACID_METABOLISM,-2.614722167,0,fenoterol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.611759449,0,fenoterol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.585535698,0,fenoterol
SIGNALING_BY_ROBO_RECEPTORS,-2.570315435,0,fenoterol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.568088295,0,fenoterol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.543541414,0,fenoterol
NONSENSE_MEDIATED_DECAY_NMD,-2.536604922,0,fenoterol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.528694095,0,fenoterol
RRNA_PROCESSING,-2.510198708,0,fenoterol
RESPIRATORY_ELECTRON_TRANSPORT,2.821272467,0,molindone
SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,-2.319184456,0.026401607,molindone
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-2.278212213,0.023401424,molindone
HEMOSTASIS,-2.146147557,0.057203482,molindone
MITOCHONDRIAL_TRANSLATION,2.057747962,0.073737298,molindone
COMPLEX_I_BIOGENESIS,2.00067691,0.073856038,molindone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.039668005,0.096905899,molindone
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.009957449,0.097685946,molindone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.008210816,0.082605028,molindone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.944594283,0.083533316,molindone
EUKARYOTIC_TRANSLATION_ELONGATION,2.304495314,0.004156355,bicalutamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.585688738,0.041426616,bicalutamide
SELENOAMINO_ACID_METABOLISM,2.199116656,0.012053429,bicalutamide
EUKARYOTIC_TRANSLATION_INITIATION,2.19806942,0.00803562,bicalutamide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.50201568,0.032987861,bicalutamide
CELLULAR_RESPONSE_TO_STARVATION,2.169869284,0.009143981,bicalutamide
HEMOSTASIS,-2.413920957,0.042960935,bicalutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.137081962,0.011804048,bicalutamide
RRNA_PROCESSING,2.128118791,0.011499249,bicalutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.125799421,0.010212758,bicalutamide
TRANSLATION,-2.426465683,0,omeprazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.373839391,0,omeprazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.323025368,0.000351574,omeprazole
SELENOAMINO_ACID_METABOLISM,-2.309008969,0.000527362,omeprazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.268821131,0.000632834,omeprazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.225594674,0.00123051,omeprazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.223193705,0.001054723,omeprazole
NONSENSE_MEDIATED_DECAY_NMD,-2.222198618,0.000922883,omeprazole
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.209389052,0.032020636,omeprazole
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.158750904,0.003281361,omeprazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.758795559,0,tianeptine
RESPIRATORY_ELECTRON_TRANSPORT,2.675282435,0.000611987,tianeptine
SIGNALING_BY_WNT,2.272686647,0.017951632,tianeptine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.222506592,0.018971611,tianeptine
DRUG_ADME,2.20361268,0.016646059,tianeptine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.142430585,0.020399582,tianeptine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.00963699,0.304338192,tianeptine
TRANSLATION,1.935002431,0.06679406,tianeptine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.869447257,0.091339128,tianeptine
CHROMOSOME_MAINTENANCE,1.842583932,0.097510002,tianeptine
CELL_CYCLE_MITOTIC,-1.996881918,0.332726353,wortmannin
CELL_CYCLE,-1.994239142,0.169145169,wortmannin
MITOTIC_G2_G2_M_PHASES,-1.916420788,0.253346822,wortmannin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.803798561,0.387788018,wortmannin
METABOLISM_OF_RNA,-1.899195993,0.220612038,wortmannin
DNA_REPLICATION_PRE_INITIATION,-1.854320303,0.269742033,wortmannin
CELL_CYCLE_CHECKPOINTS,-1.847292109,0.238509526,wortmannin
PTEN_REGULATION,-1.762885714,0.392181516,wortmannin
M_PHASE,-1.760364378,0.349279211,wortmannin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-1.756934932,0.316652616,wortmannin
BIOLOGICAL_OXIDATIONS,1.965216353,0.039168,celecoxib
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.832776354,0.045696,celecoxib
SIGNALING_BY_NOTCH,-1.835402524,1,celecoxib
NUCLEAR_ENVELOPE_NE_REASSEMBLY,1.450048123,0.269568,celecoxib
ESR_MEDIATED_SIGNALING,-1.755895334,1,celecoxib
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.7277754,1,celecoxib
SIGNALING_BY_GPCR,-1.70905444,1,celecoxib
FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,-1.705809691,0.860314356,celecoxib
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.694469893,0.783553733,celecoxib
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,-1.690789217,0.689235673,celecoxib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.850917198,0,amrinone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.819295569,0,amrinone
NONSENSE_MEDIATED_DECAY_NMD,-2.67742101,0,amrinone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.674279971,0,amrinone
SELENOAMINO_ACID_METABOLISM,-2.646753992,0,amrinone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.61901787,0,amrinone
RRNA_PROCESSING,-2.611288393,0,amrinone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.553156452,0.000156964,amrinone
EUKARYOTIC_TRANSLATION_INITIATION,-2.544113812,0.000137344,amrinone
INFLUENZA_INFECTION,-2.535548457,0.000122083,amrinone
M_PHASE,2.54673261,0.018261657,ciprofloxacin
TRNA_PROCESSING,2.386142078,0.031957901,ciprofloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.339319047,0.039566925,ciprofloxacin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.32780933,0.031957901,ciprofloxacin
MITOTIC_PROMETAPHASE,2.184002122,0.047480309,ciprofloxacin
NUCLEAR_ENVELOPE_BREAKDOWN,2.108275778,0.051741363,ciprofloxacin
CELL_CYCLE_CHECKPOINTS,2.013674694,0.083481863,ciprofloxacin
S_PHASE,1.961473804,0.090166934,ciprofloxacin
DNA_REPLICATION,1.952831374,0.081162922,ciprofloxacin
G2_M_CHECKPOINTS,1.929591633,0.082177459,ciprofloxacin
GPCR_LIGAND_BINDING,-2.681467134,0,pentamidine
CELLULAR_RESPONSE_TO_STARVATION,2.544180051,0.000781092,pentamidine
SELENOAMINO_ACID_METABOLISM,2.487470942,0.000781092,pentamidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.462240721,0.001041456,pentamidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.341538526,0.003124369,pentamidine
RESPIRATORY_ELECTRON_TRANSPORT,2.335085176,0.002499495,pentamidine
EUKARYOTIC_TRANSLATION_ELONGATION,2.276871511,0.003775279,pentamidine
SIGNALING_BY_GPCR,-2.410150622,0.023552282,pentamidine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.082112288,0.013055398,pentamidine
RRNA_PROCESSING,2.079661979,0.011716383,pentamidine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.459848345,0.005952442,diacerein
ION_CHANNEL_TRANSPORT,-2.262140538,0.025000255,diacerein
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.202444799,0.035317821,diacerein
PROTEIN_LOCALIZATION,2.013110502,0.105074569,diacerein
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.123140168,0.065774482,diacerein
MITOTIC_METAPHASE_AND_ANAPHASE,-2.067155772,0.085715162,diacerein
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.897135783,0.117179934,diacerein
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.932494783,0.220041931,diacerein
GPCR_LIGAND_BINDING,-1.91704266,0.211906927,diacerein
PEROXISOMAL_PROTEIN_IMPORT,1.713306918,0.230163342,diacerein
CHROMATIN_ORGANIZATION,-2.428330948,0.016018888,carfilzomib
CELLULAR_RESPONSE_TO_STARVATION,2.388333544,0.011983817,carfilzomib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.278289345,0.012982468,carfilzomib
STIMULI_SENSING_CHANNELS,-2.250354809,0.052061386,carfilzomib
SELENOAMINO_ACID_METABOLISM,2.138653638,0.036284334,carfilzomib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.137636973,0.027712576,carfilzomib
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.207831282,0.050392752,carfilzomib
ECM_PROTEOGLYCANS,-2.197134552,0.043301056,carfilzomib
EUKARYOTIC_TRANSLATION_ELONGATION,2.080738856,0.03595145,carfilzomib
MITOTIC_PROPHASE,-2.025482889,0.128952048,carfilzomib
NEUTROPHIL_DEGRANULATION,-2.675778882,0.002648956,riluzole
GPCR_LIGAND_BINDING,2.391363932,0.005453791,riluzole
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.285053597,0.004772067,riluzole
SENSORY_PERCEPTION,2.280489836,0.003635861,riluzole
SIGNALING_BY_GPCR,2.191092348,0.008180686,riluzole
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.189771476,0.006953583,riluzole
G_ALPHA_I_SIGNALLING_EVENTS,2.082355383,0.011816547,riluzole
INNATE_IMMUNE_SYSTEM,-1.974100242,0.133772267,riluzole
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.07864344,0.010518025,riluzole
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.076130267,0.009458919,riluzole
TRANSLATION,-1.955043842,0.224743433,progesterone
GPCR_LIGAND_BINDING,2.066357072,0.064938511,progesterone
RHO_GTPASE_CYCLE,-1.654752864,0.423218153,progesterone
PROTEIN_LOCALIZATION,-1.657822222,0.628989737,progesterone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.893625848,0.168913093,progesterone
NEUTROPHIL_DEGRANULATION,-1.617983339,0.397679126,progesterone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.610692341,0.335655776,progesterone
HIV_INFECTION,-1.588954022,0.317170386,progesterone
ADIPOGENESIS,-1.548381216,0.34399505,progesterone
CELL_CYCLE_CHECKPOINTS,-1.547738602,0.302455042,progesterone
GPCR_LIGAND_BINDING,1.779305669,0.199249883,puromycin
SIGNALING_BY_GPCR,1.765870086,0.108037714,puromycin
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.6064417,0.200430623,puromycin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.447102707,0.348687295,puromycin
SIGNALING_BY_WNT,1.338898163,0.463322394,puromycin
NERVOUS_SYSTEM_DEVELOPMENT,1.334801901,0.39171051,puromycin
NEURONAL_SYSTEM,1.267403142,0.443157041,puromycin
G_ALPHA_I_SIGNALLING_EVENTS,1.210239906,0.48860499,puromycin
HEMOSTASIS,-1.024731979,1,puromycin
SARS_COV_INFECTIONS,-0.949158803,1,puromycin
RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,-2.246341529,0.032013906,amitriptyline
RSV_HOST_INTERACTIONS,-2.105775483,0.037554775,amitriptyline
PHOSPHOLIPID_METABOLISM,2.068866925,0.240061175,amitriptyline
SARS_COV_2_HOST_INTERACTIONS,-1.574170761,0.489238161,amitriptyline
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.794778174,0.788232363,amitriptyline
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.495991274,0.543928584,amitriptyline
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.486717817,0.453366168,amitriptyline
COLLAGEN_FORMATION,1.741666737,0.719238403,amitriptyline
G_ALPHA_S_SIGNALLING_EVENTS,-1.456512858,0.431572086,amitriptyline
EXTRACELLULAR_MATRIX_ORGANIZATION,1.687052624,0.74924605,amitriptyline
SIGNALING_BY_GPCR,1.999552004,0.238611696,BRD-K55591206
GPCR_LIGAND_BINDING,1.991356494,0.127502433,BRD-K55591206
TRNA_PROCESSING,-1.748798329,0.62951359,BRD-K55591206
INTERFERON_SIGNALING,-1.650657422,0.569691392,BRD-K55591206
FATTY_ACID_METABOLISM,-1.562800721,0.60497115,BRD-K55591206
TRANSCRIPTIONAL_REGULATION_BY_RUNX3,-1.550823959,0.481798778,BRD-K55591206
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.811579376,0.431079654,BRD-K55591206
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.441337485,0.671849299,BRD-K55591206
CELL_CYCLE_CHECKPOINTS,-1.429853833,0.593927052,BRD-K55591206
MITOTIC_SPINDLE_CHECKPOINT,-1.398574365,0.584285379,BRD-K55591206
NEUTROPHIL_DEGRANULATION,-2.560408807,0.005840972,amisulpride
INNATE_IMMUNE_SYSTEM,-2.293337515,0.040886805,amisulpride
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.145423282,0.058298781,amisulpride
RESPIRATORY_ELECTRON_TRANSPORT,2.033441573,0.077245885,amisulpride
RHOG_GTPASE_CYCLE,-2.114543579,0.117306189,amisulpride
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.061001679,0.119739928,amisulpride
RAC2_GTPASE_CYCLE,-2.039912225,0.109518226,amisulpride
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.994509995,0.118766432,amisulpride
RRNA_PROCESSING,1.896621033,0.165665703,amisulpride
SENSORY_PERCEPTION,1.852825559,0.172527956,amisulpride
RESPIRATORY_ELECTRON_TRANSPORT,3.013383038,0,warfarin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.691050205,0,warfarin
RRNA_PROCESSING,2.38540359,0.003761671,warfarin
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.382086943,0.002821253,warfarin
TRANSLATION,2.211997343,0.009310136,warfarin
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,2.001337777,0.041848593,warfarin
METABOLISM_OF_RNA,1.991721784,0.038691476,warfarin
CIRCADIAN_CLOCK,1.918822646,0.053251159,warfarin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.996252441,0.40116574,warfarin
SIGNALING_BY_NOTCH,-1.906564255,0.407178931,warfarin
ION_CHANNEL_TRANSPORT,-2.911004009,1,zofenopril-calcium
TRANSPORT_OF_SMALL_MOLECULES,-2.680714049,1,zofenopril-calcium
SARS_COV_2_INFECTION,-2.501312046,1,zofenopril-calcium
SARS_COV_INFECTIONS,-2.285599413,1,zofenopril-calcium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.039317334,1,zofenopril-calcium
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.032107627,0.865837609,zofenopril-calcium
VIRAL_INFECTION_PATHWAYS,-2.03082845,0.742624606,zofenopril-calcium
EUKARYOTIC_TRANSLATION_INITIATION,-2.023705951,0.652585357,zofenopril-calcium
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.014076173,0.584290099,zofenopril-calcium
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.997047821,0.532777379,zofenopril-calcium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.828470161,0,flavoxate
RRNA_PROCESSING,-2.389453624,0,flavoxate
TRANSLATION,-2.407244181,0,flavoxate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.567028254,0,flavoxate
CELLULAR_RESPONSE_TO_STARVATION,-2.572966977,0,flavoxate
SARS_COV_1_HOST_INTERACTIONS,-2.579933638,0,flavoxate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.605416107,0,flavoxate
SIGNALING_BY_ROBO_RECEPTORS,-2.3863861,0,flavoxate
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.626228874,0,flavoxate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.649406941,0,flavoxate
GPCR_LIGAND_BINDING,-2.595193124,0.00663912,berberine
RESPIRATORY_ELECTRON_TRANSPORT,2.389610633,0.009901697,berberine
CELLULAR_RESPONSE_TO_STARVATION,2.384476972,0.006601132,berberine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.257328331,0.012102075,berberine
SIGNALING_BY_GPCR,-2.470745894,0.018968915,berberine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.159411752,0.018153112,berberine
SELENOAMINO_ACID_METABOLISM,2.154041945,0.01540264,berberine
EUKARYOTIC_TRANSLATION_ELONGATION,2.136640965,0.014302452,berberine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.115578325,0.01555981,berberine
MITOCHONDRIAL_BIOGENESIS,2.046635836,0.022416343,berberine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.639749099,0.00185511,nefazodone
NEUTROPHIL_DEGRANULATION,-2.4182198,0.012521989,nefazodone
HEMOSTASIS,-2.413162784,0.009275548,nefazodone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.373951701,0.012058212,nefazodone
RHOA_GTPASE_CYCLE,-1.94921545,0.172525188,nefazodone
EUKARYOTIC_TRANSLATION_ELONGATION,1.842959708,1,nefazodone
SIGNALING_BY_NUCLEAR_RECEPTORS,-1.872422885,0.207926862,nefazodone
ESR_MEDIATED_SIGNALING,-1.802356891,0.242886843,nefazodone
INNATE_IMMUNE_SYSTEM,-1.796536556,0.217743483,nefazodone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.638508878,0.364735149,nefazodone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.991962898,0,chlortalidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.77693753,0,chlortalidone
SARS_COV_1_HOST_INTERACTIONS,-2.748204623,0,chlortalidone
SELENOAMINO_ACID_METABOLISM,-2.72780493,0,chlortalidone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.701726215,0,chlortalidone
NONSENSE_MEDIATED_DECAY_NMD,-2.678000696,0,chlortalidone
EUKARYOTIC_TRANSLATION_INITIATION,-2.651894135,0,chlortalidone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.616254153,0,chlortalidone
SARS_COV_1_INFECTION,-2.590266132,0,chlortalidone
INFLUENZA_INFECTION,-2.582476933,0,chlortalidone
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.728124,0.352261529,acamprosate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.590201439,0.503585143,acamprosate
GPCR_LIGAND_BINDING,1.914295682,0.34123086,acamprosate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.463631667,0.608602077,acamprosate
G_ALPHA_S_SIGNALLING_EVENTS,1.84881666,0.291832964,acamprosate
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.835485673,0.217677729,acamprosate
SENSORY_PERCEPTION,1.812087675,0.19338751,acamprosate
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.253079087,1,acamprosate
SARS_COV_1_INFECTION,-2.017939709,0.901491827,acamprosate
HEMOSTASIS,-1.923105151,0.762406407,acamprosate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.212937888,0.024785064,rescinnamine
SARS_COV_1_INFECTION,-1.759719736,1,rescinnamine
DEUBIQUITINATION,-1.676338791,1,rescinnamine
L1CAM_INTERACTIONS,1.552695391,1,rescinnamine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.567299545,1,rescinnamine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.510498821,1,rescinnamine
UB_SPECIFIC_PROCESSING_PROTEASES,-1.520295784,1,rescinnamine
METABOLISM_OF_STEROIDS,1.483138622,0.988894541,rescinnamine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.463117057,0.876919164,rescinnamine
RESPIRATORY_ELECTRON_TRANSPORT,1.451864814,0.76951722,rescinnamine
NEUTROPHIL_DEGRANULATION,-2.229316687,0.047182176,BRD-K48195008
MITOCHONDRIAL_TRANSLATION,-2.097959784,0.061059286,BRD-K48195008
SARS_COV_1_INFECTION,-2.088758324,0.043481613,BRD-K48195008
TRANSLATION,-2.047930436,0.041631331,BRD-K48195008
INNATE_IMMUNE_SYSTEM,-1.796374181,0.157088891,BRD-K48195008
BIOLOGICAL_OXIDATIONS,-1.791704975,0.135533112,BRD-K48195008
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.760030013,0.138374616,BRD-K48195008
SENSORY_PERCEPTION,1.948668898,0.260157632,BRD-K48195008
CELL_CYCLE_CHECKPOINTS,-1.731966081,0.142934238,BRD-K48195008
MITOTIC_SPINDLE_CHECKPOINT,-1.692476537,0.156965539,BRD-K48195008
METABOLISM_OF_RNA,-4.786979416,0,nintedanib
UB_SPECIFIC_PROCESSING_PROTEASES,-2.484289852,0,nintedanib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.516359295,0,nintedanib
EUKARYOTIC_TRANSLATION_INITIATION,-2.600228927,0,nintedanib
G2_M_CHECKPOINTS,-2.62054322,0,nintedanib
CELL_CYCLE_CHECKPOINTS,-2.735343993,0,nintedanib
RESPIRATORY_ELECTRON_TRANSPORT,-2.856674979,0,nintedanib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.936317195,0,nintedanib
SEPARATION_OF_SISTER_CHROMATIDS,-2.587627109,0,nintedanib
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.978897072,0,nintedanib
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.779657609,0,riociguat
EUKARYOTIC_TRANSLATION_ELONGATION,-2.761042502,0,riociguat
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.607252779,0,riociguat
SELENOAMINO_ACID_METABOLISM,-2.596922835,0,riociguat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.589750154,0,riociguat
NONSENSE_MEDIATED_DECAY_NMD,-2.57652737,0,riociguat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.547675498,0,riociguat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.536627424,0,riociguat
SARS_COV_1_INFECTION,-2.357686587,0.000311992,riociguat
RRNA_PROCESSING,-2.358885729,0.000335991,riociguat
RESPIRATORY_ELECTRON_TRANSPORT,2.875869907,0,lorcaserin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.464927722,0.000420256,lorcaserin
CELLULAR_RESPONSE_TO_STARVATION,2.160644388,0.024094698,lorcaserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.141293946,0.021643202,lorcaserin
SARS_COV_2_INFECTION,-3.472785875,0.349778294,lorcaserin
RAB_REGULATION_OF_TRAFFICKING,1.95152894,0.057995377,lorcaserin
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.935838812,0.053372557,lorcaserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.835095728,0.080208927,lorcaserin
PROTEIN_LOCALIZATION,1.801912615,0.084891784,lorcaserin
ION_CHANNEL_TRANSPORT,-3.343612575,0.63013905,lorcaserin
GPCR_LIGAND_BINDING,2.559879548,0.000739757,dexketoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.452147406,0.000369878,dexketoprofen
BIOLOGICAL_OXIDATIONS,-2.075260589,0.099152212,dexketoprofen
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.939757976,0.115230949,dexketoprofen
NEURONAL_SYSTEM,2.007223382,0.025891482,dexketoprofen
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.991567507,0.021822821,dexketoprofen
SENSORY_PERCEPTION,1.978715935,0.020861137,dexketoprofen
G_ALPHA_I_SIGNALLING_EVENTS,1.968648042,0.018617209,dexketoprofen
SIGNALING_BY_GPCR,1.95315947,0.018282557,dexketoprofen
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.945761497,0.017014403,dexketoprofen
NEUTROPHIL_DEGRANULATION,-2.72222138,0,mesalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.404849193,0.000693061,mesalazine
GPCR_LIGAND_BINDING,2.326820056,0.002079182,mesalazine
TRANSLATION,-2.158877522,0.04239589,mesalazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.191358859,0.008778769,mesalazine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.118970708,0.038984726,mesalazine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.102988806,0.032162399,mesalazine
MITOCHONDRIAL_TRANSLATION,-1.987531375,0.057307548,mesalazine
RHO_GTPASE_CYCLE,-1.88383269,0.092101416,mesalazine
INNATE_IMMUNE_SYSTEM,-1.860120354,0.085209473,mesalazine
GPCR_LIGAND_BINDING,2.938849288,0,HO-013
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.760927951,0,HO-013
SIGNALING_BY_GPCR,2.566409305,0,HO-013
TRANSLATION,-2.553851408,0.003710087,HO-013
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.500944011,0.003710087,HO-013
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.470803,0.004946783,HO-013
G_ALPHA_I_SIGNALLING_EVENTS,2.229152182,0.002118361,HO-013
PROTEIN_LOCALIZATION,-2.384109803,0.009275218,HO-013
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.345019643,0.00890421,HO-013
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.114460277,0.006326837,HO-013
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,2.146715367,0.018283148,isotretinoin
SIGNALING_BY_INTERLEUKINS,1.872475579,0.078425083,isotretinoin
GPCR_LIGAND_BINDING,1.809401904,0.078906219,isotretinoin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.724691833,0.107052644,isotretinoin
EXTRACELLULAR_MATRIX_ORGANIZATION,1.602347358,0.177442765,isotretinoin
G_ALPHA_I_SIGNALLING_EVENTS,1.558530938,0.184756024,isotretinoin
SIGNALING_BY_GPCR,1.556234306,0.160561783,isotretinoin
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.753778888,1,isotretinoin
NERVOUS_SYSTEM_DEVELOPMENT,1.540260859,0.15384307,isotretinoin
SIGNALING_BY_WNT,-2.644150696,0.986141395,isotretinoin
GPCR_LIGAND_BINDING,2.588311832,0,OSI-930
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.585626656,0,OSI-930
TRNA_PROCESSING,-2.29448068,0.034386028,OSI-930
SIGNALING_BY_GPCR,2.264325419,0.002430056,OSI-930
SEPARATION_OF_SISTER_CHROMATIDS,-2.202534635,0.029228124,OSI-930
METABOLISM_OF_RNA,-2.124639014,0.035532229,OSI-930
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.056734522,0.047280789,OSI-930
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.080998753,0.015309355,OSI-930
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.944832284,0.074961542,OSI-930
ADIPOGENESIS,-1.863986197,0.095134679,OSI-930
RESPIRATORY_ELECTRON_TRANSPORT,3.30514881,0,profenamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.27723522,0,profenamine
MITOCHONDRIAL_TRANSLATION,2.154968855,0.022219592,profenamine
DISEASES_OF_METABOLISM,1.858703076,0.119163975,profenamine
BIOLOGICAL_OXIDATIONS,1.7781114,0.153589124,profenamine
TRANSLATION,1.774104341,0.131795661,profenamine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.673799826,0.190975435,profenamine
IRON_UPTAKE_AND_TRANSPORT,-2.018473937,1,profenamine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.696430573,1,profenamine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-1.685106904,1,profenamine
TRANSLATION,3.284177925,0,guaifenesin
EUKARYOTIC_TRANSLATION_ELONGATION,3.280260282,0,guaifenesin
EUKARYOTIC_TRANSLATION_INITIATION,3.255492355,0,guaifenesin
SELENOAMINO_ACID_METABOLISM,3.182002735,0,guaifenesin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.932398497,0,guaifenesin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.744738174,0,guaifenesin
RRNA_PROCESSING,2.636409936,0,guaifenesin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.609696564,0,guaifenesin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.601544303,0,guaifenesin
RESPIRATORY_ELECTRON_TRANSPORT,2.549633723,0.000136666,guaifenesin
METABOLISM_OF_STEROIDS,2.436572763,0.002960247,pelitinib
CELL_CYCLE_CHECKPOINTS,-2.371506628,0.014930553,pelitinib
G2_M_CHECKPOINTS,-2.272224675,0.015504805,pelitinib
SYNTHESIS_OF_DNA,-2.268157936,0.010719372,pelitinib
DNA_REPLICATION,-2.16849151,0.018950318,pelitinib
ORC1_REMOVAL_FROM_CHROMATIN,-2.165594678,0.015619656,pelitinib
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,2.189261096,0.01813151,pelitinib
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,-2.146452119,0.01588764,pelitinib
PHOSPHOLIPID_METABOLISM,2.135794617,0.020721726,pelitinib
DNA_REPLICATION_PRE_INITIATION,-2.118810006,0.018540138,pelitinib
DISEASES_OF_METABOLISM,-2.986305347,0.117062128,dexfenfluramine
NEDDYLATION,1.764065828,0.961123596,dexfenfluramine
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.617947914,1,dexfenfluramine
G2_M_CHECKPOINTS,1.568692046,0.86082397,dexfenfluramine
TRNA_PROCESSING,1.564590378,0.652921348,dexfenfluramine
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.86612451,0.58445617,dexfenfluramine
GLUCOSE_METABOLISM,1.543280861,0.581932584,dexfenfluramine
SNRNP_ASSEMBLY,1.503645836,0.589625468,dexfenfluramine
SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,1.481559915,0.553386838,dexfenfluramine
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.479741485,0.488960674,dexfenfluramine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.774326551,0,nortriptyline
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.355046439,0.008079829,nortriptyline
RESPIRATORY_ELECTRON_TRANSPORT,-2.34750287,0.005386553,nortriptyline
TRANSLATION,-2.199300576,0.016159659,nortriptyline
PLATELET_HOMEOSTASIS,2.152336984,0.036050157,nortriptyline
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.143663993,0.020883251,nortriptyline
TP53_REGULATES_METABOLIC_GENES,-2.133195283,0.019267285,nortriptyline
CELL_CYCLE_CHECKPOINTS,-2.130206303,0.016692395,nortriptyline
MITOCHONDRIAL_BIOGENESIS,-2.02955445,0.038845333,nortriptyline
CARDIAC_CONDUCTION,1.989359337,0.06210815,nortriptyline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.475972307,0.000572977,salbutamol
G_ALPHA_I_SIGNALLING_EVENTS,2.398587359,0.000572977,salbutamol
GPCR_LIGAND_BINDING,2.376090034,0.000572977,salbutamol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.219125715,0.002005421,salbutamol
NEUTROPHIL_DEGRANULATION,-3.756568376,0.132624964,salbutamol
SIGNALING_BY_GPCR,2.108979183,0.00813628,salbutamol
NEURONAL_SYSTEM,2.085870943,0.008117181,salbutamol
SENSORY_PERCEPTION,2.038383419,0.012032527,salbutamol
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.976835618,0.019624479,salbutamol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.962011831,0.020245205,salbutamol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.968771636,0,hexylcaine
TRANSLATION,-2.316184038,0.076559546,hexylcaine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.281600542,0.063327032,hexylcaine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.173546568,0.120510397,hexylcaine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.119737433,0.144045369,hexylcaine
INFLUENZA_INFECTION,-1.957163372,0.299621928,hexylcaine
SARS_COV_1_INFECTION,-1.853573779,0.397785579,hexylcaine
NEUTROPHIL_DEGRANULATION,-1.788797537,0.428875236,hexylcaine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.768220194,0.405166982,hexylcaine
TOLL_LIKE_RECEPTOR_CASCADES,-1.68402428,0.457655955,hexylcaine
NEUTROPHIL_DEGRANULATION,-2.823747083,0,nicorandil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.784314167,0,nicorandil
GPCR_LIGAND_BINDING,2.755708767,0,nicorandil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.708695986,0,nicorandil
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.675103128,0.001095556,nicorandil
SEPARATION_OF_SISTER_CHROMATIDS,-2.571949963,0.002921481,nicorandil
MITOTIC_METAPHASE_AND_ANAPHASE,-2.543397593,0.002191111,nicorandil
MITOTIC_PROMETAPHASE,-2.424335032,0.005696889,nicorandil
SENSORY_PERCEPTION,2.256148865,0.00139314,nicorandil
SIGNALING_BY_GPCR,2.198724853,0.002563377,nicorandil
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.95429439,0.25663587,riboflavin
RHO_GTPASE_EFFECTORS,-1.933286886,0.143716087,riboflavin
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.968432474,0.425444259,riboflavin
GPCR_LIGAND_BINDING,1.934155306,0.280953756,riboflavin
CDC42_GTPASE_CYCLE,-1.640754599,0.451679132,riboflavin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.800498352,0.453390982,riboflavin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,-1.544610171,0.534902478,riboflavin
INTERFERON_GAMMA_SIGNALING,1.772106995,0.404261238,riboflavin
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.497829728,0.43628098,riboflavin
RAC1_GTPASE_CYCLE,-1.497888272,0.523537176,riboflavin
EUKARYOTIC_TRANSLATION_ELONGATION,2.414562843,0,perindopril
EUKARYOTIC_TRANSLATION_INITIATION,2.288158038,0.003950395,perindopril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.185924694,0.015143181,perindopril
SELENOAMINO_ACID_METABOLISM,2.148898617,0.017529878,perindopril
NONSENSE_MEDIATED_DECAY_NMD,2.136206338,0.016591659,perindopril
CELLULAR_RESPONSE_TO_STARVATION,2.128720532,0.014649382,perindopril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.122814208,0.012979869,perindopril
INFLUENZA_INFECTION,2.107209414,0.014567082,perindopril
TRANSLATION,1.910216403,0.083616695,perindopril
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.681365986,1,perindopril
HEMOSTASIS,-2.650109289,0.001428948,dapsone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.632683115,0.001428948,dapsone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.574733616,0.001905265,dapsone
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.334106447,0.017861856,dapsone
ECM_PROTEOGLYCANS,-2.289920005,0.020576858,dapsone
COLLAGEN_FORMATION,-2.232553295,0.029293444,dapsone
RESPIRATORY_ELECTRON_TRANSPORT,2.050189708,0.082066806,dapsone
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.177871782,0.039398151,dapsone
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.164094463,0.040189176,dapsone
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.14929705,0.038105293,dapsone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-4.065378552,0,tranilast
NONSENSE_MEDIATED_DECAY_NMD,-2.659941629,0,tranilast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.664439278,0,tranilast
SIGNALING_BY_ROBO_RECEPTORS,-2.694375657,0,tranilast
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.159837147,0,tranilast
SELENOAMINO_ACID_METABOLISM,-3.178351111,0,tranilast
TRNA_PROCESSING,-2.849544285,0,tranilast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.244854586,0,tranilast
EUKARYOTIC_TRANSLATION_ELONGATION,-3.335720341,0,tranilast
INFLUENZA_INFECTION,-3.436001135,0,tranilast
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.107431354,0,galantamine
NEUTROPHIL_DEGRANULATION,-2.515698714,0.004805859,galantamine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.325815003,0.013883591,galantamine
INNATE_IMMUNE_SYSTEM,-2.034887831,0.068082996,galantamine
HEMOSTASIS,-1.944910374,0.098039515,galantamine
BIOLOGICAL_OXIDATIONS,-1.912820661,0.099321077,galantamine
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.695965486,0.25814326,galantamine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-1.69138882,0.231482188,galantamine
MITOCHONDRIAL_TRANSLATION,-1.66827791,0.240648918,galantamine
GLYCOSAMINOGLYCAN_METABOLISM,-1.617883027,0.279700969,galantamine
NEURONAL_SYSTEM,2.543880637,0.001898873,biotin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.338408947,0.023039071,biotin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.317632007,0.008228449,biotin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.291124242,0.018795031,biotin
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.213521655,0.026676819,biotin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.205599233,0.014347039,biotin
CARDIAC_CONDUCTION,2.097219133,0.023577671,biotin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.07962138,0.02076101,biotin
GPCR_LIGAND_BINDING,2.004064041,0.0283776,biotin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.025511072,0.107919857,biotin
CELL_CYCLE_CHECKPOINTS,-4.927122516,0,sunitinib
SENSORY_PERCEPTION,2.381785895,0,sunitinib
M_PHASE,-2.948210739,0,sunitinib
METABOLISM_OF_RNA,-2.992802358,0,sunitinib
DNA_REPAIR,-3.049125172,0,sunitinib
SEPARATION_OF_SISTER_CHROMATIDS,-3.21522254,0,sunitinib
MITOTIC_METAPHASE_AND_ANAPHASE,-3.337151993,0,sunitinib
DNA_REPLICATION_PRE_INITIATION,-3.719037385,0,sunitinib
NEDDYLATION,-2.588236519,0,sunitinib
CELL_CYCLE_MITOTIC,-3.86618902,0,sunitinib
TRANSLATION,-3.196628393,0,naphazoline
SIGNALING_BY_ROBO_RECEPTORS,-2.609417762,0,naphazoline
CELLULAR_RESPONSE_TO_STARVATION,-2.612465527,0,naphazoline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.628097425,0,naphazoline
INFLUENZA_INFECTION,-2.700871381,0,naphazoline
SELENOAMINO_ACID_METABOLISM,-2.706497681,0,naphazoline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.713335974,0,naphazoline
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.750148282,0,naphazoline
VIRAL_INFECTION_PATHWAYS,-2.618554703,0,naphazoline
NONSENSE_MEDIATED_DECAY_NMD,-2.859733597,0,naphazoline
EUKARYOTIC_TRANSLATION_ELONGATION,-3.091281306,0,otamixaban
TRANSLATION,-2.529093287,0,otamixaban
INFLUENZA_INFECTION,-2.564795116,0,otamixaban
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.587433629,0,otamixaban
SIGNALING_BY_ROBO_RECEPTORS,-2.660970859,0,otamixaban
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.746351652,0,otamixaban
CELLULAR_RESPONSE_TO_STARVATION,-2.757394231,0,otamixaban
RRNA_PROCESSING,-2.668420912,0,otamixaban
EUKARYOTIC_TRANSLATION_INITIATION,-2.816994056,0,otamixaban
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.857666151,0,otamixaban
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.694956773,0.000946074,disopyramide
GASTRULATION,-2.299280644,0.010406812,disopyramide
TRANSLATION,2.210644948,0.023536635,disopyramide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.092584152,0.045096184,disopyramide
SIGNALING_BY_INTERLEUKINS,-2.074476328,0.038789026,disopyramide
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.002021889,0.052412488,disopyramide
ESR_MEDIATED_SIGNALING,-1.927234066,0.070009461,disopyramide
EUKARYOTIC_TRANSLATION_ELONGATION,1.920209452,0.240483013,disopyramide
SELENOAMINO_ACID_METABOLISM,1.915202651,0.167826443,disopyramide
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.897318874,0.073793756,disopyramide
GPCR_LIGAND_BINDING,2.648980539,0,flunarizine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.337940478,0.000330531,flunarizine
SIGNALING_BY_GPCR,2.212087642,0.002644251,flunarizine
SENSORY_PERCEPTION,2.151802472,0.005619033,flunarizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.096346149,0.007536115,flunarizine
POTASSIUM_CHANNELS,1.889215269,0.047706692,flunarizine
STIMULI_SENSING_CHANNELS,1.805080361,0.08678809,flunarizine
G_ALPHA_I_SIGNALLING_EVENTS,1.786210536,0.087095012,flunarizine
G_ALPHA_S_SIGNALLING_EVENTS,1.779943233,0.081457616,flunarizine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.727242488,0.110463579,flunarizine
ECM_PROTEOGLYCANS,-2.439446428,0,alizapride
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.196418737,0.013552312,alizapride
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.807127738,0.193969724,alizapride
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.897890431,0.274660188,alizapride
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.840112227,0.350462786,alizapride
NEUTROPHIL_DEGRANULATION,1.566310491,0.372726135,alizapride
SIGNALING_BY_MET,-1.793010462,0.417628044,alizapride
FATTY_ACID_METABOLISM,1.509285236,0.326610784,alizapride
SENSORY_PERCEPTION,-1.727962109,0.588531732,alizapride
METABOLISM_OF_STEROIDS,1.410215928,0.392931315,alizapride
EUKARYOTIC_TRANSLATION_ELONGATION,-3.205947123,0,methyldopa
SARS_COV_1_HOST_INTERACTIONS,-2.606723878,0,methyldopa
INFLUENZA_INFECTION,-2.755329858,0,methyldopa
SIGNALING_BY_ROBO_RECEPTORS,-2.763147403,0,methyldopa
RRNA_PROCESSING,-2.782433957,0,methyldopa
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.832862189,0,methyldopa
GPCR_LIGAND_BINDING,2.880743369,0,methyldopa
CELLULAR_RESPONSE_TO_STARVATION,-2.875336729,0,methyldopa
EUKARYOTIC_TRANSLATION_INITIATION,-2.913669618,0,methyldopa
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-3.000307199,0,methyldopa
CELL_CELL_COMMUNICATION,-2.049794567,0.023022857,BRD-K18135438
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,1.893750841,0.178555161,BRD-K18135438
METABOLISM_OF_RNA,-1.61185784,0.269633073,BRD-K18135438
TRANSPORT_OF_SMALL_MOLECULES,1.635020498,0.533539826,BRD-K18135438
SIGNALING_BY_INTERLEUKINS,1.59092847,0.469061573,BRD-K18135438
NEUTROPHIL_DEGRANULATION,1.560295933,0.41742583,BRD-K18135438
GPCR_LIGAND_BINDING,1.507739903,0.436609881,BRD-K18135438
ASPARAGINE_N_LINKED_GLYCOSYLATION,-1.277075411,0.884608999,BRD-K18135438
INNATE_IMMUNE_SYSTEM,1.402335933,0.609177776,BRD-K18135438
METABOLISM_OF_LIPIDS,-1.229285599,0.800708396,BRD-K18135438
METABOLISM_OF_RNA,-3.65351365,0,mitotane
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.636539607,0,mitotane
MITOTIC_PROMETAPHASE,-2.669783855,0,mitotane
MITOTIC_PROPHASE,-2.673251138,0,mitotane
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.690290503,0,mitotane
EUKARYOTIC_TRANSLATION_INITIATION,-2.717318265,0,mitotane
SEPARATION_OF_SISTER_CHROMATIDS,-2.775442856,0,mitotane
CELL_CYCLE_CHECKPOINTS,-2.803123067,0,mitotane
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.828863605,0,mitotane
MRNA_SPLICING,-2.949292106,0,mitotane
SARS_COV_1_INFECTION,-2.602137084,0,clomethiazole
SARS_COV_1_HOST_INTERACTIONS,-2.583767311,0,clomethiazole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.550237556,0,clomethiazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.546200279,0,clomethiazole
NONSENSE_MEDIATED_DECAY_NMD,-2.480789651,0,clomethiazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.430763726,0.000369604,clomethiazole
INFLUENZA_INFECTION,-2.392539883,0.000475205,clomethiazole
SELENOAMINO_ACID_METABOLISM,-2.36997173,0.000693007,clomethiazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.306137284,0.001663217,clomethiazole
CELLULAR_RESPONSE_TO_STARVATION,-2.306553553,0.001848018,clomethiazole
METABOLISM_OF_RNA,-3.850226208,0,mianserin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.830801658,0,mianserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.828325846,0,mianserin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.824195881,0,mianserin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.809547165,0,mianserin
INFECTIOUS_DISEASE,-2.764538904,0,mianserin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.76203837,0,mianserin
CELL_CYCLE_MITOTIC,-2.761853247,0,mianserin
MRNA_SPLICING,-2.747784338,0,mianserin
SARS_COV_1_INFECTION,-2.623307552,0,mianserin
NEUTROPHIL_DEGRANULATION,-3.837634348,0.016624579,olmesartan
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.19477165,0.017696782,olmesartan
GPCR_LIGAND_BINDING,2.077166259,0.036704436,olmesartan
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.945774076,0.082803459,olmesartan
SIGNALING_BY_GPCR,1.893760691,0.096840721,olmesartan
INNATE_IMMUNE_SYSTEM,-2.216626527,1,olmesartan
VESICLE_MEDIATED_TRANSPORT,-2.103193407,1,olmesartan
G_ALPHA_I_SIGNALLING_EVENTS,1.785897191,0.168840405,olmesartan
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.652345524,1,olmesartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.603938856,1,olmesartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.969288885,0,mirtazapine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.693130241,0.007873032,mirtazapine
HEMOSTASIS,-2.407384936,0.056985754,mirtazapine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.262966364,0.113034241,mirtazapine
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.982881984,0.132287994,mirtazapine
NEUTROPHIL_DEGRANULATION,-2.197506546,0.134966258,mirtazapine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.932306402,0.407523119,mirtazapine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.868641465,0.441211126,mirtazapine
METABOLISM_OF_RNA,-1.867937951,0.387184454,mirtazapine
INFLUENZA_INFECTION,-1.79161993,0.452386903,mirtazapine
TOLL_LIKE_RECEPTOR_CASCADES,-3.084871334,0,amperozide
SENSORY_PERCEPTION,2.503389888,0.003721517,amperozide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.147140207,0.046518962,amperozide
INTERLEUKIN_1_SIGNALING,-2.065984648,0.08531654,amperozide
INNATE_IMMUNE_SYSTEM,-1.988366529,0.083162082,amperozide
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.98189931,0.063987405,amperozide
INTERLEUKIN_1_FAMILY_SIGNALING,-1.892508821,0.081438515,amperozide
GPCR_LIGAND_BINDING,2.01250118,0.121569555,amperozide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.975199555,0.120251518,amperozide
NEUTROPHIL_DEGRANULATION,-1.79421655,0.109231024,amperozide
HEMOSTASIS,-2.476990385,0,scopolamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.329959593,0.001773516,scopolamine
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.162158621,0.00867052,scopolamine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.881639631,0.046998161,scopolamine
NEURONAL_SYSTEM,1.862394334,0.140605028,scopolamine
NEUTROPHIL_DEGRANULATION,-1.654305121,0.129584866,scopolamine
SIGNALING_BY_INTERLEUKINS,-1.590918299,0.147398844,scopolamine
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.382917601,0.326157946,scopolamine
INNATE_IMMUNE_SYSTEM,-1.347386257,0.320119548,scopolamine
SENSORY_PERCEPTION,-1.326002416,0.309774041,scopolamine
GPCR_LIGAND_BINDING,-3.242118373,0,aliskiren
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.864633101,0,aliskiren
SIGNALING_BY_GPCR,-2.876683567,0,aliskiren
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.950087872,0,aliskiren
NEURONAL_SYSTEM,-2.716745087,0,aliskiren
CELLULAR_RESPONSE_TO_STARVATION,2.973844673,0,aliskiren
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.982116643,0,aliskiren
EUKARYOTIC_TRANSLATION_ELONGATION,3.052400228,0,aliskiren
SELENOAMINO_ACID_METABOLISM,2.969613959,0,aliskiren
EUKARYOTIC_TRANSLATION_INITIATION,2.785000272,0.00023126,aliskiren
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.586676035,0.007202557,thenoyltrifluoroacetone
GPCR_LIGAND_BINDING,2.1887207,0.039377597,thenoyltrifluoroacetone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.28505074,0.070825143,thenoyltrifluoroacetone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.061800714,0.227280685,thenoyltrifluoroacetone
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.819985292,0.298203263,thenoyltrifluoroacetone
HEMOSTASIS,-1.941362076,0.309709947,thenoyltrifluoroacetone
SIGNALING_BY_GPCR,1.729966555,0.352484187,thenoyltrifluoroacetone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.847144262,0.391338925,thenoyltrifluoroacetone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.810210892,0.37853438,thenoyltrifluoroacetone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-1.805985841,0.330117192,thenoyltrifluoroacetone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.918660002,0,dexbrompheniramine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.739466425,0,dexbrompheniramine
NEUTROPHIL_DEGRANULATION,-2.311829501,0.013446835,dexbrompheniramine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.239349696,0.013188242,dexbrompheniramine
GPCR_LIGAND_BINDING,2.158917694,0.034537523,dexbrompheniramine
SENSORY_PERCEPTION,2.098455711,0.029420853,dexbrompheniramine
SIGNALING_BY_GPCR,1.976117981,0.060760458,dexbrompheniramine
L1CAM_INTERACTIONS,1.963315115,0.050207326,dexbrompheniramine
M_PHASE,-1.774987343,0.195496289,dexbrompheniramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.750460094,0.186704128,dexbrompheniramine
RRNA_PROCESSING,2.86649923,0,yohimbine
RESPIRATORY_ELECTRON_TRANSPORT,2.793266271,0,yohimbine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.589923053,0.000549749,yohimbine
TRANSLATION,2.55839255,0.000824624,yohimbine
TNFR2_NON_CANONICAL_NF_KB_PATHWAY,2.151470346,0.024738715,yohimbine
EUKARYOTIC_TRANSLATION_INITIATION,2.060098533,0.039032194,yohimbine
BIOLOGICAL_OXIDATIONS,1.975946314,0.059844129,yohimbine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.95049543,0.061434475,yohimbine
SYNTHESIS_OF_DNA,1.90403076,0.068352152,yohimbine
AMYLOID_FIBER_FORMATION,-2.060155775,0.470873273,yohimbine
GPCR_LIGAND_BINDING,2.422220053,0.000853176,H-8
SIGNALING_BY_GPCR,2.362279232,0.000426588,H-8
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.228627364,0.001990744,H-8
G_ALPHA_S_SIGNALLING_EVENTS,2.101700955,0.004265881,H-8
METABOLISM_OF_RNA,-2.063037765,0.03986711,H-8
G_ALPHA_I_SIGNALLING_EVENTS,2.06435444,0.006142868,H-8
CELL_CYCLE,-1.927389644,0.038917893,H-8
SENSORY_PERCEPTION,1.986863226,0.010238114,H-8
DNA_REPAIR,-1.778462478,0.064546749,H-8
DISEASES_OF_METABOLISM,-1.637869938,0.100142383,H-8
GLUCOSE_METABOLISM,1.846079896,0.257748777,histamine
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.770016914,0.209352909,histamine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.733012396,0.176545224,histamine
NEUTROPHIL_DEGRANULATION,1.689356859,0.16639478,histamine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.852979193,0.853205936,histamine
PROTEIN_LOCALIZATION,1.628311285,0.177705275,histamine
HCMV_INFECTION,1.603381219,0.167119811,histamine
GASTRULATION,-1.830306626,0.521787214,histamine
G_ALPHA_I_SIGNALLING_EVENTS,-1.776742276,0.543816038,histamine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.517762594,0.232113726,histamine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.368826598,0,tolbutamide
TRANSLATION,-2.685720101,0,tolbutamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.745571026,0,tolbutamide
RRNA_PROCESSING,-2.849798976,0,tolbutamide
CELLULAR_RESPONSE_TO_STARVATION,-2.865234002,0,tolbutamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.998597004,0,tolbutamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.034869874,0,tolbutamide
SIGNALING_BY_ROBO_RECEPTORS,-2.947341416,0,tolbutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-3.082918391,0,tolbutamide
EUKARYOTIC_TRANSLATION_INITIATION,-3.118191849,0,tolbutamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.911552904,0,erteberel
EUKARYOTIC_TRANSLATION_ELONGATION,-2.674817944,0,erteberel
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.609943682,0,erteberel
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.567905942,0,erteberel
NONSENSE_MEDIATED_DECAY_NMD,-2.531270037,0.000275358,erteberel
INFLUENZA_INFECTION,-2.430880098,0.000122381,erteberel
SELENOAMINO_ACID_METABOLISM,-2.493670362,0.000220286,erteberel
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.460276634,0.000183572,erteberel
SIGNALING_BY_ROBO_RECEPTORS,-2.454453621,0.000157347,erteberel
EUKARYOTIC_TRANSLATION_INITIATION,-2.447804419,0.000137679,erteberel
PROTEIN_LOCALIZATION,2.162827189,0.036634684,lacosamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.930728102,0.70627336,lacosamide
MHC_CLASS_II_ANTIGEN_PRESENTATION,-1.903691451,0.432708597,lacosamide
ECM_PROTEOGLYCANS,-1.89514636,0.309769018,lacosamide
MITOTIC_METAPHASE_AND_ANAPHASE,-1.88806317,0.245104735,lacosamide
GPCR_LIGAND_BINDING,-1.884787949,0.201194977,lacosamide
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-1.848494196,0.217419129,lacosamide
SEPARATION_OF_SISTER_CHROMATIDS,-1.830703976,0.216893628,lacosamide
RHO_GTPASES_ACTIVATE_FORMINS,-1.82768973,0.19341203,lacosamide
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.815828263,0.189991664,lacosamide
RESPIRATORY_ELECTRON_TRANSPORT,4.682169845,0,dexniguldipine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.322523664,0,dexniguldipine
GPCR_LIGAND_BINDING,-2.373694255,0,dexniguldipine
PROTEIN_LOCALIZATION,2.382414022,0.002785956,dexniguldipine
SIGNALING_BY_GPCR,-2.15484164,0.014924558,dexniguldipine
NEURONAL_SYSTEM,-2.144004424,0.010226086,dexniguldipine
METABOLISM_OF_STEROIDS,2.200025552,0.017238104,dexniguldipine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.137448118,0.008913278,dexniguldipine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.065499405,0.017411984,dexniguldipine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,2.02809742,0.033013582,dexniguldipine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.127048102,0.000938054,azithromycin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.021426102,0.041274357,azithromycin
IRON_UPTAKE_AND_TRANSPORT,-2.932689649,0.176666754,azithromycin
FATTY_ACID_METABOLISM,1.616553846,0.8824808,azithromycin
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.888775021,0.251163841,azithromycin
MITOCHONDRIAL_PROTEIN_IMPORT,1.497660157,0.774960151,azithromycin
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.838036414,0.326255028,azithromycin
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.401677383,0.817562672,azithromycin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.727248068,0.366153573,azithromycin
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1.37445931,0.690262281,azithromycin
GPCR_LIGAND_BINDING,2.127495704,0.059644773,pheniramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.989472996,0.102683899,pheniramine
G_ALPHA_I_SIGNALLING_EVENTS,1.952433143,0.098052392,pheniramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.885721837,0.122678453,pheniramine
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.870035267,0.111698393,pheniramine
SIGNALING_BY_GPCR,1.839161112,0.121774745,pheniramine
TRNA_PROCESSING,-2.778607076,1,pheniramine
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.352566063,1,pheniramine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.23339218,1,pheniramine
INFLUENZA_INFECTION,-1.844182935,1,pheniramine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.85139599,0,vicriviroc
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.728367717,0,vicriviroc
NONSENSE_MEDIATED_DECAY_NMD,-2.720796487,0,vicriviroc
SELENOAMINO_ACID_METABOLISM,-2.629641458,0,vicriviroc
SIGNALING_BY_ROBO_RECEPTORS,-2.623031262,0,vicriviroc
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.605182037,0,vicriviroc
EUKARYOTIC_TRANSLATION_INITIATION,-2.595799902,0,vicriviroc
RRNA_PROCESSING,-2.579809217,0,vicriviroc
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.51464106,0,vicriviroc
CELLULAR_RESPONSE_TO_STARVATION,-2.506566039,0,vicriviroc
METABOLISM_OF_RNA,-2.439122026,0.001318076,phenylbutazone
CELL_CYCLE,-2.412766186,0.000659038,phenylbutazone
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.149572129,0.00615102,phenylbutazone
CELL_CYCLE_MITOTIC,-2.107106368,0.00593134,phenylbutazone
GPCR_LIGAND_BINDING,2.044512062,0.029543552,phenylbutazone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.979104803,0.023634842,phenylbutazone
SIGNALING_BY_GPCR,1.793035853,0.062041459,phenylbutazone
CELLULAR_RESPONSES_TO_STIMULI,-1.76474899,0.067485471,phenylbutazone
VIRAL_INFECTION_PATHWAYS,-1.631732824,0.122361352,phenylbutazone
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.597605391,0.125028886,phenylbutazone
CELL_CYCLE,-4.417901109,0,maprotiline
SIGNALING_BY_GPCR,2.514467129,0,maprotiline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.576004806,0,maprotiline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.609468276,0,maprotiline
GPCR_LIGAND_BINDING,2.769328382,0,maprotiline
G2_M_CHECKPOINTS,-2.866242093,0,maprotiline
DNA_REPLICATION,-2.895247655,0,maprotiline
TRANSCRIPTIONAL_REGULATION_BY_TP53,-2.941808659,0,maprotiline
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.019068839,0,maprotiline
MRNA_SPLICING,-3.041219767,0,maprotiline
POTASSIUM_CHANNELS,2.036872429,0.111427416,SR-27897
GPCR_LIGAND_BINDING,2.031800443,0.056384958,SR-27897
STIMULI_SENSING_CHANNELS,1.984105927,0.060636204,SR-27897
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.967662978,0.051518399,SR-27897
MUSCLE_CONTRACTION,1.925921693,0.056653457,SR-27897
SIGNALING_BY_GPCR,1.858137338,0.07920744,SR-27897
G_ALPHA_S_SIGNALLING_EVENTS,1.80714965,0.096372249,SR-27897
CARDIAC_CONDUCTION,1.789458287,0.095233522,SR-27897
NEURONAL_SYSTEM,1.778277145,0.090693265,SR-27897
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.330973912,1,SR-27897
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.34417181,0.00063448,rivaroxaban
GPCR_LIGAND_BINDING,2.295634165,0.00126896,rivaroxaban
SIGNALING_BY_GPCR,2.03983471,0.01332408,rivaroxaban
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.998205914,0.016972341,rivaroxaban
SENSORY_PERCEPTION,1.914541925,0.028551601,rivaroxaban
G_ALPHA_I_SIGNALLING_EVENTS,1.835875102,0.048114735,rivaroxaban
ION_CHANNEL_TRANSPORT,1.793143423,0.060819442,rivaroxaban
TRANSLATION,-1.649335383,1,rivaroxaban
G_ALPHA_Q_SIGNALLING_EVENTS,1.761892705,0.067413503,rivaroxaban
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.607193529,1,rivaroxaban
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.822008516,0.741641048,dinoprostone
GPCR_LIGAND_BINDING,1.692847748,0.837779702,dinoprostone
RHOA_GTPASE_CYCLE,-1.763942793,1,dinoprostone
PROTEIN_LOCALIZATION,-1.673274626,1,dinoprostone
SENSORY_PERCEPTION,1.626328953,0.818848925,dinoprostone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.66283349,1,dinoprostone
MITF_M_DEPENDENT_GENE_EXPRESSION,-1.638392909,1,dinoprostone
RHOG_GTPASE_CYCLE,-1.620397463,1,dinoprostone
CDC42_GTPASE_CYCLE,-1.552238636,1,dinoprostone
G_ALPHA_I_SIGNALLING_EVENTS,1.529618617,1,dinoprostone
RESPIRATORY_ELECTRON_TRANSPORT,3.660784924,0,liothyronine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.531883017,0,liothyronine
TRANSLATION,2.595594057,0.002025895,liothyronine
RRNA_PROCESSING,2.163018634,0.029780651,liothyronine
EUKARYOTIC_TRANSLATION_INITIATION,2.057471067,0.043030002,liothyronine
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.023402427,0.042948966,liothyronine
MITOCHONDRIAL_TRANSLATION,1.753608788,0.156804243,liothyronine
CIRCADIAN_CLOCK,1.738789617,0.148295486,liothyronine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.715552848,0.145864412,liothyronine
DRUG_ADME,1.670687732,0.163003481,liothyronine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.482349107,0,moxisylyte
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.404982849,0,moxisylyte
SELENOAMINO_ACID_METABOLISM,-2.366745144,0,moxisylyte
NONSENSE_MEDIATED_DECAY_NMD,-2.338136857,0.000264283,moxisylyte
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.324418279,0.000211426,moxisylyte
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.306310472,0.000176189,moxisylyte
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.265406561,0.000755094,moxisylyte
EUKARYOTIC_TRANSLATION_INITIATION,-2.200093474,0.001982123,moxisylyte
SIGNALING_BY_ROBO_RECEPTORS,-2.182921565,0.002231723,moxisylyte
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.242663501,0.028774336,moxisylyte
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.602442762,0,adapalene
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.725438604,0,adapalene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.754593816,0,adapalene
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.771246952,0,adapalene
NEURONAL_SYSTEM,-2.84798862,0,adapalene
INFLUENZA_INFECTION,3.013940063,0,adapalene
GPCR_LIGAND_BINDING,-3.072424534,0,adapalene
METABOLISM_OF_RNA,3.093336441,0,adapalene
TRANSLATION,3.1288087,0,adapalene
SIGNALING_BY_GPCR,-2.979105662,0,adapalene
ESR_MEDIATED_SIGNALING,-3.679137584,0.160816179,doxepin
SIGNALING_BY_NUCLEAR_RECEPTORS,-3.399131056,0.661719032,doxepin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-3.389763543,0.461357891,doxepin
GASTRULATION,-3.357067244,0.404017696,doxepin
GPCR_LIGAND_BINDING,1.862028812,0.571259819,doxepin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-3.124363055,0.687555074,doxepin
SENSORY_PERCEPTION,1.815519867,0.416360522,doxepin
INFLUENZA_INFECTION,-1.981499435,1,doxepin
CELLULAR_RESPONSE_TO_STARVATION,-1.692207398,0.989377289,doxepin
EUKARYOTIC_TRANSLATION_INITIATION,-1.666956641,0.877239075,doxepin
NEUTROPHIL_DEGRANULATION,-3.067480923,0,brinzolamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.090300944,0.113915868,brinzolamide
INNATE_IMMUNE_SYSTEM,-2.012106208,0.109987735,brinzolamide
SENSORY_PERCEPTION,1.881152161,0.51460587,brinzolamide
TRANSLATION,-1.683717138,0.583327809,brinzolamide
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.591168809,0.745821593,brinzolamide
SUMOYLATION,-1.571541752,0.684368129,brinzolamide
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.742830384,0.743782573,brinzolamide
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.486077719,0.854836647,brinzolamide
MITOTIC_METAPHASE_AND_ANAPHASE,-1.476894614,0.780389167,brinzolamide
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.01539223,0.033613077,cortisone-acetate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.809861624,0.420809869,cortisone-acetate
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.850342204,0.813670333,cortisone-acetate
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.722955688,0.879973121,cortisone-acetate
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.662340732,1,cortisone-acetate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.648157214,0.932633609,cortisone-acetate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.329570105,1,cortisone-acetate
UNFOLDED_PROTEIN_RESPONSE_UPR,1.567613719,1,cortisone-acetate
CHROMATIN_ORGANIZATION,1.562472096,1,cortisone-acetate
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.553062557,1,cortisone-acetate
FATTY_ACID_METABOLISM,-2.026948459,0.159779781,flufenamic-acid
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.841620995,0.229324218,flufenamic-acid
SARS_COV_INFECTIONS,-1.737946459,0.26591647,flufenamic-acid
SARS_COV_2_INFECTION,-1.716718076,0.221852502,flufenamic-acid
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.645104886,0.247141388,flufenamic-acid
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.741906554,1,flufenamic-acid
SIGNALING_BY_NUCLEAR_RECEPTORS,1.718267145,1,flufenamic-acid
SARS_COV_2_HOST_INTERACTIONS,-1.422985851,0.567850445,flufenamic-acid
DNA_REPAIR,1.701346822,1,flufenamic-acid
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.692378179,0.880469001,flufenamic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.789712508,0,LY-364947
NEUTROPHIL_DEGRANULATION,-2.6123191,0,LY-364947
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,-2.200733132,0.029621635,LY-364947
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-2.154483373,0.028197518,LY-364947
RHO_GTPASE_CYCLE,-1.950149023,0.097067818,LY-364947
DEATH_RECEPTOR_SIGNALING,-1.851384938,0.135575943,LY-364947
TRANSLATION,-1.836980869,0.126461594,LY-364947
G_ALPHA_12_13_SIGNALLING_EVENTS,-1.789954213,0.140133117,LY-364947
GPCR_LIGAND_BINDING,1.967239028,0.255632233,LY-364947
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.75117259,0.151146289,LY-364947
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.633665091,0.003581651,meclizine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.446290252,0.025966969,meclizine
HCMV_EARLY_EVENTS,-2.345814273,0.043576753,meclizine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.298274712,0.045218343,meclizine
SIGNALING_BY_MET,-2.118508881,0.122850627,meclizine
DEVELOPMENTAL_CELL_LINEAGES,-2.111859656,0.106554115,meclizine
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.025807533,0.151452668,meclizine
ION_CHANNEL_TRANSPORT,-2.024473603,0.13364035,meclizine
ISG15_ANTIVIRAL_MECHANISM,-1.99726697,0.138888464,meclizine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.984056323,0.133774662,meclizine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.262539907,0.011626258,ritanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.235897636,0.007954808,ritanserin
GPCR_LIGAND_BINDING,2.197757763,0.0073429,ritanserin
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.526536664,0.207781816,ritanserin
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-3.393128683,0.359517221,ritanserin
SIGNALING_BY_GPCR,1.926902657,0.065780146,ritanserin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.434373373,1,ritanserin
TRANSPORT_OF_SMALL_MOLECULES,-1.882416834,1,ritanserin
NEURONAL_SYSTEM,-1.833634778,1,ritanserin
G_ALPHA_I_SIGNALLING_EVENTS,1.755353349,0.19458685,ritanserin
RRNA_PROCESSING,-2.433113307,0.007800312,NVP-BGJ398
HOST_INTERACTIONS_OF_HIV_FACTORS,-2.400400223,0.005200208,NVP-BGJ398
INFLUENZA_INFECTION,-2.253778583,0.012133819,NVP-BGJ398
SELENOAMINO_ACID_METABOLISM,-2.168355753,0.016900676,NVP-BGJ398
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.169170289,0.032416908,NVP-BGJ398
GPCR_LIGAND_BINDING,2.168220056,0.016208454,NVP-BGJ398
DNA_REPLICATION,-1.92013295,0.053042122,NVP-BGJ398
HIV_INFECTION,-1.905147402,0.050702028,NVP-BGJ398
NEURONAL_SYSTEM,2.044081205,0.037549585,NVP-BGJ398
SIGNALING_BY_GPCR,2.03240718,0.032822119,NVP-BGJ398
M_PHASE,2.835628872,0,nafamostat
MITOTIC_SPINDLE_CHECKPOINT,2.459627218,0,nafamostat
CELL_CYCLE_CHECKPOINTS,2.249360103,0.008834637,nafamostat
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2.11481529,0.035338549,nafamostat
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,2.095113794,0.025031472,nafamostat
MITOTIC_METAPHASE_AND_ANAPHASE,2.102636398,0.030037766,nafamostat
MITOTIC_PROMETAPHASE,2.070061568,0.026503912,nafamostat
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,2.037747394,0.0298169,nafamostat
NUCLEAR_ENVELOPE_BREAKDOWN,1.987372853,0.039265054,nafamostat
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.972050808,0.041522795,nafamostat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.657239713,0,aminosalicylic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.644375514,0,aminosalicylic-acid
SELENOAMINO_ACID_METABOLISM,-2.626089535,0,aminosalicylic-acid
NONSENSE_MEDIATED_DECAY_NMD,-2.603905796,0.000278908,aminosalicylic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.559421748,0.000223127,aminosalicylic-acid
SIGNALING_BY_ROBO_RECEPTORS,-2.542510168,0.000185939,aminosalicylic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.511825529,0.000159376,aminosalicylic-acid
GPCR_LIGAND_BINDING,2.540556202,0.000932714,aminosalicylic-acid
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.528358621,0.000466357,aminosalicylic-acid
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.466518843,0.000310905,aminosalicylic-acid
METABOLISM_OF_RNA,-3.302162808,0,SB-939
CELL_CYCLE,-3.293202592,0,SB-939
CELL_CYCLE_CHECKPOINTS,-3.234399695,0,SB-939
CELL_CYCLE_MITOTIC,-3.115364281,0,SB-939
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.939643768,0,SB-939
MITOTIC_METAPHASE_AND_ANAPHASE,-2.884086479,0,SB-939
G2_M_DNA_DAMAGE_CHECKPOINT,-2.739473905,0,SB-939
G2_M_CHECKPOINTS,-2.727468756,0,SB-939
M_PHASE,-2.726189731,0,SB-939
MITOTIC_SPINDLE_CHECKPOINT,-2.718597509,0,SB-939
EUKARYOTIC_TRANSLATION_ELONGATION,-2.465834039,1,sacubitril
SELENOAMINO_ACID_METABOLISM,-2.403521708,1,sacubitril
EUKARYOTIC_TRANSLATION_INITIATION,-2.371646544,1,sacubitril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.359065887,1,sacubitril
NONSENSE_MEDIATED_DECAY_NMD,-2.354471531,0.871244561,sacubitril
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.333419398,0.73646302,sacubitril
SARS_COV_1_HOST_INTERACTIONS,-2.225394553,0.674703769,sacubitril
INFLUENZA_INFECTION,-2.1740109,0.538191428,sacubitril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.197604855,0.598994117,sacubitril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.15844767,0.488470737,sacubitril
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.669184104,0.006165418,rilmenidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.378780698,0.005684313,rilmenidine
CELLULAR_RESPONSE_TO_STARVATION,2.35746541,0.003654202,rilmenidine
EUKARYOTIC_TRANSLATION_ELONGATION,2.339953129,0.002436134,rilmenidine
RESPIRATORY_ELECTRON_TRANSPORT,2.228641905,0.003857213,rilmenidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.209517383,0.004872269,rilmenidine
RRNA_PROCESSING,2.165763528,0.005954995,rilmenidine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.476930409,0.02712784,rilmenidine
COMPLEX_IV_ASSEMBLY,2.151107037,0.006148339,rilmenidine
HEMOSTASIS,-2.417050156,0.036992509,rilmenidine
DNA_REPLICATION,-2.873106814,0,anisomycin
SYNTHESIS_OF_DNA,-2.699283832,0.000523378,anisomycin
S_PHASE,-2.604035252,0.001046755,anisomycin
DNA_STRAND_ELONGATION,-2.52770583,0.001046755,anisomycin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.434205271,0.00209351,anisomycin
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.42648205,0.001744592,anisomycin
PHASE_II_CONJUGATION_OF_COMPOUNDS,-2.386402621,0.001943974,anisomycin
CELL_CYCLE,-2.369157798,0.001700977,anisomycin
G2_M_CHECKPOINTS,-2.358991069,0.001744592,anisomycin
DNA_REPLICATION_PRE_INITIATION,-2.33376876,0.001988835,anisomycin
GPCR_LIGAND_BINDING,2.707018424,0,thiethylperazine
SIGNALING_BY_GPCR,2.376031718,0.001167027,thiethylperazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.320228817,0.001556036,thiethylperazine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.016645673,0.026063603,thiethylperazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.938512532,0.042946594,thiethylperazine
SENSORY_PERCEPTION,1.901307248,0.051089849,thiethylperazine
G_ALPHA_S_SIGNALLING_EVENTS,1.836497066,0.0753566,thiethylperazine
POTASSIUM_CHANNELS,1.826412158,0.071966665,thiethylperazine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.778245525,0.095869107,thiethylperazine
G_ALPHA_I_SIGNALLING_EVENTS,1.777310373,0.087060214,thiethylperazine
EUKARYOTIC_TRANSLATION_ELONGATION,-3.040670084,0,leflunomide
TRANSLATION,-2.417084454,0,leflunomide
RRNA_PROCESSING,-2.452391111,0,leflunomide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.468906421,0,leflunomide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.524281137,0,leflunomide
INFLUENZA_INFECTION,-2.609434393,0,leflunomide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.644650973,0,leflunomide
CELLULAR_RESPONSE_TO_STARVATION,-2.675166915,0,leflunomide
SIGNALING_BY_ROBO_RECEPTORS,-2.605719679,0,leflunomide
EUKARYOTIC_TRANSLATION_INITIATION,-2.804834664,0,leflunomide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.941805047,0,gliquidone
GPCR_LIGAND_BINDING,2.938241985,0,gliquidone
SARS_COV_1_HOST_INTERACTIONS,-2.423559979,0.004789801,gliquidone
METABOLISM_OF_RNA,-2.443198453,0.005097917,gliquidone
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.542083223,0.004071713,gliquidone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.620254869,0.004369643,gliquidone
EUKARYOTIC_TRANSLATION_INITIATION,-2.622830025,0.004915848,gliquidone
SIGNALING_BY_ROBO_RECEPTORS,-2.686097612,0.003901467,gliquidone
INFLUENZA_INFECTION,-2.586080178,0.004369643,gliquidone
SELENOAMINO_ACID_METABOLISM,-2.738551906,0.003714197,gliquidone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.063137587,0.07559151,enzalutamide
SELENOAMINO_ACID_METABOLISM,-2.03490236,0.051744189,enzalutamide
NONSENSE_MEDIATED_DECAY_NMD,-2.000119043,0.051594206,enzalutamide
EUKARYOTIC_TRANSLATION_INITIATION,-1.954911752,0.064117799,enzalutamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.92927907,0.06731244,enzalutamide
CELLULAR_RESPONSE_TO_STARVATION,-1.913090722,0.065992589,enzalutamide
TRANSLATION,-1.908314129,0.05939333,enzalutamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.907407392,0.052419113,enzalutamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.861778887,0.071691948,enzalutamide
ADIPOGENESIS,1.869149161,1,enzalutamide
GPCR_LIGAND_BINDING,2.256116446,0.007741483,iloperidone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-2.198359384,0.030582944,iloperidone
G_ALPHA_S_SIGNALLING_EVENTS,2.17691288,0.007741483,iloperidone
SENSORY_PERCEPTION,2.112041656,0.008336982,iloperidone
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.088267939,0.038678429,iloperidone
METABOLISM_OF_RNA,-2.088044751,0.02578562,iloperidone
CELL_CYCLE,-2.014079241,0.036429683,iloperidone
EXTRACELLULAR_MATRIX_ORGANIZATION,1.958435339,0.0235222,iloperidone
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.928649457,0.058647293,iloperidone
REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1.935739786,0.023700849,iloperidone
EUKARYOTIC_TRANSLATION_ELONGATION,-3.249570462,0,dicoumarol
RRNA_PROCESSING,-2.65132676,0,dicoumarol
CELLULAR_RESPONSE_TO_STARVATION,-2.711498141,0,dicoumarol
SIGNALING_BY_ROBO_RECEPTORS,-2.786872414,0,dicoumarol
EUKARYOTIC_TRANSLATION_INITIATION,-2.820437924,0,dicoumarol
INFLUENZA_INFECTION,-2.770686831,0,dicoumarol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.940999358,0,dicoumarol
SELENOAMINO_ACID_METABOLISM,-2.955592583,0,dicoumarol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.985113212,0,dicoumarol
NONSENSE_MEDIATED_DECAY_NMD,-3.078878542,0,dicoumarol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.629076855,0,VX-809
NONSENSE_MEDIATED_DECAY_NMD,-2.426545807,0.000537881,VX-809
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.386158597,0.001792938,VX-809
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.369104218,0.001613644,VX-809
EUKARYOTIC_TRANSLATION_INITIATION,-2.321417119,0.002366678,VX-809
SELENOAMINO_ACID_METABOLISM,-2.305131244,0.002151526,VX-809
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.3026521,0.001997845,VX-809
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.29005529,0.001882585,VX-809
SIGNALING_BY_ROBO_RECEPTORS,-2.284696152,0.001792938,VX-809
CELLULAR_RESPONSE_TO_STARVATION,-2.23369787,0.003119712,VX-809
DISEASES_OF_METABOLISM,2.350762232,0.00319639,labetalol
TRANSLATION,-2.322114746,0.014157391,labetalol
METABOLISM_OF_RNA,-2.278844085,0.008494435,labetalol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.205521023,0.013213565,labetalol
INFLUENZA_INFECTION,-2.10847818,0.026545108,labetalol
HEMOSTASIS,-2.104986842,0.02208553,labetalol
NONSENSE_MEDIATED_DECAY_NMD,-1.973255824,0.055449782,labetalol
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.967308256,0.049550869,labetalol
EUKARYOTIC_TRANSLATION_INITIATION,-1.949370486,0.048312097,labetalol
EUKARYOTIC_TRANSLATION_ELONGATION,-1.947174909,0.043887913,labetalol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.157679801,0.069472538,lisinopril
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.028479348,0.145648566,lisinopril
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.979698354,0.149101879,lisinopril
CHROMATIN_ORGANIZATION,-1.975237559,0.115178155,lisinopril
MITOTIC_METAPHASE_AND_ANAPHASE,-1.957744828,0.109693481,lisinopril
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.936551561,0.108271528,lisinopril
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.870581436,0.168281664,lisinopril
M_PHASE,-1.916319137,0.112131114,lisinopril
SEPARATION_OF_SISTER_CHROMATIDS,-1.863408951,0.157532026,lisinopril
MITOTIC_SPINDLE_CHECKPOINT,-1.855307088,0.150185272,lisinopril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.967713103,0,levothyroxine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.391886845,0,levothyroxine
NEURONAL_SYSTEM,-2.499962669,0,levothyroxine
SIGNALING_BY_GPCR,-2.548324894,0,levothyroxine
SIGNALING_BY_ROBO_RECEPTORS,2.66150214,0,levothyroxine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.686160369,0,levothyroxine
GPCR_LIGAND_BINDING,-2.7058645,0,levothyroxine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.803590309,0,levothyroxine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.807527723,0,levothyroxine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.920098916,0,levothyroxine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.689880667,0.18435749,olopatadine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.484973355,0.311103264,olopatadine
GPCR_LIGAND_BINDING,1.93235389,0.508568642,olopatadine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.360695827,0.481633943,olopatadine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.346897901,0.396368603,olopatadine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.210437529,0.611605973,olopatadine
ION_CHANNEL_TRANSPORT,1.787165096,0.780562049,olopatadine
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.74499809,0.702914515,olopatadine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.743750168,0.531272599,olopatadine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.713216855,0.526005281,olopatadine
METABOLISM_OF_RNA,-2.614385346,0.002762148,carmustine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.458822355,0.000893416,carmustine
REGULATION_OF_RAS_BY_GAPS,-2.245991237,0.116010201,carmustine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.063535235,0.044224069,carmustine
GPCR_LIGAND_BINDING,2.047744632,0.032758569,carmustine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.176708913,0.135345234,carmustine
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-2.157203612,0.114974395,carmustine
MRNA_SPLICING,-2.148418597,0.098332456,carmustine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.143398376,0.08493604,carmustine
MITOTIC_G2_G2_M_PHASES,-2.140775247,0.074775282,carmustine
GPCR_LIGAND_BINDING,3.200793982,0,alvespimycin
SIGNALING_BY_GPCR,3.154171877,0,alvespimycin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.949896486,0,alvespimycin
MUSCLE_CONTRACTION,2.873115733,0,alvespimycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.869187021,0,alvespimycin
SIGNALING_BY_INTERLEUKINS,2.732148402,0,alvespimycin
CARDIAC_CONDUCTION,2.679670241,0,alvespimycin
INNATE_IMMUNE_SYSTEM,2.564030511,0.000160758,alvespimycin
G_ALPHA_Q_SIGNALLING_EVENTS,2.552987499,0.000142896,alvespimycin
TRANSLATION,-2.38374887,0.001871342,alvespimycin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.594388108,0.002537127,clomipramine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.40300678,0.032982656,clomipramine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.272832511,0.135313459,clomipramine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.25662154,0.114805013,clomipramine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.233916873,0.120259837,clomipramine
GPCR_LIGAND_BINDING,1.853130689,0.571340674,clomipramine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.848200957,0.295735406,clomipramine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.800282647,0.285176951,clomipramine
HEMOSTASIS,-2.350280433,1,clomipramine
TRANSPORT_OF_SMALL_MOLECULES,-1.781718165,1,clomipramine
SENSORY_PERCEPTION,2.196980908,0.060283249,pipamperone
NEDDYLATION,-1.980647318,0.303561277,pipamperone
GPCR_LIGAND_BINDING,2.088194962,0.085057187,pipamperone
MITOTIC_G2_G2_M_PHASES,-1.837891401,0.321467982,pipamperone
VISUAL_PHOTOTRANSDUCTION,1.985710011,0.124970753,pipamperone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.911137171,0.161030596,pipamperone
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.905728891,0.132127668,pipamperone
METABOLISM_OF_RNA,-1.668427215,0.471258987,pipamperone
SIGNALING_BY_GPCR,1.844244263,0.165710117,pipamperone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.826111733,0.160204798,pipamperone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.499649249,0.029552536,spironolactone
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.292384207,0.098936751,spironolactone
SIGNALING_BY_GPCR,2.027137284,0.123595736,spironolactone
GPCR_LIGAND_BINDING,1.993748176,0.079805193,spironolactone
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.21214763,0.104932918,spironolactone
PROTEIN_LOCALIZATION,-2.001323346,0.268221387,spironolactone
MEMBRANE_TRAFFICKING,-1.910848133,0.32636279,spironolactone
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.752989548,0.35605394,spironolactone
VESICLE_MEDIATED_TRANSPORT,-1.841233121,0.353131391,spironolactone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.711132889,0.347459535,spironolactone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,5.090111071,0,fluocinonide
DNA_REPLICATION_PRE_INITIATION,2.644937979,0,fluocinonide
SARS_COV_1_HOST_INTERACTIONS,2.776068134,0,fluocinonide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.988821482,0,fluocinonide
RRNA_PROCESSING,3.098915976,0,fluocinonide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.237290449,0,fluocinonide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.46319727,0,fluocinonide
RESPIRATORY_ELECTRON_TRANSPORT,3.615314379,0,fluocinonide
SIGNALING_BY_ROBO_RECEPTORS,4.09194508,0,fluocinonide
NONSENSE_MEDIATED_DECAY_NMD,3.885087176,0,fluocinonide
GPCR_LIGAND_BINDING,2.735414006,0,lomustine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.702092485,0,lomustine
MUSCLE_CONTRACTION,2.283295574,0.006436872,lomustine
NEURONAL_SYSTEM,2.266808977,0.005395613,lomustine
CARDIAC_CONDUCTION,2.213690071,0.006929103,lomustine
SIGNALING_BY_GPCR,2.051650231,0.014672281,lomustine
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,-1.971992458,0.460942961,lomustine
ADIPOGENESIS,-1.9605276,0.25102997,lomustine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.790205926,0.04876336,lomustine
SENSORY_PERCEPTION,1.787599926,0.043235899,lomustine
RESPIRATORY_ELECTRON_TRANSPORT,2.32001086,0.015529114,FK-866
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.988877814,0.033248232,FK-866
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-1.980528942,0.29776202,FK-866
EPH_EPHRIN_SIGNALING,-1.962818492,0.172126372,FK-866
PTEN_REGULATION,-1.946367487,0.138734225,FK-866
SIGNALING_BY_ERBB2,-1.940011586,0.108755087,FK-866
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-1.922744195,0.105157591,FK-866
FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,-1.917459773,0.092059014,FK-866
SARS_COV_2_INFECTION,-1.874574622,0.120654499,FK-866
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.850219852,0.128402953,FK-866
KEAP1_NFE2L2_PATHWAY,2.28625619,0.04941499,ifosfamide
ION_CHANNEL_TRANSPORT,-2.285277943,0.0484697,ifosfamide
NEDDYLATION,2.024213932,0.079063984,ifosfamide
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,2.015954234,0.053368189,ifosfamide
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-2.188402002,0.066953907,ifosfamide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.912135621,0.078569835,ifosfamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.904974521,0.066413747,ifosfamide
MITOTIC_G2_G2_M_PHASES,1.813331298,0.094876781,ifosfamide
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.088687943,0.117477408,ifosfamide
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.772775909,0.104759779,ifosfamide
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.797594902,0.890992424,methocarbamol
TRANSLATION,-1.74424335,1,methocarbamol
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.777795362,0.511627334,methocarbamol
SENSORY_PERCEPTION,1.774433912,0.350566054,methocarbamol
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.753820493,0.303989834,methocarbamol
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.485580476,1,methocarbamol
POTASSIUM_CHANNELS,1.731266134,0.28343941,methocarbamol
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.703236724,0.290123631,methocarbamol
DNA_REPLICATION,-1.339710635,1,methocarbamol
GPCR_LIGAND_BINDING,1.618579812,0.443210574,methocarbamol
EUKARYOTIC_TRANSLATION_ELONGATION,-3.410169157,0,ketanserin
NERVOUS_SYSTEM_DEVELOPMENT,-2.695195398,0,ketanserin
VIRAL_INFECTION_PATHWAYS,-2.780796901,0,ketanserin
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.84924309,0,ketanserin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.863771501,0,ketanserin
SARS_COV_1_INFECTION,-2.873435175,0,ketanserin
SARS_COV_2_INFECTION,-2.887502484,0,ketanserin
SARS_COV_INFECTIONS,-2.916127723,0,ketanserin
SARS_COV_1_HOST_INTERACTIONS,-2.954761822,0,ketanserin
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-3.007663882,0,ketanserin
SIGNALING_BY_ROBO_RECEPTORS,-3.499156837,0,iloprost
RRNA_PROCESSING,-3.381404169,0,iloprost
CELLULAR_RESPONSE_TO_STARVATION,-2.996682746,0,iloprost
SELENOAMINO_ACID_METABOLISM,-2.928406429,0,iloprost
EUKARYOTIC_TRANSLATION_INITIATION,-2.902682412,0,iloprost
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.898616818,0,iloprost
EUKARYOTIC_TRANSLATION_ELONGATION,-2.776583697,0,iloprost
NONSENSE_MEDIATED_DECAY_NMD,-2.774571405,0,iloprost
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.740809704,0,iloprost
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.671467473,0,iloprost
RESPIRATORY_ELECTRON_TRANSPORT,2.991470946,0,hexylresorcinol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.960393256,0.184350936,hexylresorcinol
CARDIAC_CONDUCTION,1.878420263,0.198647539,hexylresorcinol
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.726226872,0.336346402,hexylresorcinol
MUSCLE_CONTRACTION,1.673054758,0.359371458,hexylresorcinol
EXTRACELLULAR_MATRIX_ORGANIZATION,1.66839401,0.305495837,hexylresorcinol
DISEASES_OF_METABOLISM,1.63434904,0.318395028,hexylresorcinol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.60411234,0.32505961,hexylresorcinol
G_ALPHA_Q_SIGNALLING_EVENTS,1.546199352,0.392947574,hexylresorcinol
CIRCADIAN_CLOCK,1.536793504,0.371109721,hexylresorcinol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.309159575,0,androstenedione
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.301268131,0.000376025,androstenedione
METABOLISM_OF_RNA,-2.256842505,0.031832877,androstenedione
GPCR_LIGAND_BINDING,2.171906893,0.003008204,androstenedione
THE_PHOTOTRANSDUCTION_CASCADE,2.064454976,0.00827256,androstenedione
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.919327894,0.111415071,androstenedione
DISEASES_OF_METABOLISM,-1.813697534,0.145900688,androstenedione
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.743680142,0.165133051,androstenedione
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.739763958,0.133698085,androstenedione
TOLL_LIKE_RECEPTOR_CASCADES,-1.7312272,0.115394181,androstenedione
CELL_CYCLE_MITOTIC,-2.483598183,0.001194036,valrubicin
CELL_CYCLE,-2.474005146,0.000597018,valrubicin
CELL_CYCLE_CHECKPOINTS,-2.465562001,0.000398012,valrubicin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.344840775,0.001791053,valrubicin
MITOTIC_PROMETAPHASE,-2.337485656,0.001432843,valrubicin
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.32004783,0.001990059,valrubicin
M_PHASE,-2.303652709,0.002388071,valrubicin
METABOLISM_OF_RNA,-2.242784313,0.004626888,valrubicin
RHO_GTPASES_ACTIVATE_FORMINS,-2.232033723,0.004510801,valrubicin
SEPARATION_OF_SISTER_CHROMATIDS,-2.210667156,0.004776142,valrubicin
GLYCOSAMINOGLYCAN_METABOLISM,2.206402504,0.027763227,oxybenzone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.322106428,0.119883281,oxybenzone
HEMOSTASIS,-3.213866137,0.420755397,oxybenzone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.123870805,0.699125151,oxybenzone
NEUTROPHIL_DEGRANULATION,-3.062742538,0.745778758,oxybenzone
INNATE_IMMUNE_SYSTEM,-2.550546054,1,oxybenzone
INTERFERON_GAMMA_SIGNALING,-2.310175053,1,oxybenzone
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.590349424,0.620481928,oxybenzone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.25544719,0.928970719,oxybenzone
NONSENSE_MEDIATED_DECAY_NMD,-2.246052134,0.815613678,oxybenzone
RESPIRATORY_ELECTRON_TRANSPORT,4.026176855,0,lenvatinib
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.273298007,0,lenvatinib
DISEASES_OF_METABOLISM,2.241417655,0.00755867,lenvatinib
SYNTHESIS_OF_DNA,2.179395954,0.009593696,lenvatinib
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.073057799,0.02058284,lenvatinib
ION_CHANNEL_TRANSPORT,-2.431977947,0.084414597,lenvatinib
PROTEIN_LOCALIZATION,2.005200284,0.026455345,lenvatinib
TRANSLATION,1.90874136,0.047345515,lenvatinib
GPCR_LIGAND_BINDING,-2.348870204,0.120965248,lenvatinib
DNA_REPLICATION,1.877099227,0.048840636,lenvatinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.829052124,0,harmine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.525603231,0,harmine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.63421291,0,harmine
EUKARYOTIC_TRANSLATION_INITIATION,2.665918198,0,harmine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.727749733,0,harmine
SELENOAMINO_ACID_METABOLISM,2.554196411,0,harmine
EUKARYOTIC_TRANSLATION_ELONGATION,2.777938957,0,harmine
NONSENSE_MEDIATED_DECAY_NMD,2.784141501,0,harmine
CELLULAR_RESPONSE_TO_STARVATION,2.787882164,0,harmine
GPCR_LIGAND_BINDING,-2.741217484,0,harmine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.423122743,0.011436807,BRD-K25836724
GPCR_LIGAND_BINDING,2.270634894,0.020490946,BRD-K25836724
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.077952252,0.073386178,BRD-K25836724
L1CAM_INTERACTIONS,2.066496183,0.06051977,BRD-K25836724
NEURONAL_SYSTEM,1.974269343,0.102550036,BRD-K25836724
SIGNALING_BY_GPCR,1.898290173,0.144230844,BRD-K25836724
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.615759617,1,BRD-K25836724
G_ALPHA_I_SIGNALLING_EVENTS,1.837955617,0.183669674,BRD-K25836724
DISEASES_OF_GLYCOSYLATION,-1.571033325,0.854146448,BRD-K25836724
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1.782293359,0.233739743,BRD-K25836724
GPCR_LIGAND_BINDING,2.264373268,0.011818554,dobutamine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.157548304,0.021526651,dobutamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.145794321,0.016039466,dobutamine
SIGNALING_BY_GPCR,2.099082474,0.016883648,dobutamine
G_ALPHA_Q_SIGNALLING_EVENTS,2.049600281,0.023637107,dobutamine
SENSORY_PERCEPTION,1.825815256,0.134225001,dobutamine
INFLUENZA_INFECTION,-2.04356066,1,dobutamine
EUKARYOTIC_TRANSLATION_INITIATION,-1.775790822,1,dobutamine
TRANSLATION,-1.601463919,1,dobutamine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.56580681,1,dobutamine
SENSORY_PERCEPTION,2.418513325,0.002999959,perospirone
NEUTROPHIL_DEGRANULATION,-2.23305509,0.064620355,perospirone
MITOCHONDRIAL_TRANSLATION,-2.058372544,0.109854604,perospirone
BIOLOGICAL_OXIDATIONS,-2.054141674,0.074313409,perospirone
TRANSLATION,-1.941673873,0.100969305,perospirone
GPCR_LIGAND_BINDING,2.060556292,0.042299417,perospirone
METABOLISM_OF_RNA,-1.865017421,0.129240711,perospirone
KEAP1_NFE2L2_PATHWAY,-1.680143868,0.29456112,perospirone
SELENOAMINO_ACID_METABOLISM,-1.650862395,0.296792061,perospirone
G_ALPHA_I_SIGNALLING_EVENTS,1.86827167,0.147597964,perospirone
COLLAGEN_FORMATION,-2.616544681,0.002658022,oxybutynin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.575583426,0.001329011,oxybutynin
RESPIRATORY_ELECTRON_TRANSPORT,2.325125477,0.010327408,oxybutynin
SIGNALING_BY_MET,-2.324709656,0.02082117,oxybutynin
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-2.185573678,0.061466752,oxybutynin
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.135736349,0.067779553,oxybutynin
CHROMATIN_ORGANIZATION,-2.083669286,0.084392189,oxybutynin
ECM_PROTEOGLYCANS,-2.05952374,0.084676977,oxybutynin
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.031664665,0.091369496,oxybutynin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.02105766,0.087862384,oxybutynin
NEURONAL_SYSTEM,2.375387355,0.006868463,BRD-K60174629
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.151409335,0.028847544,BRD-K60174629
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.132854954,0.021521184,BRD-K60174629
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.070903389,0.026443582,BRD-K60174629
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.066319764,0.022528558,BRD-K60174629
CARDIAC_CONDUCTION,2.014166308,0.026329108,BRD-K60174629
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.95735327,0.034047952,BRD-K60174629
L1CAM_INTERACTIONS,1.922632644,0.039751229,BRD-K60174629
MITOTIC_PROPHASE,-1.870214099,0.952201423,BRD-K60174629
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.841543229,0.585270301,BRD-K60174629
METABOLISM_OF_RNA,-2.530881963,0.01085562,primidone
GPCR_LIGAND_BINDING,2.295968365,0.013670273,primidone
SIGNALING_BY_GPCR,2.257237241,0.010453738,primidone
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.221983667,0.009113516,primidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.208328168,0.008041337,primidone
NEUTROPHIL_DEGRANULATION,-2.017588372,0.087749597,primidone
G_ALPHA_I_SIGNALLING_EVENTS,2.040340423,0.033773616,primidone
TRANSLATION,-1.855358775,0.136901433,primidone
MITOTIC_METAPHASE_AND_ANAPHASE,-1.838071636,0.116697918,primidone
BIOLOGICAL_OXIDATIONS,-1.676521501,0.225796901,primidone
RRNA_PROCESSING,-2.853203035,0,PP-1
S_PHASE,-2.551397085,0.000843455,PP-1
METABOLISM_OF_RNA,-2.535031544,0.000562303,PP-1
TRANSLATION,-2.297912703,0.006747638,PP-1
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-2.118464122,0.021255061,PP-1
TRNA_PROCESSING,-2.10216414,0.019680612,PP-1
SYNTHESIS_OF_DNA,-2.098363472,0.01735107,PP-1
NEDDYLATION,-2.008337496,0.028044872,PP-1
DNA_REPLICATION,-1.984949555,0.029239766,PP-1
NEURONAL_SYSTEM,2.008463933,0.137077541,PP-1
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.889346295,0,PF-02545920
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.66078328,0,PF-02545920
GPCR_LIGAND_BINDING,-2.678894899,0,PF-02545920
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.765138579,0,PF-02545920
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.875674256,0,PF-02545920
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.031773278,0,PF-02545920
TRANSLATION,3.082068854,0,PF-02545920
METABOLISM_OF_RNA,3.089031819,0,PF-02545920
RESPIRATORY_ELECTRON_TRANSPORT,3.102510267,0,PF-02545920
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.696227758,0,PF-02545920
MITF_M_DEPENDENT_GENE_EXPRESSION,2.36401786,0.007421456,tiapride
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,2.087145561,0.029685825,tiapride
POTENTIAL_THERAPEUTICS_FOR_SARS,1.687341751,0.262843242,tiapride
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.59667143,0.315875732,tiapride
NEDDYLATION,1.543761344,0.343242352,tiapride
S_PHASE,1.515324158,0.336748578,tiapride
ION_CHANNEL_TRANSPORT,-2.926408323,1,tiapride
TRANSPORT_OF_SMALL_MOLECULES,-2.707168414,1,tiapride
KEAP1_NFE2L2_PATHWAY,1.410147377,0.487165593,tiapride
SARS_COV_2_INFECTION,-2.452708603,1,tiapride
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.62925928,0,T-0901317
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-2.441061387,0.00526437,T-0901317
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.037409357,0.135823874,T-0901317
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.012805535,0.096764127,T-0901317
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.59177828,0.955483079,T-0901317
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.576917501,0.821241655,T-0901317
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,-1.453755352,1,T-0901317
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.573809338,1,T-0901317
HEMOSTASIS,-1.391052093,1,T-0901317
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.549016806,1,T-0901317
EUKARYOTIC_TRANSLATION_ELONGATION,-2.937473312,0,cinnarizine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.546960598,0,cinnarizine
SARS_COV_1_HOST_INTERACTIONS,-2.56326898,0,cinnarizine
INFLUENZA_INFECTION,-2.668295032,0,cinnarizine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.718455891,0,cinnarizine
CELLULAR_RESPONSE_TO_STARVATION,-2.7895442,0,cinnarizine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.753739974,0,cinnarizine
NONSENSE_MEDIATED_DECAY_NMD,-2.835006452,0,cinnarizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.872757955,0,cinnarizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.90118928,0,cinnarizine
METABOLISM_OF_RNA,1.965485752,0.353967953,1-benzylimidazole
EUKARYOTIC_TRANSLATION_ELONGATION,1.959559147,0.1852801,1-benzylimidazole
NONSENSE_MEDIATED_DECAY_NMD,1.955446836,0.128129025,1-benzylimidazole
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.277484895,0.586051017,1-benzylimidazole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.908215095,0.136886044,1-benzylimidazole
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.255091515,0.361102142,1-benzylimidazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.236035178,0.288092419,1-benzylimidazole
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.221415075,0.249219675,1-benzylimidazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.871522736,0.149514588,1-benzylimidazole
EUKARYOTIC_TRANSLATION_INITIATION,1.852624251,0.145028536,1-benzylimidazole
RRNA_PROCESSING,2.286457713,0.013564885,pirlindole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.035899402,0.051621925,pirlindole
RESPIRATORY_ELECTRON_TRANSPORT,2.024670545,0.036173028,pirlindole
IRON_UPTAKE_AND_TRANSPORT,-2.153347741,0.182492525,pirlindole
TRANSLATION,1.985901114,0.035231022,pirlindole
MUSCLE_CONTRACTION,1.733313191,0.14770653,pirlindole
RAC2_GTPASE_CYCLE,-1.878008979,0.778562785,pirlindole
RHOG_GTPASE_CYCLE,-1.868152323,0.555036438,pirlindole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.647781304,0.203598881,pirlindole
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.826576838,0.549637251,pirlindole
GPCR_LIGAND_BINDING,2.47607411,0.001588562,sphingosine
G_ALPHA_Q_SIGNALLING_EVENTS,2.439707193,0.001191422,sphingosine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.276901659,0.021662673,sphingosine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.157278084,0.007678051,sphingosine
G_ALPHA_I_SIGNALLING_EVENTS,2.107266012,0.008935663,sphingosine
SIGNALING_BY_GPCR,1.996874936,0.01604448,sphingosine
INNATE_IMMUNE_SYSTEM,1.991184604,0.014032301,sphingosine
NEUTROPHIL_DEGRANULATION,1.870937686,0.029161466,sphingosine
STRIATED_MUSCLE_CONTRACTION,1.831200117,0.034253376,sphingosine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.816379989,0.034242344,sphingosine
GPCR_LIGAND_BINDING,2.753165901,0,phenolphthalein
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.67713296,0,phenolphthalein
SENSORY_PERCEPTION,2.63312033,0,phenolphthalein
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.620924496,0,phenolphthalein
SIGNALING_BY_GPCR,2.397756925,0.000247837,phenolphthalein
METABOLISM_OF_RNA,-2.270413761,0.051808309,phenolphthalein
VISUAL_PHOTOTRANSDUCTION,2.226626843,0.002684905,phenolphthalein
MITOTIC_METAPHASE_AND_ANAPHASE,-2.213902202,0.038856232,phenolphthalein
NEUTROPHIL_DEGRANULATION,-2.160359334,0.032811929,phenolphthalein
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.046354432,0.050513102,phenolphthalein
SENSORY_PERCEPTION,2.167040713,0.021793047,tofacitinib
GPCR_LIGAND_BINDING,2.07483658,0.028694178,tofacitinib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.027276647,0.035837455,tofacitinib
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.315038991,0.751597525,tofacitinib
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.959518856,0.050668834,tofacitinib
SIGNALING_BY_GPCR,1.857872859,0.095453545,tofacitinib
G_ALPHA_I_SIGNALLING_EVENTS,1.842262172,0.089230419,tofacitinib
TRANSLATION,-1.883805871,1,tofacitinib
VISUAL_PHOTOTRANSDUCTION,1.769978624,0.135635772,tofacitinib
S_PHASE,-1.698156732,1,tofacitinib
METABOLISM_OF_RNA,-3.148812541,0,midodrine
TRANSLATION,-3.062643748,0,midodrine
EUKARYOTIC_TRANSLATION_INITIATION,-3.02119712,0,midodrine
GPCR_LIGAND_BINDING,2.963453316,0,midodrine
VIRAL_INFECTION_PATHWAYS,-2.932399554,0,midodrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.77326806,0,midodrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.758572103,0,midodrine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.733243115,0,midodrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.650521613,0,midodrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.642595144,0,midodrine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.961498065,0,naftifine
EUKARYOTIC_TRANSLATION_INITIATION,-2.817144178,0,naftifine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.80906305,0,naftifine
SELENOAMINO_ACID_METABOLISM,-2.801042234,0,naftifine
NONSENSE_MEDIATED_DECAY_NMD,-2.744855937,0,naftifine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.740250478,0,naftifine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.673783313,0,naftifine
INFLUENZA_INFECTION,-2.641548652,0,naftifine
SIGNALING_BY_ROBO_RECEPTORS,-2.525609032,0,naftifine
CELLULAR_RESPONSE_TO_STARVATION,-2.506128202,0,naftifine
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-1.55719429,1,bepridil
INTERFERON_SIGNALING,-1.554945879,0.674605203,bepridil
SIGNALING_BY_INTERLEUKINS,-1.531983488,0.497333947,bepridil
NEUTROPHIL_DEGRANULATION,-1.397397287,0.666172638,bepridil
GPCR_LIGAND_BINDING,-1.38656806,0.556774161,bepridil
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.297244689,0.64481014,bepridil
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.293530669,1,bepridil
INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1.26767584,1,bepridil
METABOLISM_OF_RNA,-1.15199955,0.913126328,bepridil
NEURONAL_SYSTEM,1.203185079,1,bepridil
GPCR_LIGAND_BINDING,2.284631231,0.00553912,pseudoephedrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.12229953,0.01592497,pseudoephedrine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.704229977,0.190652656,pseudoephedrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.06057552,0.02215648,pseudoephedrine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.931946571,0.060584125,pseudoephedrine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.886150589,0.07200856,pseudoephedrine
SIGNALING_BY_GPCR,1.853514935,0.077663079,pseudoephedrine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.348644176,0.939793256,pseudoephedrine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.337805687,0.653468887,pseudoephedrine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.322617381,0.52066826,pseudoephedrine
CELL_CYCLE_CHECKPOINTS,-4.125361005,0,NVP-TAE226
CELL_CYCLE,-3.794678128,0,NVP-TAE226
DNA_REPLICATION,-3.790173523,0,NVP-TAE226
MITOTIC_METAPHASE_AND_ANAPHASE,-3.701534674,0,NVP-TAE226
SEPARATION_OF_SISTER_CHROMATIDS,-3.510621341,0,NVP-TAE226
G2_M_CHECKPOINTS,-3.502449564,0,NVP-TAE226
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.389928817,0,NVP-TAE226
METABOLISM_OF_RNA,-3.197671256,0,NVP-TAE226
RRNA_PROCESSING,-3.127803327,0,NVP-TAE226
TRANSLATION,-2.52144127,0.000643774,NVP-TAE226
RESPIRATORY_ELECTRON_TRANSPORT,2.329854006,0.024045343,purvalanol-b
C_TYPE_LECTIN_RECEPTORS_CLRS,2.293041604,0.018434763,purvalanol-b
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.232760471,0.018701933,purvalanol-b
TRANSLATION,2.197051572,0.020438541,purvalanol-b
RRNA_PROCESSING,2.155143401,0.02244232,purvalanol-b
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.116578019,0.080028129,purvalanol-b
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.956986881,0.066258278,purvalanol-b
HOST_INTERACTIONS_OF_HIV_FACTORS,1.849675186,0.105112498,purvalanol-b
SYNTHESIS_OF_DNA,1.812525669,0.114215378,purvalanol-b
G2_M_CHECKPOINTS,1.804160004,0.107224417,purvalanol-b
ION_CHANNEL_TRANSPORT,-2.320940905,0.148061797,epinephrine
GPCR_LIGAND_BINDING,-2.243832217,0.150375262,epinephrine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1.785109646,0.625282708,epinephrine
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.058710997,0.360900629,epinephrine
TRANSPORT_OF_SMALL_MOLECULES,-2.055602273,0.27553375,epinephrine
SIGNALING_BY_GPCR,-2.049442622,0.22708978,epinephrine
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.597674157,0.857435543,epinephrine
G_ALPHA_Q_SIGNALLING_EVENTS,-1.930081834,0.305685918,epinephrine
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.912884554,0.276426086,epinephrine
G_ALPHA_S_SIGNALLING_EVENTS,-1.886846847,0.263735075,epinephrine
SIGNALING_BY_GPCR,2.947831183,0,reversine
NEURONAL_SYSTEM,2.843725638,0,reversine
GPCR_LIGAND_BINDING,2.679273902,0,reversine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.362949308,0.002371088,reversine
MUSCLE_CONTRACTION,2.244422454,0.004085568,reversine
SENSORY_PERCEPTION,2.218095119,0.004498988,reversine
G_ALPHA_Q_SIGNALLING_EVENTS,2.212167486,0.003856276,reversine
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.18330022,0.003465437,reversine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.046312275,0.008025222,reversine
G_ALPHA_I_SIGNALLING_EVENTS,2.015693154,0.008754788,reversine
GPCR_LIGAND_BINDING,3.345522915,0,diflunisal
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.998161924,0,diflunisal
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.93336164,0,diflunisal
SIGNALING_BY_GPCR,2.769670529,0,diflunisal
METABOLISM_OF_RNA,-2.5090167,0,diflunisal
CELL_CYCLE_MITOTIC,-2.433662754,0.004345096,diflunisal
MUSCLE_CONTRACTION,2.382258469,0.000788168,diflunisal
POTASSIUM_CHANNELS,2.397338011,0.000945801,diflunisal
CELL_CYCLE,-2.38529285,0.005793461,diflunisal
NEURONAL_SYSTEM,2.334646237,0.000844465,diflunisal
RESPIRATORY_ELECTRON_TRANSPORT,4.159772115,0,clonazepam
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.985847561,0,clonazepam
CELLULAR_RESPONSE_TO_STARVATION,2.644205993,0,clonazepam
PROTEIN_LOCALIZATION,2.298044847,0.005090827,clonazepam
ION_CHANNEL_TRANSPORT,-2.579043743,0.016941222,clonazepam
DISEASES_OF_METABOLISM,2.028035992,0.025522012,clonazepam
NEUTROPHIL_DEGRANULATION,1.960744862,0.033712586,clonazepam
TRANSLATION,1.9043626,0.039562997,clonazepam
GLYCOSAMINOGLYCAN_METABOLISM,1.72095305,0.101477148,clonazepam
GPCR_LIGAND_BINDING,-2.255035193,0.588236858,clonazepam
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.340583791,0.013866847,AR-A014418
NEURONAL_SYSTEM,2.151806162,0.034133777,AR-A014418
SENSORY_PERCEPTION,1.948518742,0.107734735,AR-A014418
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.967159797,0.371714459,AR-A014418
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.798966292,0.219202851,AR-A014418
PTEN_REGULATION,1.783956385,0.190935817,AR-A014418
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.764488676,0.179913451,AR-A014418
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.708992592,0.220802872,AR-A014418
PROTEIN_LOCALIZATION,-1.749178742,0.857434125,AR-A014418
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.7307923,0.64730688,AR-A014418
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.81801944,0,nicotinamide
SENSORY_PERCEPTION,-2.489352043,0,nicotinamide
NEURONAL_SYSTEM,-2.809939039,0,nicotinamide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.870467076,0,nicotinamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.94351198,0,nicotinamide
GPCR_LIGAND_BINDING,-2.947830066,0,nicotinamide
INFLUENZA_INFECTION,3.019697745,0,nicotinamide
METABOLISM_OF_RNA,3.119888451,0,nicotinamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.181527167,0,nicotinamide
RESPIRATORY_ELECTRON_TRANSPORT,3.194136668,0,nicotinamide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.411692855,0.079308741,pargyline
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.367099089,0.090323844,pargyline
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-3.320250002,0.125572173,pargyline
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-3.218150829,0.310625903,pargyline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.204283297,0.280224219,pargyline
GPCR_LIGAND_BINDING,1.86031103,0.491997721,pargyline
GASTRULATION,-3.133576275,0.405722958,pargyline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.083736676,0.450989786,pargyline
CELL_JUNCTION_ORGANIZATION,1.815408622,0.358203128,pargyline
ESR_MEDIATED_SIGNALING,-3.068620491,0.419675422,pargyline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.662601183,0,candesartan-cilextil
GPCR_LIGAND_BINDING,2.627012211,0,candesartan-cilextil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.561538066,0,candesartan-cilextil
SENSORY_PERCEPTION,2.550413146,0,candesartan-cilextil
G_ALPHA_I_SIGNALLING_EVENTS,2.523707906,0,candesartan-cilextil
METABOLISM_OF_RNA,-2.401351164,0.011473529,candesartan-cilextil
SIGNALING_BY_GPCR,2.265730226,0.001777853,candesartan-cilextil
VISUAL_PHOTOTRANSDUCTION,2.1178538,0.005143074,candesartan-cilextil
MITOTIC_METAPHASE_AND_ANAPHASE,-1.99980657,0.104409113,candesartan-cilextil
CELL_CYCLE_CHECKPOINTS,-1.933432595,0.113970387,candesartan-cilextil
RESPIRATORY_ELECTRON_TRANSPORT,3.364416584,0,tipifarnib-P2
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.648622036,0,tipifarnib-P2
COLLAGEN_FORMATION,-2.647965382,0,tipifarnib-P2
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.582185438,0.000402647,tipifarnib-P2
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.538892161,0.000905956,tipifarnib-P2
COLLAGEN_DEGRADATION,-2.536552622,0.000966353,tipifarnib-P2
SIGNALING_BY_MET,-2.438804588,0.002013236,tipifarnib-P2
DEVELOPMENTAL_CELL_LINEAGES,-2.326215075,0.007075088,tipifarnib-P2
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.185989491,0.016100844,tipifarnib-P2
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.212591918,0.019629054,tipifarnib-P2
EUKARYOTIC_TRANSLATION_ELONGATION,-3.348626818,0,sasapyrine
NERVOUS_SYSTEM_DEVELOPMENT,-2.504946534,0,sasapyrine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.554867695,0,sasapyrine
TRANSLATION,-2.61838203,0,sasapyrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.760160258,0,sasapyrine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.786371488,0,sasapyrine
RRNA_PROCESSING,-2.909855529,0,sasapyrine
SIGNALING_BY_ROBO_RECEPTORS,-2.913051534,0,sasapyrine
SARS_COV_1_HOST_INTERACTIONS,-2.547837613,0,sasapyrine
CELLULAR_RESPONSE_TO_STARVATION,-2.982526438,0,sasapyrine
GPCR_LIGAND_BINDING,2.759628269,0,GW-9662
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.570148996,0,GW-9662
G_ALPHA_I_SIGNALLING_EVENTS,2.439442539,0,GW-9662
SIGNALING_BY_GPCR,2.375627174,0.000163739,GW-9662
SENSORY_PERCEPTION,2.291433767,0.000523964,GW-9662
L1CAM_INTERACTIONS,1.894427488,0.046720166,GW-9662
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.850246092,0.060630176,GW-9662
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.845895532,0.054852532,GW-9662
NEURONAL_SYSTEM,1.837715295,0.051377628,GW-9662
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.834536521,0.047680768,GW-9662
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.685711264,0,primaquine
EUKARYOTIC_TRANSLATION_INITIATION,-2.437338601,0.009140742,primaquine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.424391772,0.00788613,primaquine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.421072899,0.005914598,primaquine
METABOLISM_OF_STEROIDS,2.339009671,0.022578792,primaquine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.375114421,0.007742746,primaquine
GLYCOSAMINOGLYCAN_METABOLISM,2.243470038,0.015937971,primaquine
SELENOAMINO_ACID_METABOLISM,-2.331853372,0.009499203,primaquine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.325142652,0.008910303,primaquine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.311684614,0.008871897,primaquine
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-2.329036433,0.021223202,carbenoxolone
RAC1_GTPASE_CYCLE,-1.847089142,0.206926221,carbenoxolone
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.817288638,0.162269066,carbenoxolone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,2.007979798,0.331084658,carbenoxolone
CDC42_GTPASE_CYCLE,-1.811046506,0.126675988,carbenoxolone
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.779907069,0.118319352,carbenoxolone
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-1.486741583,0.400809015,carbenoxolone
NEUTROPHIL_DEGRANULATION,1.672115179,1,carbenoxolone
CELL_CYCLE_MITOTIC,1.655070885,1,carbenoxolone
ONCOGENIC_MAPK_SIGNALING,-1.340724173,0.653181944,carbenoxolone
NEURONAL_SYSTEM,2.120066983,0.039580937,alprostadil
MUSCLE_CONTRACTION,1.848539472,0.144995472,alprostadil
L1CAM_INTERACTIONS,1.830024533,0.107972487,alprostadil
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.696216868,0.177912271,alprostadil
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.9971714,1,alprostadil
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.659356807,1,alprostadil
PI3K_AKT_SIGNALING_IN_CANCER,1.420210756,0.563826402,alprostadil
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.632379268,1,alprostadil
MITOTIC_PROPHASE,-1.633155829,1,alprostadil
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.575543839,1,alprostadil
GPCR_LIGAND_BINDING,3.88997793,0,lypressin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.488279516,0,lypressin
SIGNALING_BY_GPCR,3.383602851,0,lypressin
NEURONAL_SYSTEM,2.832745436,0,lypressin
G_ALPHA_Q_SIGNALLING_EVENTS,2.634129596,0.000128994,lypressin
MUSCLE_CONTRACTION,2.705308064,0.000154793,lypressin
CARDIAC_CONDUCTION,2.497303668,0.000884531,lypressin
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.495343274,0.000773965,lypressin
SENSORY_PERCEPTION,2.317193082,0.002579882,lypressin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.281364329,0.002863669,lypressin
TRANSLATION,-2.847523406,0,dofetilide
GPCR_LIGAND_BINDING,2.816169357,0,dofetilide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.646213533,0,dofetilide
SARS_COV_1_INFECTION,-2.64066245,0.001398601,dofetilide
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.441863834,0.000201967,dofetilide
NEUTROPHIL_DEGRANULATION,-2.369909427,0.004662005,dofetilide
MITOCHONDRIAL_TRANSLATION,-2.364296366,0.003496503,dofetilide
SIGNALING_BY_GPCR,2.243530895,0.003180985,dofetilide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.187271652,0.021258741,dofetilide
M_PHASE,-2.060788387,0.031701632,dofetilide
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.963329188,0.33085717,KD-025
HCMV_INFECTION,1.728933762,0.41603689,KD-025
METABOLISM_OF_NUCLEOTIDES,1.66815948,0.28184642,KD-025
SIGNALING_BY_NTRKS,1.634946477,0.224734213,KD-025
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.827310271,0.581017469,KD-025
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.595585303,0.21173306,KD-025
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.542408751,0.228077366,KD-025
PROTEIN_UBIQUITINATION,-1.786104104,0.557817118,KD-025
SIGNALING_BY_NUCLEAR_RECEPTORS,1.451049156,0.306765296,KD-025
RAC1_GTPASE_CYCLE,1.382715571,0.373186152,KD-025
RESPIRATORY_ELECTRON_TRANSPORT,4.267057215,0,tirofiban
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.487048191,0,tirofiban
STIMULI_SENSING_CHANNELS,-2.394630239,0.003529646,tirofiban
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.594053669,0.003317914,tirofiban
PROTEIN_LOCALIZATION,2.310832233,0.006221088,tirofiban
GPCR_LIGAND_BINDING,-2.334469249,0.007941704,tirofiban
ION_CHANNEL_TRANSPORT,-2.318156806,0.005882744,tirofiban
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,2.260176187,0.007962993,tirofiban
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.251546599,0.011250747,tirofiban
NEUTROPHIL_DEGRANULATION,2.063413755,0.02073696,tirofiban
TRNA_PROCESSING,2.866252692,0,dexloxiglumide
GLUCOSE_METABOLISM,2.69214536,0,dexloxiglumide
TRNA_PROCESSING_IN_THE_NUCLEUS,2.337384691,0.008020939,dexloxiglumide
SNRNP_ASSEMBLY,2.147420152,0.025566743,dexloxiglumide
G2_M_CHECKPOINTS,2.06838506,0.036094225,dexloxiglumide
NEDDYLATION,1.956117609,0.058151807,dexloxiglumide
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.921305085,0.069610291,dexloxiglumide
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,1.799363496,0.130089602,dexloxiglumide
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.925176347,0.201283631,dexloxiglumide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.735635891,0.157745131,dexloxiglumide
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2.108055462,0.108348135,dicycloverine
SENSORY_PERCEPTION,1.951285047,0.164298401,dicycloverine
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.946354273,0.112492599,dicycloverine
CARDIAC_CONDUCTION,1.935331877,0.090808171,dicycloverine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-3.135078264,1,dicycloverine
SIGNALING_BY_WNT,-3.110492537,0.700963189,dicycloverine
NEURONAL_SYSTEM,1.764224574,0.210479574,dicycloverine
RESPIRATORY_ELECTRON_TRANSPORT,1.694867206,0.255032564,dicycloverine
MUSCLE_CONTRACTION,1.673358601,0.244607968,dicycloverine
BIOLOGICAL_OXIDATIONS,1.643064361,0.24955595,dicycloverine
GPCR_LIGAND_BINDING,2.982165976,0,dactinomycin
SIGNALING_BY_GPCR,2.580975184,0.000544558,dactinomycin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.474581612,0.000726078,dactinomycin
G_ALPHA_I_SIGNALLING_EVENTS,2.175502512,0.012524842,dactinomycin
G_ALPHA_S_SIGNALLING_EVENTS,2.175479676,0.010019874,dactinomycin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,2.123732418,0.013432439,dactinomycin
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1.985391171,0.033140265,dactinomycin
COLLAGEN_DEGRADATION,1.931061212,0.046559739,dactinomycin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.916529149,0.046953031,dactinomycin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.875595615,0.058594478,dactinomycin
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-3.382265364,0.011009444,acepromazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.23956313,0.051744385,acepromazine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.187990212,0.068258551,acepromazine
GPCR_LIGAND_BINDING,2.085606844,0.065841872,acepromazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.084496691,0.134315213,acepromazine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.908976704,0.169493927,acepromazine
G_ALPHA_I_SIGNALLING_EVENTS,1.853037999,0.172101526,acepromazine
SIGNALING_BY_GPCR,1.831578886,0.154174284,acepromazine
G_ALPHA_S_SIGNALLING_EVENTS,1.813112595,0.141592619,acepromazine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.905590634,0.565004648,acepromazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.694812526,0.006802157,buspirone
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.686182369,0.004081294,buspirone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.851036599,0.334346638,buspirone
HEMOSTASIS,-3.46793455,0.535103,buspirone
NEUTROPHIL_DEGRANULATION,-3.287653812,0.944479469,buspirone
INFLUENZA_INFECTION,-2.784929555,1,buspirone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.643959343,0.977243191,buspirone
EUKARYOTIC_TRANSLATION_INITIATION,-2.615291514,0.847354388,buspirone
INNATE_IMMUNE_SYSTEM,-2.614661408,0.742115305,buspirone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.591441847,0.664646297,buspirone
RESPIRATORY_ELECTRON_TRANSPORT,4.589761237,0,acetazolamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,4.236447042,0,acetazolamide
PROTEIN_LOCALIZATION,2.484386189,0.00276394,acetazolamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.349118552,0.005182387,acetazolamide
GPCR_LIGAND_BINDING,-2.231472484,0.013327017,acetazolamide
SIGNALING_BY_GPCR,-2.138316692,0.015409363,acetazolamide
TRANSLATION,2.197024674,0.012437728,acetazolamide
DISEASES_OF_METABOLISM,2.170442409,0.01140125,acetazolamide
DNA_REPLICATION,2.146861719,0.010364773,acetazolamide
SYNTHESIS_OF_DNA,2.146861719,0.010364773,acetazolamide
MITOCHONDRIAL_BIOGENESIS,-1.770355038,0.256793478,epothilone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.551778244,0.385190217,epothilone
RESPIRATORY_ELECTRON_TRANSPORT,-1.536692483,0.277173913,epothilone
DISEASES_OF_METABOLISM,-1.397017846,0.432574728,epothilone
GPCR_LIGAND_BINDING,1.640711219,1,epothilone
SARS_COV_2_INFECTION,1.612772957,1,epothilone
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.234544091,0.701378106,epothilone
DNA_REPLICATION,-1.186129786,0.707492236,epothilone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.183825941,0.613284716,epothilone
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.181987311,0.54066382,epothilone
CELL_CYCLE_MITOTIC,-3.716035244,0,amonafide
CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,-2.610893781,0,amonafide
RHO_GTPASE_EFFECTORS,-2.625062787,0,amonafide
HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,-2.629928228,0,amonafide
ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,-2.675393967,0,amonafide
METABOLISM_OF_RNA,-2.708653242,0,amonafide
ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,-2.711308756,0,amonafide
S_PHASE,-2.715667367,0,amonafide
DNA_STRAND_ELONGATION,-2.759293035,0,amonafide
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.779210257,0,amonafide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.490359496,0.063797669,BRD-K81538844
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.419589734,0.060738877,BRD-K81538844
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.067151474,0.165579295,BRD-K81538844
NONSENSE_MEDIATED_DECAY_NMD,2.04610675,0.094540436,BRD-K81538844
RRNA_PROCESSING,2.045651192,0.063739126,BRD-K81538844
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.359071148,0.083024364,BRD-K81538844
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,1.967949397,0.093739246,BRD-K81538844
EUKARYOTIC_TRANSLATION_ELONGATION,1.964572083,0.077555205,BRD-K81538844
EUKARYOTIC_TRANSLATION_INITIATION,1.953276583,0.070148647,BRD-K81538844
METABOLISM_OF_RNA,1.940219672,0.066842148,BRD-K81538844
VIRAL_MESSENGER_RNA_SYNTHESIS,2.630618036,0.009891352,fingolimod
TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,2.630618036,0.009891352,fingolimod
INFLUENZA_INFECTION,2.453444594,0.008792313,fingolimod
HIV_INFECTION,2.277208862,0.029674056,fingolimod
KEAP1_NFE2L2_PATHWAY,2.269536018,0.023739245,fingolimod
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.19381015,0.026376939,fingolimod
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,2.064250289,0.04521761,fingolimod
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,2.027582605,0.048632481,fingolimod
HOST_INTERACTIONS_OF_HIV_FACTORS,1.980080745,0.051288493,fingolimod
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.973104069,0.049456761,fingolimod
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.238449951,0.032683079,sertindole
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.175848694,0.039340743,sertindole
MITOTIC_METAPHASE_AND_ANAPHASE,-2.083270833,0.059717231,sertindole
CELL_CYCLE_MITOTIC,-2.041863557,0.069602854,sertindole
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.038478284,0.056166477,sertindole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.981089113,0.105213622,sertindole
MRNA_SPLICING,-2.011674236,0.061129463,sertindole
M_PHASE,-1.996219005,0.060351294,sertindole
CELL_CYCLE,-1.98058971,0.060978152,sertindole
PROTEIN_LOCALIZATION,1.880692618,0.102119103,sertindole
CELLULAR_RESPONSE_TO_STARVATION,2.550598695,0.003607347,dofequidar
EUKARYOTIC_TRANSLATION_ELONGATION,2.460670116,0.003156429,dofequidar
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.418891753,0.003306735,dofequidar
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.402089545,0.003156429,dofequidar
RRNA_PROCESSING,2.380593806,0.003066245,dofequidar
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.364854216,0.002319009,dofequidar
RESPIRATORY_ELECTRON_TRANSPORT,2.36967387,0.00270551,dofequidar
SELENOAMINO_ACID_METABOLISM,2.341509162,0.00293097,dofequidar
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.545265171,0.099882825,dofequidar
GPCR_LIGAND_BINDING,-2.526702348,0.056848203,dofequidar
G2_M_DNA_DAMAGE_CHECKPOINT,2.032966669,0.083896785,naproxen
UB_SPECIFIC_PROCESSING_PROTEASES,1.870376501,0.134676418,naproxen
G_ALPHA_Q_SIGNALLING_EVENTS,-1.943401112,0.195661421,naproxen
FORMATION_OF_PARAXIAL_MESODERM,1.738236501,0.192815418,naproxen
UNFOLDED_PROTEIN_RESPONSE_UPR,1.736390206,0.146819374,naproxen
PROTEASOME_ASSEMBLY,1.695245657,0.154988271,naproxen
C_TYPE_LECTIN_RECEPTORS_CLRS,1.640226234,0.179200589,naproxen
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.633600703,0.158331526,naproxen
G2_M_CHECKPOINTS,1.622497666,0.148751207,naproxen
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,1.599418085,0.135338761,naproxen
EUKARYOTIC_TRANSLATION_ELONGATION,3.653026156,0,andarine
SARS_COV_1_INFECTION,2.620267692,0,andarine
SARS_COV_1_HOST_INTERACTIONS,2.642087171,0,andarine
METABOLISM_OF_RNA,2.668945667,0,andarine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,2.781808413,0,andarine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.793907047,0,andarine
SIGNALING_BY_ROBO_RECEPTORS,2.837574901,0,andarine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2.86677132,0,andarine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.953471687,0,andarine
INFLUENZA_INFECTION,3.019050982,0,andarine
SENSORY_PERCEPTION,2.635972118,0,alverine
GPCR_LIGAND_BINDING,2.420154625,0.000342883,alverine
G_ALPHA_I_SIGNALLING_EVENTS,2.335570941,0.001371532,alverine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.285399437,0.001885856,alverine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.236584241,0.002331604,alverine
SIGNALING_BY_GPCR,2.103411777,0.008343485,alverine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,-3.492663627,0.555319945,alverine
VISUAL_PHOTOTRANSDUCTION,2.020010492,0.016556349,alverine
PI3K_AKT_SIGNALING_IN_CANCER,-3.439637869,0.379817887,alverine
MAPK1_MAPK3_SIGNALING,-3.165070769,0.762255208,alverine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.271100796,0.443397143,BRD-K57044355
G_ALPHA_Q_SIGNALLING_EVENTS,2.053354534,0.085589092,BRD-K57044355
PEPTIDE_LIGAND_BINDING_RECEPTORS,-3.013478176,1,BRD-K57044355
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.778636905,0.444427145,BRD-K57044355
G_ALPHA_I_SIGNALLING_EVENTS,-2.664808141,1,BRD-K57044355
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.597552681,1,BRD-K57044355
NEUTROPHIL_DEGRANULATION,-2.565468073,1,BRD-K57044355
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.364723981,1,BRD-K57044355
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.310198492,1,BRD-K57044355
NCAM1_INTERACTIONS,1.717685298,0.485004856,BRD-K57044355
GPCR_LIGAND_BINDING,2.479285779,0.002370279,sulfasalazine
SIGNALING_BY_GPCR,2.32988378,0.002370279,sulfasalazine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.317473091,0.001777709,sulfasalazine
NEURONAL_SYSTEM,2.245719122,0.002666564,sulfasalazine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.24278063,0.002133251,sulfasalazine
CHROMOSOME_MAINTENANCE,-2.423061806,0.049256461,sulfasalazine
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.416501257,0.025699023,sulfasalazine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-2.392443859,0.022129714,sulfasalazine
CELL_CYCLE,-2.361481942,0.020880456,sulfasalazine
L1CAM_INTERACTIONS,2.113277818,0.00612322,sulfasalazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.539604007,0.005203596,nialamide
EUKARYOTIC_TRANSLATION_INITIATION,2.375123352,0.009392225,nialamide
NONSENSE_MEDIATED_DECAY_NMD,2.345577248,0.004696112,nialamide
CELLULAR_RESPONSE_TO_STARVATION,2.314906756,0.00430477,nialamide
RRNA_PROCESSING,2.309557,0.003522084,nialamide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.276238049,0.00375689,nialamide
EUKARYOTIC_TRANSLATION_ELONGATION,2.273934576,0.003130742,nialamide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.259609677,0.002851211,nialamide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.240972814,0.002788317,nialamide
SIGNALING_BY_ROBO_RECEPTORS,2.227007744,0.002869846,nialamide
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.348714438,0.022268663,idarubicin
HIV_LIFE_CYCLE,2.054219519,0.29021424,idarubicin
METABOLISM_OF_STEROIDS,2.022303142,0.183699439,idarubicin
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.989024464,0.155055362,idarubicin
HIV_INFECTION,1.968011515,0.13790322,idarubicin
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.9176165,0.15992657,idarubicin
INTERFERON_GAMMA_SIGNALING,-1.620557362,0.449655692,idarubicin
RRNA_PROCESSING,1.864296906,0.198793324,idarubicin
COPII_MEDIATED_VESICLE_TRANSPORT,1.853593473,0.183772948,idarubicin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.535185144,0.448228214,idarubicin
G2_M_CHECKPOINTS,-3.482458311,0,vinblastine
CELL_CYCLE,-3.400347162,0,vinblastine
CELL_CYCLE_MITOTIC,-3.368819224,0,vinblastine
CELL_CYCLE_CHECKPOINTS,-3.287009,0,vinblastine
METABOLISM_OF_RNA,-3.196268707,0,vinblastine
DNA_REPLICATION,-3.142229493,0,vinblastine
SYNTHESIS_OF_DNA,-3.126235081,0,vinblastine
S_PHASE,-3.095460474,0,vinblastine
DNA_REPAIR,-3.088034977,0,vinblastine
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-3.012224553,0,vinblastine
GPCR_LIGAND_BINDING,2.265985149,0.007135048,parecoxib
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.222181342,0.006162087,parecoxib
NEUTROPHIL_DEGRANULATION,-2.206375554,0.104733132,parecoxib
SIGNALING_BY_GPCR,2.17142754,0.007783689,parecoxib
G_ALPHA_I_SIGNALLING_EVENTS,2.137788787,0.009891772,parecoxib
SENSORY_PERCEPTION,2.073536264,0.012713359,parecoxib
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-2.011392362,0.163645519,parecoxib
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.047645122,0.013405243,parecoxib
CELL_CYCLE,-1.910429797,0.171064115,parecoxib
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.933190007,0.034192635,parecoxib
NEUTROPHIL_DEGRANULATION,-3.366321891,0,doconexent
INNATE_IMMUNE_SYSTEM,-2.687297546,0,doconexent
RESOLUTION_OF_SISTER_CHROMATID_COHESION,-2.106681049,0.05093133,doconexent
ANTIGEN_PROCESSING_CROSS_PRESENTATION,-2.078331164,0.043377954,doconexent
SEPARATION_OF_SISTER_CHROMATIDS,-2.046601386,0.044543332,doconexent
MITOTIC_METAPHASE_AND_ANAPHASE,-1.795080742,0.13811886,doconexent
RHO_GTPASES_ACTIVATE_FORMINS,-1.780258452,0.126896703,doconexent
PROGRAMMED_CELL_DEATH,-1.719634038,0.153117705,doconexent
SARS_COV_1_INFECTION,-1.714043434,0.141284084,doconexent
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-1.706778113,0.134665889,doconexent
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.656399155,0,benzonatate
NEURONAL_SYSTEM,2.538348186,0,benzonatate
TRANSLATION,-2.636562671,0.006934126,benzonatate
GPCR_LIGAND_BINDING,2.264513205,0.003395575,benzonatate
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.260379365,0.002696486,benzonatate
METABOLISM_OF_RNA,-2.50698172,0.025136206,benzonatate
RRNA_PROCESSING,-2.464735681,0.01964669,benzonatate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.038962455,0.013901883,benzonatate
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.259860601,0.069341258,benzonatate
SIGNALING_BY_ROBO_RECEPTORS,-2.177023532,0.1047053,benzonatate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.468712473,0.00309813,reserpine
RESPIRATORY_ELECTRON_TRANSPORT,2.216799985,0.013167052,reserpine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.244652329,0.156975862,reserpine
ION_CHANNEL_TRANSPORT,-2.228372062,0.090163821,reserpine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.114292,0.141840448,reserpine
CDC42_GTPASE_CYCLE,-2.050314878,0.176760009,reserpine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.043463699,0.150489256,reserpine
MEMBRANE_TRAFFICKING,-2.039965905,0.128434796,reserpine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-1.953622881,0.198860802,reserpine
RHOA_GTPASE_CYCLE,-1.897474596,0.250058655,reserpine
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.818098752,0.954859898,epinastine
SIGNALING_BY_NTRKS,1.490766329,0.745381714,epinastine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.455796885,0.440205344,epinastine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.743794609,0.993641255,epinastine
G_ALPHA_I_SIGNALLING_EVENTS,-1.647611005,1,epinastine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.237950304,0.808903408,epinastine
PROTEIN_LOCALIZATION,-1.639207468,1,epinastine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.201345667,0.710807763,epinastine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.606550038,1,epinastine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.163612754,0.668611208,epinastine
SARS_COV_1_HOST_INTERACTIONS,-2.120776308,0.043095127,piclamilast
NONSENSE_MEDIATED_DECAY_NMD,-2.027301252,0.069898193,piclamilast
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.02506234,0.04835063,piclamilast
EUKARYOTIC_TRANSLATION_ELONGATION,-2.011231385,0.045197328,piclamilast
EUKARYOTIC_TRANSLATION_INITIATION,-2.001560893,0.040152045,piclamilast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.990702438,0.037839623,piclamilast
SIGNALING_BY_ROBO_RECEPTORS,-1.950365229,0.049551888,piclamilast
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.923982516,0.055576947,piclamilast
CELLULAR_RESPONSE_TO_STARVATION,-1.919627579,0.051971088,piclamilast
SELENOAMINO_ACID_METABOLISM,-1.907568483,0.053080583,piclamilast
PTEN_REGULATION,2.010088466,0.246337718,promazine
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.783676972,0.539735237,promazine
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.774088866,0.38654881,promazine
PCP_CE_PATHWAY,1.738276988,0.363987218,promazine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-1.973627863,1,promazine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,1.673034219,0.420633274,promazine
RESPIRATORY_ELECTRON_TRANSPORT,1.642913101,0.402429071,promazine
INTERLEUKIN_1_SIGNALING,1.641054033,0.348923102,promazine
INTERLEUKIN_1_FAMILY_SIGNALING,1.634467992,0.31765365,promazine
TRANSLATION,1.604361631,0.331548879,promazine
RESPIRATORY_ELECTRON_TRANSPORT,4.2466992,0,efaproxiral
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.317558159,0,efaproxiral
PROTEIN_LOCALIZATION,2.419591952,0.004409609,efaproxiral
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.889546384,0.088881172,efaproxiral
SARS_COV_2_INFECTION,-3.188402169,0.262160277,efaproxiral
DISEASES_OF_METABOLISM,1.797591046,0.110791414,efaproxiral
NEUTROPHIL_DEGRANULATION,1.783216178,0.099491793,efaproxiral
ION_CHANNEL_TRANSPORT,-3.163821786,0.208922951,efaproxiral
TRANSLATION,1.653321195,0.171029817,efaproxiral
GLYCOSAMINOGLYCAN_METABOLISM,1.627792921,0.168667527,efaproxiral
GPCR_LIGAND_BINDING,2.38696474,0,argatroban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.289728346,0.002982309,argatroban
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.2219214,0.006406443,argatroban
SIGNALING_BY_GPCR,2.152810608,0.010438083,argatroban
NEUTROPHIL_DEGRANULATION,-2.080857057,0.181189397,argatroban
TRANSLATION,-1.959620084,0.152645862,argatroban
MITOCHONDRIAL_TRANSLATION,-1.916372009,0.136512559,argatroban
SENSORY_PERCEPTION,2.04615389,0.022267911,argatroban
G_ALPHA_I_SIGNALLING_EVENTS,1.997367561,0.029491727,argatroban
PROTEIN_LOCALIZATION,-1.830066319,0.180568885,argatroban
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.025775794,1,toremifene
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.854611371,0.737213917,toremifene
INTERFERON_GAMMA_SIGNALING,-1.704423607,1,toremifene
INFLUENZA_INFECTION,-1.616780502,1,toremifene
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.596721349,1,toremifene
SIGNALING_BY_INTERLEUKINS,-1.532080294,1,toremifene
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,-1.500201986,1,toremifene
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.691177356,1,toremifene
SELENOAMINO_ACID_METABOLISM,-1.489687906,1,toremifene
PROTEIN_FOLDING,-1.453946265,1,toremifene
GPCR_LIGAND_BINDING,2.093571266,0.075160417,BRD-K92073408
SIGNALING_BY_GPCR,2.034613481,0.068168751,BRD-K92073408
G_ALPHA_S_SIGNALLING_EVENTS,1.940846792,0.10021389,BRD-K92073408
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.863034767,0.149883856,BRD-K92073408
G_ALPHA_I_SIGNALLING_EVENTS,1.835414576,0.14979646,BRD-K92073408
CARDIAC_CONDUCTION,1.831197634,0.129200175,BRD-K92073408
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.810256727,0.12997009,BRD-K92073408
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.799723116,0.12377435,BRD-K92073408
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.332319662,1,BRD-K92073408
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.330925666,1,BRD-K92073408
RESPIRATORY_ELECTRON_TRANSPORT,3.284286891,0,sulfinpyrazone
TRANSLATION,2.658540159,0,sulfinpyrazone
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.558797071,0.00035014,sulfinpyrazone
EUKARYOTIC_TRANSLATION_INITIATION,2.453287269,0.001313025,sulfinpyrazone
RRNA_PROCESSING,2.410407202,0.001260504,sulfinpyrazone
BIOLOGICAL_OXIDATIONS,2.19018586,0.007878151,sulfinpyrazone
REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,-2.142486412,0.057128217,sulfinpyrazone
MITF_M_DEPENDENT_GENE_EXPRESSION,-2.024125783,0.102929287,sulfinpyrazone
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,-1.937036687,0.150371973,sulfinpyrazone
METABOLISM_OF_NUCLEOTIDES,1.789991734,0.093337335,sulfinpyrazone
G_ALPHA_S_SIGNALLING_EVENTS,2.168832379,0.036415917,fluocinolone
GASTRULATION,-2.91955821,0.302622104,fluocinolone
GPCR_LIGAND_BINDING,2.041641153,0.06819059,fluocinolone
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-2.886068449,0.248305316,fluocinolone
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.86221242,0.231234326,fluocinolone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.851650224,0.194376505,fluocinolone
SIGNALING_BY_GPCR,1.893380931,0.160182433,fluocinolone
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.864460792,0.148519819,fluocinolone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.775980273,0.414669878,fluocinolone
VISUAL_PHOTOTRANSDUCTION,-2.732138546,0.528942054,fluocinolone
INFLUENZA_INFECTION,-2.794730926,0.011542546,zolmitriptan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.55670905,0.01500531,zolmitriptan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.494175398,0.015390061,zolmitriptan
SELENOAMINO_ACID_METABOLISM,-2.41351399,0.02135371,zolmitriptan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.348569913,0.029087215,zolmitriptan
EUKARYOTIC_TRANSLATION_INITIATION,-2.297280348,0.034242886,zolmitriptan
TRANSLATION,-2.155916535,0.075851015,zolmitriptan
RRNA_PROCESSING,-2.05267144,0.120908168,zolmitriptan
SENSORY_PERCEPTION,1.928057965,0.404720839,zolmitriptan
TRNA_PROCESSING,-1.831301497,0.305236212,zolmitriptan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.057534563,0.452591611,IC-261
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.827456704,0.672499846,IC-261
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.000227042,0.587583686,IC-261
EXTRA_NUCLEAR_ESTROGEN_SIGNALING,1.704757806,0.710733871,IC-261
NEURONAL_SYSTEM,1.682144185,0.534578019,IC-261
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.957505735,0.710467381,IC-261
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.941963271,0.634462752,IC-261
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.617565737,0.5619878,IC-261
CELL_JUNCTION_ORGANIZATION,1.576033631,0.552036478,IC-261
COLLAGEN_FORMATION,1.57469892,0.463871259,IC-261
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.431046943,0.019460735,cilostazol
ECM_PROTEOGLYCANS,-2.290865815,0.037840317,cilostazol
INTERLEUKIN_12_FAMILY_SIGNALING,-2.182033097,0.066310651,cilostazol
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.154837193,0.060003931,cilostazol
HEMOSTASIS,-2.111920847,0.058814664,cilostazol
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.049041908,0.072797562,cilostazol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.985743763,0.089581159,cilostazol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.907359517,0.123521607,cilostazol
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.861376565,0.142231541,cilostazol
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.801243704,0.182498444,cilostazol
CELLULAR_RESPONSE_TO_STARVATION,2.701691889,0,doxazosin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.556537467,0.000422579,doxazosin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.508930797,0.000281719,doxazosin
SELENOAMINO_ACID_METABOLISM,2.427056277,0.000845158,doxazosin
EUKARYOTIC_TRANSLATION_ELONGATION,2.418338995,0.001183221,doxazosin
RESPIRATORY_ELECTRON_TRANSPORT,2.378192701,0.001408596,doxazosin
TRANSLATION,2.211368362,0.004587998,doxazosin
ION_CHANNEL_TRANSPORT,-2.561312903,0.136313668,doxazosin
RRNA_PROCESSING,2.108910952,0.011620917,doxazosin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.064826536,0.013992054,doxazosin
GPCR_LIGAND_BINDING,2.642160276,0,W-7
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.535779579,0,W-7
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.454376919,0,W-7
G_ALPHA_I_SIGNALLING_EVENTS,2.025153651,0.027426469,W-7
SIGNALING_BY_GPCR,2.004096829,0.028614007,W-7
POTASSIUM_CHANNELS,1.870494316,0.072194761,W-7
NEURONAL_SYSTEM,1.829493874,0.082562154,W-7
G_ALPHA_S_SIGNALLING_EVENTS,1.813234802,0.080370864,W-7
VOLTAGE_GATED_POTASSIUM_CHANNELS,1.782583635,0.09085607,W-7
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.826446147,1,W-7
GPCR_LIGAND_BINDING,2.304057999,0.003554249,diltiazem
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.477248195,0.059548872,diltiazem
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.357955322,0.14887218,diltiazem
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.009546419,0.058898985,diltiazem
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.966569542,0.058560485,diltiazem
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1.890038291,0.071592731,diltiazem
SIGNALING_BY_GPCR,1.890293953,0.089490914,diltiazem
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.117822174,1,diltiazem
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.962952419,1,diltiazem
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.66903008,1,diltiazem
TRNA_PROCESSING,2.232042648,0.061904762,bopindolol
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.217794896,0.038095238,bopindolol
S_PHASE,2.083796852,0.079365079,bopindolol
MITOTIC_SPINDLE_CHECKPOINT,2.062864762,0.066666667,bopindolol
MITOTIC_METAPHASE_AND_ANAPHASE,2.032986759,0.06,bopindolol
M_PHASE,2.011954315,0.061904762,bopindolol
MITOTIC_PROMETAPHASE,1.991577137,0.055102041,bopindolol
CELL_CYCLE_CHECKPOINTS,1.961454973,0.056547619,bopindolol
GLUCOSE_METABOLISM,1.821184704,0.097354497,bopindolol
RESOLUTION_OF_SISTER_CHROMATID_COHESION,1.743165345,0.13,bopindolol
SENSORY_PERCEPTION,2.376625084,0.017556112,ropinirole
CELL_CELL_COMMUNICATION,2.233969128,0.03149773,ropinirole
RSV_HOST_INTERACTIONS,2.055928294,0.094321072,ropinirole
MAPK_FAMILY_SIGNALING_CASCADES,2.046927311,0.077711613,ropinirole
VISUAL_PHOTOTRANSDUCTION,1.918150952,0.162135857,ropinirole
MAPK1_MAPK3_SIGNALING,1.898374627,0.155595345,ropinirole
BIOLOGICAL_OXIDATIONS,-1.656293641,0.952687625,ropinirole
BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1.840502516,0.195625247,ropinirole
SIGNALING_BY_FGFR2,1.839332443,0.172592071,ropinirole
HEMOSTASIS,1.827603376,0.165807724,ropinirole
NEUTROPHIL_DEGRANULATION,1.972111619,0.636201121,terbutaline
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.720419219,0.785222274,terbutaline
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.884494835,0.61405488,terbutaline
SIGNALING_BY_HEDGEHOG,1.840930624,0.555333785,terbutaline
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.836557997,0.427321797,terbutaline
SARS_COV_2_HOST_INTERACTIONS,-1.561795973,0.855901961,terbutaline
HEMOSTASIS,1.799402625,0.437690265,terbutaline
INFLUENZA_INFECTION,-1.469980722,0.845251598,terbutaline
SUMOYLATION,-1.429563594,0.748188055,terbutaline
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.726677479,0.590901991,terbutaline
TRANSLATION,-2.863849489,0,cerivastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.199868254,0.025334389,cerivastatin
EUKARYOTIC_TRANSLATION_INITIATION,-2.179513071,0.018667444,cerivastatin
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-2.110156238,0.023334306,cerivastatin
SELENOAMINO_ACID_METABOLISM,-2.095551603,0.019734156,cerivastatin
INFLUENZA_INFECTION,-1.994468144,0.032445796,cerivastatin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.955962147,0.026667778,cerivastatin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.955962147,0.026667778,cerivastatin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.955962147,0.026667778,cerivastatin
NONSENSE_MEDIATED_DECAY_NMD,-1.88479677,0.0408017,cerivastatin
GPCR_LIGAND_BINDING,2.383972273,0.004425414,brimonidine
CARDIAC_CONDUCTION,2.143781844,0.018586738,brimonidine
SIGNALING_BY_GPCR,2.12082222,0.016226517,brimonidine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.113026548,0.013497512,brimonidine
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,-1.995107399,0.230216778,brimonidine
SENSORY_PERCEPTION,1.943705907,0.047794469,brimonidine
MUSCLE_CONTRACTION,1.866531749,0.067413804,brimonidine
G_ALPHA_I_SIGNALLING_EVENTS,1.860400052,0.059300545,brimonidine
TRANSLATION,-1.843025872,0.281712637,brimonidine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.85386799,0.053658143,brimonidine
GPCR_LIGAND_BINDING,1.956518374,0.275468028,buphenine
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.276842669,1,buphenine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.26040745,0.72524622,buphenine
POTASSIUM_CHANNELS,1.846475499,0.317324858,buphenine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.786530049,0.331754136,buphenine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.019412115,1,buphenine
G_ALPHA_S_SIGNALLING_EVENTS,1.706194125,0.43788684,buphenine
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.854421525,1,buphenine
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.689049959,0.392810253,buphenine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.701190903,1,buphenine
TRANSLATION,-2.569230442,0.008031395,modafinil
NONSENSE_MEDIATED_DECAY_NMD,-2.263568049,0.03614128,modafinil
SARS_COV_1_INFECTION,-2.247429443,0.02944845,modafinil
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.230874136,0.015833147,modafinil
INFLUENZA_INFECTION,-2.188194739,0.032125582,modafinil
CELLULAR_RESPONSES_TO_STIMULI,-2.138484869,0.039353838,modafinil
METABOLISM_OF_RNA,-2.103991916,0.038818411,modafinil
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.132314945,0.018660495,modafinil
MITOCHONDRIAL_PROTEIN_DEGRADATION,-2.079173782,0.039583306,modafinil
GPCR_LIGAND_BINDING,2.118169421,0.014702208,modafinil
NEURONAL_SYSTEM,2.025551719,0.14962347,BRD-K82216340
G_ALPHA_S_SIGNALLING_EVENTS,1.998226218,0.093764041,BRD-K82216340
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.98244762,0.069602622,BRD-K82216340
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.899578202,0.105567671,BRD-K82216340
SIGNALING_BY_GPCR,1.845437593,0.127013701,BRD-K82216340
GPCR_LIGAND_BINDING,1.837087789,0.112383851,BRD-K82216340
G_ALPHA_I_SIGNALLING_EVENTS,1.766649697,0.167008292,BRD-K82216340
EUKARYOTIC_TRANSLATION_INITIATION,-2.093094813,1,BRD-K82216340
CARDIAC_CONDUCTION,1.737674325,0.178966295,BRD-K82216340
INFLUENZA_INFECTION,-2.002777594,1,BRD-K82216340
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.54387481,0,domperidone
SENSORY_PERCEPTION,2.484234331,0,domperidone
GPCR_LIGAND_BINDING,2.447310976,0,domperidone
G_ALPHA_I_SIGNALLING_EVENTS,2.299873537,0.001558567,domperidone
SIGNALING_BY_GPCR,2.242307939,0.002119651,domperidone
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.193255369,0.003013229,domperidone
VISUAL_PHOTOTRANSDUCTION,2.127833483,0.004987413,domperidone
POTASSIUM_CHANNELS,2.038257721,0.010676181,domperidone
TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,-3.157124927,1,domperidone
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-3.119639509,0.850535695,domperidone
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.007477465,0.657111347,trimetazidine
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.690571824,0.338823827,trimetazidine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.666705558,0.190201365,trimetazidine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.636740946,0.153635521,trimetazidine
ADIPOGENESIS,1.598391515,0.14397801,trimetazidine
G_ALPHA_I_SIGNALLING_EVENTS,-1.925865229,0.594433034,trimetazidine
SIGNALING_BY_NUCLEAR_RECEPTORS,1.46160849,0.239742186,trimetazidine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.418234496,0.249768304,trimetazidine
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.765954037,1,trimetazidine
SIGNALING_BY_GPCR,-1.754907475,0.883309292,trimetazidine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.239785023,0.017332217,colchicine
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.216897176,0.00917588,colchicine
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.098389325,0.026508097,colchicine
COLLAGEN_FORMATION,-2.074328027,0.027782524,colchicine
DEVELOPMENTAL_CELL_LINEAGES,-2.047634977,0.030382357,colchicine
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-1.991316005,0.042650848,colchicine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.915451909,0.072824441,colchicine
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-1.898970269,0.073407037,colchicine
SIGNALING_BY_GPCR,-1.887172931,0.071934365,colchicine
ECM_PROTEOGLYCANS,-1.876924508,0.071469906,colchicine
SARS_COV_1_HOST_INTERACTIONS,-1.940292502,0.284865816,E-2012
CELL_CELL_COMMUNICATION,1.804080747,0.262184686,E-2012
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.869019069,0.31035381,E-2012
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.868158288,0.209234775,E-2012
SARS_COV_1_INFECTION,-1.784953718,0.350085095,E-2012
EUKARYOTIC_TRANSLATION_ELONGATION,-1.77321441,0.308454705,E-2012
EUKARYOTIC_TRANSLATION_INITIATION,-1.752442951,0.307188634,E-2012
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-1.751339181,0.266017552,E-2012
NONSENSE_MEDIATED_DECAY_NMD,-1.746998681,0.239012415,E-2012
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.736514517,0.231668652,E-2012
MUSCLE_CONTRACTION,2.416839628,0.001305824,propoxycaine
GPCR_LIGAND_BINDING,2.186875658,0.0081614,propoxycaine
SIGNALING_BY_GPCR,1.993293952,0.019804997,propoxycaine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.763253113,0.049458083,propoxycaine
NEURONAL_SYSTEM,1.570407656,0.116610081,propoxycaine
CDC42_GTPASE_CYCLE,1.515925049,0.129276574,propoxycaine
NONSENSE_MEDIATED_DECAY_NMD,-2.167060954,1,propoxycaine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.165190542,1,propoxycaine
SELENOAMINO_ACID_METABOLISM,-2.131474416,1,propoxycaine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.066311395,0.963590846,propoxycaine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-3.704035498,0.084654577,triamcinolone
SIGNALING_BY_INTERLEUKINS,-3.109438688,1,triamcinolone
NEUTROPHIL_DEGRANULATION,-2.702801749,1,triamcinolone
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.007173207,1,triamcinolone
TRANSPORT_OF_SMALL_MOLECULES,-1.840034839,1,triamcinolone
BIOLOGICAL_OXIDATIONS,-1.740808365,0.979085759,triamcinolone
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1.770130779,0.94012584,triamcinolone
INNATE_IMMUNE_SYSTEM,-1.65577145,0.90224921,triamcinolone
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-1.593734599,0.833077992,triamcinolone
MAPK1_MAPK3_SIGNALING,1.74919807,0.543573477,triamcinolone
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-2.772140978,0.678607858,bisacodyl
NONSENSE_MEDIATED_DECAY_NMD,1.898824012,0.526599365,bisacodyl
EUKARYOTIC_TRANSLATION_ELONGATION,1.862699668,0.355475909,bisacodyl
SIGNALING_BY_WNT,-2.383861015,1,bisacodyl
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.269688688,1,bisacodyl
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.173232503,0.897348933,bisacodyl
CELLULAR_RESPONSE_TO_STARVATION,1.791510743,0.424750326,bisacodyl
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.106892663,0.766575544,bisacodyl
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,1.778755118,0.35099512,bisacodyl
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.756903903,0.335760438,bisacodyl
NEURONAL_SYSTEM,2.711527115,0,MEK-162
CELL_CYCLE,-2.634933495,0,MEK-162
CELL_CYCLE_MITOTIC,-2.582520482,0,MEK-162
CHROMOSOME_MAINTENANCE,-2.502978309,0.000358933,MEK-162
DNA_REPLICATION,-2.488452445,0.0002692,MEK-162
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,-2.431341364,0.000646079,MEK-162
S_PHASE,-2.409981823,0.0005384,MEK-162
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.350057388,0.000717866,MEK-162
CELL_CYCLE_CHECKPOINTS,-2.361761251,0.000587345,MEK-162
MITOTIC_SPINDLE_CHECKPOINT,-2.377307155,0.000598222,MEK-162
RESPIRATORY_ELECTRON_TRANSPORT,2.454828283,0.003220769,TG-100115
DISEASES_OF_METABOLISM,1.810843027,0.336570369,TG-100115
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.794407187,0.24692563,TG-100115
SARS_COV_2_INFECTION,-3.32516746,0.945008144,TG-100115
SARS_COV_INFECTIONS,-3.276811723,0.454750558,TG-100115
ION_CHANNEL_TRANSPORT,-3.277683655,0.679194064,TG-100115
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.694058479,0.304094281,TG-100115
TRANSPORT_OF_SMALL_MOLECULES,-3.22135248,0.433169452,TG-100115
AUTOPHAGY,1.638936276,0.313488191,TG-100115
VIRAL_INFECTION_PATHWAYS,-2.904155074,0.60453158,TG-100115
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.331933979,0.056257041,BRD-K73589401
NONSENSE_MEDIATED_DECAY_NMD,2.055497734,0.207958144,BRD-K73589401
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.238350094,0.112094254,BRD-K73589401
RRNA_PROCESSING,1.959242206,0.233000224,BRD-K73589401
EUKARYOTIC_TRANSLATION_INITIATION,1.911397204,0.236266582,BRD-K73589401
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.164136192,0.195080387,BRD-K73589401
EUKARYOTIC_TRANSLATION_ELONGATION,1.887093243,0.213402074,BRD-K73589401
METABOLISM_OF_RNA,1.850275558,0.22233012,BRD-K73589401
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,1.830602424,0.219571862,BRD-K73589401
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.822431918,0.203447458,BRD-K73589401
RESPIRATORY_ELECTRON_TRANSPORT,2.662333665,0,orlistat
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.070551682,0.05678967,orlistat
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.256614978,0.233363214,orlistat
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.99591004,0.061522143,orlistat
ECM_PROTEOGLYCANS,-2.237258716,0.141496247,orlistat
GPCR_LIGAND_BINDING,-2.171273553,0.149591804,orlistat
METABOLISM_OF_STEROIDS,1.927254621,0.07919497,orlistat
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.155060868,0.123545231,orlistat
G_ALPHA_S_SIGNALLING_EVENTS,-2.142682795,0.105805403,orlistat
SIGNALING_BY_GPCR,-2.123204347,0.098202619,orlistat
EUKARYOTIC_TRANSLATION_ELONGATION,2.738543407,0,BRD-K77245796
CELLULAR_RESPONSE_TO_STARVATION,2.737253899,0,BRD-K77245796
NONSENSE_MEDIATED_DECAY_NMD,2.703505502,0,BRD-K77245796
SELENOAMINO_ACID_METABOLISM,2.624024276,0,BRD-K77245796
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.605234993,0.00026795,BRD-K77245796
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.580565837,0.000223292,BRD-K77245796
EUKARYOTIC_TRANSLATION_INITIATION,2.5648732,0.000191393,BRD-K77245796
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.539203318,0.000167469,BRD-K77245796
SIGNALING_BY_ROBO_RECEPTORS,2.510445233,0.000297723,BRD-K77245796
RRNA_PROCESSING,2.489073656,0.00026795,BRD-K77245796
GPCR_LIGAND_BINDING,-2.345636078,0.012495332,apixaban
SIGNALING_BY_GPCR,-2.195207535,0.043733663,apixaban
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.136001502,0.050814351,apixaban
DISEASES_OF_METABOLISM,1.939417194,0.340872545,apixaban
G_ALPHA_I_SIGNALLING_EVENTS,-2.030410521,0.096630569,apixaban
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.022300464,0.082802401,apixaban
ION_CHANNEL_TRANSPORT,-1.98297522,0.093853829,apixaban
PEPTIDE_LIGAND_BINDING_RECEPTORS,-1.979402874,0.082231186,apixaban
NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1.649351667,0.867193884,apixaban
RESPIRATORY_ELECTRON_TRANSPORT,1.597779444,0.754747155,apixaban
EUKARYOTIC_TRANSLATION_ELONGATION,-2.808252583,0,sobetirome
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.722420135,0.000561917,sobetirome
SELENOAMINO_ACID_METABOLISM,-2.70816737,0.000374611,sobetirome
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.707630186,0.000280958,sobetirome
NONSENSE_MEDIATED_DECAY_NMD,-2.686766474,0.000224767,sobetirome
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.591438188,0.000749222,sobetirome
EUKARYOTIC_TRANSLATION_INITIATION,-2.579944158,0.000642191,sobetirome
SIGNALING_BY_ROBO_RECEPTORS,-2.53665798,0.000561917,sobetirome
RRNA_PROCESSING,-2.419691399,0.000624352,sobetirome
INFLUENZA_INFECTION,-2.398498252,0.000561917,sobetirome
MITOCHONDRIAL_PROTEIN_DEGRADATION,2.460392546,0.023529412,nepafenac
MITOTIC_PROMETAPHASE,1.928915171,0.308823529,nepafenac
CELL_CYCLE,1.848542312,0.331372549,nepafenac
NEDDYLATION,1.740847519,0.420588235,nepafenac
SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1.717897296,0.385882353,nepafenac
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.698952156,0.292436975,nepafenac
GLUCOSE_METABOLISM,1.698955047,0.341176471,nepafenac
S_PHASE,1.696122336,0.258088235,nepafenac
SNRNP_ASSEMBLY,1.602078333,0.348366013,nepafenac
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.599604771,0.317058824,nepafenac
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.16365487,0,BRD-K47869605
METABOLISM_OF_RNA,-2.672901042,0,BRD-K47869605
CELLULAR_RESPONSE_TO_STARVATION,-2.705021489,0,BRD-K47869605
SIGNALING_BY_ROBO_RECEPTORS,-2.720175627,0,BRD-K47869605
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.79229643,0,BRD-K47869605
TRANSLATION,-2.833988423,0,BRD-K47869605
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.911199754,0,BRD-K47869605
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.915624471,0,BRD-K47869605
INFLUENZA_INFECTION,-2.838073919,0,BRD-K47869605
NONSENSE_MEDIATED_DECAY_NMD,-2.973375201,0,BRD-K47869605
EUKARYOTIC_TRANSLATION_INITIATION,2.716573908,0,PIK-93
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.70881986,0,PIK-93
INFLUENZA_INFECTION,2.681526454,0,PIK-93
EUKARYOTIC_TRANSLATION_ELONGATION,2.645261152,0,PIK-93
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.572035155,0.000244752,PIK-93
NONSENSE_MEDIATED_DECAY_NMD,2.469405186,0.000407921,PIK-93
TRANSLATION,2.390996691,0.000874115,PIK-93
SELENOAMINO_ACID_METABOLISM,2.289711266,0.002141583,PIK-93
METABOLISM_OF_RNA,2.281980541,0.002175576,PIK-93
RRNA_PROCESSING,2.215898631,0.002937028,PIK-93
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.924262636,0.265111492,dipraglurant
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.847503739,0.208439108,dipraglurant
FATTY_ACID_METABOLISM,1.842437986,0.141841052,dipraglurant
PROTEIN_LOCALIZATION,1.809357718,0.126552316,dipraglurant
BIOLOGICAL_OXIDATIONS,1.728885994,0.149461407,dipraglurant
SARS_COV_2_INFECTION,-3.216628,0.996189448,dipraglurant
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.64485109,0.197072613,dipraglurant
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.630371009,0.18058319,dipraglurant
SARS_COV_INFECTIONS,-3.119856117,0.99063824,dipraglurant
ION_CHANNEL_TRANSPORT,-3.082082913,0.746889758,dipraglurant
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2.027371767,0.086365985,desvenlafaxine
RRNA_PROCESSING,1.93646321,0.084151473,desvenlafaxine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.714544987,0.171255629,desvenlafaxine
EUKARYOTIC_TRANSLATION_ELONGATION,1.669361233,0.160275338,desvenlafaxine
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.583104096,0.207721267,desvenlafaxine
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1.543756817,0.211116852,desvenlafaxine
SIGNALING_BY_VEGF,1.419897857,0.33375866,desvenlafaxine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.934060879,1,desvenlafaxine
SELENOAMINO_ACID_METABOLISM,1.37092368,0.370654019,desvenlafaxine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.342388781,0.371053862,desvenlafaxine
SIGNALING_BY_NTRKS,1.984314993,0.083645946,felbinac
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.746147121,0.213827314,felbinac
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.941926873,0.569127413,felbinac
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.624819508,0.307487211,felbinac
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.621493603,0.234149744,felbinac
MUSCLE_CONTRACTION,1.592046972,0.225490622,felbinac
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.853012532,0.641490693,felbinac
SIGNALING_BY_NUCLEAR_RECEPTORS,1.494234424,0.320053738,felbinac
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.455724831,0.335256992,felbinac
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.753163513,0.952457218,felbinac
MITOTIC_G2_G2_M_PHASES,-1.872270544,0.405309033,coumarin
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.862150864,0.220087163,coumarin
NEURONAL_SYSTEM,1.909563757,0.793234242,coumarin
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1.891890538,0.440437276,coumarin
G_ALPHA_S_SIGNALLING_EVENTS,1.88070775,0.31866494,coumarin
GPCR_LIGAND_BINDING,1.835937007,0.322167571,coumarin
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,-1.523900862,0.798512062,coumarin
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,-1.514396575,0.625759377,coumarin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,-1.51430938,0.500607501,coumarin
DISEASES_OF_METABOLISM,-1.485457624,0.483513823,coumarin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.414036211,0.026866876,azacitidine
INTERFERON_ALPHA_BETA_SIGNALING,-2.389893431,0.015185626,azacitidine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.255702954,0.023362501,azacitidine
GPCR_LIGAND_BINDING,2.020505259,0.228732218,azacitidine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.888567585,0.126741568,azacitidine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.714195239,0.235961261,azacitidine
METABOLISM_OF_STEROIDS,-1.585113917,0.357835641,azacitidine
FATTY_ACID_METABOLISM,-1.554359717,0.352440016,azacitidine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,-1.530181171,0.344304859,azacitidine
HEMOSTASIS,-1.46936775,0.405339393,azacitidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.317176801,0,theobromine
RESPIRATORY_ELECTRON_TRANSPORT,3.307208875,0,theobromine
SELENOAMINO_ACID_METABOLISM,3.183276569,0,theobromine
CELLULAR_RESPONSE_TO_STARVATION,3.157698234,0,theobromine
EUKARYOTIC_TRANSLATION_ELONGATION,3.127386184,0,theobromine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.111435825,0,theobromine
METABOLISM_OF_RNA,2.941433291,0,theobromine
NONSENSE_MEDIATED_DECAY_NMD,2.934718661,0,theobromine
GPCR_LIGAND_BINDING,-2.89084976,0,theobromine
RRNA_PROCESSING,2.820077817,0,theobromine
RESPIRATORY_ELECTRON_TRANSPORT,4.506104717,0,conivaptan
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.4767353,0,conivaptan
GPCR_LIGAND_BINDING,-2.30585414,0.002525341,conivaptan
ION_CHANNEL_TRANSPORT,-2.238356556,0.005050682,conivaptan
NEUTROPHIL_DEGRANULATION,2.17845676,0.02339051,conivaptan
PROTEIN_LOCALIZATION,2.088451049,0.029071063,conivaptan
SIGNALING_BY_GPCR,-2.154849979,0.01627442,conivaptan
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.991907911,0.04571174,conivaptan
SENSORY_PERCEPTION,-2.082120743,0.027147417,conivaptan
G_ALPHA_Q_SIGNALLING_EVENTS,-2.06366985,0.025590123,conivaptan
EUKARYOTIC_TRANSLATION_ELONGATION,2.815901539,0,cyproheptadine
NONSENSE_MEDIATED_DECAY_NMD,2.794005768,0,cyproheptadine
EUKARYOTIC_TRANSLATION_INITIATION,2.593118769,0.000161761,cyproheptadine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.758553584,0.000377442,cyproheptadine
SELENOAMINO_ACID_METABOLISM,2.727943871,0.000283081,cyproheptadine
CELLULAR_RESPONSE_TO_STARVATION,2.727539251,0.000226465,cyproheptadine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.705787011,0.000188721,cyproheptadine
DEVELOPMENTAL_CELL_LINEAGES,-2.956729859,0.001615708,cyproheptadine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.547713277,0.000283081,cyproheptadine
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.82187203,0.001211781,cyproheptadine
PROTEIN_LOCALIZATION,2.079522226,0.07980532,roflumilast
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.859330009,0.149476632,roflumilast
ECM_PROTEOGLYCANS,-1.912884656,0.438505973,roflumilast
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.820558853,0.50744141,roflumilast
G_ALPHA_I_SIGNALLING_EVENTS,-1.790212618,0.429250753,roflumilast
METABOLISM_OF_LIPIDS,1.513059116,0.63506456,roflumilast
MITF_M_DEPENDENT_GENE_EXPRESSION,1.449897902,0.640026002,roflumilast
ASPARAGINE_N_LINKED_GLYCOSYLATION,1.441133318,0.535835722,roflumilast
ORGANELLE_BIOGENESIS_AND_MAINTENANCE,1.391802297,0.564126497,roflumilast
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.375339396,0.52190146,roflumilast
CELL_CYCLE,-2.382061966,0.013609836,palonosetron
CELL_CYCLE_CHECKPOINTS,-2.314652107,0.014290328,palonosetron
DEUBIQUITINATION,-2.300448628,0.010887869,palonosetron
CELL_CYCLE_MITOTIC,-2.223217258,0.014290328,palonosetron
M_PHASE,-2.129198992,0.024497705,palonosetron
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,-1.934423636,0.091412732,palonosetron
MITOTIC_METAPHASE_AND_ANAPHASE,-1.896839213,0.109461967,palonosetron
PROGRAMMED_CELL_DEATH,-1.850736899,0.129123319,palonosetron
TRANSCRIPTIONAL_REGULATION_BY_TP53,-1.849666384,0.115683606,palonosetron
RNA_POLYMERASE_II_TRANSCRIPTION,-1.846931066,0.105748426,palonosetron
GPCR_LIGAND_BINDING,-2.938797133,0,TG-100801
CELLULAR_RESPONSE_TO_STARVATION,2.767629428,0.000972418,TG-100801
SIGNALING_BY_GPCR,-2.752101807,0.000508636,TG-100801
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.644041466,0.000486209,TG-100801
EUKARYOTIC_TRANSLATION_ELONGATION,2.444436569,0.000972418,TG-100801
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.526213988,0.001620696,TG-100801
RESPIRATORY_ELECTRON_TRANSPORT,2.476438871,0.001458626,TG-100801
SELENOAMINO_ACID_METABOLISM,2.468054774,0.001166901,TG-100801
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.396522265,0.001250251,TG-100801
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.649477136,0.002373635,TG-100801
TCR_SIGNALING,2.327536742,0.018579235,ceritinib
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-2.023440783,0.021864237,ceritinib
SARS_COV_2_HOST_INTERACTIONS,1.895365752,0.18579235,ceritinib
NEURONAL_SYSTEM,-1.969462517,0.022547495,ceritinib
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1.847523236,0.158955677,ceritinib
S_PHASE,1.788207882,0.170309654,ceritinib
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1.782495694,0.13996357,ceritinib
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1.768337557,0.130054645,ceritinib
RHO_GTPASE_CYCLE,1.767084933,0.112360135,ceritinib
POTASSIUM_CHANNELS,-1.921901586,0.030746584,ceritinib
EUKARYOTIC_TRANSLATION_ELONGATION,-2.56640291,0,quinapril
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.528720976,0.000518069,quinapril
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.468764168,0.000345379,quinapril
NONSENSE_MEDIATED_DECAY_NMD,-2.408196093,0.000518069,quinapril
SIGNALING_BY_ROBO_RECEPTORS,-2.333474738,0.000414455,quinapril
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.324290943,0.000345379,quinapril
SELENOAMINO_ACID_METABOLISM,-2.310943839,0.000296039,quinapril
EUKARYOTIC_TRANSLATION_INITIATION,-2.296359396,0.000518069,quinapril
NERVOUS_SYSTEM_DEVELOPMENT,-2.245674747,0.000690758,quinapril
INFLUENZA_INFECTION,-2.148062089,0.003833707,quinapril
SIGNALING_BY_NTRKS,1.713691137,0.314486563,telcagepant
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.671949316,0.199791463,telcagepant
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.87134233,0.671002094,telcagepant
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.603908998,0.195351653,telcagepant
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.847490037,0.41808592,telcagepant
PROTEIN_UBIQUITINATION,-1.778890947,0.527166773,telcagepant
TP53_REGULATES_METABOLIC_GENES,-1.774735592,0.410343588,telcagepant
SIGNALING_BY_GPCR,-1.772919886,0.333849349,telcagepant
G_ALPHA_I_SIGNALLING_EVENTS,-1.77090663,0.281132672,telcagepant
RAC1_GTPASE_CYCLE,1.346690068,0.581430157,telcagepant
PEPTIDE_LIGAND_BINDING_RECEPTORS,1.739541087,0.254669618,EX-527
EUKARYOTIC_TRANSLATION_ELONGATION,-2.508634183,1,EX-527
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.459715323,1,EX-527
SELENOAMINO_ACID_METABOLISM,-2.451467471,1,EX-527
NONSENSE_MEDIATED_DECAY_NMD,-2.461945596,1,EX-527
EUKARYOTIC_TRANSLATION_INITIATION,-2.437767781,0.857160906,EX-527
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.420626666,0.722229421,EX-527
INFLUENZA_INFECTION,-2.417319354,0.621525062,EX-527
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.395405486,0.551808145,EX-527
CELLULAR_RESPONSE_TO_STARVATION,-2.363720389,0.501067684,EX-527
CELL_CYCLE_CHECKPOINTS,-3.073490178,0,olomoucine
CELL_CYCLE,-2.614144244,0,olomoucine
GPCR_LIGAND_BINDING,2.403443455,0.000692238,olomoucine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.390062438,0.000346119,olomoucine
SIGNALING_BY_GPCR,2.256458322,0.001384475,olomoucine
SEPARATION_OF_SISTER_CHROMATIDS,-2.32519683,0.006706266,olomoucine
MITOTIC_METAPHASE_AND_ANAPHASE,-2.307490871,0.005029699,olomoucine
RHO_GTPASE_EFFECTORS,-2.127156862,0.01034681,olomoucine
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,-1.980893344,0.020597816,olomoucine
CELL_CYCLE_MITOTIC,-1.973204699,0.019297621,olomoucine
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.064037646,1,eprosartan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.005573431,1,eprosartan
DNA_DOUBLE_STRAND_BREAK_REPAIR,1.767882822,1,eprosartan
G_ALPHA_S_SIGNALLING_EVENTS,1.720412418,1,eprosartan
GPCR_LIGAND_BINDING,1.711923818,0.784028102,eprosartan
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.843752964,1,eprosartan
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.785184975,1,eprosartan
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.586701277,1,eprosartan
METABOLISM_OF_VITAMINS_AND_COFACTORS,-1.647213941,1,eprosartan
TRANSPORT_OF_SMALL_MOLECULES,-1.632530705,1,eprosartan
ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,-2.833225004,0,quercetin
SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,-2.502638668,0.004466715,quercetin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.306239379,0.002768656,quercetin
ISG15_ANTIVIRAL_MECHANISM,-2.36865848,0.017122409,quercetin
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,-2.317710335,0.016750183,quercetin
SARS_COV_2_HOST_INTERACTIONS,-2.280443307,0.01742019,quercetin
INTERFERON_SIGNALING,-2.278373681,0.014516825,quercetin
METABOLISM_OF_RNA,-2.123435427,0.035733724,quercetin
MITOTIC_METAPHASE_AND_ANAPHASE,-2.064755897,0.045504664,quercetin
INFLUENZA_INFECTION,-2.05469355,0.043674551,quercetin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.806621652,0,acebutolol
GPCR_LIGAND_BINDING,-2.594344477,0.006706424,acebutolol
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.287499131,0.081035959,acebutolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.207161779,0.104368726,acebutolol
SIGNALING_BY_INTERLEUKINS,-2.134655489,0.131445914,acebutolol
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.04046882,0.171991836,acebutolol
CELLULAR_RESPONSE_TO_STARVATION,1.845341938,1,acebutolol
SIGNALING_BY_GPCR,-1.976583346,0.193288725,acebutolol
EUKARYOTIC_TRANSLATION_ELONGATION,1.797528435,0.752986941,acebutolol
ESR_MEDIATED_SIGNALING,-1.941088525,0.195743755,acebutolol
SENSORY_PERCEPTION,2.396751849,0.015349756,mephentermine
G_ALPHA_I_SIGNALLING_EVENTS,2.281037382,0.019412927,mephentermine
GPCR_LIGAND_BINDING,2.08007926,0.066816587,mephentermine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.034880161,0.070202562,mephentermine
PROTEIN_LOCALIZATION,-1.825188024,0.535224154,mephentermine
SIGNALING_BY_GPCR,1.969750303,0.089931514,mephentermine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.914098784,0.110909514,mephentermine
VISUAL_PHOTOTRANSDUCTION,1.822800188,0.179424463,mephentermine
INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,-1.520952819,1,mephentermine
G_ALPHA_Q_SIGNALLING_EVENTS,1.751458241,0.249433541,mephentermine
GPCR_LIGAND_BINDING,3.432270797,0,pimavanserin
EUKARYOTIC_TRANSLATION_ELONGATION,-3.174715841,0,pimavanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.150845947,0,pimavanserin
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.085908037,0,pimavanserin
SELENOAMINO_ACID_METABOLISM,-3.021771099,0,pimavanserin
NONSENSE_MEDIATED_DECAY_NMD,-3.016168925,0,pimavanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.960833683,0,pimavanserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.949592343,0,pimavanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.901278731,0,pimavanserin
EUKARYOTIC_TRANSLATION_INITIATION,-2.872048693,0,pimavanserin
ION_CHANNEL_TRANSPORT,-2.172782401,0.287693016,BRD-K97440753
CHROMATIN_ORGANIZATION,-1.869346162,1,BRD-K97440753
SIGNALING_BY_GPCR,-1.83433468,1,BRD-K97440753
SIGNALING_BY_TGFB_FAMILY_MEMBERS,-1.7226502,1,BRD-K97440753
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.700734985,1,BRD-K97440753
PROTEIN_LOCALIZATION,1.342815055,1,BRD-K97440753
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.330696108,1,BRD-K97440753
BIOLOGICAL_OXIDATIONS,1.301565078,1,BRD-K97440753
EUKARYOTIC_TRANSLATION_INITIATION,-1.660954352,1,BRD-K97440753
GPCR_LIGAND_BINDING,-1.65896569,0.995944905,BRD-K97440753
GPCR_LIGAND_BINDING,2.202786309,0.01952465,MDL-29951
SIGNALING_BY_GPCR,2.093055513,0.029662449,MDL-29951
DEVELOPMENTAL_CELL_LINEAGES,-3.163497337,0.541841512,MDL-29951
EPIGENETIC_REGULATION_BY_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,-3.112223908,0.431108028,MDL-29951
ADIPOGENESIS,-3.028193232,0.522490029,MDL-29951
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.830269016,0.213018936,MDL-29951
G_ALPHA_I_SIGNALLING_EVENTS,1.821644869,0.170277475,MDL-29951
METABOLISM_OF_VITAMINS_AND_COFACTORS,-2.907474424,0.671388937,MDL-29951
THE_PHOTOTRANSDUCTION_CASCADE,1.763648593,0.211466977,MDL-29951
VISUAL_PHOTOTRANSDUCTION,-2.642059049,0.867806485,MDL-29951
EUKARYOTIC_TRANSLATION_INITIATION,-3.226082995,0,phentolamine
INFECTIOUS_DISEASE,-2.586448318,0,phentolamine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.711891121,0,phentolamine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.744846481,0,phentolamine
SARS_COV_1_HOST_INTERACTIONS,-2.750393672,0,phentolamine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.790027169,0,phentolamine
VIRAL_INFECTION_PATHWAYS,-2.793752027,0,phentolamine
SIGNALING_BY_ROBO_RECEPTORS,-2.812965956,0,phentolamine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.816179595,0,phentolamine
SARS_COV_2_HOST_INTERACTIONS,-2.572075693,0,phentolamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,3.060718692,0,perphenazine
VISUAL_PHOTOTRANSDUCTION,2.423410482,0.003518322,perphenazine
PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,2.365749628,0.003350783,perphenazine
SENSORY_PERCEPTION,2.284880963,0.008293188,perphenazine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.05667314,0.063329799,perphenazine
VESICLE_MEDIATED_TRANSPORT,1.861319169,0.236900361,perphenazine
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.790077145,0.33890777,perphenazine
HEMOSTASIS,1.754228029,0.374826968,perphenazine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.747153294,0.348369743,perphenazine
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.647467726,0.586152477,perphenazine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.491018631,0.000911626,torcitabine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.249698667,0.00387441,torcitabine
GPCR_LIGAND_BINDING,2.238290767,0.002734878,torcitabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.218779666,0.03239054,torcitabine
EUKARYOTIC_TRANSLATION_INITIATION,-2.216156483,0.01619527,torcitabine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.20111941,0.01475569,torcitabine
SARS_COV_1_HOST_INTERACTIONS,-2.196226293,0.012146452,torcitabine
INTRINSIC_PATHWAY_FOR_APOPTOSIS,-2.14369087,0.019866198,torcitabine
NONSENSE_MEDIATED_DECAY_NMD,-2.093259283,0.032750434,torcitabine
SARS_COV_1_INFECTION,-2.090441477,0.028688764,torcitabine
RESPIRATORY_ELECTRON_TRANSPORT,2.832767309,0,vortioxetine
DISEASES_OF_METABOLISM,2.457975011,0.00095856,vortioxetine
GPCR_LIGAND_BINDING,-2.49731557,0.008228785,vortioxetine
SIGNALING_BY_GPCR,-2.265076455,0.029388516,vortioxetine
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.249744016,0.022727119,vortioxetine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.205087188,0.011928742,vortioxetine
ECM_PROTEOGLYCANS,-2.191341055,0.031739597,vortioxetine
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.181275215,0.027977867,vortioxetine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,2.094616108,0.018532153,vortioxetine
METABOLISM_OF_VITAMINS_AND_COFACTORS,2.062646846,0.018020922,vortioxetine
CARDIAC_CONDUCTION,2.336263492,0.01334241,lovastatin
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-2.277924845,0.017190288,lovastatin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,2.096334532,0.038597686,lovastatin
GPCR_LIGAND_BINDING,1.933414389,0.068300431,lovastatin
MUSCLE_CONTRACTION,1.841466731,0.085534377,lovastatin
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.724513243,0.141429544,lovastatin
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1.71119,0.126911731,lovastatin
SIGNALING_BY_GPCR,1.699331982,0.117358747,lovastatin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.629077364,0.145575221,lovastatin
G_ALPHA_I_SIGNALLING_EVENTS,1.616585166,0.137765676,lovastatin
DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,-2.172181961,0.111466332,clobetasol
EPH_EPHRIN_SIGNALING,-1.855728131,0.314774641,clobetasol
TRANSCRIPTIONAL_REGULATION_BY_RUNX2,-1.806375015,0.270031114,clobetasol
TRANSLATION,-1.583299263,0.589908087,clobetasol
DISEASES_OF_GLYCOSYLATION,1.808307502,1,clobetasol
G2_M_CHECKPOINTS,-1.48000329,0.755145149,clobetasol
DNA_REPLICATION_PRE_INITIATION,-1.46773702,0.664088145,clobetasol
NUCLEOTIDE_EXCISION_REPAIR,-1.403047292,0.761424942,clobetasol
G_ALPHA_Q_SIGNALLING_EVENTS,1.678618217,1,clobetasol
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.666042598,1,clobetasol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.953116562,0,miconazole
CELLULAR_RESPONSE_TO_STARVATION,-2.466769316,0,miconazole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.538136533,0,miconazole
INFLUENZA_INFECTION,-2.594039339,0,miconazole
RRNA_PROCESSING,-2.608485866,0,miconazole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.637374347,0,miconazole
SIGNALING_BY_ROBO_RECEPTORS,-2.631297259,0,miconazole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.721566468,0,miconazole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.740459104,0,miconazole
EUKARYOTIC_TRANSLATION_INITIATION,-2.75951841,0,miconazole
SIGNALING_BY_GPCR,1.555934316,0.734766065,DNQX
SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,1.433620493,0.675277346,DNQX
G_ALPHA_I_SIGNALLING_EVENTS,1.391323733,0.546385122,DNQX
SIGNALING_BY_INTERLEUKINS,-1.193660403,1,DNQX
INTERFERON_SIGNALING,-1.164084947,1,DNQX
NEURONAL_SYSTEM,1.268349959,0.700600247,DNQX
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-1.008504113,1,DNQX
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-0.948212437,1,DNQX
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,-0.905991017,1,DNQX
RNA_POLYMERASE_II_TRANSCRIPTION,1.127783106,0.937510049,DNQX
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.051155729,0.000718059,chlordiazepoxide
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.625575455,0.069651741,chlordiazepoxide
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.553931076,0.081140688,chlordiazepoxide
RRNA_PROCESSING,1.998465203,0.335378213,chlordiazepoxide
CLATHRIN_MEDIATED_ENDOCYTOSIS,-2.453391365,0.126019388,chlordiazepoxide
METABOLISM_OF_RNA,1.895952503,0.391083155,chlordiazepoxide
TRANSPORT_OF_SMALL_MOLECULES,-2.094288227,0.347684259,chlordiazepoxide
EUKARYOTIC_TRANSLATION_INITIATION,1.772472399,0.651230981,chlordiazepoxide
HEMOSTASIS,-1.890898189,0.393257082,chlordiazepoxide
BIOLOGICAL_OXIDATIONS,-1.873328332,0.346104529,chlordiazepoxide
DISEASES_OF_METABOLISM,-2.865848585,0.296281541,dabigatran-etexilate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.828605894,0.22966478,dabigatran-etexilate
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.656360147,0.962201849,dabigatran-etexilate
METABOLISM_OF_STEROIDS,1.501364872,1,dabigatran-etexilate
HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1.460530422,0.917773807,dabigatran-etexilate
MITOTIC_G2_G2_M_PHASES,1.416071905,0.857674229,dabigatran-etexilate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.740237521,0.801575113,dabigatran-etexilate
POTENTIAL_THERAPEUTICS_FOR_SARS,1.352259805,0.939926968,dabigatran-etexilate
SNRNP_ASSEMBLY,1.320775605,0.906818947,dabigatran-etexilate
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.302554641,0.844045862,dabigatran-etexilate
EUKARYOTIC_TRANSLATION_ELONGATION,-3.484915624,0,procainamide
CELLULAR_RESPONSES_TO_STIMULI,-2.50815628,0,procainamide
INFECTIOUS_DISEASE,-2.579117204,0,procainamide
VIRAL_INFECTION_PATHWAYS,-2.702947571,0,procainamide
SARS_COV_1_INFECTION,-2.734288622,0,procainamide
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.739411293,0,procainamide
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-2.786775927,0,procainamide
NERVOUS_SYSTEM_DEVELOPMENT,-2.804639078,0,procainamide
SARS_COV_1_HOST_INTERACTIONS,-2.829841706,0,procainamide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.883074927,0,procainamide
ION_CHANNEL_TRANSPORT,-3.016516539,0.657994954,carglumic-acid
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.480526485,1,carglumic-acid
MITOCHONDRIAL_TRANSLATION,1.480116744,0.717674542,carglumic-acid
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.421206769,0.491576768,carglumic-acid
CELL_CELL_COMMUNICATION,1.421933426,0.653232546,carglumic-acid
TRANSPORT_OF_SMALL_MOLECULES,-2.666740851,1,carglumic-acid
SARS_COV_2_INFECTION,-2.543078884,1,carglumic-acid
SARS_COV_INFECTIONS,-2.332504602,1,carglumic-acid
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.280789002,1,carglumic-acid
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.251021987,0.914157146,carglumic-acid
MITOTIC_G2_G2_M_PHASES,1.63781257,1,pasireotide
SNRNP_ASSEMBLY,1.592606004,0.741823457,pasireotide
ION_CHANNEL_TRANSPORT,-2.933022282,1,pasireotide
NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,1.545535968,0.657552312,pasireotide
TRNA_PROCESSING,1.53845272,0.511561456,pasireotide
LATE_SARS_COV_2_INFECTION_EVENTS,-2.879144222,0.97589102,pasireotide
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.469180062,0.593933533,pasireotide
HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,1.439229769,0.576446281,pasireotide
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.438328416,0.495453289,pasireotide
TRANSPORT_OF_SMALL_MOLECULES,-2.601043548,1,pasireotide
CELLULAR_RESPONSE_TO_STARVATION,2.114659142,0.064811928,proguanil
EUKARYOTIC_TRANSLATION_ELONGATION,2.083680093,0.046771494,proguanil
ION_CHANNEL_TRANSPORT,-3.86253147,0.283598237,proguanil
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.041166736,0.046326051,proguanil
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.952291181,0.069489077,proguanil
EUKARYOTIC_TRANSLATION_INITIATION,1.931906845,0.064945561,proguanil
SELENOAMINO_ACID_METABOLISM,1.893432713,0.073609423,proguanil
INFLUENZA_INFECTION,1.843868038,0.094306605,proguanil
NONSENSE_MEDIATED_DECAY_NMD,1.830511438,0.092791304,proguanil
SARS_COV_2_INFECTION,-3.245292788,1,proguanil
EUKARYOTIC_TRANSLATION_INITIATION,-2.491774675,0,ketoprofen
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.446397549,0,ketoprofen
NONSENSE_MEDIATED_DECAY_NMD,-2.437008734,0,ketoprofen
EUKARYOTIC_TRANSLATION_ELONGATION,-2.435744471,0,ketoprofen
INFLUENZA_INFECTION,-2.418193479,0.000226629,ketoprofen
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.376541049,0.000188858,ketoprofen
TRANSLATION,-2.326210396,0.000485634,ketoprofen
SIGNALING_BY_ROBO_RECEPTORS,-2.31884705,0.000566573,ketoprofen
RRNA_PROCESSING,-2.285388158,0.000629526,ketoprofen
GPCR_LIGAND_BINDING,-2.28425446,0.000679888,ketoprofen
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.905095759,0,macitentan
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.889871921,0,macitentan
EUKARYOTIC_TRANSLATION_ELONGATION,-2.88033593,0,macitentan
NONSENSE_MEDIATED_DECAY_NMD,-2.699005805,0,macitentan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.670033393,0,macitentan
SELENOAMINO_ACID_METABOLISM,-2.669358468,0,macitentan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.613248522,0,macitentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.582603821,0,macitentan
SIGNALING_BY_ROBO_RECEPTORS,-2.4950722,0.000134995,macitentan
EUKARYOTIC_TRANSLATION_INITIATION,-2.560295805,0.00015428,macitentan
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.913044592,0.224618519,resatorvid
DISEASES_OF_METABOLISM,-2.908185681,0.115105341,resatorvid
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1.743761732,0.529854449,resatorvid
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.704407403,0.332492557,resatorvid
ION_CHANNEL_TRANSPORT,-2.85071475,0.144774869,resatorvid
AURKA_ACTIVATION_BY_TPX2,1.695027394,0.232329915,resatorvid
TRNA_PROCESSING,1.682527419,0.186693682,resatorvid
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.841692877,0.124192604,resatorvid
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.669827059,0.163223619,resatorvid
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-2.779708414,0.308314548,resatorvid
MUSCLE_CONTRACTION,2.970458815,0,xaliproden
CARDIAC_CONDUCTION,2.827090512,0,xaliproden
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.338668201,0.010180904,xaliproden
TRANSLATION,-2.331918323,0.005090452,xaliproden
EUKARYOTIC_TRANSLATION_INITIATION,-2.294600121,0.006787269,xaliproden
EUKARYOTIC_TRANSLATION_ELONGATION,-2.238515258,0.01272613,xaliproden
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.224201929,0.0117646,xaliproden
ION_CHANNEL_TRANSPORT,-2.20195939,0.013197468,xaliproden
SELENOAMINO_ACID_METABOLISM,-2.136538641,0.029573102,xaliproden
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.131334461,0.026583472,xaliproden
EUKARYOTIC_TRANSLATION_ELONGATION,-2.667605684,0,etizolam
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.527407883,0,etizolam
NONSENSE_MEDIATED_DECAY_NMD,-2.506676944,0,etizolam
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.504648915,0,etizolam
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.500955583,0,etizolam
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.470829762,0,etizolam
SELENOAMINO_ACID_METABOLISM,-2.452067487,0,etizolam
SIGNALING_BY_ROBO_RECEPTORS,-2.314760878,9.03E-05,etizolam
CELLULAR_RESPONSE_TO_STARVATION,-2.336914588,0.000108359,etizolam
INFLUENZA_INFECTION,-2.33049566,9.85E-05,etizolam
DISEASES_OF_METABOLISM,-3.094642561,0.048382618,vilazodone
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,2.003847641,0.126176631,vilazodone
REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1.746371543,0.311090658,vilazodone
NEDDYLATION,1.562798157,0.590999735,vilazodone
C_TYPE_LECTIN_RECEPTORS_CLRS,-2.960485534,0.477106373,vilazodone
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.536851606,0.504162657,vilazodone
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.528203993,0.421168891,vilazodone
GLUCOSE_METABOLISM,1.521530445,0.362213948,vilazodone
PROTEIN_FOLDING,1.520052193,0.313887677,vilazodone
ADIPOGENESIS,1.50986275,0.286888675,vilazodone
EUKARYOTIC_TRANSLATION_ELONGATION,-2.353095185,0,ixabepilone
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.696674291,0.005297375,ixabepilone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.294108739,0.000383501,ixabepilone
NONSENSE_MEDIATED_DECAY_NMD,-2.285433678,0.000511334,ixabepilone
SELENOAMINO_ACID_METABOLISM,-2.259053282,0.000383501,ixabepilone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.211379907,0.000920402,ixabepilone
EUKARYOTIC_TRANSLATION_INITIATION,-2.173697947,0.00178967,ixabepilone
DEVELOPMENTAL_CELL_LINEAGES,-2.169543695,0.001534003,ixabepilone
CELLULAR_RESPONSE_TO_STARVATION,-2.161047998,0.001725753,ixabepilone
MITOCHONDRIAL_TRANSLATION,2.122521666,0.082109319,ixabepilone
SARS_COV_2_INFECTION,2.063171277,0.189384972,alpelisib
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.010914068,0.148477818,alpelisib
EUKARYOTIC_TRANSLATION_ELONGATION,1.81240852,0.495936114,alpelisib
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.808813789,0.381421334,alpelisib
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.79045692,0.344529142,alpelisib
INFLUENZA_INFECTION,1.788568753,0.290895317,alpelisib
SIGNALING_BY_TGFB_FAMILY_MEMBERS,1.70762787,0.425304538,alpelisib
EUKARYOTIC_TRANSLATION_INITIATION,1.703653723,0.381610719,alpelisib
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.673741236,0.368012878,alpelisib
KERATINIZATION,1.673741236,0.368012878,alpelisib
RESPIRATORY_ELECTRON_TRANSPORT,3.475028928,0,icosapent
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.291237148,0,icosapent
RRNA_PROCESSING,3.225636636,0,icosapent
TRANSLATION,2.399712957,0.005656297,icosapent
DNA_REPLICATION,2.341972981,0.005656297,icosapent
MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,2.196539678,0.012726668,icosapent
SYNTHESIS_OF_DNA,2.166333678,0.012928678,icosapent
MITOCHONDRIAL_TRANSLATION,1.97904291,0.035705373,icosapent
DNA_REPLICATION_PRE_INITIATION,1.934631867,0.039908316,icosapent
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.919159659,0.038745633,icosapent
SENSORY_PERCEPTION,2.419169506,0.002496706,carbinoxamine
NEUTROPHIL_DEGRANULATION,-2.273134213,0.066604758,carbinoxamine
GPCR_LIGAND_BINDING,2.047728185,0.042443998,carbinoxamine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.667358711,1,carbinoxamine
STRIATED_MUSCLE_CONTRACTION,-1.66110394,0.789864122,carbinoxamine
EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,-1.632560415,0.690383938,carbinoxamine
MITOTIC_METAPHASE_AND_ANAPHASE,-1.629436818,0.557942938,carbinoxamine
SIGNALING_BY_GPCR,1.799007475,0.218877869,carbinoxamine
TRANSLATION,-1.551115945,0.678856191,carbinoxamine
FORMATION_OF_THE_CORNIFIED_ENVELOPE,-1.516751906,0.690566918,carbinoxamine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1.910709886,0.819402973,hyoscyamine
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.832396741,0.688424237,hyoscyamine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.765979573,0.723701177,hyoscyamine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.764987584,0.54618133,hyoscyamine
CDC42_GTPASE_CYCLE,1.764289932,0.43925029,hyoscyamine
HEMOSTASIS,1.716975949,0.482874941,hyoscyamine
RRNA_PROCESSING,-1.411540573,1,hyoscyamine
POTASSIUM_CHANNELS,-1.345945904,1,hyoscyamine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.630015361,0.691867107,hyoscyamine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1.625518388,0.620577252,hyoscyamine
METABOLISM_OF_RNA,-3.997750053,0,benzthiazide
SEPARATION_OF_SISTER_CHROMATIDS,-2.794253949,0,benzthiazide
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.870526941,0,benzthiazide
VIRAL_INFECTION_PATHWAYS,-2.877376583,0,benzthiazide
NONSENSE_MEDIATED_DECAY_NMD,-2.877477357,0,benzthiazide
INFLUENZA_INFECTION,-2.908685084,0,benzthiazide
CELL_CYCLE_MITOTIC,-2.949487486,0,benzthiazide
MUSCLE_CONTRACTION,2.728409536,0,benzthiazide
GPCR_LIGAND_BINDING,3.035388031,0,benzthiazide
MITOTIC_METAPHASE_AND_ANAPHASE,-3.03934078,0,benzthiazide
NONSENSE_MEDIATED_DECAY_NMD,-2.579386107,0,dequalinium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.567227633,0,dequalinium
SELENOAMINO_ACID_METABOLISM,-2.487291313,0,dequalinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.463911957,0,dequalinium
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.425029588,0.000216391,dequalinium
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.410864604,0.000180326,dequalinium
EUKARYOTIC_TRANSLATION_INITIATION,-2.402733743,0.000154565,dequalinium
INFLUENZA_INFECTION,-2.37664359,0.000135244,dequalinium
CELLULAR_RESPONSE_TO_STARVATION,-2.328030323,0.000432781,dequalinium
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.330215899,0.000480868,dequalinium
TRNA_PROCESSING,2.459106423,0.008063992,rilpivirine
CELL_CYCLE_MITOTIC,2.414714746,0.004031996,rilpivirine
CELL_CYCLE,2.390206868,0.002687997,rilpivirine
MITOTIC_SPINDLE_CHECKPOINT,2.351504027,0.004031996,rilpivirine
SEPARATION_OF_SISTER_CHROMATIDS,2.152546325,0.025804773,rilpivirine
MITOTIC_METAPHASE_AND_ANAPHASE,2.107854087,0.029951969,rilpivirine
M_PHASE,2.108231171,0.034943964,rilpivirine
G2_M_CHECKPOINTS,2.031381989,0.041327957,rilpivirine
GLUCOSE_METABOLISM,1.906809401,0.08691191,rilpivirine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.890400074,0.085478312,rilpivirine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.372519116,0.115901768,mepyramine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.361336194,0.073704523,mepyramine
NEUTROPHIL_DEGRANULATION,-3.036789304,1,mepyramine
HEMOSTASIS,-2.8538505,1,mepyramine
EUKARYOTIC_TRANSLATION_INITIATION,-2.431752458,0.995855,mepyramine
NONSENSE_MEDIATED_DECAY_NMD,-2.364913553,0.843382285,mepyramine
RRNA_PROCESSING,-2.345007784,0.727560892,mepyramine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.332175289,0.640413533,mepyramine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.314605773,0.574257629,mepyramine
INNATE_IMMUNE_SYSTEM,-2.292147922,0.52122038,mepyramine
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,2.155606946,0.102968763,brompheniramine
NEURONAL_SYSTEM,2.104655143,0.077481445,brompheniramine
SENSORY_PERCEPTION,2.069445607,0.073063644,brompheniramine
CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,-1.833154916,0.328777739,brompheniramine
HEMOSTASIS,1.916497638,0.186312291,brompheniramine
THE_PHOTOTRANSDUCTION_CASCADE,1.912128203,0.153943398,brompheniramine
VISUAL_PHOTOTRANSDUCTION,1.864685921,0.173993421,brompheniramine
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.857316603,0.157584443,brompheniramine
DNA_REPAIR,1.789995907,0.216132452,brompheniramine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.520053152,0.729904896,brompheniramine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.279657401,0.003049468,CTS-1027
NONSENSE_MEDIATED_DECAY_NMD,-2.260766088,0.002032979,CTS-1027
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.24077556,0.002371808,CTS-1027
EUKARYOTIC_TRANSLATION_INITIATION,-2.187392817,0.003557713,CTS-1027
SARS_COV_1_HOST_INTERACTIONS,-2.186426328,0.00284617,CTS-1027
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.170997664,0.002541223,CTS-1027
SELENOAMINO_ACID_METABOLISM,-2.134424945,0.004356383,CTS-1027
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.123854846,0.004447141,CTS-1027
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.114531086,0.00451773,CTS-1027
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.114156797,0.004167606,CTS-1027
CELLULAR_SENESCENCE,2.181332913,0.109298888,flupentixol
C_TYPE_LECTIN_RECEPTORS_CLRS,-1.867520186,0.220313667,flupentixol
CLATHRIN_MEDIATED_ENDOCYTOSIS,1.844394492,0.749478091,flupentixol
HOST_INTERACTIONS_OF_HIV_FACTORS,-1.521314356,0.580283794,flupentixol
CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1.792521034,0.698124963,flupentixol
AUTOPHAGY,1.762757453,0.647465796,flupentixol
ECM_PROTEOGLYCANS,-1.326273385,0.918098083,flupentixol
DNA_REPAIR,1.656668471,1,flupentixol
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,-1.251504577,0.921396565,flupentixol
ESR_MEDIATED_SIGNALING,1.595497764,1,flupentixol
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.997236754,0,carteolol
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.661043878,0.000420414,carteolol
GPCR_LIGAND_BINDING,2.465443628,0.001121105,carteolol
SIGNALING_BY_GPCR,2.042198584,0.047717023,carteolol
G_ALPHA_Q_SIGNALLING_EVENTS,2.011958647,0.049945219,carteolol
SENSORY_PERCEPTION,1.8708347,0.129347466,carteolol
PROTEIN_LOCALIZATION,-1.548215267,1,carteolol
CARDIAC_CONDUCTION,1.805427603,0.175733177,carteolol
MITOTIC_G2_G2_M_PHASES,-1.520153648,1,carteolol
REGULATION_OF_TP53_ACTIVITY,-1.457691436,1,carteolol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.799330988,0,nimesulide
SELENOAMINO_ACID_METABOLISM,-2.680241747,0,nimesulide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.677612459,0,nimesulide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.672678147,0,nimesulide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.663067162,0,nimesulide
NONSENSE_MEDIATED_DECAY_NMD,-2.624201803,0,nimesulide
EUKARYOTIC_TRANSLATION_INITIATION,-2.573991449,0,nimesulide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.561666004,0,nimesulide
SIGNALING_BY_ROBO_RECEPTORS,-2.560178459,0,nimesulide
RRNA_PROCESSING,-2.515319921,0,nimesulide
ION_CHANNEL_TRANSPORT,-3.007672048,1,fomepizole
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.437510521,1,fomepizole
SARS_COV_2_INFECTION,-2.819265683,1,fomepizole
TRANSPORT_OF_SMALL_MOLECULES,-2.71679567,1,fomepizole
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.677496734,1,fomepizole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.557878209,1,fomepizole
SARS_COV_INFECTIONS,-2.539606189,0.852776026,fomepizole
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.521244411,0.738822658,fomepizole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.481519082,0.656678539,fomepizole
SELENOAMINO_ACID_METABOLISM,-2.450595197,0.590164742,fomepizole
GPCR_LIGAND_BINDING,-2.642785195,0.000882164,triptorelin
RESPIRATORY_ELECTRON_TRANSPORT,2.521842288,0.003066349,triptorelin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.360221587,0.013232459,triptorelin
SIGNALING_BY_GPCR,-2.280311079,0.021465989,triptorelin
STIMULI_SENSING_CHANNELS,-2.263634456,0.020951393,triptorelin
PEPTIDE_LIGAND_BINDING_RECEPTORS,-2.221077035,0.028405679,triptorelin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.173623126,0.038080076,triptorelin
G_ALPHA_I_SIGNALLING_EVENTS,-2.149088564,0.043226033,triptorelin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1.798799463,0.342664552,triptorelin
ION_CHANNEL_TRANSPORT,-2.03522822,0.088657475,triptorelin
SIGNALING_BY_GPCR,2.195617053,0.007297454,forskolin
GPCR_LIGAND_BINDING,2.155653103,0.004560909,forskolin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.973954338,0.012162424,forskolin
DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,-2.009156413,0.050833287,forskolin
NEUTROPHIL_DEGRANULATION,1.842445023,0.02554109,forskolin
ADAPTIVE_IMMUNE_SYSTEM,1.740701561,0.033933162,forskolin
MEMBRANE_TRAFFICKING,-1.692915226,0.217630009,forskolin
POST_TRANSLATIONAL_PROTEIN_MODIFICATION,-1.639275644,0.207569255,forskolin
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,-1.57930311,0.222130873,forskolin
RNA_POLYMERASE_II_TRANSCRIPTION,-1.572750483,0.183847054,forskolin
TRNA_PROCESSING,2.082682362,0.144219464,tizanidine
TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1.938804091,0.210320052,tizanidine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.861982239,0.242368822,tizanidine
CELL_CYCLE_CHECKPOINTS,1.838847506,0.20731548,tizanidine
SNRNP_ASSEMBLY,1.823935585,0.174265186,tizanidine
TRNA_PROCESSING_IN_THE_NUCLEUS,1.713976627,0.270411496,tizanidine
G2_M_CHECKPOINTS,1.685676092,0.268694597,tizanidine
M_PHASE,1.633045965,0.32073808,tizanidine
PROTEASOME_ASSEMBLY,1.629235164,0.293112708,tizanidine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1.620198108,0.274016982,tizanidine
PROTEIN_UBIQUITINATION,-1.825625138,1,carbimazole
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.813495378,0.67406472,carbimazole
SELENOAMINO_ACID_METABOLISM,1.520018014,0.879738562,carbimazole
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.801698034,0.505635359,carbimazole
UNFOLDED_PROTEIN_RESPONSE_UPR,1.514218382,0.453267974,carbimazole
TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,-1.796641842,0.399281768,carbimazole
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.763415592,0.429234412,carbimazole
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.414202693,0.521568627,carbimazole
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.341952863,0.554575163,carbimazole
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.637172679,0.973070245,carbimazole
METABOLISM_OF_RNA,-3.438383428,0,ofloxacin
CELL_CYCLE_MITOTIC,-2.56224368,0,ofloxacin
CELL_CYCLE_CHECKPOINTS,-2.563247549,0,ofloxacin
CELLULAR_RESPONSES_TO_STIMULI,-2.59921929,0,ofloxacin
M_PHASE,-2.617572918,0,ofloxacin
CELLULAR_RESPONSE_TO_STARVATION,-2.618562524,0,ofloxacin
MRNA_SPLICING,-2.640129311,0,ofloxacin
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,-2.654265045,0,ofloxacin
MUSCLE_CONTRACTION,2.721001955,0,ofloxacin
SIGNALING_BY_GPCR,2.722454791,0,ofloxacin
DEUBIQUITINATION,-2.06235602,0.25084474,captopril
ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,-1.887726836,0.335504839,captopril
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2.029163026,0.315380235,captopril
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,2.005526604,0.192732366,captopril
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.923737929,0.231019266,captopril
TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1.890606049,0.222712956,captopril
REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,-1.652570361,0.751140637,captopril
UB_SPECIFIC_PROCESSING_PROTEASES,-1.601853023,0.719610847,captopril
VESICLE_MEDIATED_TRANSPORT,1.836869824,0.260870071,captopril
MRNA_SPLICING,1.801693942,0.278261409,captopril
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.388947468,0.07094143,vecuronium
RHOA_GTPASE_CYCLE,2.059018967,0.221797448,vecuronium
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,-3.263142816,0.165135885,vecuronium
CLATHRIN_MEDIATED_ENDOCYTOSIS,-3.225512334,0.182345751,vecuronium
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.202699948,0.177550636,vecuronium
METABOLISM_OF_RNA,1.760263641,1,vecuronium
EUKARYOTIC_TRANSLATION_INITIATION,1.718401899,0.996346651,vecuronium
RRNA_PROCESSING,1.704773745,0.814902403,vecuronium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1.668917271,0.826572897,vecuronium
TRANSPORT_OF_SMALL_MOLECULES,-2.287796564,1,vecuronium
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.515144338,0.003655763,theophylline
DEVELOPMENTAL_CELL_LINEAGES,2.362593617,0.005483644,theophylline
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2.348508516,0.003655763,theophylline
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.264707035,0.005666432,theophylline
GPCR_LIGAND_BINDING,2.095234408,0.01169844,theophylline
CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,2.043627082,0.012795169,theophylline
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,2.026593619,0.011802891,theophylline
G_ALPHA_I_SIGNALLING_EVENTS,1.865525595,0.026778461,theophylline
PI3K_AKT_SIGNALING_IN_CANCER,1.649262917,0.071977903,theophylline
SIGNALING_BY_GPCR,1.560318149,0.101557084,theophylline
CELLULAR_RESPONSE_TO_STARVATION,4.586060459,0,amodiaquine
CELL_CYCLE_CHECKPOINTS,2.726396731,0,amodiaquine
MITOTIC_METAPHASE_AND_ANAPHASE,2.769558854,0,amodiaquine
MITOTIC_G2_G2_M_PHASES,2.832821638,0,amodiaquine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.912025074,0,amodiaquine
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.137708277,0,amodiaquine
RESPIRATORY_ELECTRON_TRANSPORT,3.22308891,0,amodiaquine
CELLULAR_RESPONSES_TO_STIMULI,3.296065312,0,amodiaquine
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.411795409,0,amodiaquine
SARS_COV_1_INFECTION,3.461153127,0,amodiaquine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.317861922,0.01023283,azelaic-acid
DISEASES_OF_GLYCOSYLATION,2.185137038,0.015349245,azelaic-acid
DISEASES_OF_METABOLISM,2.061599748,0.02046566,azelaic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,-2.063413989,0.118271908,azelaic-acid
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.904393325,0.044187221,azelaic-acid
SELENOAMINO_ACID_METABOLISM,-1.987708574,0.133434973,azelaic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.94975722,0.130739317,azelaic-acid
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.676463457,0.139166489,azelaic-acid
VISUAL_PHOTOTRANSDUCTION,1.63704962,0.141399107,azelaic-acid
RRNA_PROCESSING,-1.842817543,0.277989527,azelaic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.927652767,0,eflornithine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.284204849,0.016045583,eflornithine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.283401214,0.010697055,eflornithine
CELLULAR_RESPONSE_TO_STARVATION,2.14451926,0.018719846,eflornithine
PROTEIN_LOCALIZATION,2.07293611,0.022463816,eflornithine
RRNA_PROCESSING,1.989393768,0.032091165,eflornithine
DISEASES_OF_METABOLISM,-3.102772613,0.751994409,eflornithine
NEDDYLATION,1.718245675,0.128670291,eflornithine
ION_CHANNEL_TRANSPORT,-3.077431353,0.589095097,eflornithine
G2_M_CHECKPOINTS,1.660187566,0.15056105,eflornithine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.245102348,0.014723054,carbachol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.197771664,0.012093937,carbachol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.183278227,0.00946482,carbachol
NONSENSE_MEDIATED_DECAY_NMD,-2.154610878,0.010779379,carbachol
SIGNALING_BY_ROBO_RECEPTORS,-2.153250089,0.009044162,carbachol
SARS_COV_1_HOST_INTERACTIONS,-2.084811063,0.016475798,carbachol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.077138147,0.015323995,carbachol
BIOLOGICAL_OXIDATIONS,1.905890606,0.092793296,carbachol
EUKARYOTIC_TRANSLATION_INITIATION,-2.016943517,0.023004772,carbachol
SELENOAMINO_ACID_METABOLISM,-2.014791675,0.020916084,carbachol
EUKARYOTIC_TRANSLATION_ELONGATION,-2.316132266,0,BRD-K76022557
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.235488615,0.002036496,BRD-K76022557
NONSENSE_MEDIATED_DECAY_NMD,-2.221727752,0.002375912,BRD-K76022557
SELENOAMINO_ACID_METABOLISM,-2.196591066,0.002800182,BRD-K76022557
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.180756264,0.016969697,BRD-K76022557
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.152206235,0.005294891,BRD-K76022557
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.129081598,0.006109489,BRD-K76022557
RRNA_PROCESSING,-2.101511613,0.008000521,BRD-K76022557
EUKARYOTIC_TRANSLATION_INITIATION,-2.074163058,0.009291515,BRD-K76022557
METABOLISM_OF_STEROIDS,1.946900636,0.04030303,BRD-K76022557
EUKARYOTIC_TRANSLATION_ELONGATION,-2.520025155,0,almitrine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.486304293,0,almitrine
NONSENSE_MEDIATED_DECAY_NMD,-2.371031448,0.000710685,almitrine
SIGNALING_BY_ROBO_RECEPTORS,-2.28555468,0.001066027,almitrine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.277766205,0.000852822,almitrine
EUKARYOTIC_TRANSLATION_INITIATION,-2.250366404,0.001243698,almitrine
SELENOAMINO_ACID_METABOLISM,-2.224916894,0.001675185,almitrine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.209832221,0.001998801,almitrine
SIGNALING_BY_NOTCH,-2.188724198,0.002605844,almitrine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.169743553,0.002878273,almitrine
GPCR_LIGAND_BINDING,3.523146744,0,solifenacin-succinate
RRNA_PROCESSING,-2.5687333,0,solifenacin-succinate
INFLUENZA_INFECTION,-2.600460394,0,solifenacin-succinate
SIGNALING_BY_ROBO_RECEPTORS,-2.600729865,0,solifenacin-succinate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.606270012,0,solifenacin-succinate
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.63407,0,solifenacin-succinate
NONSENSE_MEDIATED_DECAY_NMD,-2.676072216,0,solifenacin-succinate
TRANSLATION,-2.654453817,0,solifenacin-succinate
SELENOAMINO_ACID_METABOLISM,-2.812899279,0,solifenacin-succinate
EUKARYOTIC_TRANSLATION_INITIATION,-2.818510092,0,solifenacin-succinate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.952643241,0.137030707,EMD-1214063
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.003463165,0.264242987,EMD-1214063
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.924583292,0.479194494,EMD-1214063
MITF_M_DEPENDENT_GENE_EXPRESSION,1.523515345,0.66437791,EMD-1214063
NEUTROPHIL_DEGRANULATION,-2.696309432,1,EMD-1214063
PROTEIN_LOCALIZATION,1.498285679,0.50716096,EMD-1214063
HEMOSTASIS,-2.44680929,0.921293339,EMD-1214063
INNATE_IMMUNE_SYSTEM,-2.193597452,0.846390615,EMD-1214063
GPCR_LIGAND_BINDING,-2.089710866,0.771894419,EMD-1214063
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.4199818,0.569782519,EMD-1214063
CELLULAR_RESPONSE_TO_STARVATION,5.172933572,0,lesinurad
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.030639383,0,lesinurad
SARS_COV_1_INFECTION,3.118259568,0,lesinurad
SARS_COV_1_HOST_INTERACTIONS,3.330162123,0,lesinurad
RESPIRATORY_ELECTRON_TRANSPORT,3.380096121,0,lesinurad
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.603187321,0,lesinurad
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,3.711482883,0,lesinurad
SIGNALING_BY_ROBO_RECEPTORS,3.734457421,0,lesinurad
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.745569983,0,lesinurad
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,4.033599365,0,lesinurad
RESPIRATORY_ELECTRON_TRANSPORT,2.802855167,0,acrivastine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.391647991,0.003510361,acrivastine
PROTEIN_LOCALIZATION,2.193319573,0.013001338,acrivastine
COMPLEX_I_BIOGENESIS,2.07762918,0.026132689,acrivastine
ION_CHANNEL_TRANSPORT,-3.339387121,0.524942985,acrivastine
UNFOLDED_PROTEIN_RESPONSE_UPR,1.891544662,0.082220461,acrivastine
SARS_COV_2_INFECTION,-3.289567995,0.475799386,acrivastine
STIMULI_SENSING_CHANNELS,-3.130758111,0.743855378,acrivastine
SARS_COV_INFECTIONS,-3.125488744,0.565430608,acrivastine
TRANSPORT_OF_SMALL_MOLECULES,-3.038371438,0.540132824,acrivastine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.721120991,0,phenprocoumon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.105897171,0,phenprocoumon
INFLUENZA_INFECTION,3.144390321,0,phenprocoumon
NONSENSE_MEDIATED_DECAY_NMD,3.18182319,0,phenprocoumon
RRNA_PROCESSING,3.315073472,0,phenprocoumon
TRANSLATION,3.418592727,0,phenprocoumon
RESPIRATORY_ELECTRON_TRANSPORT,3.076001426,0,phenprocoumon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.603685643,0,phenprocoumon
METABOLISM_OF_RNA,3.639875664,0,phenprocoumon
SELENOAMINO_ACID_METABOLISM,3.648492124,0,phenprocoumon
PROTEIN_LOCALIZATION,1.672342318,0.721514147,diosmin
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.594958859,0.52921871,diosmin
MITF_M_DEPENDENT_GENE_EXPRESSION,1.484666269,0.631595718,diosmin
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.46389838,0.525697808,diosmin
GPCR_LIGAND_BINDING,-2.092993957,1,diosmin
METABOLISM_OF_STEROIDS,1.450910087,0.448725465,diosmin
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.425897872,0.422688844,diosmin
SIGNALING_BY_GPCR,-1.929925549,1,diosmin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-1.909578507,1,diosmin
ION_CHANNEL_TRANSPORT,-1.842053755,1,diosmin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,3.36568588,0,KPT-330
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.140385542,0,KPT-330
GPCR_LIGAND_BINDING,3.014674013,0,KPT-330
KERATINIZATION,2.912633539,0,KPT-330
FORMATION_OF_THE_CORNIFIED_ENVELOPE,2.912633539,0,KPT-330
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.707943178,0,KPT-330
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.488401228,0.000262444,KPT-330
BIOLOGICAL_OXIDATIONS,2.292061631,0.002526026,KPT-330
NEURONAL_SYSTEM,2.018800897,0.012927808,KPT-330
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1.891718415,0.026515615,KPT-330
EUKARYOTIC_TRANSLATION_ELONGATION,-2.299116743,0.006311541,bosentan
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.17656615,0.021564432,bosentan
SELENOAMINO_ACID_METABOLISM,-2.170449716,0.016129494,bosentan
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.133886255,0.018934623,bosentan
EUKARYOTIC_TRANSLATION_INITIATION,-2.132469112,0.015568468,bosentan
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.090548503,0.019285264,bosentan
NONSENSE_MEDIATED_DECAY_NMD,-2.086624901,0.017281601,bosentan
SIGNALING_BY_ROBO_RECEPTORS,-2.052117575,0.021958903,bosentan
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.025371783,0.026414968,bosentan
SARS_COV_1_INFECTION,-1.959924337,0.044601557,bosentan
RESPIRATORY_ELECTRON_TRANSPORT,3.257271158,0,safinamide
PROTEIN_LOCALIZATION,2.497027959,0.001787916,safinamide
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.423726721,0.002860666,safinamide
ION_CHANNEL_TRANSPORT,-3.192109367,0.070748365,safinamide
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.987099503,0.026818742,safinamide
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1.751989623,0.081528977,safinamide
SARS_COV_2_INFECTION,-3.043762183,0.559123274,safinamide
STIMULI_SENSING_CHANNELS,-3.00206401,0.534308549,safinamide
SARS_COV_INFECTIONS,-2.827706497,0.793543231,safinamide
TRANSPORT_OF_SMALL_MOLECULES,-2.732168306,0.675382901,safinamide
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.750245074,0.597572245,cariprazine
ESR_MEDIATED_SIGNALING,1.573152303,0.818863407,cariprazine
REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC,1.566279636,0.427513861,cariprazine
METABOLISM_OF_POLYAMINES,1.566279636,0.427513861,cariprazine
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.489319914,0.520421707,cariprazine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.773917738,1,cariprazine
ACTIVATION_OF_APC_C_AND_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS,1.468427393,0.481042787,cariprazine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.462988491,0.425607239,cariprazine
SIGNALING_BY_NUCLEAR_RECEPTORS,1.430495029,0.43655494,cariprazine
PROTEASOME_ASSEMBLY,1.402955261,0.445643855,cariprazine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.525723798,0,clenbuterol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.409975112,0.00050973,clenbuterol
NONSENSE_MEDIATED_DECAY_NMD,-2.372358961,0.00067964,clenbuterol
SELENOAMINO_ACID_METABOLISM,-2.322792158,0.000764595,clenbuterol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.310466597,0.000815568,clenbuterol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.307877077,0.00084955,clenbuterol
EUKARYOTIC_TRANSLATION_INITIATION,-2.296400167,0.000728185,clenbuterol
RRNA_PROCESSING,-2.254819632,0.000764595,clenbuterol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.251880854,0.000792913,clenbuterol
SIGNALING_BY_ROBO_RECEPTORS,-2.177371455,0.002242811,clenbuterol
EUKARYOTIC_TRANSLATION_ELONGATION,2.611046406,0,aminoguanidine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.565229675,0,aminoguanidine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.666416352,0,aminoguanidine
INFLUENZA_INFECTION,2.570966785,0,aminoguanidine
SELENOAMINO_ACID_METABOLISM,2.533699994,0.00024532,aminoguanidine
EUKARYOTIC_TRANSLATION_INITIATION,2.537687276,0.000294384,aminoguanidine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.511217363,0.000367979,aminoguanidine
NONSENSE_MEDIATED_DECAY_NMD,2.524938437,0.000420548,aminoguanidine
RRNA_PROCESSING,2.44303406,0.001308371,aminoguanidine
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.394184544,0.001471918,aminoguanidine
PROTEIN_LOCALIZATION,2.25308433,0.01804874,goserelin-acetate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.007355062,0.102012059,goserelin-acetate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.874460078,0.734486824,goserelin-acetate
NEUTROPHIL_DEGRANULATION,-2.491527756,1,goserelin-acetate
HEMOSTASIS,-2.303124353,1,goserelin-acetate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1.351051918,1,goserelin-acetate
INNATE_IMMUNE_SYSTEM,-1.94708958,1,goserelin-acetate
GPCR_LIGAND_BINDING,-1.849918427,1,goserelin-acetate
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-1.821277349,1,goserelin-acetate
DISEASES_OF_GLYCOSYLATION,-1.817305587,1,goserelin-acetate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.270653185,0.017786037,mercaptopurine
RRNA_PROCESSING,1.727243626,0.300609519,mercaptopurine
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.558875201,0.363441836,mercaptopurine
ECM_PROTEOGLYCANS,-1.869719688,0.697840379,mercaptopurine
SIGNALING_BY_NTRKS,1.465691879,0.383153936,mercaptopurine
NEURONAL_SYSTEM,1.418890188,0.360823823,mercaptopurine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.76515604,1,mercaptopurine
RESPIRATORY_ELECTRON_TRANSPORT,-1.731051789,1,mercaptopurine
CARDIAC_CONDUCTION,1.298048801,0.505738555,mercaptopurine
REGULATED_NECROSIS,-1.676391841,1,mercaptopurine
RESPIRATORY_ELECTRON_TRANSPORT,2.772564408,0,levomequitazine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.430630894,0.003015602,levomequitazine
DISEASES_OF_METABOLISM,2.164594697,0.013707284,levomequitazine
COMPLEX_I_BIOGENESIS,2.109165807,0.017134105,levomequitazine
METABOLISM_OF_VITAMINS_AND_COFACTORS,1.981488836,0.037283812,levomequitazine
ION_CHANNEL_TRANSPORT,-3.249875772,0.87476709,levomequitazine
PROTEIN_LOCALIZATION,1.809598456,0.093483676,levomequitazine
STIMULI_SENSING_CHANNELS,-3.142762495,1,levomequitazine
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.749146904,0.114436239,levomequitazine
SARS_COV_2_INFECTION,-3.073611312,0.905045894,levomequitazine
RESPIRATORY_ELECTRON_TRANSPORT,2.611263245,0.001202779,ARRY-334543
GPCR_LIGAND_BINDING,-2.270599372,0.042865446,ARRY-334543
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.234374167,0.034292357,ARRY-334543
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.231669786,0.023678056,ARRY-334543
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.208798559,0.022351268,ARRY-334543
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.118777406,0.032475024,ARRY-334543
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-2.114114443,0.041640719,ARRY-334543
COLLAGEN_FORMATION,-2.075458056,0.045723142,ARRY-334543
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.051944704,0.048639159,ARRY-334543
PROTEIN_LOCALIZATION,2.004587362,0.051719483,ARRY-334543
EUKARYOTIC_TRANSLATION_ELONGATION,-2.513421931,0,cyclizine
SELENOAMINO_ACID_METABOLISM,-2.460463129,0,cyclizine
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.363342524,0,cyclizine
NONSENSE_MEDIATED_DECAY_NMD,-2.360428005,0,cyclizine
INFLUENZA_INFECTION,-2.300985584,0.000404538,cyclizine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.291824674,0.000505672,cyclizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.236516682,0.001011345,cyclizine
EUKARYOTIC_TRANSLATION_INITIATION,-2.22192532,0.001137763,cyclizine
CELLULAR_RESPONSE_TO_STARVATION,-2.21488987,0.001011345,cyclizine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.196632217,0.001415883,cyclizine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.707304582,0.414942988,retigabine
RRNA_PROCESSING,1.55952632,0.437916833,retigabine
MUSCLE_CONTRACTION,1.426213179,0.570929506,retigabine
SELENOAMINO_ACID_METABOLISM,1.413943171,0.454175247,retigabine
G2_M_DNA_DAMAGE_CHECKPOINT,1.378433663,0.428939361,retigabine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.750304461,1,retigabine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,1.270168739,0.585538515,retigabine
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.247259351,0.558845095,retigabine
REPRODUCTION,1.239996911,0.503569014,retigabine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.239212,0.449501935,retigabine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.325089803,0.002066868,resorcinol
NONSENSE_MEDIATED_DECAY_NMD,-2.175872582,0.008267474,resorcinol
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.163717054,0.00723404,resorcinol
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.121470814,0.011884494,resorcinol
EUKARYOTIC_TRANSLATION_INITIATION,-2.114767834,0.009920969,resorcinol
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.050123625,0.020840924,resorcinol
SELENOAMINO_ACID_METABOLISM,-2.023673691,0.022735553,resorcinol
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.006593368,0.024802421,resorcinol
SIGNALING_BY_ROBO_RECEPTORS,-1.996723132,0.024572769,resorcinol
NERVOUS_SYSTEM_DEVELOPMENT,-1.918892189,0.05373858,resorcinol
RESPIRATORY_ELECTRON_TRANSPORT,2.631627321,0,gabapentin
ECM_PROTEOGLYCANS,-2.391858861,0.057197882,gabapentin
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.383823048,0.034448724,gabapentin
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.309329833,0.048098219,gabapentin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.164861997,0.02619468,gabapentin
STIMULI_SENSING_CHANNELS,-2.270658486,0.047448243,gabapentin
DISEASES_OF_METABOLISM,2.091165463,0.027318545,gabapentin
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.232301646,0.057717862,gabapentin
COLLAGEN_FORMATION,-2.172609743,0.079297063,gabapentin
COMPLEX_I_BIOGENESIS,1.979412441,0.044219733,gabapentin
RESPIRATORY_ELECTRON_TRANSPORT,2.729447767,0,diminazene-aceturate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.589359831,0.000322136,diminazene-aceturate
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.313670094,0.009739061,diminazene-aceturate
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.292978049,0.005410589,diminazene-aceturate
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,1.622057315,0.300875322,diminazene-aceturate
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-1.824011633,0.574243885,diminazene-aceturate
PROTEIN_LOCALIZATION,1.56598843,0.303130276,diminazene-aceturate
CELLULAR_RESPONSE_TO_STARVATION,1.562602184,0.248560384,diminazene-aceturate
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.789575536,0.56486553,diminazene-aceturate
ESR_MEDIATED_SIGNALING,-1.783018475,0.475915441,diminazene-aceturate
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.004672749,1,ARN-509
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.002677954,1,ARN-509
UNFOLDED_PROTEIN_RESPONSE_UPR,1.399141509,1,ARN-509
SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,-1.81544105,1,ARN-509
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.318254219,1,ARN-509
MITOCHONDRIAL_BIOGENESIS,-1.755037795,1,ARN-509
FORMATION_OF_THE_CORNIFIED_ENVELOPE,1.223384247,0.890241143,ARN-509
KERATINIZATION,1.223384247,0.890241143,ARN-509
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.689274402,1,ARN-509
PROTEIN_UBIQUITINATION,-1.681148634,1,ARN-509
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.049207162,0.572835373,trapidil
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.027079249,0.414368765,trapidil
PROTEIN_LOCALIZATION,1.594053592,0.764431647,trapidil
HEMOSTASIS,-2.604484522,1,trapidil
NEUTROPHIL_DEGRANULATION,-2.484398271,1,trapidil
GPCR_LIGAND_BINDING,-2.164788447,1,trapidil
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.099432826,0.874600051,trapidil
SIGNALING_BY_GPCR,-2.021700143,0.780096236,trapidil
INNATE_IMMUNE_SYSTEM,-1.842012665,0.808260004,trapidil
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-1.840131099,0.720594778,trapidil
EUKARYOTIC_TRANSLATION_ELONGATION,4.543126156,0,miglustat
CELLULAR_RESPONSES_TO_STIMULI,2.669797749,0,miglustat
VIRAL_INFECTION_PATHWAYS,2.684462432,0,miglustat
MITOTIC_METAPHASE_AND_ANAPHASE,2.734133043,0,miglustat
MITOTIC_PROMETAPHASE,2.736324535,0,miglustat
SEPARATION_OF_SISTER_CHROMATIDS,2.825836346,0,miglustat
M_PHASE,2.915723656,0,miglustat
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.124823168,0,miglustat
SARS_COV_1_INFECTION,3.129095583,0,miglustat
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.154838129,0,miglustat
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,4.188811652,0,mecamylamine
GPCR_LIGAND_BINDING,3.787102212,0,mecamylamine
PEPTIDE_LIGAND_BINDING_RECEPTORS,3.239194802,0,mecamylamine
NONSENSE_MEDIATED_DECAY_NMD,-2.922214859,0,mecamylamine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.921132213,0,mecamylamine
SELENOAMINO_ACID_METABOLISM,-2.843121871,0,mecamylamine
SIGNALING_BY_ROBO_RECEPTORS,-2.813990639,0,mecamylamine
INFLUENZA_INFECTION,-2.799683298,0,mecamylamine
SIGNALING_BY_GPCR,2.624934015,0.000186065,mecamylamine
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.715873527,0.000120837,mecamylamine
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.212388317,0.030123171,oxandrolone
ION_CHANNEL_TRANSPORT,-2.204580476,0.058097744,oxandrolone
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.086372324,0.089740265,oxandrolone
CHROMATIN_ORGANIZATION,-2.007286533,0.13971124,oxandrolone
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,-1.998446016,0.113601838,oxandrolone
RESPIRATORY_ELECTRON_TRANSPORT,1.790706648,0.180331959,oxandrolone
NEURONAL_SYSTEM,-1.95810843,0.129889955,oxandrolone
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.890607535,0.187780207,oxandrolone
GPCR_LIGAND_BINDING,-1.86269632,0.199933306,oxandrolone
PROTEIN_LOCALIZATION,1.539868383,0.468130367,oxandrolone
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.05125714,0.038692779,indoramin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.055169449,0.114320708,indoramin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.030118357,0.08033347,indoramin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-1.990958329,0.082736608,indoramin
NONSENSE_MEDIATED_DECAY_NMD,-1.959016539,0.092949945,indoramin
EUKARYOTIC_TRANSLATION_INITIATION,-1.944248045,0.089396733,indoramin
SELENOAMINO_ACID_METABOLISM,-1.905945286,0.11260418,indoramin
SIGNALING_BY_GPCR,-1.864427716,0.140068615,indoramin
SIGNALING_BY_ROBO_RECEPTORS,-1.864023862,0.122560038,indoramin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.854487341,0.119699159,indoramin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.96314295,0.417647034,rotigotine
HCMV_INFECTION,1.728494976,0.39551525,rotigotine
PYRUVATE_METABOLISM,-1.868113771,0.512340276,rotigotine
RRNA_PROCESSING,1.525409072,0.617414715,rotigotine
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.82864554,0.48210489,rotigotine
TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1.472276994,0.545502852,rotigotine
ECM_PROTEOGLYCANS,-1.786910934,0.505362879,rotigotine
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.773341089,0.44595533,rotigotine
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.425894037,0.520076871,rotigotine
SIGNALING_BY_NTRKS,1.414758114,0.438251444,rotigotine
RRNA_PROCESSING,1.925925268,0.089332471,bazedoxifene
CELLULAR_RESPONSES_TO_MECHANICAL_STIMULI,1.865501788,0.064997074,bazedoxifene
PLATELET_HOMEOSTASIS,1.747406593,0.081528715,bazedoxifene
MUSCLE_CONTRACTION,1.47292655,0.278932939,bazedoxifene
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.65705352,1,bazedoxifene
SIGNALING_BY_VEGF,1.412286537,0.300033885,bazedoxifene
UNFOLDED_PROTEIN_RESPONSE_UPR,1.358761075,0.328681884,bazedoxifene
SIGNALING_BY_NTRKS,1.355269082,0.286479993,bazedoxifene
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,-2.577428264,1,bazedoxifene
ECM_PROTEOGLYCANS,-2.578599532,1,bazedoxifene
EUKARYOTIC_TRANSLATION_ELONGATION,-2.666705413,0,betrixaban
NONSENSE_MEDIATED_DECAY_NMD,-2.560506223,0,betrixaban
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.429146922,0,betrixaban
EUKARYOTIC_TRANSLATION_INITIATION,-2.426545667,0,betrixaban
SELENOAMINO_ACID_METABOLISM,-2.420607668,0.000206849,betrixaban
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.396747091,0.000344748,betrixaban
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.393789803,0.000295498,betrixaban
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.312832001,0.000459664,betrixaban
INFLUENZA_INFECTION,-2.335101684,0.000517122,betrixaban
RRNA_PROCESSING,-2.236322795,0.002068489,betrixaban
DEVELOPMENTAL_CELL_LINEAGES,-3.012234538,0.000638555,ellagic-acid
GPCR_LIGAND_BINDING,-2.868091767,0.002234943,ellagic-acid
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.822526758,0.003192775,ellagic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.285797096,0.038066235,ellagic-acid
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.251815151,0.022693333,ellagic-acid
EUKARYOTIC_TRANSLATION_INITIATION,2.249059213,0.015128888,ellagic-acid
ECM_PROTEOGLYCANS,-2.762526554,0.006066273,ellagic-acid
NONSENSE_MEDIATED_DECAY_NMD,2.216704188,0.017569032,ellagic-acid
EUKARYOTIC_TRANSLATION_ELONGATION,2.175281865,0.021375655,ellagic-acid
SELENOAMINO_ACID_METABOLISM,2.118581136,0.030257777,ellagic-acid
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.959552087,0,metamizole
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.568191607,0,metamizole
EUKARYOTIC_TRANSLATION_ELONGATION,-2.550178014,0,metamizole
NONSENSE_MEDIATED_DECAY_NMD,-2.432151336,0.000501838,metamizole
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.363403233,0.001672794,metamizole
SELENOAMINO_ACID_METABOLISM,-2.351065494,0.001254595,metamizole
BIOLOGICAL_OXIDATIONS,2.455455,0.000973552,metamizole
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.326047466,0.001405147,metamizole
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.275042196,0.001840073,metamizole
EUKARYOTIC_TRANSLATION_INITIATION,-2.240536676,0.002150735,metamizole
EUKARYOTIC_TRANSLATION_ELONGATION,4.976098699,0,elacridar
DNA_REPLICATION,2.906803454,0,elacridar
CELL_CYCLE_CHECKPOINTS,2.932224475,0,elacridar
MRNA_SPLICING,3.138266212,0,elacridar
G2_M_CHECKPOINTS,3.143568915,0,elacridar
CELLULAR_RESPONSES_TO_STIMULI,3.295177209,0,elacridar
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,3.318855746,0,elacridar
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.338067515,0,elacridar
SIGNALING_BY_ROBO_RECEPTORS,3.384039634,0,elacridar
SARS_COV_1_INFECTION,3.405121456,0,elacridar
CELLULAR_RESPONSE_TO_STARVATION,4.790906659,0,enprofylline
CELLULAR_RESPONSES_TO_STIMULI,3.164194383,0,enprofylline
SARS_COV_1_INFECTION,3.149697152,0,enprofylline
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,3.077657437,0,enprofylline
SYNTHESIS_OF_DNA,3.058136654,0,enprofylline
MITOTIC_METAPHASE_AND_ANAPHASE,3.007636553,0,enprofylline
CELL_CYCLE_CHECKPOINTS,2.984145946,0,enprofylline
SARS_COV_2_HOST_INTERACTIONS,2.704018111,0,enprofylline
MITOTIC_G2_G2_M_PHASES,2.938793358,0,enprofylline
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.883468534,0,enprofylline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.237589751,0,VX-661
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.100742423,0.026495652,VX-661
PROTEIN_LOCALIZATION,1.866796749,0.236943058,VX-661
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.602512376,0.48479302,VX-661
HEMOSTASIS,-2.626704425,1,VX-661
NEUTROPHIL_DEGRANULATION,-2.527784396,1,VX-661
GPCR_LIGAND_BINDING,-2.182896822,0.952181007,VX-661
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.163066564,0.804220973,VX-661
SIGNALING_BY_GPCR,-1.974867528,0.845337475,VX-661
CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1.415967187,0.820901136,VX-661
PROTEIN_LOCALIZATION,2.08570932,0.025699318,darifenacin
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.060011212,0.217291274,darifenacin
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.030151309,0.215669697,darifenacin
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.607506477,0.316793516,darifenacin
HEMOSTASIS,-2.499201068,1,darifenacin
NEUTROPHIL_DEGRANULATION,-2.488804535,0.951054718,darifenacin
PHASE_II_CONJUGATION_OF_COMPOUNDS,1.471928862,0.420908702,darifenacin
INNATE_IMMUNE_SYSTEM,-1.921748564,1,darifenacin
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-1.884872817,0.890245593,darifenacin
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.868735207,0.777430187,darifenacin
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-3.001701223,0,ramelteon
GPCR_LIGAND_BINDING,-2.756623209,0.0004898,ramelteon
ECM_PROTEOGLYCANS,-2.553832225,0.003918398,ramelteon
CELLULAR_RESPONSE_TO_STARVATION,2.178676102,0.059547044,ramelteon
SIGNALING_BY_GPCR,-2.416232365,0.01738789,ramelteon
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.05790181,0.079567171,ramelteon
EUKARYOTIC_TRANSLATION_ELONGATION,2.014428435,0.072551571,ramelteon
G_ALPHA_S_SIGNALLING_EVENTS,-2.250442802,0.061714766,ramelteon
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.244343479,0.054041236,ramelteon
NONSENSE_MEDIATED_DECAY_NMD,1.989125967,0.068787103,ramelteon
EUKARYOTIC_TRANSLATION_ELONGATION,-2.610431172,0,furosemide
NONSENSE_MEDIATED_DECAY_NMD,-2.598543858,0,furosemide
SELENOAMINO_ACID_METABOLISM,-2.55435939,0,furosemide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.507389346,0,furosemide
EUKARYOTIC_TRANSLATION_INITIATION,-2.505834369,0,furosemide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.4593798,0,furosemide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.379348206,0,furosemide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.37522201,0,furosemide
INFLUENZA_INFECTION,-2.289875009,0.000192108,furosemide
RRNA_PROCESSING,-2.293316825,0.00010566,furosemide
EUKARYOTIC_TRANSLATION_ELONGATION,4.018662069,0,mestinon
SIGNALING_BY_ROBO_RECEPTORS,2.959690504,0,mestinon
INFLUENZA_INFECTION,3.239553806,0,mestinon
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,3.274324282,0,mestinon
METABOLISM_OF_RNA,3.528793738,0,mestinon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,3.561976735,0,mestinon
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.988491603,0,mestinon
RRNA_PROCESSING,3.614220442,0,mestinon
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.577011447,0,mestinon
EUKARYOTIC_TRANSLATION_INITIATION,3.739989373,0,mestinon
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.947336713,0.525976317,carisoprodol
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.855997984,0.614701615,carisoprodol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.575906768,0.624381625,carisoprodol
PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1.46667445,0.530565371,carisoprodol
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.745493173,1,carisoprodol
G_ALPHA_S_SIGNALLING_EVENTS,-1.7390978,0.80304364,carisoprodol
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.333605589,0.683392226,carisoprodol
POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,-1.688109586,0.931456242,carisoprodol
O_LINKED_GLYCOSYLATION,1.251566011,0.743639576,carisoprodol
G_ALPHA_I_SIGNALLING_EVENTS,-1.646357237,1,carisoprodol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.042454656,0.147811973,indacaterol
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.971836915,0.145744672,indacaterol
RAB_REGULATION_OF_TRAFFICKING,1.700018367,0.530844061,indacaterol
HCMV_EARLY_EVENTS,1.653258994,0.327896546,indacaterol
G_ALPHA_I_SIGNALLING_EVENTS,-1.869442672,0.254277939,indacaterol
HCMV_INFECTION,1.616750223,0.25646104,indacaterol
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.451052285,0.424826702,indacaterol
DEATH_RECEPTOR_SIGNALING,-1.725099207,0.702365282,indacaterol
APOPTOSIS,-1.707764401,0.647271729,indacaterol
ADIPOGENESIS,1.373263433,0.489194385,indacaterol
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.956870719,0.10856975,temazepam
SIGNALING_BY_PTK6,-1.961996875,0.381453933,temazepam
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.899743665,0.366570615,temazepam
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.899399937,0.245115388,temazepam
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,-1.893513412,0.193207519,temazepam
P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,-1.884397916,0.167354645,temazepam
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.847778054,0.18613335,temazepam
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-1.785183134,0.263647351,temazepam
PROTEIN_LOCALIZATION,1.558833311,0.511750881,temazepam
NEURONAL_SYSTEM,-1.756743328,0.291740598,temazepam
GPCR_LIGAND_BINDING,-3.027156724,0,BRD-K26619122
SIGNALING_BY_GPCR,-2.974253743,0,BRD-K26619122
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.768219686,0.000210296,BRD-K26619122
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-2.576196172,0.000315444,BRD-K26619122
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.459342737,0.007149595,BRD-K26619122
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.432863089,0.004289757,BRD-K26619122
CELLULAR_RESPONSE_TO_STARVATION,2.39371631,0.003336478,BRD-K26619122
CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,-2.398322017,0.001766486,BRD-K26619122
SIGNALING_BY_INTERLEUKINS,-2.382229381,0.00157722,BRD-K26619122
NONSENSE_MEDIATED_DECAY_NMD,2.340446248,0.005719676,BRD-K26619122
CELLULAR_RESPONSE_TO_STARVATION,3.511998453,0,SN-38
SELENOAMINO_ACID_METABOLISM,3.361927837,0,SN-38
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,3.278263657,0,SN-38
EUKARYOTIC_TRANSLATION_ELONGATION,3.270541438,0,SN-38
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,3.245748592,0,SN-38
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.178048524,0,SN-38
EUKARYOTIC_TRANSLATION_INITIATION,3.135000673,0,SN-38
RRNA_PROCESSING,3.004858803,0,SN-38
TRANSLATION,2.837439112,0,SN-38
NONSENSE_MEDIATED_DECAY_NMD,2.831910454,0,SN-38
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,4.629357375,0,armodafinil
PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,2.852828641,0,armodafinil
MITOTIC_METAPHASE_AND_ANAPHASE,2.884939841,0,armodafinil
MRNA_SPLICING,2.986757242,0,armodafinil
SARS_COV_1_INFECTION,3.011805516,0,armodafinil
SIGNALING_BY_ROBO_RECEPTORS,3.099191107,0,armodafinil
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.15634706,0,armodafinil
RESPIRATORY_ELECTRON_TRANSPORT,3.235252472,0,armodafinil
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,3.279228485,0,armodafinil
SARS_COV_1_HOST_INTERACTIONS,3.324843798,0,armodafinil
RESPIRATORY_ELECTRON_TRANSPORT,2.729544707,0,aminocaproic-acid
ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,-2.86525051,0.003471581,aminocaproic-acid
COLLAGEN_FORMATION,-2.841606305,0.002314388,aminocaproic-acid
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.416996815,0.001842124,aminocaproic-acid
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.779558591,0.003857313,aminocaproic-acid
SIGNALING_BY_MET,-2.735067853,0.005207372,aminocaproic-acid
DEVELOPMENTAL_CELL_LINEAGES,-2.721566741,0.004397336,aminocaproic-acid
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.662368576,0.008486088,aminocaproic-acid
COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,-2.61356295,0.013390385,aminocaproic-acid
COLLAGEN_DEGRADATION,-2.539982148,0.021986682,aminocaproic-acid
RESPIRATORY_ELECTRON_TRANSPORT,2.642766034,0,ORE-1001
NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,-2.47481557,0.002499827,ORE-1001
GPCR_LIGAND_BINDING,-2.299521988,0.014374007,ORE-1001
GOLGI_TO_ER_RETROGRADE_TRANSPORT,-2.272537863,0.013332413,ORE-1001
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.163637736,0.025310752,ORE-1001
COLLAGEN_FORMATION,-2.151129074,0.024248325,ORE-1001
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.104507584,0.03353935,ORE-1001
ECM_PROTEOGLYCANS,-2.092810384,0.032676315,ORE-1001
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,-2.074352765,0.033122713,ORE-1001
DEVELOPMENTAL_CELL_LINEAGES,-1.989565237,0.056662753,ORE-1001
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.551970652,0,umeclidinium
SELENOAMINO_ACID_METABOLISM,-2.434100931,0,umeclidinium
EUKARYOTIC_TRANSLATION_INITIATION,-2.445979205,0,umeclidinium
SARS_COV_1_HOST_INTERACTIONS,-2.448479401,0,umeclidinium
NONSENSE_MEDIATED_DECAY_NMD,-2.451881106,0,umeclidinium
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.39577318,0,umeclidinium
INFLUENZA_INFECTION,-2.520837117,0,umeclidinium
CELLULAR_RESPONSE_TO_STARVATION,-2.530038885,0,umeclidinium
EUKARYOTIC_TRANSLATION_ELONGATION,-2.548346189,0,umeclidinium
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.462031138,0,umeclidinium
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.074774979,0.137126275,PH-797804
MITF_M_DEPENDENT_GENE_EXPRESSION,1.835577238,0.273315884,PH-797804
PROTEIN_LOCALIZATION,1.73403678,0.25267484,PH-797804
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.989546823,0.558972754,PH-797804
NEUTROPHIL_DEGRANULATION,-2.842252755,1,PH-797804
HEMOSTASIS,-2.52166,1,PH-797804
INNATE_IMMUNE_SYSTEM,-2.069023338,1,PH-797804
GPCR_LIGAND_BINDING,-2.047306954,0.992857036,PH-797804
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.025077271,0.859394441,PH-797804
SIGNALING_BY_GPCR,-1.996030044,0.765839778,PH-797804
GPCR_LIGAND_BINDING,-3.153649602,0,blonanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,-2.862253165,0,blonanserin
SIGNALING_BY_GPCR,-2.753266809,0,blonanserin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.6556654,0,blonanserin
EUKARYOTIC_TRANSLATION_ELONGATION,2.652423363,0,blonanserin
CELLULAR_RESPONSE_TO_STARVATION,2.586471854,0,blonanserin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.538856335,0.00037968,blonanserin
EUKARYOTIC_TRANSLATION_INITIATION,2.516027645,0.000303744,blonanserin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.434003468,0.00037968,blonanserin
NONSENSE_MEDIATED_DECAY_NMD,2.463645714,0.00043392,blonanserin
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,3.589686034,0,tafamidis-meglumine
INFLUENZA_INFECTION,-2.609412914,0,tafamidis-meglumine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.656579541,0,tafamidis-meglumine
TRANSLATION,-2.708280072,0,tafamidis-meglumine
CELLULAR_RESPONSE_TO_STARVATION,-2.795157045,0,tafamidis-meglumine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.917982086,0,tafamidis-meglumine
RRNA_PROCESSING,-2.965668729,0,tafamidis-meglumine
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.994428106,0,tafamidis-meglumine
METABOLISM_OF_RNA,-2.76539616,0,tafamidis-meglumine
SELENOAMINO_ACID_METABOLISM,-3.025171813,0,tafamidis-meglumine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.296651658,0.007347895,mCPP
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.393126585,0.004952027,mCPP
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.168472951,0.029916428,mCPP
NONSENSE_MEDIATED_DECAY_NMD,-2.154213141,0.023793182,mCPP
EUKARYOTIC_TRANSLATION_INITIATION,-2.150408297,0.019157011,mCPP
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.134401533,0.018474706,mCPP
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.117851951,0.019069536,mCPP
SELENOAMINO_ACID_METABOLISM,-2.101089028,0.018294758,mCPP
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.056980285,0.022830958,mCPP
BIOLOGICAL_OXIDATIONS,1.973879318,0.036830703,mCPP
CELLULAR_RESPONSE_TO_STARVATION,2.335093717,0.013352771,ganaxolone
ION_CHANNEL_TRANSPORT,-3.483575401,0.12723383,ganaxolone
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,2.106816359,0.048821069,ganaxolone
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,2.052533478,0.047012881,ganaxolone
EUKARYOTIC_TRANSLATION_ELONGATION,2.029017317,0.041310135,ganaxolone
EUKARYOTIC_TRANSLATION_INITIATION,1.955526348,0.058418373,ganaxolone
RESPIRATORY_ELECTRON_TRANSPORT,1.845795199,0.107239441,ganaxolone
SARS_COV_2_INFECTION,-3.261779241,0.939616207,ganaxolone
NONSENSE_MEDIATED_DECAY_NMD,1.785349456,0.134123815,ganaxolone
SARS_COV_INFECTIONS,-3.074298089,0.891762776,ganaxolone
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.763171923,0,pralatrexate
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.115094047,0.057555156,pralatrexate
SIGNALING_BY_ROBO_RECEPTORS,-2.088842338,0.041110826,pralatrexate
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.040492275,0.054129254,pralatrexate
BIOLOGICAL_OXIDATIONS,1.891469646,0.067670426,pralatrexate
EXTRACELLULAR_MATRIX_ORGANIZATION,1.888848822,0.045632165,pralatrexate
EUKARYOTIC_TRANSLATION_INITIATION,-2.024341061,0.048819105,pralatrexate
NERVOUS_SYSTEM_DEVELOPMENT,-1.985505901,0.059405143,pralatrexate
NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,-1.96316667,0.062865304,pralatrexate
EUKARYOTIC_TRANSLATION_ELONGATION,-1.960960617,0.055059141,pralatrexate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.337678148,0.008957165,suvorexant
RESPIRATORY_ELECTRON_TRANSPORT,2.096969994,0.024258987,suvorexant
ION_CHANNEL_TRANSPORT,-1.919889296,0.958499803,suvorexant
ECM_PROTEOGLYCANS,-1.798189975,1,suvorexant
ADAPTIVE_IMMUNE_SYSTEM,1.523443563,0.496625011,suvorexant
SARS_COV_2_INFECTION,-1.737900521,1,suvorexant
TRANSCRIPTIONAL_REGULATION_BY_RUNX1,-1.737582619,0.820854159,suvorexant
NEDDYLATION,1.447585411,0.545827213,suvorexant
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.443786103,0.443976788,suvorexant
RAC2_GTPASE_CYCLE,-1.681523527,0.934193854,suvorexant
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.91761494,0.161167476,rupatadine
PROTEIN_LOCALIZATION,1.856715791,0.119436612,rupatadine
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.897529275,0.37810746,rupatadine
FATTY_ACID_METABOLISM,1.763375202,0.134945783,rupatadine
HIV_LIFE_CYCLE,1.687477067,0.15780982,rupatadine
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.818958938,0.929681772,rupatadine
HATS_ACETYLATE_HISTONES,1.507312607,0.319073229,rupatadine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.485119124,0.29403471,rupatadine
NEUTROPHIL_DEGRANULATION,-2.612296426,1,rupatadine
ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1.340246393,0.51488623,rupatadine
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.284613371,0.013294476,tazarotene
BIOLOGICAL_OXIDATIONS,1.996166093,0.044631455,tazarotene
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.984583559,0.031970049,tazarotene
EXTRACELLULAR_MATRIX_ORGANIZATION,-2.035555664,0.118652163,tazarotene
SIGNALING_BY_ALK_IN_CANCER,1.816425073,0.066947182,tazarotene
ECM_PROTEOGLYCANS,-1.922097283,0.24082367,tazarotene
EUKARYOTIC_TRANSLATION_ELONGATION,-1.901656304,0.20043501,tazarotene
RRNA_PROCESSING,-1.885506077,0.170185412,tazarotene
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.808635678,0.273905502,tazarotene
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1.557005035,0.222587511,tazarotene
PROTEIN_LOCALIZATION,2.175460283,0.024194226,tanaproget
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.963937166,0.202030453,tanaproget
MITF_M_DEPENDENT_GENE_EXPRESSION,1.820046398,0.114922573,tanaproget
NEUTROPHIL_DEGRANULATION,-2.837952732,0.891865004,tanaproget
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.826087285,0.660873364,tanaproget
HEMOSTASIS,-2.311477239,1,tanaproget
INNATE_IMMUNE_SYSTEM,-2.203898712,0.878884809,tanaproget
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.335370584,0.88532945,tanaproget
TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,-1.841924091,1,tanaproget
DISEASES_OF_GLYCOSYLATION,-1.828512671,1,tanaproget
EUKARYOTIC_TRANSLATION_ELONGATION,-2.532769038,0,enoxacin
SELENOAMINO_ACID_METABOLISM,-2.449231393,0,enoxacin
NONSENSE_MEDIATED_DECAY_NMD,-2.411653201,0,enoxacin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.3269885,0,enoxacin
EUKARYOTIC_TRANSLATION_INITIATION,-2.294011525,0.000210898,enoxacin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.293242297,0.000175749,enoxacin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.219277086,0.001054492,enoxacin
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.347285183,0.005054536,enoxacin
RRNA_PROCESSING,-2.185147233,0.001186303,enoxacin
INFLUENZA_INFECTION,-2.165192187,0.002343315,enoxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-2.213633468,0.012229133,arbutin
MUSCLE_CONTRACTION,2.09157526,0.05556681,arbutin
NEURONAL_SYSTEM,2.050119992,0.037768066,arbutin
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.04184646,0.027204584,arbutin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.048229353,0.073374796,arbutin
SELENOAMINO_ACID_METABOLISM,-2.02173545,0.062844154,arbutin
NONSENSE_MEDIATED_DECAY_NMD,-2.007648612,0.052483361,arbutin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.996056792,0.046674523,arbutin
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-1.975805005,0.046029097,arbutin
INFLUENZA_INFECTION,-1.9715635,0.04207404,arbutin
NEURONAL_SYSTEM,1.682253365,0.465654375,PS-178990
MUSCLE_CONTRACTION,1.662806564,0.265422993,PS-178990
SIGNALING_BY_NTRKS,1.577516115,0.280723066,PS-178990
ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,-1.913492505,1,PS-178990
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.870831163,1,PS-178990
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.805276677,1,PS-178990
GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1.28117097,0.854309472,PS-178990
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,-1.773362354,1,PS-178990
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.216207277,0.902039046,PS-178990
SIGNALING_BY_VEGF,1.212822241,0.761677513,PS-178990
PEPTIDE_LIGAND_BINDING_RECEPTORS,2.226914418,0.010878589,resiquimod
MUSCLE_CONTRACTION,2.118447805,0.013168819,resiquimod
CARDIAC_CONDUCTION,1.955348127,0.020612064,resiquimod
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.84328602,0.0342103,resiquimod
GPCR_LIGAND_BINDING,1.713694813,0.064011909,resiquimod
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.392598674,0.287614631,resiquimod
VESICLE_MEDIATED_TRANSPORT,-2.286238357,1,resiquimod
NEUTROPHIL_DEGRANULATION,-2.233217967,1,resiquimod
EUKARYOTIC_TRANSLATION_INITIATION,-2.139925578,1,resiquimod
EUKARYOTIC_TRANSLATION_ELONGATION,-2.094908664,1,resiquimod
EUKARYOTIC_TRANSLATION_ELONGATION,-2.884152968,0,tamsulosin
SIGNALING_BY_ROBO_RECEPTORS,-2.49156519,0,tamsulosin
INFLUENZA_INFECTION,-2.493924125,0,tamsulosin
SARS_COV_1_HOST_INTERACTIONS,-2.500466593,0,tamsulosin
RRNA_PROCESSING,-2.584583575,0,tamsulosin
EUKARYOTIC_TRANSLATION_INITIATION,-2.586884937,0,tamsulosin
CELLULAR_RESPONSE_TO_STARVATION,-2.532426433,0,tamsulosin
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.672581834,0,tamsulosin
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.697841314,0,tamsulosin
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.698875893,0,tamsulosin
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-2.008538707,0.170562086,chlormezanone
RRNA_PROCESSING,1.683570417,0.420545838,chlormezanone
TRNA_PROCESSING,1.61389919,0.321833514,chlormezanone
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.560460597,0.284960021,chlormezanone
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.781845666,0.867023937,chlormezanone
FATTY_ACID_METABOLISM,1.43018981,0.417412113,chlormezanone
MITOCHONDRIAL_PROTEIN_DEGRADATION,-1.713241425,1,chlormezanone
HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,-1.711368249,0.78648073,chlormezanone
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.388690233,0.404375819,chlormezanone
SENSORY_PERCEPTION,-1.68720546,0.763949689,chlormezanone
GPCR_LIGAND_BINDING,-2.140030022,0.065970548,thiomersal
CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,-2.024946528,0.124370706,thiomersal
SIGNALING_BY_GPCR,-2.022883045,0.083995288,thiomersal
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-1.980263509,0.10328176,thiomersal
TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,-1.909195221,0.164601926,thiomersal
METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1.696695648,0.501116508,thiomersal
REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1.688902993,0.259121987,thiomersal
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-1.869887616,0.193765955,thiomersal
APOPTOSIS,-1.854243577,0.193585708,thiomersal
L1CAM_INTERACTIONS,-1.835013265,0.196830161,thiomersal
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.615782417,0.001267813,CP-945598
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,2.286256795,0.00697297,CP-945598
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.853142639,0.067827983,CP-945598
NONSENSE_MEDIATED_DECAY_NMD,-1.982770021,0.496024936,CP-945598
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.753476651,0.084784979,CP-945598
EUKARYOTIC_TRANSLATION_ELONGATION,-1.943384027,0.354832337,CP-945598
GPCR_LIGAND_BINDING,1.678064847,0.105482022,CP-945598
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-1.910093151,0.324337556,CP-945598
BIOLOGICAL_OXIDATIONS,1.609270361,0.121921328,CP-945598
SELENOAMINO_ACID_METABOLISM,-1.858798101,0.382594927,CP-945598
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.018333715,0.273038719,clinofibrate
TP53_REGULATES_METABOLIC_GENES,-1.96790669,0.227353106,clinofibrate
EXTRACELLULAR_MATRIX_ORGANIZATION,-1.940695351,0.199225102,clinofibrate
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1.579090252,0.530674201,clinofibrate
DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,-1.782407698,0.598481523,clinofibrate
NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1.411171716,0.592443416,clinofibrate
G_ALPHA_I_SIGNALLING_EVENTS,-1.761053481,0.568221523,clinofibrate
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-1.760564995,0.475130369,clinofibrate
UNFOLDED_PROTEIN_RESPONSE_UPR,1.390724742,0.433737113,clinofibrate
DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,-1.722115973,0.549916565,clinofibrate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.59003709,0.001172709,travoprost
MUSCLE_CONTRACTION,2.506386849,0.000488454,travoprost
METABOLISM_OF_RNA,-2.546923711,0.001172709,travoprost
SELENOAMINO_ACID_METABOLISM,-2.467945416,0.003127224,travoprost
NONSENSE_MEDIATED_DECAY_NMD,-2.45372363,0.002931772,travoprost
EUKARYOTIC_TRANSLATION_INITIATION,-2.435600638,0.002345418,travoprost
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.376167491,0.002345418,travoprost
SIGNALING_BY_ROBO_RECEPTORS,-2.37136353,0.002052241,travoprost
INFLUENZA_INFECTION,-2.387829373,0.002736321,travoprost
RRNA_PROCESSING,-2.287831735,0.003257525,travoprost
NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,2.151400703,0.021272954,tiludronate
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.98945459,0.042545908,tiludronate
CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1.764490724,0.136440326,tiludronate
ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1.734313241,0.12195271,tiludronate
REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1.699937109,0.113260141,tiludronate
COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1.62519301,0.141208402,tiludronate
INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1.549808016,0.182653984,tiludronate
EUKARYOTIC_TRANSLATION_INITIATION,-2.023649689,1,tiludronate
EUKARYOTIC_TRANSLATION_ELONGATION,-2.020881163,1,tiludronate
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.949140562,1,tiludronate
RESPIRATORY_ELECTRON_TRANSPORT,2.593532682,0.000727546,pranlukast
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.274236793,0.088490696,pranlukast
PROTEIN_LOCALIZATION,1.92805268,0.074209734,pranlukast
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.192288888,0.274426504,pranlukast
NEUTROPHIL_DEGRANULATION,-3.047130554,0.694932887,pranlukast
HEMOSTASIS,-2.627503047,0.882536674,pranlukast
INNATE_IMMUNE_SYSTEM,-2.374709314,0.789252732,pranlukast
GPCR_LIGAND_BINDING,-2.161370014,0.694055003,pranlukast
NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,-2.158520624,0.595054783,pranlukast
SIGNALING_BY_GPCR,-2.128311121,0.524755095,pranlukast
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.9635705,0,cromoglicic-acid
MITOTIC_G2_G2_M_PHASES,-2.448575758,0,cromoglicic-acid
INFLUENZA_INFECTION,-2.503813924,0,cromoglicic-acid
CELL_CYCLE_MITOTIC,-2.508377851,0,cromoglicic-acid
CELL_CYCLE,-2.51428434,0,cromoglicic-acid
M_PHASE,-2.51832391,0,cromoglicic-acid
INFECTIOUS_DISEASE,-2.588095686,0,cromoglicic-acid
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.589511782,0,cromoglicic-acid
EUKARYOTIC_TRANSLATION_INITIATION,-2.637229457,0,cromoglicic-acid
SARS_COV_2_HOST_INTERACTIONS,-2.512812287,0,cromoglicic-acid
RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,-2.097304431,0.06486476,acenocoumarol
INTEGRIN_CELL_SURFACE_INTERACTIONS,-1.98360358,0.156845117,acenocoumarol
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.974234889,0.114842527,acenocoumarol
FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,-1.920723955,0.149135781,acenocoumarol
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,-1.908053386,0.13589699,acenocoumarol
SENSORY_PERCEPTION,-1.830020808,0.244040369,acenocoumarol
CYTOPROTECTION_BY_HMOX1,-1.814808884,0.240014804,acenocoumarol
MUSCLE_CONTRACTION,1.521714887,1,acenocoumarol
HOMOLOGY_DIRECTED_REPAIR,1.393598027,1,acenocoumarol
CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1.357895834,0.79265338,acenocoumarol
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-3.080517243,0.095481996,zaleplon
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-3.062211558,0.071349184,zaleplon
MITF_M_DEPENDENT_GENE_EXPRESSION,1.515087384,1,zaleplon
NEUTROPHIL_DEGRANULATION,-2.633429563,1,zaleplon
HEMOSTASIS,-2.505923887,1,zaleplon
COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,-2.086114168,1,zaleplon
INNATE_IMMUNE_SYSTEM,-2.042490459,0.884520025,zaleplon
GPCR_LIGAND_BINDING,-1.928933535,0.863684864,zaleplon
METABOLISM_OF_STEROIDS,1.408152844,1,zaleplon
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.404029292,0.52688857,zaleplon
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.33342019,0.001026219,BRD-A20239487
EUKARYOTIC_TRANSLATION_ELONGATION,-2.32332016,0.00051311,BRD-A20239487
SELENOAMINO_ACID_METABOLISM,-2.320831213,0.000342073,BRD-A20239487
SIGNALING_BY_ROBO_RECEPTORS,-2.246729342,0.00051311,BRD-A20239487
NONSENSE_MEDIATED_DECAY_NMD,-2.227444851,0.001231463,BRD-A20239487
EUKARYOTIC_TRANSLATION_INITIATION,-2.157616323,0.003420731,BRD-A20239487
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.061310586,0.015686496,BRD-A20239487
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.050101223,0.015649846,BRD-A20239487
INTEGRIN_CELL_SURFACE_INTERACTIONS,-2.006904234,0.022690851,BRD-A20239487
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-1.979603077,0.027810545,BRD-A20239487
EUKARYOTIC_TRANSLATION_ELONGATION,3.990851861,0,asymmetrical-dimethylarginine
MRNA_SPLICING,2.705485131,0,asymmetrical-dimethylarginine
MITOTIC_G2_G2_M_PHASES,2.727484594,0,asymmetrical-dimethylarginine
G2_M_CHECKPOINTS,2.780456756,0,asymmetrical-dimethylarginine
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.787623902,0,asymmetrical-dimethylarginine
SARS_COV_1_HOST_INTERACTIONS,2.847934648,0,asymmetrical-dimethylarginine
CELLULAR_RESPONSES_TO_STIMULI,2.947026673,0,asymmetrical-dimethylarginine
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,2.952530302,0,asymmetrical-dimethylarginine
SIGNALING_BY_ROBO_RECEPTORS,3.043526202,0,asymmetrical-dimethylarginine
METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,3.256037033,0,asymmetrical-dimethylarginine
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,4.569649784,0,urea
DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,2.690975685,0,urea
G2_M_CHECKPOINTS,2.803942451,0,urea
SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,2.818049493,0,urea
AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,2.838243857,0,urea
MITOTIC_G2_G2_M_PHASES,2.839536336,0,urea
SYNTHESIS_OF_DNA,2.852951192,0,urea
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,2.869038303,0,urea
MITOTIC_METAPHASE_AND_ANAPHASE,2.914473105,0,urea
CELL_CYCLE_CHECKPOINTS,2.917561427,0,urea
SIGNALING_BY_ROBO_RECEPTORS,-3.024891221,0,marimastat
EUKARYOTIC_TRANSLATION_ELONGATION,-2.993210046,0,marimastat
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.993087614,0,marimastat
PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,2.954823626,0,marimastat
METABOLISM_OF_RNA,-2.864700257,0,marimastat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.845783395,0,marimastat
INFLUENZA_INFECTION,-2.836587918,0,marimastat
RRNA_PROCESSING,-2.818558178,0,marimastat
CELLULAR_RESPONSE_TO_STARVATION,-2.610763013,0,marimastat
NONSENSE_MEDIATED_DECAY_NMD,-2.784635259,0,marimastat
TRANSLATION,-2.682570744,0,ibutilide
EUKARYOTIC_TRANSLATION_INITIATION,-2.680643554,0,ibutilide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.677309847,0,ibutilide
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.379472908,8.10E-05,ibutilide
SELENOAMINO_ACID_METABOLISM,-2.624465187,0.000263187,ibutilide
NONSENSE_MEDIATED_DECAY_NMD,-2.620005805,0.000210549,ibutilide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.614144979,0.000175458,ibutilide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.609425408,0.000150392,ibutilide
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.508521702,0.000131593,ibutilide
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,-2.493717181,0.000116972,ibutilide
EUKARYOTIC_TRANSLATION_ELONGATION,-3.223578502,0,varenicline
METABOLISM_OF_RNA,-2.403835102,0,varenicline
SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,-2.410630192,0,varenicline
SARS_COV_1_HOST_INTERACTIONS,-2.425916682,0,varenicline
ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,-2.470368505,0,varenicline
RRNA_PROCESSING,-2.625982281,0,varenicline
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.709592237,0,varenicline
SIGNALING_BY_ROBO_RECEPTORS,-2.737940924,0,varenicline
TRANSLATION,-2.593168192,0,varenicline
INFLUENZA_INFECTION,-2.889046087,0,varenicline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.893603163,0.273480958,niacin
RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,1.722121704,0.402220729,niacin
REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,1.707351685,0.221737069,niacin
AURKA_ACTIVATION_BY_TPX2,1.630695699,0.236443145,niacin
DISEASES_OF_METABOLISM,-2.81748532,0.379615264,niacin
ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,1.571490604,0.239212471,niacin
RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,1.512806126,0.258979729,niacin
PROTEIN_LOCALIZATION,1.499548916,0.228039673,niacin
FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,-2.769123609,0.751332161,niacin
RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,-2.763588021,0.628167001,niacin
EXTRACELLULAR_MATRIX_ORGANIZATION,2.905101636,0,staurosporine
TRANSCRIPTION_OF_THE_HIV_GENOME,-1.752514551,1,staurosporine
SENSORY_PERCEPTION,1.320676385,1,staurosporine
ESTROGEN_DEPENDENT_GENE_EXPRESSION,-1.701409467,1,staurosporine
BIOLOGICAL_OXIDATIONS,1.257724277,1,staurosporine
RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,-1.677201756,1,staurosporine
HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,-1.670646848,0.836258604,staurosporine
RAC1_GTPASE_CYCLE,1.202081647,1,staurosporine
EUKARYOTIC_TRANSLATION_ELONGATION,-1.657908396,0.741342635,staurosporine
CDC42_GTPASE_CYCLE,1.194717839,0.840987267,staurosporine
DISEASES_OF_METABOLISM,-3.00691808,0.140185245,rasagiline
RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,-2.972095118,0.090557622,rasagiline
IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1.686214232,0.382962778,rasagiline
MITF_M_DEPENDENT_GENE_EXPRESSION,1.624650527,0.266425181,rasagiline
ION_CHANNEL_TRANSPORT,-2.830450157,1,rasagiline
METABOLISM_OF_CARBOHYDRATES_AND_CARBOHYDRATE_DERIVATIVES,1.368108151,0.668248813,rasagiline
MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1.320759361,0.633837122,rasagiline
PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,-2.784735753,1,rasagiline
MITOCHONDRIAL_PROTEIN_DEGRADATION,1.310755567,0.5335998,rasagiline
SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1.273956358,0.526105421,rasagiline
EUKARYOTIC_TRANSLATION_ELONGATION,-2.612289063,0,topiroxostat
SELENOAMINO_ACID_METABOLISM,-2.502461573,0.000544704,topiroxostat
SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,-2.485619886,0.000363136,topiroxostat
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.485173594,0.000272352,topiroxostat
EUKARYOTIC_TRANSLATION_INITIATION,-2.445069471,0.000435763,topiroxostat
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.409526059,0.000544704,topiroxostat
NONSENSE_MEDIATED_DECAY_NMD,-2.40406788,0.000466889,topiroxostat
TRANSLATION,-2.283101198,0.001089408,topiroxostat
CELLULAR_RESPONSE_TO_STARVATION,-2.274211696,0.001089408,topiroxostat
SARS_COV_1_HOST_INTERACTIONS,-2.216128378,0.002178816,topiroxostat
MUSCLE_CONTRACTION,2.035103603,0.036716418,lomitapide
DEVELOPMENTAL_CELL_LINEAGES,1.818796114,0.067835821,lomitapide
DEVELOPMENTAL_CELL_LINEAGES_OF_THE_EXOCRINE_PANCREAS,1.550820123,0.188208955,lomitapide
EUKARYOTIC_TRANSLATION_INITIATION,-2.672122563,1,lomitapide
EUKARYOTIC_TRANSLATION_ELONGATION,-2.659053508,1,lomitapide
RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,-2.617071218,1,lomitapide
NONSENSE_MEDIATED_DECAY_NMD,-2.594808077,0.712012284,lomitapide
SELENOAMINO_ACID_METABOLISM,-2.598156612,0.887605566,lomitapide
CELLULAR_RESPONSE_TO_STARVATION,-2.585477262,0.596556622,lomitapide
SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,-2.499331384,0.554786948,lomitapide
EXTRACELLULAR_MATRIX_ORGANIZATION,2.14917314,0.012580415,norfloxacin
NEURONAL_SYSTEM,1.809843484,0.040600429,norfloxacin
HEMOSTASIS,1.682607423,0.056802478,norfloxacin
NEUTROPHIL_DEGRANULATION,-2.890171169,0.577780521,norfloxacin
VESICLE_MEDIATED_TRANSPORT,-2.867970407,0.410245649,norfloxacin
INNATE_IMMUNE_SYSTEM,-2.373193485,0.985520306,norfloxacin
SELENOAMINO_ACID_METABOLISM,-1.767263259,0.948827305,norfloxacin
EUKARYOTIC_TRANSLATION_ELONGATION,-1.705851153,0.80631527,norfloxacin
NONSENSE_MEDIATED_DECAY_NMD,-1.684028092,0.690186397,norfloxacin
EUKARYOTIC_TRANSLATION_INITIATION,-1.679471756,0.594963585,norfloxacin
EUKARYOTIC_TRANSLATION_INITIATION,2.271528478,0.051923628,tolcapone
FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2.207928785,0.04874463,tolcapone
SIGNALING_BY_ROBO_RECEPTORS,2.201128345,0.035322196,tolcapone
C_TYPE_LECTIN_RECEPTORS_CLRS,2.201117223,0.026491647,tolcapone
REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,2.159861977,0.031154177,tolcapone
NONSENSE_MEDIATED_DECAY_NMD,2.152437543,0.02702148,tolcapone
SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,2.085443839,0.044505967,tolcapone
SIGNALING_BY_NTRKS,2.078755675,0.040267303,tolcapone
SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,2.068390784,0.038147971,tolcapone
DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,2.046253698,0.040479236,tolcapone
GPCR_LIGAND_BINDING,1.815090538,0.083818296,procaine
NEURONAL_SYSTEM,1.793990389,0.046451748,procaine
VESICLE_MEDIATED_TRANSPORT,-3.021554102,0.736912955,procaine
EXTRACELLULAR_MATRIX_ORGANIZATION,1.667458485,0.062033354,procaine
NEUTROPHIL_DEGRANULATION,-2.963703093,0.704900552,procaine
MITF_M_DEPENDENT_GENE_EXPRESSION,1.486915042,0.111293699,procaine
INNATE_IMMUNE_SYSTEM,-2.586970091,1,procaine
EUKARYOTIC_TRANSLATION_ELONGATION,-2.325203242,1,procaine
EUKARYOTIC_TRANSLATION_INITIATION,-2.278091912,0.839854798,procaine
SELENOAMINO_ACID_METABOLISM,-2.273423191,0.700925156,procaine
